<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Low protein diets for non‐diabetic adults with chronic kidney disease - Hahn, D - 2020 | Cochrane Library</title> <meta content="Low protein diets for non‐diabetic adults with chronic kidney disease - Hahn, D - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001892.pub5/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Low protein diets for non‐diabetic adults with chronic kidney disease - Hahn, D - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001892.pub5/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD001892.pub5" name="dc.identifier" scheme="DOI"/> <meta content="Low protein diets for non‐diabetic adults with chronic kidney disease" name="citation_title"/> <meta content="Deirdre Hahn" name="citation_author"/> <meta content="The Children's Hospital at Westmead" name="citation_author_institution"/> <meta content="Elisabeth M Hodson" name="citation_author"/> <meta content="The Children's Hospital at Westmead" name="citation_author_institution"/> <meta content="Denis Fouque" name="citation_author"/> <meta content="Université de Lyon, UCBL, CARMEN, Centre Hospitalier Lyon Sud" name="citation_author_institution"/> <meta content="denis.fouque@chu-lyon.fr" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="10" name="citation_issue"/> <meta content="10.1002/14651858.CD001892.pub5" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/10/29" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001892.pub5/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001892.pub5/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001892.pub5/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Bias; Cause of Death; Chronic Disease; *Diet, Protein-Restricted; *Disease Progression; Glomerular Filtration Rate; Kidney Failure, Chronic [*diet therapy, mortality, *prevention &amp; control]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001892.pub5&amp;doi=10.1002/14651858.CD001892.pub5&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001892.pub5&amp;doi=10.1002/14651858.CD001892.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001892.pub5&amp;doi=10.1002/14651858.CD001892.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001892.pub5&amp;doi=10.1002/14651858.CD001892.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001892.pub5&amp;doi=10.1002/14651858.CD001892.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001892.pub5&amp;doi=10.1002/14651858.CD001892.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001892.pub5&amp;doi=10.1002/14651858.CD001892.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001892.pub5&amp;doi=10.1002/14651858.CD001892.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001892.pub5&amp;doi=10.1002/14651858.CD001892.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001892.pub5&amp;doi=10.1002/14651858.CD001892.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001892.pub5&amp;doi=10.1002/14651858.CD001892.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001892.pub5&amp;doi=10.1002/14651858.CD001892.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001892.pub5&amp;doi=10.1002/14651858.CD001892.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001892.pub5&amp;doi=10.1002/14651858.CD001892.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001892.pub5&amp;doi=10.1002/14651858.CD001892.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001892.pub5&amp;doi=10.1002/14651858.CD001892.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001892.pub5&amp;doi=10.1002/14651858.CD001892.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001892.pub5&amp;doi=10.1002/14651858.CD001892.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001892.pub5&amp;doi=10.1002/14651858.CD001892.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001892.pub5&amp;doi=10.1002/14651858.CD001892.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001892.pub5&amp;doi=10.1002/14651858.CD001892.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001892.pub5&amp;doi=10.1002/14651858.CD001892.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001892.pub5&amp;doi=10.1002/14651858.CD001892.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="mvgXlmVk";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD001892\x2epub5\x26doi\x3d10\x2e1002\x2f14651858\x2eCD001892\x2epub5\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001892\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001892\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANS","zh_HANT","ru","ms","ja","hr","fa","fr","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD001892.pub5",title:"Low protein diets for non\\u2010diabetic adults with chronic kidney disease",firstPublishedDate:"Oct 29, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Kidney and Transplant Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=mvgXlmVk&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001892.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001892.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD001892.pub5/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD001892.pub5/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001892.pub5%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD001892.PUB5" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD001892.pub5/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD001892.PUB5" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD001892.pub5/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD001892.pub5/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>8720 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD001892.pub5" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001892.pub5/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001892.pub5/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001892.pub5/full#CD001892-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001892.pub5/full#CD001892-sec-0069"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001892.pub5/full#CD001892-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001892.pub5/full#CD001892-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001892.pub5/full#CD001892-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001892.pub5/full#CD001892-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001892.pub5/full#CD001892-sec-0039"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001892.pub5/full#CD001892-sec-0063"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001892.pub5/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001892.pub5/appendices#CD001892-sec-0074"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001892.pub5/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001892.pub5/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/table_n/CD001892StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/table_n/CD001892StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001892.pub5/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001892.pub5/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001892.pub5/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001892.pub5/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001892.pub5/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD001892.pub5/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Low protein diets for non‐diabetic adults with chronic kidney disease</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001892.pub5/information#CD001892-cr-0004">Deirdre Hahn</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001892.pub5/information#CD001892-cr-0005">Elisabeth M Hodson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001892.pub5/information#CD001892-cr-0006"><i class="icon corresponding-author fa fa-envelope"></i>Denis Fouque</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/information/en#CD001892-sec-0080">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 29 October 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD001892.pub5">https://doi.org/10.1002/14651858.CD001892.pub5</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD001892-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001892-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001892-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001892-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD001892-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD001892-abs-0004">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD001892-abs-0001" lang="en"> <section id="CD001892-sec-0001"> <h3 class="title" id="CD001892-sec-0001">Background</h3> <p>Chronic kidney disease (CKD) is defined as reduced function of the kidneys present for 3 months or longer with adverse implications for health and survival. For several decades low protein diets have been proposed for participants with CKD with the aim of slowing the progression to end‐stage kidney disease (ESKD) and delaying the onset of renal replacement therapy. However the relative benefits and harms of dietary protein restriction for preventing progression of CKD have not been resolved. This is an update of a systematic review first published in 2000 and updated in 2006, 2009, and 2018. </p> </section> <section id="CD001892-sec-0002"> <h3 class="title" id="CD001892-sec-0002">Objectives</h3> <p>To determine the efficacy of low protein diets in preventing the natural progression of CKD towards ESKD and in delaying the need for commencing dialysis treatment in non‐diabetic adults. </p> </section> <section id="CD001892-sec-0003"> <h3 class="title" id="CD001892-sec-0003">Search methods</h3> <p>We searched the Cochrane Kidney and Transplant Register of Studies up to 7 September 2020 through contact with the Information Specialist using search terms relevant to this review. Studies in the Register are identified through searches of CENTRAL, MEDLINE, and EMBASE, conference proceedings, the International Clinical Trials Register (ICTRP) Search Portal and ClinicalTrials.gov. </p> </section> <section id="CD001892-sec-0004"> <h3 class="title" id="CD001892-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) or quasi RCTs in which adults with non‐diabetic CKD (stages 3 to 5) not on dialysis were randomised to receive a very low protein intake (0.3 to 0.4 g/kg/day) compared with a low protein intake (0.5 to 0.6 g/kg/day) or a low protein intake compared with a normal protein intake (≥ 0.8 g/kg/day) for 12 months or more. </p> </section> <section id="CD001892-sec-0005"> <h3 class="title" id="CD001892-sec-0005">Data collection and analysis</h3> <p>Two authors independently selected studies and extracted data. For dichotomous outcomes (death, all causes), requirement for dialysis, adverse effects) the risk ratios (RR) with 95% confidence intervals (CI) were calculated and summary statistics estimated using the random effects model. Where continuous scales of measurement were used (glomerular filtration rate (GFR), weight), these data were analysed as the mean difference (MD) or standardised mean difference (SMD) if different scales had been used. The certainty of the evidence was assessed using GRADE. </p> </section> <section id="CD001892-sec-0006"> <h3 class="title" id="CD001892-sec-0006">Main results</h3> <p>We identified 17 studies with 2996 analysed participants (range 19 to 840). Four larger multicentre studies were subdivided according to interventions so that the review included 21 separate data sets. Mean duration of participant follow‐up ranged from 12 to 50 months. </p> <p>Random sequence generation and allocation concealment were considered at low risk of bias in eleven and nine studies respectively. All studies were considered at high risk for performance bias as they were open‐label studies. We assessed detection bias for outcome assessment for GFR and ESKD separately. As GFR measurement was a laboratory outcome all studies were assessed at low risk of detection bias. For ESKD, nine studies were at low risk of detection bias as the need to commence dialysis was determined by personnel independent of the study investigators. Five studies were assessed at high risk of attrition bias with eleven studies at low risk. Ten studies were at high risk for reporting bias as they did not include data which could be included in a meta‐analysis. Eight studies reported funding from government bodies while the remainder did not report on funding. </p> <p>Ten studies compared a low protein diet with a normal protein diet in participants with CKD categories 3a and b (9 studies) or 4 (one study). There was probably little or no difference in the numbers of participants who died (5 studies 1680 participants: RR 0.77, 95% CI 0.51 to 1.18; 13 fewer deaths per 1000; moderate certainty evidence). A low protein diet may make little or no difference in the number of participants who reached ESKD compared with a normal protein diet (6 studies, 1814 participants: RR 1.05, 95% CI 0.73 to 1.53; 7 more per 1000 reached ESKD; low certainty evidence). It remains uncertain whether a low protein diet compared with a normal protein intake impacts on the outcome of final or change in GFR (8 studies, 1680 participants: SMD ‐0.18, 95% CI ‐0.75 to 0.38; very low certainty evidence). </p> <p>Eight studies compared a very low protein diet with a low protein diet and two studies compared a very low protein diet with a normal protein diet. A very low protein intake compared with a low protein intake probably made little or no difference to death (6 studies, 681 participants: RR 1.26, 95% CI 0.62 to 2.54; 10 more deaths per 1000; moderate certainty evidence). However it probably reduces the number who reach ESKD (10 studies, 1010 participants: RR 0.65, 95% CI 0.49 to 0.85; 165 per 1000 fewer reached ESKD; moderate certainty evidence). It remains uncertain whether a very low protein diet compared with a low or normal protein intake influences the final or change in GFR (6 studies, 456 participants: SMD 0.12, 95% CI ‐0.27 to 0.52; very low certainty evidence). </p> <p>Final body weight was reported in only three studies. It is uncertain whether the intervention alters final body weight (3 studies, 89 participants: MD ‐0.40 kg, 95% CI ‐6.33 to 5.52; very low certainty evidence).Twelve studies reported no evidence of protein energy wasting (malnutrition) in their study participants while three studies reported small numbers of participants in each group with protein energy wasting. Most studies reported that adherence to diet was satisfactory. Quality of life was not formally assessed in any studies. </p> </section> <section id="CD001892-sec-0007"> <h3 class="title" id="CD001892-sec-0007">Authors' conclusions</h3> <p>This review found that very low protein diets probably reduce the number of people with CKD 4 or 5, who progress to ESKD. In contrast low protein diets may make little difference to the number of people who progress to ESKD. Low or very low protein diets probably do not influence death. However there are limited data on adverse effects such as weight differences and protein energy wasting. There are no data on whether quality of life is impacted by difficulties in adhering to protein restriction. Studies evaluating the adverse effects and the impact on quality of life of dietary protein restriction are required before these dietary approaches can be recommended for widespread use. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD001892-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001892-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD001892-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD001892-abs-0017">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001892-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD001892-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD001892-abs-0010">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD001892-abs-0009">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD001892-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD001892-abs-0015">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD001892-abs-0007">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD001892-abs-0005">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD001892-abs-0006">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD001892-abs-0002" lang="en"> <h3>Low protein diets for non‐diabetic adults with chronic kidney disease</h3> <p><b>What is the issue?</b> </p> <p>Various forms of kidney disease can lead to kidney failure with affected people ultimately requiring dialysis treatment. A diet low in protein may be recommended to try to slow the progress of kidney disease to kidney failure. We still do not know whether low protein diets can slow the progress of kidney disease and delay the need to start dialysis. </p> <p><b>What did we do?</b> </p> <p>We searched the Cochrane Kidney and Transplant Specialised Register up to 7 September 2020 for randomised controlled trials (RCT), which enrolled non‐diabetic adult patients with chronic kidney disease, not yet requiring dialysis, and which compared different dietary protein intakes, including very low (0.3 to 0.4 g/kg/day), low (0.5 to 0.6 g/kg/day) or normal protein intakes (≥ 0.8 g/kg/day) for 12 months or more. </p> <p><b>What did we find?</b> </p> <p>We examined the evidence from 17 studies (21 data sets) with 2996 people with reduced kidney function. We found that very low protein diets compared with low or normal protein intakes probably reduce the number of people with advanced kidney failure, who progress to dialysis. When low protein diets were compared with normal protein diets, there was little of no difference in the number of people with less severe kidney failure, who progressed to dialysis. Side effects of low protein diets such as weight loss were uncommon but many studies did not report on side effects. </p> <p><b>Conclusions</b> </p> <p>In people with advanced kidney failure, a very low protein intake probably slows the progress to kidney failure. However we need more information on the side effects of low protein diets and on whether quality of life is reduced because of difficulties in keeping to such a diet. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD001892-sec-0069" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD001892-sec-0069"></div> <h3 class="title" id="CD001892-sec-0070">Implications for practice</h3> <section id="CD001892-sec-0070"> <p>Available data from RCTs outlined in this systematic review found that very low protein diets (0.3 to 0.4 g/kg/day with supplements of essential amino acids and keto‐analogues) compared with low or normal protein intakes probably reduce the number of participants with CKD 4 or 5, who progress to ESKD (moderate certainty evidence). Compared with normal protein diets (0.8 to ≥ 1.0 g/kg/day), low protein diets (0.5 to 0.6 g/kg/day) in participants with CKD 3 may make little or no difference to the number progressing to ESKD (low certainty evidence). However there were very limited data available on adverse effects ‐ in particular weight differences and protein energy malnutrition ‐ and on participants' quality of life, which could be affected by difficulties in maintaining dietary adherence. In this systematic review, we found a very small difference in GFR between very low and low protein intakes although the ESKD was lower in the participants receiving a very low protein intake compared with a low protein intake. This suggests that the benefit of protein restriction in participants with advanced CKD is not due to a direct effect on kidney function but via its role in maintaining nutrition and health in participants with CKD, particularly in correcting metabolic acidosis and reducing adverse effects associated with phosphate and sodium retention (<a href="./references#CD001892-bbs2-0072" title="MitchWE , RemuzziG . Diets for patients with chronic kidney disease, should we reconsider?BMC Nephrology2016;17(1):80. [MEDLINE: 27401192]">Mitch 2016</a>; <a href="./references#CD001892-bbs2-0066" title="Kalantar-ZadehK , FouqueD . Nutritional management of chronic kidney disease. New England Journal of Medicine2017;377(18):1765-76. [MEDLINE: 29414270]">Kalantar‐Zadeh 2017</a>). </p> </section> <h3 class="title" id="CD001892-sec-0071">Implications for research</h3> <section id="CD001892-sec-0071"> <p>Additional studies in CKD participants are required to evaluate the effects of nutritional interventions, including reduced protein intake, on slowing the progression to ESKD. These include strategies to control metabolic acidosis, to reduce phosphate retention leading to lower parathyroid hormone levels and less metabolic bone disease and to reduce sodium intake, which would enhance the efficacy of angiotensin‐converting enzyme inhibitors, angiotensin II receptor antagonists or other antiproteinuric medications in slowing the progression to ESKD (<a href="./references#CD001892-bbs2-0072" title="MitchWE , RemuzziG . Diets for patients with chronic kidney disease, should we reconsider?BMC Nephrology2016;17(1):80. [MEDLINE: 27401192]">Mitch 2016</a>; <a href="./references#CD001892-bbs2-0056" title="BellizziV , CupistiA , LocatelliF , BolascoP , BrunoriG , CancariniG , et al. Low-protein diets for chronic kidney disease patients: the Italian experience. BMC Nephrology2016;17(1):77. [MEDLINE: 27401096]">Bellizzi 2016</a>). Further information on the role of the different rates of CKD progression prior to the intervention and of adherence to reduced protein diets on CKD outcome are required to understand the contribution of dietary restrictions to slowing the progression to ESKD. Whether a reduced protein intake, achieved with satisfactory adherence to the diet and without interfering with quality of life, could achieve these outcomes needs to be further evaluated (<a href="./references#CD001892-bbs2-0074" title="PiccoliGB , CapizziI , VigottiFN , LeoneF , D'AlessandroC , GiuffridaD , et al. Low protein diets in patients with chronic kidney disease: a bridge between mainstream and complementary-alternative medicines?BMC Nephrology2016;17(1):76. [MEDLINE: 27391228]">Piccoli 2016</a>). </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD001892-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD001892-sec-0008"></div> <div class="table" id="CD001892-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Low protein diet versus normal protein diet for non‐diabetic adults with chronic kidney disease (CKD)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Low protein diet versus normal protein diet for non‐diabetic adults with CKD</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> non‐diabetic adults with CKD<br/><b>Setting:</b> all settings<br/><b>Intervention:</b> low protein diet<br/><b>Comparison:</b> normal protein diet </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with normal protein diet</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with low protein diet</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Death (all causes)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>55 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>42 per 1,000<br/>(28 to 65) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.77<br/>(0.51 to 1.18) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1680 (5)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ESKD</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>144 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>151 per 1,000<br/>(105 to 220) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.05<br/>(0.73 to 1.53) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1814 (6)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>End or change in GFR</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>The SMD for end or change in GFR was 0.18 lower (0.75 lower to 0.38 higher) with low protein diet compared to normal protein diet </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1680 (8)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>ESKD:</b> end‐stage kidney disease; <b>GFR:</b> glomerular filtration rate; <b>SMD</b> ‐ standardised mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> The confidence intervals include potential for important benefits and harms </p> <p><sup>2</sup> Important and unexplained heterogeneity present </p> <p><sup>3</sup> The outcome reported is a surrogate outcome </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD001892-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Very low protein diet versus low or normal protein diet for non‐diabetic adults with chronic kidney disease (CKD)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Very low protein diet versus low or normal protein diet for non‐diabetic adults with CKD</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> non‐diabetic adults with CKD<br/><b>Setting:</b> all settings<br/><b>Intervention:</b> Very low protein diet<br/><b>Comparison:</b> low or normal protein diet </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with low or normal protein diet</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with very low protein diet</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Death (all causes)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>39 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>49 per 1,000<br/>(24 to 99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.26<br/>(0.62 to 2.54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>681 (6)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ESKD</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>458 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>293 per 1,000<br/>(225 to 389) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.64<br/>(0.49 to 0.85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1010 (10)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>End or change in GFR</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>The SMD for end or change in GFR was 0.12 (0.27 lower to 0.52 higher) with very low protein diet compared to low or normal protein diet </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>456 (6)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2 3 4</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>ESKD:</b> end‐stage kidney disease; <b>GFR:</b> glomerular filtration rate; <b>SMD</b> ‐ standardised mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> The confidence intervals are wide and include potential for important benefits and harms </p> <p><sup>2</sup> Serious unexplained heterogeneity </p> <p><sup>3</sup> Outcome is a surrogate outcome </p> <p><sup>4</sup> Unclear allocation concealment in 4 studies contributing information to analysis </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD001892-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Nutritional measures for non‐diabetic adults with chronic kidney disease (CKD)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Nutritional measures for non‐diabetic adults with CKD</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> non‐diabetic adults with CKD<br/><b>Setting:</b> all settings<br/><b>Intervention:</b> very low of low protein diet<br/><b>Comparison:</b> normal or low protein diet </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with normal or low protein diet</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with very low or low protein diet</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Final body weight: low protein versus normal protein diet</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>The mean final body weight 3.09 kg lower (5.02 to 1.16 lower) with low protein diet compared to normal protein diet </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>223 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Final body weight: very low protein diet versus low protein diet</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>The mean final body weight 1.4 kg higher (3.40 lower to 6.21 higher) with very low protein diet compared to low protein diet </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>291 (4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>3 4</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Protein energy wasting (malnutrition)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>6 per 1,000<br/>(2 to 17) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.31<br/>(0.42 to 4.13) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2373 (15)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Increased risk of bias related to incomplete outcome data and selective reporting </p> <p><sup>2</sup> Small studies and wide confidence intervals and include potential for important benefits and harms </p> <p><sup>3</sup> 3/4 studies are unclear for allocation concealment and random sequence generation </p> <p><sup>4</sup> Serious unexplained heterogeneity </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD001892-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD001892-sec-0009"></div> <section id="CD001892-sec-0010"> <h3 class="title" id="CD001892-sec-0010">Description of the condition</h3> <p>Chronic kidney disease (CKD) is defined as abnormalities of the structure or function of the kidneys present for three months or more with adverse implications for health (<a href="./references#CD001892-bbs2-0068" title="LevinA , StevensPE , BilousRW , CoreshJ , De FranciscoAL , De JongPE , et al. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney international - Supplement2013;3(1):1-150. [EMBASE: 369856107]">KDIGO 2012</a>). It is classified based on the cause, the severity of reduced kidney function as measured by the glomerular filtration rate (GFR) and the severity of albuminuria. <a href="./references#CD001892-bbs2-0068" title="LevinA , StevensPE , BilousRW , CoreshJ , De FranciscoAL , De JongPE , et al. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney international - Supplement2013;3(1):1-150. [EMBASE: 369856107]">KDIGO 2012</a> defined a GFR of less than 60 mL/min/1.73 m<sup>2</sup> as indicating reduced kidney function (normal GFR in young healthy adults is approximately 125 mL/min/1.73 m<sup>2</sup>). CKD is associated with a range of complications leading to adverse health outcomes. Death (all causes) and cardiovascular death increase in individuals with GFR &lt; 60 mL/min/1.73 m<sup>2</sup> (<a href="./references#CD001892-bbs2-0071" title="Chronic Kidney Disease Prognosis Consortium, MatshushitaK , vande VeldeM , AstorBC , WoodwardM , LeveyAS , et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet2010;375(9731):2073-81. [MEDLINE: 20483451]">Matshushita 2010</a>). The rate of deterioration in kidney function is variable and depends on the underlying cause of CKD and is associated among other factors with elevated blood pressure, increasing levels of proteinuria and diabetes mellitus. In many people, though not all, with CKD, kidney function deteriorates progressively with people developing symptoms of uraemia. Eventually people require treatment with haemodialysis or peritoneal dialysis with some receiving kidney transplants. </p> </section> <section id="CD001892-sec-0011"> <h3 class="title" id="CD001892-sec-0011">Description of the intervention</h3> <p>The World Health Organisation (WHO) recommends that healthy adults should receive a daily protein intake of 0.8 g/kg/day. Most healthy adults in developed countries consume a diet with a protein intake exceeding 1 g/kg/day. In CKD with reduced GFR, nephrologists and dietitians have prescribed low (0.5 to 0.6 g/kg/day) or very low (0.3 to 0.4 g/kg/day) high biologic‐value protein diets aiming to reduce the rate at which GFR deteriorates and to alleviate some of the complications of advanced CKD including metabolic acidosis, bone disease and uraemic symptoms and thus delay the onset of end‐stage kidney disease (ESKD), which leads to significant reduction in quality of life. To achieve very low protein intakes, some centres prescribe vegetarian diets (<a href="./references#CD001892-bbs2-0007" title="GarneataL , MircescuG . Effect of low-protein diet supplemented with keto acids on progression of chronic kidney disease. Journal of Renal Nutrition2013;23(3):210-3. [MEDLINE: 23611549]GarneataL , MocanuE , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues-effects on mineral bone metabolism disorders in advanced chronic kidney disease [abstract no: FP396]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i167-8. [EMBASE: 622605156]GarneataL , StancuA , DragomirD , MircescuG . Effect of very low protein diet supplemented with ketoanalogues of the essential amino acids on the progression of chronic kidney disease [abstract]. Nephrology Dialysis Transplantation2014;29(Suppl 3):iii39. [EMBASE: 71491557]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression. Journal of the American Society of Nephrology2016;27(7):2164-76. [MEDLINE: 26823552]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues in stage 5 CKD patients [abstract no: SP373]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i472. [EMBASE: 622606118]">Garneata 2013</a>). Very low protein diets are frequently supplemented with essential amino acids and nitrogen free keto‐analogues of amino acids to reduce the risk of malnutrition. If sufficient calories are ingested, keto‐analogues can be converted to amino acids via urea recycling. Extensive nutritional counselling is required to ensure that participants understand how to maintain a low or very low protein diet with an adequate calorie intake (30 to 35 Kcal/kg ideal body weight/day). Compliance with a reduced protein diet is frequently assessed with measurement of the urinary urea nitrogen in 24‐hour urine collections and calculation of protein intake using the Maroni formula (6.25 X [urinary urea nitrogen x 0.03 body weight in kg]) (<a href="./references#CD001892-bbs2-0070" title="MaroniBJ , SteinmanTI , MitchWE . A method for estimating nitrogen intake of patients with chronic renal failure. Kidney International1985;27(1):58-65. [MEDLINE: 3981873]">Maroni 1985</a>). </p> </section> <section id="CD001892-sec-0012"> <h3 class="title" id="CD001892-sec-0012">How the intervention might work</h3> <p>Experimental studies in rats have shown that loss of nephrons leads to increased glomerular filtration in the remaining nephrons. The compensatory hyperfiltration results from increased plasma flow rates and increasing hydraulic pressure in the remaining nephrons. Eventually these haemodynamic changes lead to increased glomerular permeability with proteinuria and the development of progressive glomerulosclerosis. Long‐term studies in rats have demonstrated that compared with rats with CKD on a high protein diet, rats with CKD on a low protein diet had fewer sclerotic glomeruli and less proteinuria (<a href="./references#CD001892-bbs2-0062" title="HostetterTH , MeyerTW , RennkeHG , BrennerBM . Chronic effects of dietary protein in the rat with intact and reduced renal mass. Kidney International1986;30(4):509-17. [MEDLINE: 3784291]">Hostetter 1986</a>). These experimental data supported the view that protein restriction in people with CKD could protect glomeruli from progressive glomerulosclerosis, slow the deterioration in kidney function and delay the onset of ESKD. In addition, protein restriction reduces uraemic symptoms associated with metabolic acidosis, CKD‐metabolic bone disease, hypertension, and fluid overload which could also delay the onset of ESKD even if the rate of kidney function deterioration measured by GFR does not change (<a href="./references#CD001892-bbs2-0067" title="KasiskeBL , LakatuaJD , MaJZ , LouisTA . A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. American Journal of Kidney Diseases1998;31(6):954-61. [MEDLINE: 9631839]">Kasiske 1998</a>). </p> </section> <section id="CD001892-sec-0013"> <h3 class="title" id="CD001892-sec-0013">Why it is important to do this review</h3> <p>There remains considerable controversy as to whether protein restriction does slow the rate of deterioration in kidney function in people with non‐diabetic CKD with proponents providing data to support or refute the benefit of protein restriction (<a href="./references#CD001892-bbs2-0063" title="JohnsonDW . Dietary protein restriction as a treatment for slowing chronic kidney disease progression: the case against. Nephrology2006;11(1):58-62. [MEDLINE: 16509934]">Johnson 2006</a>; <a href="./references#CD001892-bbs2-0069" title="MandayamS , MitchWE . Dietary protein restriction benefits patients with chronic kidney disease. Nephrology2006;11(1):53-7. [MEDLINE: 16509933]">Mandayam 2006</a>). <a href="./references#CD001892-bbs2-0068" title="LevinA , StevensPE , BilousRW , CoreshJ , De FranciscoAL , De JongPE , et al. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney international - Supplement2013;3(1):1-150. [EMBASE: 369856107]">KDIGO 2012</a> concluded that dietary protein intake &lt; 0.8 g/kg/day did not offer any advantage over 0.8 g/kg/day and suggested that protein restriction to 0.8 g/kg/day be limited to adults with GFR &lt; 30 mL/min/1.73 m<sup>2</sup>. <a href="./references#CD001892-bbs2-0068" title="LevinA , StevensPE , BilousRW , CoreshJ , De FranciscoAL , De JongPE , et al. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney international - Supplement2013;3(1):1-150. [EMBASE: 369856107]">KDIGO 2012</a> also advised that people on any dietary protein restriction required careful monitoring of clinical and biochemical markers to avoid nutritional deficiencies. </p> <p>Most of the clinical studies (both randomised controlled trials (RCTs) and observational studies) were designed to test the efficacy of reducing protein intake on surrogate kidney function outcomes, such as decline in creatinine clearance (CrCl) or changes in the reciprocal of creatinine over time. Unfortunately, changing protein intake modifies creatinine markers because reducing protein intake decreases creatinine production and changes kidney function (glomerular filtration as well as CrCl) by unidentified mechanisms. Although a few studies used methods to measure GFR using non‐creatinine measures such as <sup>51Cr</sup>EDTA clearance and I‐125 Iothalamate clearance, the results from these studies have been conflicting. </p> <p>Two non‐Cochrane systematic reviews (<a href="./references#CD001892-bbs2-0067" title="KasiskeBL , LakatuaJD , MaJZ , LouisTA . A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. American Journal of Kidney Diseases1998;31(6):954-61. [MEDLINE: 9631839]">Kasiske 1998</a>; <a href="./references#CD001892-bbs2-0073" title="PedriniMT , LeveyAS , LauJ , ChalmersTC , WangPH . The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis. Annals of Internal Medicine1996;124(7):627-32. [MEDLINE: 96201235]">Pedrini 1996</a>) have evaluated the efficacy of reduced protein diets. <a href="./references#CD001892-bbs2-0073" title="PedriniMT , LeveyAS , LauJ , ChalmersTC , WangPH . The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis. Annals of Internal Medicine1996;124(7):627-32. [MEDLINE: 96201235]">Pedrini 1996</a> reported that a low‐protein diet significantly reduced the risk of kidney failure or death. In contrast <a href="./references#CD001892-bbs2-0067" title="KasiskeBL , LakatuaJD , MaJZ , LouisTA . A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. American Journal of Kidney Diseases1998;31(6):954-61. [MEDLINE: 9631839]">Kasiske 1998</a> found that dietary protein restriction reduced the rate of decline in estimated GFR by only 0.53 mL/min/year. Because the decision to commence dialysis is not based only on declining GFR but also on the presence of uraemic symptoms and nephrologists vary in their criteria for commencing dialysis, it is quite possible that those on a higher protein intake will have more uraemic symptoms and be considered for dialysis earlier than those on lower protein intakes with an equivalent rate of GFR decline but fewer uraemic symptoms. In this publication we update a Cochrane systematic review first published in 2000 (<a href="./references#CD001892-bbs2-0079" title="FouqueD , WangPH , LavilleM , BoisselJP . Low protein diets for chronic renal failure in non diabetic adults. Cochrane Database of Systematic Reviews2000, Issue 4. Art. No: CD001892. [DOI: 10.1002/14651858.CD001892]">Fouque 2000b</a>) and updated in 2006 (<a href="./references#CD001892-bbs2-0080" title="FouqueD , LavilleM , Boissel J-P. Low protein diets for chronic kidney disease in non diabetic adults. Cochrane Database of Systematic Reviews2006, Issue 1. Art. No: CD001892. [DOI: 10.1002/14651858.CD001892.pub2]">Fouque 2006</a>) and 2009 (<a href="./references#CD001892-bbs2-0081" title="FouqueD , LavilleM . Low protein diets for chronic kidney disease in non diabetic adults. Cochrane Database of Systematic Reviews2009, Issue 2. Art. No: CD001892. [DOI: 10.1002/14651858.CD001892.pub3]">Fouque 2009</a>). The 2009 update (<a href="./references#CD001892-bbs2-0081" title="FouqueD , LavilleM . Low protein diets for chronic kidney disease in non diabetic adults. Cochrane Database of Systematic Reviews2009, Issue 2. Art. No: CD001892. [DOI: 10.1002/14651858.CD001892.pub3]">Fouque 2009</a>) reported the composite outcome of death and ESKD (dialysis initiation or renal transplantation) as the primary outcome. Overall fewer events (deaths, ESKD) were observed with very low or low protein intake compared with those occurring with low or normal protein intake suggesting that a reduced protein intake reduces the number of people who die or reach ESKD. We aimed to determine whether the addition of further RCTs would further clarify whether low or very low protein diets benefit adults with non‐diabetic CKD by delaying the onset of ESKD and/or slowing the rate of GFR decline without adverse effects on nutritional status. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD001892-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD001892-sec-0014"></div> <p>To determine the efficacy of low protein diets in preventing the natural progression of CKD towards ESKD and in delaying the need for commencing dialysis treatment in non‐diabetic adults. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD001892-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD001892-sec-0015"></div> <section id="CD001892-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD001892-sec-0017"> <h4 class="title">Types of studies</h4> <p>We included all randomised controlled trials (RCTs) and quasi‐RCTs (RCTs in which allocation to treatment was obtained by alternation, use of alternate medical records, date of birth or other predictable methods) in which those in the experimental group received a reduced protein intake for 12 months or more while those in the control group received a higher or normal protein intake. Cross‐over studies were to be considered if the starting period of the intervention was randomly allocated and each intervention was in place for at least 12 months. </p> </section> <section id="CD001892-sec-0018"> <h4 class="title">Types of participants</h4> <p> <ul id="CD001892-list-0001"> <li> <p>Adults suffering from moderate to severe CKD, as estimated by either serum creatinine (SCr), CrCl or GFR measurement but excluding participants on peritoneal dialysis, haemodialysis or following a kidney transplant. </p> </li> <li> <p>Because of the difficulty to control for confounding factors, studies of diabetic participants or children with CKD were excluded from the review though studies including small numbers of diabetic participants were included. </p> </li> </ul> </p> </section> <section id="CD001892-sec-0019"> <h4 class="title">Types of interventions</h4> <p> <ul id="CD001892-list-0002"> <li> <p>Studies comparing a normal protein intake (≥ 0.8 g/kg/day) with a low protein intake (0.5 to 0.6 g/kg/day) or very low protein intake (0.3 to 0.4 g/kg/day) for 12 months or more </p> </li> <li> <p>Studies comparing a low protein intake (0.5 to 0.6 g/kg/day) with a very low protein intake (0.3 to 0.4 g/kg/day) for 12 months or more </p> </li> <li> <p>Studies in which participants received supplements of essential amino acids, keto‐analogues or both were included provided that the total nitrogen intake differed between treatment groups. </p> </li> </ul> </p> </section> <section id="CD001892-sec-0020"> <h4 class="title">Types of outcome measures</h4> <section id="CD001892-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD001892-list-0003"> <li> <p>Death (all causes)</p> </li> <li> <p>ESKD as defined by the need to commence dialysis during follow up or to receive a kidney transplant during follow‐up. </p> </li> </ul> </p> </section> <section id="CD001892-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD001892-list-0004"> <li> <p>End of study or change in GFR</p> </li> <li> <p>End of study body weight</p> </li> <li> <p>End of study body mass index (BMI)</p> </li> <li> <p>Development of protein energy wasting (malnutrition) as defined by the study authors</p> </li> <li> <p>Quality of life.</p> </li> </ul> </p> </section> </section> </section> <section id="CD001892-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD001892-sec-0024"> <h4 class="title">Electronic searches</h4> <p>We searched the <a href="http://kidneyandtransplant.cochrane.org/cochrane-kidney-and-transplant-specialised-register" target="_blank">Cochrane Kidney and Transplant Specialised Register</a> up to 7 September 2020 through contact with the Information Specialist using search terms relevant to this review. The Cochrane Kidney and Transplant Specialised Register contains studies identified from several sources. </p> <p> <ol id="CD001892-list-0005"> <li> <p>Monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL)</p> </li> <li> <p>Weekly searches of MEDLINE OVID SP</p> </li> <li> <p>Handsearching of kidney‐related journals and the proceedings of major kidney conferences</p> </li> <li> <p>Searching of the current year of EMBASE OVID SP</p> </li> <li> <p>Weekly current awareness alerts for selected kidney and transplant journals</p> </li> <li> <p>Searches of the International Clinical Trials Register (ICTRP) Search Portal and ClinicalTrials.gov.</p> </li> </ol> </p> <p>Studies contained in the Specialised Register are identified through search strategies for CENTRAL, MEDLINE, and EMBASE based on the scope of Cochrane Kidney and Transplant. Details of these strategies as well as a list of handsearched journals, conference proceedings and current awareness alerts are available in the Specialised Register section of information about <a href="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/RENAL/frame.html" target="_blank">Cochrane Kidney and Transplant</a>. </p> <p>See <a href="./appendices#CD001892-sec-0075">Appendix 1</a> for search terms used in strategies for this review. </p> </section> <section id="CD001892-sec-0025"> <h4 class="title">Searching other resources</h4> <p> <ol id="CD001892-list-0006"> <li> <p>Reference lists of review articles, relevant studies and clinical practice guidelines.</p> </li> <li> <p>Letters seeking information about unpublished or incomplete trials to investigators known to be involved in previous studies. </p> </li> </ol> </p> </section> </section> <section id="CD001892-sec-0026"> <h3 class="title" id="CD001892-sec-0026">Data collection and analysis</h3> <section id="CD001892-sec-0027"> <h4 class="title">Selection of studies</h4> <p>The initial review and updates to 2009 was undertaken by four authors using the search strategy described. The titles and abstracts were screened by two authors, based on the defined inclusion criteria. They discarded studies that were not relevant (i.e. studies of lipid lowering agents) although studies and reviews that could have included relevant data or information on studies was retained initially. Disagreements were resolved by discussion. </p> <p>The 2018 update was undertaken by three authors (DH, EH, DF). Potentially relevant studies were initially determined by two authors from titles and abstracts. Full text articles of potentially eligible articles were reviewed for eligibility by two authors to determine which studies satisfied the inclusion criteria. </p> </section> <section id="CD001892-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>Data extraction and assessment of risk of bias were performed independently by two authors using standardised data extraction forms. Studies in languages other than English were translated before data extraction. Where more than one report of a study was identified, data were extracted from the most complete report but the remaining reports were checked for additional information. Where there were discrepancies between reports, data from the primary source were used. Any further information required from the original authors was requested by written correspondence and any relevant information obtained in this manner was included in the review. Any disagreements were resolved in consultation with the third author. </p> </section> <section id="CD001892-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>The following items were assessed independently by two authors using the risk of bias assessment tool (<a href="./references#CD001892-bbs2-0061" title="HigginsJP , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>) (<a href="./appendices#CD001892-sec-0076">Appendix 2</a>). </p> <p> <ul id="CD001892-list-0007"> <li> <p>Was there adequate sequence generation (selection bias)?</p> </li> <li> <p>Was allocation adequately concealed (selection bias)?</p> </li> <li> <p>Was knowledge of the allocated interventions adequately prevented during the study?</p> <ul id="CD001892-list-0008"> <li> <p>Participants and personnel (performance bias)</p> </li> <li> <p>Outcome assessors (detection bias)</p> </li> </ul> </li> <li> <p>Were incomplete outcome data adequately addressed (attrition bias)?</p> </li> <li> <p>Are reports of the study free of suggestion of selective outcome reporting (reporting bias)? </p> </li> <li> <p>Was the study apparently free of other problems that could put it at a risk of bias?</p> </li> </ul> </p> </section> <section id="CD001892-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous outcomes (death (all causes), requirement for dialysis, adverse effects) the risk ratios (RR) with 95% confidence intervals (CI) for individual studies were calculated and summary statistics estimated using the random effects model. Where continuous scales of measurement were used to assess the effects of treatment (GFR, weight, BMI), these data were analysed as the mean difference (MD) or standardised mean difference (SMD) if different scales had been used. Either final levels or change in levels were included in meta‐analyses of continuous scales of measurement. When both measures were provided in a study, final levels were included. Where standard deviations (SD) for changes in levels or final levels were missing and not available from triallists, these were imputed (<a href="./references#CD001892-bbs2-0061" title="HigginsJP , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). </p> </section> <section id="CD001892-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <p>Data from cross‐over studies were to be included in the meta‐analyses if separate data for the first part of the study were available. No cross‐over studies were identified. </p> </section> <section id="CD001892-sec-0032"> <h4 class="title">Dealing with missing data</h4> <p>We aimed to analyse available data in meta‐analyses using intention‐to‐treat (ITT) data. However, where ITT data were not provided, or additional information could not be obtained from authors, available published data were used in the analyses. </p> </section> <section id="CD001892-sec-0033"> <h4 class="title">Assessment of heterogeneity</h4> <p>We first assessed the heterogeneity by visual inspection of the forest plot. Heterogeneity was then analysed using a Chi<sup>2</sup> test on N‐1 degrees of freedom, with an alpha of 0.05 used for statistical significance and with the I<sup>2</sup> test (<a href="./references#CD001892-bbs2-0060" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ2003;327(7414):557-60. [MEDLINE: 12958120]">Higgins 2003</a>). A guide to the interpretation of I<sup>2</sup> values was as follows. </p> <p> <ul id="CD001892-list-0009"> <li> <p>0% to 40%: might not be important</p> </li> <li> <p>30% to 60%: may represent moderate heterogeneity</p> </li> <li> <p>50% to 90%: may represent substantial heterogeneity</p> </li> <li> <p>75% to 100%: considerable heterogeneity.</p> </li> </ul> </p> <p>The importance of the observed value of I<sup>2</sup> depends on the magnitude and direction of treatment effects and the strength of evidence for heterogeneity (e.g. P‐value from the Chi<sup>2</sup> test, or a confidence interval for I<sup>2</sup>) (<a href="./references#CD001892-bbs2-0061" title="HigginsJP , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). </p> </section> <section id="CD001892-sec-0034"> <h4 class="title">Assessment of reporting biases</h4> <p>The search strategy used aimed to reduce publication bias related to failure to publish negative results. Where there were multiple publications from the same study, the primary publications and additional reports were reviewed to identify all outcomes to reduce the risk of selective outcome reporting bias. </p> </section> <section id="CD001892-sec-0035"> <h4 class="title">Data synthesis</h4> <p>Data were combined using random‐effects model for dichotomous and continuous data.</p> </section> <section id="CD001892-sec-0036"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Subgroup analyses were planned to assess differences in results possibly related to population groups, different ways of measuring decline in GFR and to risk of bias assessment but there were too few studies in each analysis to allow meaningful subgroup analyses. </p> </section> <section id="CD001892-sec-0037"> <h4 class="title">Sensitivity analysis</h4> <p>Where a single study differed considerably from the other studies in the meta‐analysis, this study was temporarily excluded to determine whether its removal altered the results of the meta‐analysis. </p> </section> <section id="CD001892-sec-0038"> <h4 class="title">'Summary of findings' tables</h4> <p>We presented the main results of the review in 'Summary of findings' tables. These tables present key information concerning the quality of the evidence, the magnitude of the effects of the interventions examined, and the sum of the available data for the main outcomes (<a href="./references#CD001892-bbs2-0075" title="SchünemannHJ , OxmanAD , HigginsJP , VistGE , GlasziouP , GuyattGH . Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Schünemann 2011a</a>). The 'Summary of findings' tables also include an overall grading of the evidence related to each of the main outcomes using the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) approach (<a href="./references#CD001892-bbs2-0057" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck-YtterY , Alonso-CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924-6. [MEDLINE: 18436948]">GRADE 2008</a>). The GRADE approach defines the quality of a body of evidence as the extent to which one can be confident that an estimate of effect or association is close to the true quantity of specific interest. The quality of a body of evidence involves consideration of within‐trial risk of bias (methodological quality), directness of evidence, heterogeneity, precision of effect estimates and risk of publication bias (<a href="./references#CD001892-bbs2-0076" title="SchünemannHJ , OxmanAD , HigginsJP , DeeksJJ , GlasziouP , GuyattGH . Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Schünemann 2011b</a>). We presented the following outcomes in the 'Summary of findings' tables. </p> <p> <ul id="CD001892-list-0010"> <li> <p>Death in low protein versus normal protein diet groups</p> </li> <li> <p>ESKD in low protein versus normal protein diet groups</p> </li> <li> <p>End or change in GFR low protein versus normal protein diet</p> </li> <li> <p>Death in very low protein versus higher protein diet groups</p> </li> <li> <p>ESKD in very low versus low protein diet groups</p> </li> <li> <p>End or change in GFR in very low protein diet versus higher protein diet</p> </li> <li> <p>Adverse effects ‐ weight loss in very low protein diet versus higher protein diets.</p> </li> </ul> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD001892-sec-0039" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD001892-sec-0039"></div> <section id="CD001892-sec-0040"> <h3 class="title">Description of studies</h3> <section id="CD001892-sec-0041"> <h4 class="title">Results of the search</h4> <p>The first version of this review included five studies (six reports; 1494 participants) (<a href="./references#CD001892-bbs2-0079" title="FouqueD , WangPH , LavilleM , BoisselJP . Low protein diets for chronic renal failure in non diabetic adults. Cochrane Database of Systematic Reviews2000, Issue 4. Art. No: CD001892. [DOI: 10.1002/14651858.CD001892]">Fouque 2000b</a>). Subsequent updates of the review published in 2006 and 2009 included eight studies (18 reports; 1524 participants) (<a href="./references#CD001892-bbs2-0080" title="FouqueD , LavilleM , Boissel J-P. Low protein diets for chronic kidney disease in non diabetic adults. Cochrane Database of Systematic Reviews2006, Issue 1. Art. No: CD001892. [DOI: 10.1002/14651858.CD001892.pub2]">Fouque 2006</a>) and 10 studies (30 reports; 2000 participants) (<a href="./references#CD001892-bbs2-0081" title="FouqueD , LavilleM . Low protein diets for chronic kidney disease in non diabetic adults. Cochrane Database of Systematic Reviews2009, Issue 2. Art. No: CD001892. [DOI: 10.1002/14651858.CD001892.pub3]">Fouque 2009</a>) respectively. </p> <p>For the 2018 update search (to 2 March 2018) we identified seven new studies with 24 reports (<a href="./references#CD001892-bbs2-0005" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 1 1990</a>; <a href="./references#CD001892-bbs2-0006" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 2 1990</a>; <a href="./references#CD001892-bbs2-0001" title="AlvestrandA , BuchtH , GutierrezA , BergströmJ . Progression of chronic renal failure in man as influenced by frequency and quality of clinical follow-ups [abstract]. Kidney International1985;27(1):240. BergstromJ , AlvestrandA , BuchtH , GutierrezA . Progression of chronic renal failure in man is retarded with more frequent clinical follow-ups and better blood pressure control. Clinical Nephrology1986;25(1):1-6. [MEDLINE: 3955903]BergstromJ , AlvestrandA , BuchtH , GutierrezA . Stockholm clinical study on progression of chronic renal failure--an interim report. Kidney International - Supplement1989;36(Suppl 27):S110-4. [MEDLINE: 2636644]BergstromJ , AlvestrandA , BuchtH , GutierrezA . What is the role of controls in an outpatient department on progression of renal disease?Blood Purification1988;6(6):336-42. [MEDLINE: 3061400]">Bergstrom 1986</a>; <a href="./references#CD001892-bbs2-0007" title="GarneataL , MircescuG . Effect of low-protein diet supplemented with keto acids on progression of chronic kidney disease. Journal of Renal Nutrition2013;23(3):210-3. [MEDLINE: 23611549]GarneataL , MocanuE , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues-effects on mineral bone metabolism disorders in advanced chronic kidney disease [abstract no: FP396]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i167-8. [EMBASE: 622605156]GarneataL , StancuA , DragomirD , MircescuG . Effect of very low protein diet supplemented with ketoanalogues of the essential amino acids on the progression of chronic kidney disease [abstract]. Nephrology Dialysis Transplantation2014;29(Suppl 3):iii39. [EMBASE: 71491557]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression. Journal of the American Society of Nephrology2016;27(7):2164-76. [MEDLINE: 26823552]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues in stage 5 CKD patients [abstract no: SP373]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i472. [EMBASE: 622606118]">Garneata 2013</a>; <a href="./references#CD001892-bbs2-0013" title="CogginsCH , DwyerJT , GreeneT , PetotG , SnetselaarLG , Van LenteF , et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):514-23. [MEDLINE: 8154486]KlahrS , LeveyAS , SandbergAM , WilliamsGW , MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International1989;35(1):195. KoppleJD , BergR , HouserH , SteinmanTI , TeschanP . Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S184-94. [MEDLINE: 2636655]LaidlawSA , BergRL , KoppleJD , NaitoH , WalkerWG , WalserM . Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):504-13. [MEDLINE: 8154485]LeveyAS , BergRL , GassmanJJ , HallPM , WalkerWG . Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S73-80. [MEDLINE: 2636677]LeveyAS , GassmanJJ , HallPM , WalkerWG , MDRD Study Group. Poor correlation of rates of change of creatinine clearance, reciprocal serum creatinine and GFR [abstract]. Kidney International1989;35(1):197. LeveyAS , GassmanJJ , HallPM , WalkerWG . Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. Journal of the American Society of Nephrology1991;1(9):1087-94. [MEDLINE: 1912407]MDRD Study Group, MitchME , SteinmanTI . Objectives and design of the cooperative study, Modification of Diet in Renal Disease [abstract]. Kidney International1987;31(1):210. PerroneR , SteinmanT , RoyalH , LawlorM , HunsickerL , Modification of Diet in Renal Disease Study Group. Markers of GFR: comparison of 99TC-DTPA (TC), 169YB-DTPA (YB) and 125I-Iothalamate (IO) to inulin (IN) [abstract]. Kidney International1987;31(1):213. PerroneRD , SteinmanTI , BeckGJ , SkibinskiCI , RoyalHD , LawlorM , et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1990;16(3):224-35. [MEDLINE: 2205098]TeschanPE , BeckGJ , DwyerJT , GreeneT , KlahrS , LevyAS , et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clinical Nephrology1998;50(5):273-83. [MEDLINE: 9840314]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]">MDRD Feasibility A 1989</a>; <a href="./references#CD001892-bbs2-0014" title="CogginsCH , DwyerJT , GreeneT , PetotG , SnetselaarLG , Van LenteF , et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):514-23. [MEDLINE: 8154486]KlahrS , LeveyAS , SandbergAM , WilliamsGW , MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International1989;35(1):195. KoppleJD , BergR , HouserH , SteinmanTI , TeschanP . Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S184-94. [MEDLINE: 2636655]LaidlawSA , BergRL , KoppleJD , NaitoH , WalkerWG , WalserM . Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):504-13. [MEDLINE: 8154485]LeveyAS , BergRL , GassmanJJ , HallPM , WalkerWG . Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S73-80. [MEDLINE: 2636677]LeveyAS , GassmanJJ , HallPM , WalkerWG , Modification of Diet in Renal Disease Study. Poor correlation of rates of change of creatinine clearance, reciprocal serum creatinine and GFR [abstract]. Kidney International1989;35(1):197. LeveyAS , GassmanJJ , HallPM , WalkerWG . Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. Journal of the American Society of Nephrology1991;1(9):1087-94. [MEDLINE: 1912407]MDRD Study Group, MitchME , SteinmanTI . Objectives and design of the cooperative study, Modification of Diet in Renal Disease [abstract]. Kidney International1987;31(1):210. PerroneR , SteinmanT , RoyalH , LawlorM , HunsickerL , Modification of Diet in Renal Disease Study Group. Markers of GFR: comparison of 99TC-DTPA (TC), 169YB-DTPA (YB) and 125I-Iothalamate (IO) to inulin (IN) [abstract]. Kidney International1987;31(1):213. PerroneRD , SteinmanTI , BeckGJ , SkibinskiCI , RoyalHD , LawlorM , et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1990;16(3):224-35. [MEDLINE: 2205098]TeschanPE , BeckGJ , DwyerJT , GreeneT , KlahrS , LevyAS , et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clinical Nephrology1998;50(5):273-83. [MEDLINE: 9840314]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]">MDRD Feasibility B 1989</a>; <a href="./references#CD001892-bbs2-0015" title="MeloniC , TatangeloP , CiprianiS , RossiV , SuraciC , TozzoC , et al. Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure. Journal of Renal Nutrition2004;14(4):208-13. [MEDLINE: 15483780]">Meloni 2004</a>; <a href="./references#CD001892-bbs2-0016" title="Milovanov IuS, LysenkoLV , MilovanovaLI , DobrosmyslovIA . The role of balanced low-protein diet in inhibition of predialysis chronic kidney disease progression in patients with systemic diseases. Terapevticheskii Arkhiv2009;81(8):52-7. [MEDLINE: 19799201]">Milovanov 2009</a>; <a href="./references#CD001892-bbs2-0020" title="TeplanV , SchuckO , BubenicekP , MengerovaO , TesarovaZ , HajnyJ , et al. The effect of long-term administration of a low-protein diet on the metabolic status and progression of chronic renal failure: a multicentre study [abstract]. Nephrology Dialysis Transplantation1998;13:820. [CENTRAL: CN-00301551] ">Teplan 1998</a>) and 109 additional reports of eight previously included studies. We excluded 34 reports. </p> <p>In a further search to 7 September, 2020, we did not identify any new studies for inclusion but did find four new reports of three included studies (<a href="./references#CD001892-bbs2-0007" title="GarneataL , MircescuG . Effect of low-protein diet supplemented with keto acids on progression of chronic kidney disease. Journal of Renal Nutrition2013;23(3):210-3. [MEDLINE: 23611549]GarneataL , MocanuE , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues-effects on mineral bone metabolism disorders in advanced chronic kidney disease [abstract no: FP396]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i167-8. [EMBASE: 622605156]GarneataL , StancuA , DragomirD , MircescuG . Effect of very low protein diet supplemented with ketoanalogues of the essential amino acids on the progression of chronic kidney disease [abstract]. Nephrology Dialysis Transplantation2014;29(Suppl 3):iii39. [EMBASE: 71491557]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression. Journal of the American Society of Nephrology2016;27(7):2164-76. [MEDLINE: 26823552]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues in stage 5 CKD patients [abstract no: SP373]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i472. [EMBASE: 622606118]">Garneata 2013</a>; <a href="./references#CD001892-bbs2-0011" title="BeckGJ , BergRL , CogginsCH , GassmanJJ , HunsickerLG , SchluchterMD , et al. Design and statistical issues of the Modification of Diet in Renal Disease Trial. The Modification of Diet in Renal Disease Study Group. Controlled Clinical Trials1991;12(5):566-86. [MEDLINE: 1664792]Buckalew VM Jr, BergRL , WangSR , PorushJG , RauchS , SchulmanG . Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. American Journal of Kidney Diseases1996;28(6):811-21. [MEDLINE: 8957032]ChawlaV , WangX , GreeneJ , KusekJW , CollinsAJ , LeveyAS , et al. Dyslipidemia and mortality in chronic kidney disease [abstract no: TH-PO895]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A-2A. ChenJL , LernerD , RuthazerR , Castaneda-SceppaC , LeveyAS . Association of physical activity with mortality in chronic kidney disease. Journal of Nephrology2008;21(2):243-52. [MEDLINE: 18446720]ChenJL , SceppaC , RuthazerR , LeveyAS . Leisure time physical activity status and mortality in chronic kidney disease: preliminary findings from the MDRD study [abstract no: 21]. American Journal of Kidney Diseases2006;47(4):A24. CogginsCH , Breyer LewisJ , CaggiulaAW , CastaldoLS , KlahrS , WangSR . Differences between women and men with chronic renal disease. Nephrology Dialysis Transplantation1998;13(6):1430-7. [MEDLINE: 9641172]CoyneT , OlsonM , BradhamK , GarconM , GregoryP , ScherchL . Dietary satisfaction correlated with adherence in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1301-6. [MEDLINE: 7594127]DennisVW . Decoding the Modification of Diet in Renal Disease Study. Cleveland Clinic Journal of Medicine1994;61(4):254-7. [MEDLINE: 7923742]DolecekTA , OlsonMB , CaggiulaAW , DwyerJT , MilasNC , GillisBP , et al. Registered dietitian time requirements in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1307-12. [MEDLINE: 7594128]Effects of diet and antihypertensive therapy on creatinine clearance and serum creatinine concentration in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Aug;8(8):1354]. Journal of the American Society of Nephrology1996;7(4):556-66. [MEDLINE: 8724889]Effects of dietary protein restriction on the progression of moderate renal disease in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Mar;8(3):493]. Journal of the American Society of Nephrology1996;7(12):2616-26. [MEDLINE: 8989740]GassmanJJ , DrabikMJ , LeathermanJR , FaticaKJ , McPhersonJA , Modification of Diet in Renal Disease Study Group. Development and use of distributed data entry and electronic communication in a multi-center study of progressive renal disease [abstract]. Kidney International1989;35(1):226. GennariFJ , HoodVL , GreeneT , WangX , LeveyAS . Effect of Dietary Protein Intake on Serum Total CO2 Concentration in Chronic Kidney Disease: Modification of Diet in Renal Disease Study Findings. Clinical Journal of the American Society of Nephrology: CJASN2006;1(1):52-7. [MEDLINE: 17699190]GillisBP , AverbachFM , CaggiulaAW , JonesFL , NaujelisJ , MaurerE , et al. Features of the nutrient database and analysis system for the Modification of Diet in Renal Disease Study.[Erratum appears in Control Clin Trials 1994 Aug;15(4):326]. Controlled Clinical Trials1994;15(1):44-58. [MEDLINE: 8149770]GillisBP , CaggiulaAW , ChiavacciAT , CoyneT , DoroshenkoL , MilasNC , et al. Nutrition intervention program of the Modification of Diet in Renal Disease Study: a self-management approach. Journal of the American Dietetic Association1995;95(11):1288-94. [MEDLINE: 7594125]GramsME , CoreshJ , SegevDL , KucirkaLM , TighiouartH , SarnakMJ . Vascular disease, ESRD, and death: interpreting competing risk analyses. Clinical Journal of the American Society of Nephrology: CJASN2012;7(10):1606-14. [MEDLINE: 22859747]GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. GramsME , TinA , RebholzCM , ShafiT , KottgenA , PerroneRD , et al. Metabolomic alterations associated with cause of CKD. Clinical Journal of The American Society of Nephrology: CJASN2017;12(11):1787-94. [MEDLINE: 28971980]GreeneT , BeckG , WangS , KusekJ , LeveyA , Modification of Diet in Renal Disease Study Group. The effect of the low protein diet in the MDRD study A is dependent on the underlying rate of disease progression [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A. GreeneT , BourgoignieJJ , HabweV , KusekJW , SnetselaarLG , SoucieJM , et al. Baseline characteristics in the Modification of Diet in Renal Disease Study.[Republished from J Am Soc Nephrol 1993 May;3(11):1819-34]. Journal of the American Society of Nephrology1993;4(5):1221-36. [MEDLINE: 8305650]HebertLA , GreeneT , HunsickerLG , LeveyAS , WangS , MDRD Study Group. Relationship of urine volume (uv) and urine osmolality (Uosm) to the progression of renal disease in the Modification of Diet in Renal Disease (MDRD) study [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A-6A. HebertLA , KusekJW , GreeneT , AgodoaLY , JonesCA , LeveyAS , et al. Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group. Hypertension1997;30(3 (Pt 1)):428-35. [MEDLINE: 9314428]HunsickerLG , AdlerS , CaggiulaA , EnglandBK , GreeneT , KusekJW , et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney International1997;51(6):1908-19. [MEDLINE: 9186882]HunsickerLG , MDRD Study Group. Secondary analysis of the Modification of Diet in Renal Disease (MDRD) study [abstract]. In: 13th International Congress of Nephrology; 1995 Jul 2-6; Madrid, Spain. 1995:64. IxJH , ShlipakMG , SarnakMJ , BeckGJ , GreeneT , WangX , et al. Fetuin-A is not associated with all-cause or cardiovascular mortality in chronic kidney disease: data from the Modification of Diet in Renal Disease (MDRD) study [abstract no: SU-PO711]. Journal of the American Society of Nephrology2007;18(Abstracts Issue):741A. KlahrS , BreyerJA , BeckGJ , DennisVW , HartmanJA , RothD , et al. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group.[Erratum appears in J Am Soc Nephrol 1995 Oct;6(4):1318]. Journal of the American Society of Nephrology1995;5(12):2037-47. [MEDLINE: 7579052]KlahrS , LeveyAS , BeckGJ , CaggiulaAW , HunsickerL , KusekJW , et al. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. New England Journal of Medicine1994;330(13):877-84. [MEDLINE: 8114857]KlahrS , Modification of Diet in Renal Disease Study. The Modification of Diet in Renal Disease Study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]KlahrS . Primary and secondary results of the modification of diet in renal disease study. Mineral &amp; Electrolyte Metabolism1996;22(1-3):138-42. [MEDLINE: 8676806]KoppleJD , GreeneT , ChumleaWC , HollingerD , MaroniBJ , MerrillD , et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney International2000;57(4):1688-703. [MEDLINE: 10760105]KoppleJD , LeveyAS , GreeneT , ChumleaWC , GassmanJJ , HollingerDL , et al. Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. Kidney International1997;52(3):778-91. [MEDLINE: 9291200]KuE , GliddenDV , JohansenKL , SarnakM , TighiouartH , GrimesB , et al. Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease. Kidney International2015;87(5):1055-60. [MEDLINE: 25493952]KusekJW , CoyneT , deVelascoA , DrabikMJ , FinlayRA , GassmanJJ , et al. Recruitment experience in the full-scale phase of the Modification of Diet in Renal Disease Study. Controlled Clinical Trials1993;14(6):538-57. [MEDLINE: 8119068]KusekJW , CoyneT , deVelascoA , GassmanJ , KieferS , PowersS , et al. Recruitment experience in the full scale phase of the Modification of Diet in Renal Disease (MDRD) Study [abstract]. Controlled Clinical Trials1991;12:678. KwongYT , StevensLA , SelvinE , ZhangYL , GreeneT , Van LenteF , et al. Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. American Journal of Kidney Diseases2010;56(1):39-49. [MEDLINE: 20537455]LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , LeveyAS , MilasNC , et al. Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. Hypertension1997;29(2):641-50. [MEDLINE: 9040451]Leonberg-YooAK , TighiouartH , LeveyAS , BeckGJ , SarnakMJ . Urine potassium excretion, kidney failure, and mortality in CKD. American Journal of Kidney Diseases2017;69(3):341-9. [MEDLINE: 27233381]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , BoschJP , LewisJB , GreeneT , RogersN , RothD , et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of Internal Medicine1999;130(6):461-70. [MEDLINE: 10075613]LeveyAS , CoreshJ , GreeneT , StevensLA , ZhangYL , HendriksenS , et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate.[Erratum appears in Ann Intern Med. 2008 Oct 7;149(7):519]. Annals of Internal Medicine2006;145(4):247-54. [MEDLINE: 16908915]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study Group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]LeveyAS , GreeneT , SarnakM , WangX , BeckGJ , KusekJW , et al. Effect of low protein diet on progression of kidney disease in the Modification of Diet in Renal Disease study A: long-term follow-up [abstract no: SU-PO247]. Journal of the American Society of Nephrology2004;15(Oct):586A-7A. LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2006;48(6):879-88. [MEDLINE: 17162142]LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. The effect of very low protein diet on progression of kidney disease and mortality in Modification of Diet in Renal Disease Study B [abstract no: SU-PO246]. Journal of the American Society of Nephrology2004;15(Oct):586A. LeveyAS , GreeneT , SchluchterMD , ClearyPA , TeschanPE , LorenzRA , et al. Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. Journal of the American Society of Nephrology1993;4(5):1159-71. [MEDLINE: 8305642]MaderoM , SarnakM , WangX , GreeneT , CollinsA , BeckG , et al. Uric acid and development of kidney failure in chronic kidney disease [abstract no: F-PO1932]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):547A. MaderoM , SarnakMJ , WangX , GreeneT , BeckGJ , KusekJW , et al. Uric acid and long-term outcomes in CKD. American Journal of Kidney Diseases2009;53(5):796-803. [MEDLINE: 19303683]MaderoM , SarnakMJ , WangX , SceppaCC , GreeneT , BeckGJ , et al. Body mass index and mortality in CKD. American Journal of Kidney Diseases2007;50(3):404-11. [MEDLINE: 17720519]MaderoM , WangX , GreenT , HunsickerLG , BeckGJ , KusekJW , et al. Effect of trial participation on outcomes in the randomized and non-randomized cohorts of the Modification of Diet in Renal Disease study [abstract no: F-PO037]. Journal of the American Society of Nephrology2006;17(Abstracts):344A. MDRD Study Group, ChumleaWC , GassmanJJ , HollingerDL , MerrillD , ScherchLK , et al. Nutritional response to diet prescription in the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, HunsickerLG , AdlerS , CaggiulaAW , EnglandB , GreeneT , et al. Relationship among baseline proteinuria (p), mean arterial blood pressure (map) during follow-up, and decline in glomerular filtration rate (aGFR) in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, KoppleJD , ChumleaWC , GassmanJJ , HollingerDL , MaroniBJ , et al. Relationship between FGR and nutritional status - results from the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, KusekJW , AgodoaL , GreeneT , JonesC . Comparison of decline of GFR in blacks versus non-blacks in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , BoschJP , CaggiulaAW , GreeneT , et al. Short-term effects of protein intake, blood pressure, and antihypertensive therapy on GFR in the MDRD study. Journal of the American Society of Nephrology1995;6(3):395. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , HunsickerLG , et al. A hypothesis for the results of the Modification of Diet in Renal Disease (MDRD) study. [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , KusekJW , et al. Trends toward a beneficial effect of a low protein diet during additional follow-up in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1994;5(3):336. MDRD Study Group, LeveyAS , BeckGJ . Trends toward a beneficial effect of a low protein diet during additional follow-up in the modification of diet in renal disease study. MDRD Study Group. [abstract]. Nephrology Dialysis Transplantation1995;10(6):985. MDRD Study Group, LeveyAS , BoschJP , CogginsCH , GreeneT , MitchWE , et al. Effects of diet and blood pressure on creatinine clearance (CCr) and serum creatinine (PCr) in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, PetersonJC , BurkartJ , GreeneT , HebertL , KingA , et al. The effect of blood pressure control on progression of renal disease depends on level of proteinuria (p) at baseline evaluation [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, PetersonJC , GreeneT , KlahrS , BurkartJM , HebertL , et al. Effect of reducing proteinuria (PR) on subsequent glomerular filtration rate (GFR) decline in patients with chronic renal failure (CRF) [abstract]. Journal of the American Society of Nephrology1994;5(3):339. MDRD Study Group, PorushJG , LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , et al. Efficacy of anti-hypertensive interventions in reducing blood pressure in the MDRD study [abstract]. Journal of the American Society of Nephrology1995;6(3):400. MDRD Study Group, PowersSN , KurtzmanDA , PetotGJ , RaizmanDJ , WetsteinL . Promoting dietary compliance through computer-assisted education, assessment, and counseling. [abstract]. Kidney International1988;36(Suppl 27):S306. MDRD Study Group, RoccoMV , CoyneT , EastinS , FaubertJ , GassmanJJ , et al. Patient symptoms and quality of life in the MDRD study at enrollment-correlation with GFR [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group. The modification of diet in renal disease study: results from the full-scale trial [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:593. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Hemoglobin A1c and mortality in chronic kidney disease [abstract no: F-FC149]. Journal of the American Society of Nephrology2005;16:71A. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Insulin resistance as a predictor of all-cause and cardiovascular mortality (CVD) in chronic kidney disease (CKD) [abstract no: F-P0284]. Journal of the American Society of Nephrology2004;15(Oct):128A. MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. Journal of the American Society of Nephrology2005;16(11):3411-7. [MEDLINE: 16207824]MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD. American Journal of Kidney Diseases2005;46(3):455-63. [MEDLINE: 16129207]MenonV , GreeneT , WangX , PereiraAA , MarcovinaSM , BeckGJ , et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney International2005;68(2):766-72. [MEDLINE: 16014054]MenonV , GreenT , PereiraA , XueleiW , BeckG , KusekJ , et al. C-reactive protein (CRP) as a predictor of all-cause and cardiovascular (CVD) mortality in patients with chronic kidney disease (CKD) [abstract no: F-P0275]. Journal of the American Society of Nephrology2004;15(Oct):125A-6A. MenonV , KoppleJD , WangX , BeckGJ , CollinsAJ , KusekJW , et al. Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2009;53(2):208-17. [MEDLINE: 18950911]MenonV , LiL , GreeneT , WangX , ChandraP , BalakrishnanV , et al. Adiponectin and outcomes in chronic kidney disease [abstract no: TH-PO430]. Journal of the American Society of Nephrology2006;17(Abstracts):199A. MenonV , LiL , WangX , GreeneT , BalakrishnanV , MaderoM , et al. Adiponectin and mortality in patients with chronic kidney disease. Journal of the American Society of Nephrology2006;17(9):2599-606. [MEDLINE: 16885405]MenonV , SarnakMJ , GreeneT , WangX , PereiraAA , BeckGJ , et al. Relationship between homocysteine and mortality in chronic kidney disease. Circulation2006;113(12):1572-7. [MEDLINE: 16549639]MenonV , ShlipakMG , WangX , CoreshJ , GreeneT , StevensL , et al. Cystatin C as a risk factor for outcomes in chronic kidney disease. Annals of Internal Medicine2007;147(1):19-27. [MEDLINE: 17606957]MenonV , TighiouartH , VaughnNS , BeckGJ , KusekJW , CollinsAJ , et al. Serum bicarbonate and long-term outcomes in CKD. American Journal of Kidney Diseases2010;56(5):907-14. [MEDLINE: 20605301]MenonV , WangX , GreeneT , BeckGJ , KusekJW , MarcovinaSM , et al. Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. American Journal of Kidney Diseases2003;42(1):44-52. [MEDLINE: 12830455]MenonV , WangX , GreeneT , BeckGJ , KusekJW , SelhubJ , et al. Homocysteine in chronic kidney disease: effect of low protein diet and repletion with B vitamins. Kidney International2005;67(4):1539-46. [MEDLINE: 15780109]MenonV , WangX , SarnakMJ , HunsickerLH , MaderoM , BeckGJ , et al. Long-term outcomes in nondiabetic chronic kidney disease. Kidney International2008;73(11):1310-5. [MEDLINE: 18337713]MilasNC , NowalkMP , AkpeleL , CastaldoL , CoyneT , DoroshenkoL , et al. Factors associated with adherence to the dietary protein intervention in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1295-300. [MEDLINE: 7594126]NewsomeB , IxJH , TighiouartH , SarnakMJ , LeveyAS , BeckGJ , et al. Effect of protein restriction on serum and urine phosphate in the modification of diet in renal disease (MDRD) study. American Journal of Kidney Diseases2013;61(6):1045-6. [MEDLINE: 23415016]OlsonM , CoyneT , CaggiulaA , GregoryP . Patient satisfaction with a dietary intervention: the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):107S. OlsonM , CoyneT , CaggiulaA . Social factors influence dietary satisfaction in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1996;17(2 Suppl):133S. OlsonM , DolecekT , CaggiulaA , DwyerJ . Time required for the protein intervention in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):129S-30S. PetersonJC , AdlerS , BurkartJM , GreeneT , HebertLA , HunsickerLG , et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Annals of Internal Medicine1995;123(10):754-62. [MEDLINE: 7574193]PiccoliM , CodognottoM . Missing stratification by polycistic kidney disease (PKD) flaws risk estimates of GFR decline. Lesson from the MDRD Study [abstract no: F-PO175]. Journal of the American Society of Nephrology2004;15(Oct):103A. RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]RoccoMV , GassmanJJ , WangSR , KaplanRM . Cross-sectional study of quality of life and symptoms in chronic renal disease patients: the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1997;29(6):888-96. [MEDLINE: 9186075]SarnakMJ , GreeneT , WangX , BeckG , KusekJW , CollinsAJ , et al. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease study. Annals of Internal Medicine2005;142(5):342-51. [MEDLINE: 15738453]SarnakMJ , WangSR , BeckGJ , KusekJW , SelhubJ , GreeneT , et al. Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression. American Journal of Kidney Diseases2002;40(5):932-9. [MEDLINE: 12407637]SarnakMJ , WangX , GreeneT , GeraldJ , BeckJ , KusekJW , et al. Effect of strict blood pressure control on long-term outcome in the Modification of Diet in Renal Disease (MDRD) study [abstract no: F-P0599]. Journal of the American Society of Nephrology2003;14(Nov):192A. SchluchterMD . Estimating correlation between alternative measures of disease progression in a longitudinal study. Modification of Diet in Renal Disease Study. Statistics in Medicine1990;9(10):1175-88. [MEDLINE: 2247718]Short-term effects of protein intake, blood pressure, and antihypertensive therapy on glomerular filtration rate in the Modification of Diet in Renal Disease Study. Journal of the American Society of Nephrology1996;7(10):2097-109. [MEDLINE: 8915969]StollarC , ScherchL , AdlerS , KusekJ , CaggiulaA . Patterns of patient dietary compliance in the Modification of Diet in Renal Disease (MDRD) study, phase III. [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:609. TangriN , StevensLA , SchmidCH , ZhangYL , BeckGJ , GreeneT , et al. Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney International2011;79(4):471-7. [MEDLINE: 20980977]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]YamamotoME , OlsonMB , StollarC , MDRD Study Group. Effects of weight and Na+ change on blood pressures of hypertensive MDRD study patients [abstract]. Journal of the American Society of Nephrology1995;6(3):408. YoungJA , TerrinN , GreeneT , WangX , BeckG , KusekJ , et al. Asymmetric dimethylarginine and prevalent cardiovascular disease in patients with chronic kidney disease [abstract no: F-PO935]. Journal of the American Society of Nephrology2007;18(Abstracts):308A-9A. YoungJA , TerrinN , WangX , GreenT , BeckG , KusekJ , et al. ADMA and mortality in stage 3-4 chronic kidney disease [abstract no: TH-PO894]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A. ">MDRD 1 1989</a>; <a href="./references#CD001892-bbs2-0012" title="GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. KlahrS . The modification of diet in renal disease study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]">MDRD 2 1989</a>), four new excluded studies (<a href="./references#CD001892-bbs2-0028" title="Di IorioBR , MarzoccoS , BellasiA , De SimoneE , Dal PiazF , RocchettiMT , et al. Nutritional therapy reduces protein carbamylation through urea lowering in chronic kidney disease. Nephrology Dialysis Transplantation2018;33(5):804-13. [MEDLINE: 28992314]">Di Iorio 2018</a>; <a href="./references#CD001892-bbs2-0038" title="KoppleJD , SorensenMK , CoburnJW , GordonS , RubiniME . Controlled comparison of 20-g and 40-g protein diets in the treatment of chronic uremia. American Journal of Clinical Nutrition1968;21(6):553-64. [MEDLINE: 4875254]">Kopple 1968</a>; <a href="./references#CD001892-bbs2-0043" title="MilovanovaL , FominV , MoiseevS , TaranovaM , MilovanovY , LysenkoKL , et al. Effect of essential amino acid ketoanalogues and protein restriction diet on morphogenetic proteins (FGF-23 and Klotho) in 3b-4 stages chronic kidney disease patients: a randomized pilot study. Clinical &amp; Experimental Nephrology2018;22(6):1351-9. [MEDLINE: 29948444]">Milovanova 2018</a>; <a href="./references#CD001892-bbs2-0048" title="SaxenaA , GuptaA , SachanT , PandeyCM . Randomized controlled clinical study to prevent decline in renal function and nutritional status in predialysis patients using ketoanalogue supplementation [abstract no: SA-PO147]. Journal of the American Society of Nephrology2017;28(Abstract Suppl):716. SaxenaA , GuptaA . Randomized, controlled study on supplementation of ketoanalogues in predialysis patients to prevent decline in glomerular filtration rate (GFR) [abstract no: SP405]. Nephrology Dialysis Transplantation2017;32(Suppl 3):iii255-6. [EMBASE: 617289914]SaxenaA , GuptaA . Renal function is preserved during ketoanalogue supplementation but declines after supplementation is withdrawn- a follow-up of randomized clinical trial [abstract no: PUB106]. Journal of the American Society of Nephrology2018;29(Abstract Suppl):1055. ">Saxena 2017</a>) with six reports, and one additional report of an already excluded study (<a href="./references#CD001892-bbs2-0050" title="TeplanV , MareckovaO , VyhnankovaI , ValkovskyI , LopatnikM , RacekJ , et al. Asymmetric dimethylarginine and pentosidin in patients with chronic kidney disease and obesity: a randomized controlled trial [Asymetricky dimethylarginin a pentosidin u nemocnych s chronickym onemocnenim ledvin a obezitou: Randomizovana kontrolovana studie]. Aktuality v Nefrologii2008;14(4):185-90. [EMBASE: 2009017142]TeplanV , RacekJ , SirokaR , StollovaM , HanzalV , Keto Group C . Asymmetric dimethylarginine (ADMA) in chronic renal failure patients with obesity: Czech multicenter study [abstract no: S-PO-0424]. In: 4th World Congress of Nephrology.19th International Congress of the International Society of Nephrology (ISN); 2007 Apr 21-25; Rio de Janeiro, Brazil. 2007:163. TeplanV , SchuckO , HanzalV , HajnyJ , HorackovaM , RybaM , et al. Obesity and progression of chronic renal insufficiency: a Czech long term prospective double-blind randomised multicentre study [Obezita a progrese chronicke renalni insuficience: ceska dlouhodoba prospektivni randomizovana dvojite slepa multicentricka studie]. Vnitrni Lekarstvi2006;52(6):571-6. [MEDLINE: 16871760]TeplanV , SchuckO , RacekJ , MareckovaO , StollovaM , HanzalV , et al. Reduction of plasma asymmetric dimethylarginine in obese patients with chronic kidney disease after three years of a low-protein diet supplemented with keto-amino acids: a randomized controlled trial. Wiener Klinische Wochenschrift2008;120(15-16):478-85. [MEDLINE: 18820852]">Teplan 2006</a>). Therefore 17 studies (21 data sets; 163 reports; 3100 randomised participants, 2996 analysed participants) were included in the update of this review (<a href="#CD001892-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD001892-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD001892-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_n/nCD001892-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> <p>One ongoing study was identified and will be assessed in a future update (<a href="./references#CD001892-bbs2-0055" title="LiX , ChenL . Effects of low protein diet supplemented keto-/amino acid in preventing the progression of chronic kidney disease(CKD)- ELPD study (ELPD-CKD). www.clinicaltrials.gov/ct2/show/NCT01418508 (first received 15 August 2011). ">NCT01418508</a>). However the estimated completion date was December 2014 and no publication of the results has been identified. </p> </section> <section id="CD001892-sec-0042"> <h4 class="title">Included studies</h4> <p>Two previously included studies (<a href="./references#CD001892-bbs2-0011" title="BeckGJ , BergRL , CogginsCH , GassmanJJ , HunsickerLG , SchluchterMD , et al. Design and statistical issues of the Modification of Diet in Renal Disease Trial. The Modification of Diet in Renal Disease Study Group. Controlled Clinical Trials1991;12(5):566-86. [MEDLINE: 1664792]Buckalew VM Jr, BergRL , WangSR , PorushJG , RauchS , SchulmanG . Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. American Journal of Kidney Diseases1996;28(6):811-21. [MEDLINE: 8957032]ChawlaV , WangX , GreeneJ , KusekJW , CollinsAJ , LeveyAS , et al. Dyslipidemia and mortality in chronic kidney disease [abstract no: TH-PO895]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A-2A. ChenJL , LernerD , RuthazerR , Castaneda-SceppaC , LeveyAS . Association of physical activity with mortality in chronic kidney disease. Journal of Nephrology2008;21(2):243-52. [MEDLINE: 18446720]ChenJL , SceppaC , RuthazerR , LeveyAS . Leisure time physical activity status and mortality in chronic kidney disease: preliminary findings from the MDRD study [abstract no: 21]. American Journal of Kidney Diseases2006;47(4):A24. CogginsCH , Breyer LewisJ , CaggiulaAW , CastaldoLS , KlahrS , WangSR . Differences between women and men with chronic renal disease. Nephrology Dialysis Transplantation1998;13(6):1430-7. [MEDLINE: 9641172]CoyneT , OlsonM , BradhamK , GarconM , GregoryP , ScherchL . Dietary satisfaction correlated with adherence in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1301-6. [MEDLINE: 7594127]DennisVW . Decoding the Modification of Diet in Renal Disease Study. Cleveland Clinic Journal of Medicine1994;61(4):254-7. [MEDLINE: 7923742]DolecekTA , OlsonMB , CaggiulaAW , DwyerJT , MilasNC , GillisBP , et al. Registered dietitian time requirements in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1307-12. [MEDLINE: 7594128]Effects of diet and antihypertensive therapy on creatinine clearance and serum creatinine concentration in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Aug;8(8):1354]. Journal of the American Society of Nephrology1996;7(4):556-66. [MEDLINE: 8724889]Effects of dietary protein restriction on the progression of moderate renal disease in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Mar;8(3):493]. Journal of the American Society of Nephrology1996;7(12):2616-26. [MEDLINE: 8989740]GassmanJJ , DrabikMJ , LeathermanJR , FaticaKJ , McPhersonJA , Modification of Diet in Renal Disease Study Group. Development and use of distributed data entry and electronic communication in a multi-center study of progressive renal disease [abstract]. Kidney International1989;35(1):226. GennariFJ , HoodVL , GreeneT , WangX , LeveyAS . Effect of Dietary Protein Intake on Serum Total CO2 Concentration in Chronic Kidney Disease: Modification of Diet in Renal Disease Study Findings. Clinical Journal of the American Society of Nephrology: CJASN2006;1(1):52-7. [MEDLINE: 17699190]GillisBP , AverbachFM , CaggiulaAW , JonesFL , NaujelisJ , MaurerE , et al. Features of the nutrient database and analysis system for the Modification of Diet in Renal Disease Study.[Erratum appears in Control Clin Trials 1994 Aug;15(4):326]. Controlled Clinical Trials1994;15(1):44-58. [MEDLINE: 8149770]GillisBP , CaggiulaAW , ChiavacciAT , CoyneT , DoroshenkoL , MilasNC , et al. Nutrition intervention program of the Modification of Diet in Renal Disease Study: a self-management approach. Journal of the American Dietetic Association1995;95(11):1288-94. [MEDLINE: 7594125]GramsME , CoreshJ , SegevDL , KucirkaLM , TighiouartH , SarnakMJ . Vascular disease, ESRD, and death: interpreting competing risk analyses. Clinical Journal of the American Society of Nephrology: CJASN2012;7(10):1606-14. [MEDLINE: 22859747]GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. GramsME , TinA , RebholzCM , ShafiT , KottgenA , PerroneRD , et al. Metabolomic alterations associated with cause of CKD. Clinical Journal of The American Society of Nephrology: CJASN2017;12(11):1787-94. [MEDLINE: 28971980]GreeneT , BeckG , WangS , KusekJ , LeveyA , Modification of Diet in Renal Disease Study Group. The effect of the low protein diet in the MDRD study A is dependent on the underlying rate of disease progression [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A. GreeneT , BourgoignieJJ , HabweV , KusekJW , SnetselaarLG , SoucieJM , et al. Baseline characteristics in the Modification of Diet in Renal Disease Study.[Republished from J Am Soc Nephrol 1993 May;3(11):1819-34]. Journal of the American Society of Nephrology1993;4(5):1221-36. [MEDLINE: 8305650]HebertLA , GreeneT , HunsickerLG , LeveyAS , WangS , MDRD Study Group. Relationship of urine volume (uv) and urine osmolality (Uosm) to the progression of renal disease in the Modification of Diet in Renal Disease (MDRD) study [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A-6A. HebertLA , KusekJW , GreeneT , AgodoaLY , JonesCA , LeveyAS , et al. Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group. Hypertension1997;30(3 (Pt 1)):428-35. [MEDLINE: 9314428]HunsickerLG , AdlerS , CaggiulaA , EnglandBK , GreeneT , KusekJW , et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney International1997;51(6):1908-19. [MEDLINE: 9186882]HunsickerLG , MDRD Study Group. Secondary analysis of the Modification of Diet in Renal Disease (MDRD) study [abstract]. In: 13th International Congress of Nephrology; 1995 Jul 2-6; Madrid, Spain. 1995:64. IxJH , ShlipakMG , SarnakMJ , BeckGJ , GreeneT , WangX , et al. Fetuin-A is not associated with all-cause or cardiovascular mortality in chronic kidney disease: data from the Modification of Diet in Renal Disease (MDRD) study [abstract no: SU-PO711]. Journal of the American Society of Nephrology2007;18(Abstracts Issue):741A. KlahrS , BreyerJA , BeckGJ , DennisVW , HartmanJA , RothD , et al. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group.[Erratum appears in J Am Soc Nephrol 1995 Oct;6(4):1318]. Journal of the American Society of Nephrology1995;5(12):2037-47. [MEDLINE: 7579052]KlahrS , LeveyAS , BeckGJ , CaggiulaAW , HunsickerL , KusekJW , et al. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. New England Journal of Medicine1994;330(13):877-84. [MEDLINE: 8114857]KlahrS , Modification of Diet in Renal Disease Study. The Modification of Diet in Renal Disease Study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]KlahrS . Primary and secondary results of the modification of diet in renal disease study. Mineral &amp; Electrolyte Metabolism1996;22(1-3):138-42. [MEDLINE: 8676806]KoppleJD , GreeneT , ChumleaWC , HollingerD , MaroniBJ , MerrillD , et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney International2000;57(4):1688-703. [MEDLINE: 10760105]KoppleJD , LeveyAS , GreeneT , ChumleaWC , GassmanJJ , HollingerDL , et al. Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. Kidney International1997;52(3):778-91. [MEDLINE: 9291200]KuE , GliddenDV , JohansenKL , SarnakM , TighiouartH , GrimesB , et al. Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease. Kidney International2015;87(5):1055-60. [MEDLINE: 25493952]KusekJW , CoyneT , deVelascoA , DrabikMJ , FinlayRA , GassmanJJ , et al. Recruitment experience in the full-scale phase of the Modification of Diet in Renal Disease Study. Controlled Clinical Trials1993;14(6):538-57. [MEDLINE: 8119068]KusekJW , CoyneT , deVelascoA , GassmanJ , KieferS , PowersS , et al. Recruitment experience in the full scale phase of the Modification of Diet in Renal Disease (MDRD) Study [abstract]. Controlled Clinical Trials1991;12:678. KwongYT , StevensLA , SelvinE , ZhangYL , GreeneT , Van LenteF , et al. Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. American Journal of Kidney Diseases2010;56(1):39-49. [MEDLINE: 20537455]LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , LeveyAS , MilasNC , et al. Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. Hypertension1997;29(2):641-50. [MEDLINE: 9040451]Leonberg-YooAK , TighiouartH , LeveyAS , BeckGJ , SarnakMJ . Urine potassium excretion, kidney failure, and mortality in CKD. American Journal of Kidney Diseases2017;69(3):341-9. [MEDLINE: 27233381]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , BoschJP , LewisJB , GreeneT , RogersN , RothD , et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of Internal Medicine1999;130(6):461-70. [MEDLINE: 10075613]LeveyAS , CoreshJ , GreeneT , StevensLA , ZhangYL , HendriksenS , et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate.[Erratum appears in Ann Intern Med. 2008 Oct 7;149(7):519]. Annals of Internal Medicine2006;145(4):247-54. [MEDLINE: 16908915]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study Group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]LeveyAS , GreeneT , SarnakM , WangX , BeckGJ , KusekJW , et al. Effect of low protein diet on progression of kidney disease in the Modification of Diet in Renal Disease study A: long-term follow-up [abstract no: SU-PO247]. Journal of the American Society of Nephrology2004;15(Oct):586A-7A. LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2006;48(6):879-88. [MEDLINE: 17162142]LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. The effect of very low protein diet on progression of kidney disease and mortality in Modification of Diet in Renal Disease Study B [abstract no: SU-PO246]. Journal of the American Society of Nephrology2004;15(Oct):586A. LeveyAS , GreeneT , SchluchterMD , ClearyPA , TeschanPE , LorenzRA , et al. Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. Journal of the American Society of Nephrology1993;4(5):1159-71. [MEDLINE: 8305642]MaderoM , SarnakM , WangX , GreeneT , CollinsA , BeckG , et al. Uric acid and development of kidney failure in chronic kidney disease [abstract no: F-PO1932]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):547A. MaderoM , SarnakMJ , WangX , GreeneT , BeckGJ , KusekJW , et al. Uric acid and long-term outcomes in CKD. American Journal of Kidney Diseases2009;53(5):796-803. [MEDLINE: 19303683]MaderoM , SarnakMJ , WangX , SceppaCC , GreeneT , BeckGJ , et al. Body mass index and mortality in CKD. American Journal of Kidney Diseases2007;50(3):404-11. [MEDLINE: 17720519]MaderoM , WangX , GreenT , HunsickerLG , BeckGJ , KusekJW , et al. Effect of trial participation on outcomes in the randomized and non-randomized cohorts of the Modification of Diet in Renal Disease study [abstract no: F-PO037]. Journal of the American Society of Nephrology2006;17(Abstracts):344A. MDRD Study Group, ChumleaWC , GassmanJJ , HollingerDL , MerrillD , ScherchLK , et al. Nutritional response to diet prescription in the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, HunsickerLG , AdlerS , CaggiulaAW , EnglandB , GreeneT , et al. Relationship among baseline proteinuria (p), mean arterial blood pressure (map) during follow-up, and decline in glomerular filtration rate (aGFR) in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, KoppleJD , ChumleaWC , GassmanJJ , HollingerDL , MaroniBJ , et al. Relationship between FGR and nutritional status - results from the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, KusekJW , AgodoaL , GreeneT , JonesC . Comparison of decline of GFR in blacks versus non-blacks in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , BoschJP , CaggiulaAW , GreeneT , et al. Short-term effects of protein intake, blood pressure, and antihypertensive therapy on GFR in the MDRD study. Journal of the American Society of Nephrology1995;6(3):395. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , HunsickerLG , et al. A hypothesis for the results of the Modification of Diet in Renal Disease (MDRD) study. [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , KusekJW , et al. Trends toward a beneficial effect of a low protein diet during additional follow-up in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1994;5(3):336. MDRD Study Group, LeveyAS , BeckGJ . Trends toward a beneficial effect of a low protein diet during additional follow-up in the modification of diet in renal disease study. MDRD Study Group. [abstract]. Nephrology Dialysis Transplantation1995;10(6):985. MDRD Study Group, LeveyAS , BoschJP , CogginsCH , GreeneT , MitchWE , et al. Effects of diet and blood pressure on creatinine clearance (CCr) and serum creatinine (PCr) in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, PetersonJC , BurkartJ , GreeneT , HebertL , KingA , et al. The effect of blood pressure control on progression of renal disease depends on level of proteinuria (p) at baseline evaluation [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, PetersonJC , GreeneT , KlahrS , BurkartJM , HebertL , et al. Effect of reducing proteinuria (PR) on subsequent glomerular filtration rate (GFR) decline in patients with chronic renal failure (CRF) [abstract]. Journal of the American Society of Nephrology1994;5(3):339. MDRD Study Group, PorushJG , LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , et al. Efficacy of anti-hypertensive interventions in reducing blood pressure in the MDRD study [abstract]. Journal of the American Society of Nephrology1995;6(3):400. MDRD Study Group, PowersSN , KurtzmanDA , PetotGJ , RaizmanDJ , WetsteinL . Promoting dietary compliance through computer-assisted education, assessment, and counseling. [abstract]. Kidney International1988;36(Suppl 27):S306. MDRD Study Group, RoccoMV , CoyneT , EastinS , FaubertJ , GassmanJJ , et al. Patient symptoms and quality of life in the MDRD study at enrollment-correlation with GFR [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group. The modification of diet in renal disease study: results from the full-scale trial [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:593. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Hemoglobin A1c and mortality in chronic kidney disease [abstract no: F-FC149]. Journal of the American Society of Nephrology2005;16:71A. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Insulin resistance as a predictor of all-cause and cardiovascular mortality (CVD) in chronic kidney disease (CKD) [abstract no: F-P0284]. Journal of the American Society of Nephrology2004;15(Oct):128A. MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. Journal of the American Society of Nephrology2005;16(11):3411-7. [MEDLINE: 16207824]MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD. American Journal of Kidney Diseases2005;46(3):455-63. [MEDLINE: 16129207]MenonV , GreeneT , WangX , PereiraAA , MarcovinaSM , BeckGJ , et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney International2005;68(2):766-72. [MEDLINE: 16014054]MenonV , GreenT , PereiraA , XueleiW , BeckG , KusekJ , et al. C-reactive protein (CRP) as a predictor of all-cause and cardiovascular (CVD) mortality in patients with chronic kidney disease (CKD) [abstract no: F-P0275]. Journal of the American Society of Nephrology2004;15(Oct):125A-6A. MenonV , KoppleJD , WangX , BeckGJ , CollinsAJ , KusekJW , et al. Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2009;53(2):208-17. [MEDLINE: 18950911]MenonV , LiL , GreeneT , WangX , ChandraP , BalakrishnanV , et al. Adiponectin and outcomes in chronic kidney disease [abstract no: TH-PO430]. Journal of the American Society of Nephrology2006;17(Abstracts):199A. MenonV , LiL , WangX , GreeneT , BalakrishnanV , MaderoM , et al. Adiponectin and mortality in patients with chronic kidney disease. Journal of the American Society of Nephrology2006;17(9):2599-606. [MEDLINE: 16885405]MenonV , SarnakMJ , GreeneT , WangX , PereiraAA , BeckGJ , et al. Relationship between homocysteine and mortality in chronic kidney disease. Circulation2006;113(12):1572-7. [MEDLINE: 16549639]MenonV , ShlipakMG , WangX , CoreshJ , GreeneT , StevensL , et al. Cystatin C as a risk factor for outcomes in chronic kidney disease. Annals of Internal Medicine2007;147(1):19-27. [MEDLINE: 17606957]MenonV , TighiouartH , VaughnNS , BeckGJ , KusekJW , CollinsAJ , et al. Serum bicarbonate and long-term outcomes in CKD. American Journal of Kidney Diseases2010;56(5):907-14. [MEDLINE: 20605301]MenonV , WangX , GreeneT , BeckGJ , KusekJW , MarcovinaSM , et al. Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. American Journal of Kidney Diseases2003;42(1):44-52. [MEDLINE: 12830455]MenonV , WangX , GreeneT , BeckGJ , KusekJW , SelhubJ , et al. Homocysteine in chronic kidney disease: effect of low protein diet and repletion with B vitamins. Kidney International2005;67(4):1539-46. [MEDLINE: 15780109]MenonV , WangX , SarnakMJ , HunsickerLH , MaderoM , BeckGJ , et al. Long-term outcomes in nondiabetic chronic kidney disease. Kidney International2008;73(11):1310-5. [MEDLINE: 18337713]MilasNC , NowalkMP , AkpeleL , CastaldoL , CoyneT , DoroshenkoL , et al. Factors associated with adherence to the dietary protein intervention in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1295-300. [MEDLINE: 7594126]NewsomeB , IxJH , TighiouartH , SarnakMJ , LeveyAS , BeckGJ , et al. Effect of protein restriction on serum and urine phosphate in the modification of diet in renal disease (MDRD) study. American Journal of Kidney Diseases2013;61(6):1045-6. [MEDLINE: 23415016]OlsonM , CoyneT , CaggiulaA , GregoryP . Patient satisfaction with a dietary intervention: the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):107S. OlsonM , CoyneT , CaggiulaA . Social factors influence dietary satisfaction in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1996;17(2 Suppl):133S. OlsonM , DolecekT , CaggiulaA , DwyerJ . Time required for the protein intervention in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):129S-30S. PetersonJC , AdlerS , BurkartJM , GreeneT , HebertLA , HunsickerLG , et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Annals of Internal Medicine1995;123(10):754-62. [MEDLINE: 7574193]PiccoliM , CodognottoM . Missing stratification by polycistic kidney disease (PKD) flaws risk estimates of GFR decline. Lesson from the MDRD Study [abstract no: F-PO175]. Journal of the American Society of Nephrology2004;15(Oct):103A. RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]RoccoMV , GassmanJJ , WangSR , KaplanRM . Cross-sectional study of quality of life and symptoms in chronic renal disease patients: the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1997;29(6):888-96. [MEDLINE: 9186075]SarnakMJ , GreeneT , WangX , BeckG , KusekJW , CollinsAJ , et al. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease study. Annals of Internal Medicine2005;142(5):342-51. [MEDLINE: 15738453]SarnakMJ , WangSR , BeckGJ , KusekJW , SelhubJ , GreeneT , et al. Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression. American Journal of Kidney Diseases2002;40(5):932-9. [MEDLINE: 12407637]SarnakMJ , WangX , GreeneT , GeraldJ , BeckJ , KusekJW , et al. Effect of strict blood pressure control on long-term outcome in the Modification of Diet in Renal Disease (MDRD) study [abstract no: F-P0599]. Journal of the American Society of Nephrology2003;14(Nov):192A. SchluchterMD . Estimating correlation between alternative measures of disease progression in a longitudinal study. Modification of Diet in Renal Disease Study. Statistics in Medicine1990;9(10):1175-88. [MEDLINE: 2247718]Short-term effects of protein intake, blood pressure, and antihypertensive therapy on glomerular filtration rate in the Modification of Diet in Renal Disease Study. Journal of the American Society of Nephrology1996;7(10):2097-109. [MEDLINE: 8915969]StollarC , ScherchL , AdlerS , KusekJ , CaggiulaA . Patterns of patient dietary compliance in the Modification of Diet in Renal Disease (MDRD) study, phase III. [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:609. TangriN , StevensLA , SchmidCH , ZhangYL , BeckGJ , GreeneT , et al. Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney International2011;79(4):471-7. [MEDLINE: 20980977]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]YamamotoME , OlsonMB , StollarC , MDRD Study Group. Effects of weight and Na+ change on blood pressures of hypertensive MDRD study patients [abstract]. Journal of the American Society of Nephrology1995;6(3):408. YoungJA , TerrinN , GreeneT , WangX , BeckG , KusekJ , et al. Asymmetric dimethylarginine and prevalent cardiovascular disease in patients with chronic kidney disease [abstract no: F-PO935]. Journal of the American Society of Nephrology2007;18(Abstracts):308A-9A. YoungJA , TerrinN , WangX , GreenT , BeckG , KusekJ , et al. ADMA and mortality in stage 3-4 chronic kidney disease [abstract no: TH-PO894]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A. ">MDRD 1 1989</a>; <a href="./references#CD001892-bbs2-0012" title="GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. KlahrS . The modification of diet in renal disease study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]">MDRD 2 1989</a>; <a href="./references#CD001892-bbs2-0018" title="BockHA , BrunnerFP . Dietary protein restriction in chronic renal failure. Lancet1985;1(8426):465-6. [MEDLINE: 2857845]DonkerAJ , Piers-BechtTP . Four-years follow-up of patients with chronic renal insufficiency randomly allocated to a protein-restricted diet and a control group [abstract]. Nephrology Dialysis Transplantation1989;4(5):455. DonkerAJ , RosmanJB , Piers-BechtTP , SluiterWJ . Effect of protein restriction in chronic renal insufficiency: a prospective randomized trial [abstract]. Kidney International1985;27:137. RosmanJB , DonkerAJ , MeijerS , SluiterWJ , Piers-BechtTP , van derHemGK . Two years' experience with protein restriction in chronic renal failure. Contributions to Nephrology1986;53:109-20. [MEDLINE: 3542377]RosmanJB , DonkerAJ . The response to a low-protein diet to retard the progression of renal failure is sex-dependent [abstract]. Nephrology Dialysis Transplantation1989;4(5):457. RosmanJB , LangerK , BrandlM , Piers-BechtTP , van derHemGK , ter WeePM , et al. Protein-restricted diets in chronic renal failure: a four year follow-up shows limited indications. Kidney International - Supplement1989;27:S96-S102. [MEDLINE: 2636680]RosmanJB , ter WeePM , MeijerS , Piers-BechtTP , SluiterWJ , DonkerAJ . Prospective randomised trial of early dietary protein restriction in chronic renal failure. Lancet1984;324(8415):1291-6. [MEDLINE: 6150320]RosmanJB , Ter WeePM , Piers-BechtGP , SluiterWJ , van derWoudeF , MeijerS , et al. Early protein restriction in chronic renal failure [abstract]. Kidney International1984;26(4):510. RosmanJB , ter WeePM , Piers-BechtGP , SluiterWJ , van derWoudeFJ , MeijerS , et al. Early protein restriction in chronic renal failure. Proceedings of the European Dialysis &amp; Transplant Association - European Renal Association1985;21:567-73. [MEDLINE: 3887375]RosmanJB , Ter WeePM , SluiterWJ , MeijerS , van derHemGK , DonkerAJ . Four years experience with dietary protein restriction in chronic renal failure [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:28. RosmanJB , ter WeePM . Relationship between proteinuria and response to low protein diets early in chronic renal failure. Blood Purification1989;7(1):52-7. [MEDLINE: 2645924]">Rosman 1 1984</a>; <a href="./references#CD001892-bbs2-0019" title="BockHA , BrunnerFP . Dietary protein restriction in chronic renal failure. Lancet1985;1(8426):465-6. [MEDLINE: 2857845]DonkerAJ , Piers-BechtTP . Four-years follow-up of patients with chronic renal insufficiency randomly allocated to a protein-restricted diet and a control group [abstract]. Nephrology Dialysis Transplantation1989;4(5):455. DonkerAJ , RosmanJB , Piers-BechtTP , SluiterWJ . Effect of protein restriction in chronic renal insufficiency: a prospective randomized trial [abstract]. Kidney International1985;27:137. RosmanJB , DonkerAJ , MeijerS , SluiterWJ , Piers-BechtTP , van derHemGK . Two years' experience with protein restriction in chronic renal failure. Contributions to Nephrology1986;53:109-20. [MEDLINE: 3542377]RosmanJB , DonkerAJ . The response to a low-protein diet to retard the progression of renal failure is sex-dependent [abstract]. Nephrology Dialysis Transplantation1989;4(5):457. RosmanJB , LangerK , BrandlM , Piers-BechtTP , van derHemGK , ter WeePM , et al. Protein-restricted diets in chronic renal failure: a four year follow-up shows limited indications. Kidney International - Supplement1989;27:S96-102. [MEDLINE: 2636680]RosmanJB , ter WeePM , MeijerS , Piers-BechtTP , SluiterWJ , DonkerAJ . Prospective randomised trial of early dietary protein restriction in chronic renal failure. Lancet1984;324(8415):1291-6. [MEDLINE: 6150320]RosmanJB , Ter WeePM , Piers-BechtGP , SluiterWJ , van derWoudeF , MeijerS , et al. Early protein restriction in chronic renal failure [abstract]. Kidney International1984;26(4):510. RosmanJB , ter WeePM , Piers-BechtGP , SluiterWJ , van derWoudeFJ , MeijerS , et al. Early protein restriction in chronic renal failure. Proceedings of the European Dialysis &amp; Transplant Association - European Renal Association1985;21:567-73. [MEDLINE: 3887375]RosmanJB , Ter WeePM , SluiterWJ , MeijerS , van derHemGK , DonkerAJ . Four years experience with dietary protein restriction in chronic renal failure. [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:28. RosmanJB , ter WeePM . Relationship between proteinuria and response to low protein diets early in chronic renal failure. Blood Purification1989;7(1):52-7. [MEDLINE: 2645924]">Rosman 2 1984</a>) and two newly identified studies (<a href="./references#CD001892-bbs2-0005" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 1 1990</a>; <a href="./references#CD001892-bbs2-0006" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 2 1990</a>; <a href="./references#CD001892-bbs2-0013" title="CogginsCH , DwyerJT , GreeneT , PetotG , SnetselaarLG , Van LenteF , et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):514-23. [MEDLINE: 8154486]KlahrS , LeveyAS , SandbergAM , WilliamsGW , MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International1989;35(1):195. KoppleJD , BergR , HouserH , SteinmanTI , TeschanP . Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S184-94. [MEDLINE: 2636655]LaidlawSA , BergRL , KoppleJD , NaitoH , WalkerWG , WalserM . Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):504-13. [MEDLINE: 8154485]LeveyAS , BergRL , GassmanJJ , HallPM , WalkerWG . Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S73-80. [MEDLINE: 2636677]LeveyAS , GassmanJJ , HallPM , WalkerWG , MDRD Study Group. Poor correlation of rates of change of creatinine clearance, reciprocal serum creatinine and GFR [abstract]. Kidney International1989;35(1):197. LeveyAS , GassmanJJ , HallPM , WalkerWG . Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. Journal of the American Society of Nephrology1991;1(9):1087-94. [MEDLINE: 1912407]MDRD Study Group, MitchME , SteinmanTI . Objectives and design of the cooperative study, Modification of Diet in Renal Disease [abstract]. Kidney International1987;31(1):210. PerroneR , SteinmanT , RoyalH , LawlorM , HunsickerL , Modification of Diet in Renal Disease Study Group. Markers of GFR: comparison of 99TC-DTPA (TC), 169YB-DTPA (YB) and 125I-Iothalamate (IO) to inulin (IN) [abstract]. Kidney International1987;31(1):213. PerroneRD , SteinmanTI , BeckGJ , SkibinskiCI , RoyalHD , LawlorM , et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1990;16(3):224-35. [MEDLINE: 2205098]TeschanPE , BeckGJ , DwyerJT , GreeneT , KlahrS , LevyAS , et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clinical Nephrology1998;50(5):273-83. [MEDLINE: 9840314]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]">MDRD Feasibility A 1989</a>; <a href="./references#CD001892-bbs2-0014" title="CogginsCH , DwyerJT , GreeneT , PetotG , SnetselaarLG , Van LenteF , et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):514-23. [MEDLINE: 8154486]KlahrS , LeveyAS , SandbergAM , WilliamsGW , MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International1989;35(1):195. KoppleJD , BergR , HouserH , SteinmanTI , TeschanP . Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S184-94. [MEDLINE: 2636655]LaidlawSA , BergRL , KoppleJD , NaitoH , WalkerWG , WalserM . Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):504-13. [MEDLINE: 8154485]LeveyAS , BergRL , GassmanJJ , HallPM , WalkerWG . Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S73-80. [MEDLINE: 2636677]LeveyAS , GassmanJJ , HallPM , WalkerWG , Modification of Diet in Renal Disease Study. Poor correlation of rates of change of creatinine clearance, reciprocal serum creatinine and GFR [abstract]. Kidney International1989;35(1):197. LeveyAS , GassmanJJ , HallPM , WalkerWG . Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. Journal of the American Society of Nephrology1991;1(9):1087-94. [MEDLINE: 1912407]MDRD Study Group, MitchME , SteinmanTI . Objectives and design of the cooperative study, Modification of Diet in Renal Disease [abstract]. Kidney International1987;31(1):210. PerroneR , SteinmanT , RoyalH , LawlorM , HunsickerL , Modification of Diet in Renal Disease Study Group. Markers of GFR: comparison of 99TC-DTPA (TC), 169YB-DTPA (YB) and 125I-Iothalamate (IO) to inulin (IN) [abstract]. Kidney International1987;31(1):213. PerroneRD , SteinmanTI , BeckGJ , SkibinskiCI , RoyalHD , LawlorM , et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1990;16(3):224-35. [MEDLINE: 2205098]TeschanPE , BeckGJ , DwyerJT , GreeneT , KlahrS , LevyAS , et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clinical Nephrology1998;50(5):273-83. [MEDLINE: 9840314]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]">MDRD Feasibility B 1989</a>) were divided into two studies each because they included two groups of participants with different mean GFRs, who received different protein intakes (low protein intake versus normal protein intake or very low protein intake versus low protein intake). <a href="./references#CD001892-bbs2-0020" title="TeplanV , SchuckO , BubenicekP , MengerovaO , TesarovaZ , HajnyJ , et al. The effect of long-term administration of a low-protein diet on the metabolic status and progression of chronic renal failure: a multicentre study [abstract]. Nephrology Dialysis Transplantation1998;13:820. [CENTRAL: CN-00301551] ">Teplan 1998</a> (published only as an abstract) was a three‐arm study comparing very low (0.4 g/kd/day), low (0.6 g/kg/day) and a restricted diet (0.8 to 1.0 g/kg/day); data could not be extracted and was not included in any of the meta‐analyses. Therefore in this systematic review we considered there to be 21 separate studies. </p> <p>Nine studies (<a href="./references#CD001892-bbs2-0001" title="AlvestrandA , BuchtH , GutierrezA , BergströmJ . Progression of chronic renal failure in man as influenced by frequency and quality of clinical follow-ups [abstract]. Kidney International1985;27(1):240. BergstromJ , AlvestrandA , BuchtH , GutierrezA . Progression of chronic renal failure in man is retarded with more frequent clinical follow-ups and better blood pressure control. Clinical Nephrology1986;25(1):1-6. [MEDLINE: 3955903]BergstromJ , AlvestrandA , BuchtH , GutierrezA . Stockholm clinical study on progression of chronic renal failure--an interim report. Kidney International - Supplement1989;36(Suppl 27):S110-4. [MEDLINE: 2636644]BergstromJ , AlvestrandA , BuchtH , GutierrezA . What is the role of controls in an outpatient department on progression of renal disease?Blood Purification1988;6(6):336-42. [MEDLINE: 3061400]">Bergstrom 1986</a>; <a href="./references#CD001892-bbs2-0005" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 1 1990</a>; <a href="./references#CD001892-bbs2-0009" title="D'AmicoG , GentileMG , FellinG , MannaG , CofanoF . Effect of dietary protein restriction on the progression of renal failure: a prospective randomized trial. Nephrology Dialysis Transplantation1994;9(11):1590-4. [MEDLINE: 7870348]LocatelliF , AlbertiD , GentileMG , GrazianiG , BucciantiG , CosciP , et al. Effects of two different protein prescriptions on chronic renal failure progression. Cooperative study. [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:20. LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA , et al. Blood pressure and chronic renal failure progression: results from a multicentre trial [abstract]. Nephrology Dialysis Transplantation1992;7(7):712. LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA , et al. Factors affecting chronic renal failure progression: results from a multicentre trial. The Northern Italian Cooperative Study Group. Mineral &amp; Electrolyte Metabolism1992;18(2-5):295-302. [MEDLINE: 1465079]LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA . Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group. Lancet1991;337(8753):1299-304. [MEDLINE: 1674294]LocatelliF , Del VecchioL , AndrulliS , MaraiP , TentoriF . The role of underlying nephropathy in the progression of renal disease. Kidney International - Supplement2000;75:S49-55. [MEDLINE: 10828762]LocatelliF , MarcelliD , et al. Factors affecting the progression of chronic renal failure: a multivariate analysis [abstract]. Nephrology Dialysis Transplantation1989;4(5):457. LocatelliF , MarcelliD , TentoriF , MaraiP . Hypertension and progression of chronic renal failure (CRF): a prospective study [abstract]. In: 11th International Congress of Nephrology; 1990 Jul 15-20; Tokyo, Japan. 1990:37A. LocatelliF . Controlled study of protein-restricted diet in chronic renal failure. Contributions to Nephrology1989;75:141-6. [MEDLINE: 2697498]LocatelliF . Dietary compliance in patients with chronic renal failure: experience in a northern Italy trial. Contributions to Nephrology1990;81:102-6. [MEDLINE: 2093485]TentoriF , MaraiP , MarcelliD , PontiR , LocatelliF . Monocentric prospective randomized controlled study on the progression rate of chronic renal failure (CRF) with two different protein intakes [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:20. TentoriF , MaraiP . Monocentric prospective randomised controlled study on the progression rate of chronic renal failure with two different protein intakes [abstract]. Nephrology Dialysis Transplantation1987;2(5):400-1. ">Locatelli 1989</a>; <a href="./references#CD001892-bbs2-0011" title="BeckGJ , BergRL , CogginsCH , GassmanJJ , HunsickerLG , SchluchterMD , et al. Design and statistical issues of the Modification of Diet in Renal Disease Trial. The Modification of Diet in Renal Disease Study Group. Controlled Clinical Trials1991;12(5):566-86. [MEDLINE: 1664792]Buckalew VM Jr, BergRL , WangSR , PorushJG , RauchS , SchulmanG . Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. American Journal of Kidney Diseases1996;28(6):811-21. [MEDLINE: 8957032]ChawlaV , WangX , GreeneJ , KusekJW , CollinsAJ , LeveyAS , et al. Dyslipidemia and mortality in chronic kidney disease [abstract no: TH-PO895]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A-2A. ChenJL , LernerD , RuthazerR , Castaneda-SceppaC , LeveyAS . Association of physical activity with mortality in chronic kidney disease. Journal of Nephrology2008;21(2):243-52. [MEDLINE: 18446720]ChenJL , SceppaC , RuthazerR , LeveyAS . Leisure time physical activity status and mortality in chronic kidney disease: preliminary findings from the MDRD study [abstract no: 21]. American Journal of Kidney Diseases2006;47(4):A24. CogginsCH , Breyer LewisJ , CaggiulaAW , CastaldoLS , KlahrS , WangSR . Differences between women and men with chronic renal disease. Nephrology Dialysis Transplantation1998;13(6):1430-7. [MEDLINE: 9641172]CoyneT , OlsonM , BradhamK , GarconM , GregoryP , ScherchL . Dietary satisfaction correlated with adherence in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1301-6. [MEDLINE: 7594127]DennisVW . Decoding the Modification of Diet in Renal Disease Study. Cleveland Clinic Journal of Medicine1994;61(4):254-7. [MEDLINE: 7923742]DolecekTA , OlsonMB , CaggiulaAW , DwyerJT , MilasNC , GillisBP , et al. Registered dietitian time requirements in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1307-12. [MEDLINE: 7594128]Effects of diet and antihypertensive therapy on creatinine clearance and serum creatinine concentration in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Aug;8(8):1354]. Journal of the American Society of Nephrology1996;7(4):556-66. [MEDLINE: 8724889]Effects of dietary protein restriction on the progression of moderate renal disease in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Mar;8(3):493]. Journal of the American Society of Nephrology1996;7(12):2616-26. [MEDLINE: 8989740]GassmanJJ , DrabikMJ , LeathermanJR , FaticaKJ , McPhersonJA , Modification of Diet in Renal Disease Study Group. Development and use of distributed data entry and electronic communication in a multi-center study of progressive renal disease [abstract]. Kidney International1989;35(1):226. GennariFJ , HoodVL , GreeneT , WangX , LeveyAS . Effect of Dietary Protein Intake on Serum Total CO2 Concentration in Chronic Kidney Disease: Modification of Diet in Renal Disease Study Findings. Clinical Journal of the American Society of Nephrology: CJASN2006;1(1):52-7. [MEDLINE: 17699190]GillisBP , AverbachFM , CaggiulaAW , JonesFL , NaujelisJ , MaurerE , et al. Features of the nutrient database and analysis system for the Modification of Diet in Renal Disease Study.[Erratum appears in Control Clin Trials 1994 Aug;15(4):326]. Controlled Clinical Trials1994;15(1):44-58. [MEDLINE: 8149770]GillisBP , CaggiulaAW , ChiavacciAT , CoyneT , DoroshenkoL , MilasNC , et al. Nutrition intervention program of the Modification of Diet in Renal Disease Study: a self-management approach. Journal of the American Dietetic Association1995;95(11):1288-94. [MEDLINE: 7594125]GramsME , CoreshJ , SegevDL , KucirkaLM , TighiouartH , SarnakMJ . Vascular disease, ESRD, and death: interpreting competing risk analyses. Clinical Journal of the American Society of Nephrology: CJASN2012;7(10):1606-14. [MEDLINE: 22859747]GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. GramsME , TinA , RebholzCM , ShafiT , KottgenA , PerroneRD , et al. Metabolomic alterations associated with cause of CKD. Clinical Journal of The American Society of Nephrology: CJASN2017;12(11):1787-94. [MEDLINE: 28971980]GreeneT , BeckG , WangS , KusekJ , LeveyA , Modification of Diet in Renal Disease Study Group. The effect of the low protein diet in the MDRD study A is dependent on the underlying rate of disease progression [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A. GreeneT , BourgoignieJJ , HabweV , KusekJW , SnetselaarLG , SoucieJM , et al. Baseline characteristics in the Modification of Diet in Renal Disease Study.[Republished from J Am Soc Nephrol 1993 May;3(11):1819-34]. Journal of the American Society of Nephrology1993;4(5):1221-36. [MEDLINE: 8305650]HebertLA , GreeneT , HunsickerLG , LeveyAS , WangS , MDRD Study Group. Relationship of urine volume (uv) and urine osmolality (Uosm) to the progression of renal disease in the Modification of Diet in Renal Disease (MDRD) study [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A-6A. HebertLA , KusekJW , GreeneT , AgodoaLY , JonesCA , LeveyAS , et al. Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group. Hypertension1997;30(3 (Pt 1)):428-35. [MEDLINE: 9314428]HunsickerLG , AdlerS , CaggiulaA , EnglandBK , GreeneT , KusekJW , et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney International1997;51(6):1908-19. [MEDLINE: 9186882]HunsickerLG , MDRD Study Group. Secondary analysis of the Modification of Diet in Renal Disease (MDRD) study [abstract]. In: 13th International Congress of Nephrology; 1995 Jul 2-6; Madrid, Spain. 1995:64. IxJH , ShlipakMG , SarnakMJ , BeckGJ , GreeneT , WangX , et al. Fetuin-A is not associated with all-cause or cardiovascular mortality in chronic kidney disease: data from the Modification of Diet in Renal Disease (MDRD) study [abstract no: SU-PO711]. Journal of the American Society of Nephrology2007;18(Abstracts Issue):741A. KlahrS , BreyerJA , BeckGJ , DennisVW , HartmanJA , RothD , et al. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group.[Erratum appears in J Am Soc Nephrol 1995 Oct;6(4):1318]. Journal of the American Society of Nephrology1995;5(12):2037-47. [MEDLINE: 7579052]KlahrS , LeveyAS , BeckGJ , CaggiulaAW , HunsickerL , KusekJW , et al. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. New England Journal of Medicine1994;330(13):877-84. [MEDLINE: 8114857]KlahrS , Modification of Diet in Renal Disease Study. The Modification of Diet in Renal Disease Study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]KlahrS . Primary and secondary results of the modification of diet in renal disease study. Mineral &amp; Electrolyte Metabolism1996;22(1-3):138-42. [MEDLINE: 8676806]KoppleJD , GreeneT , ChumleaWC , HollingerD , MaroniBJ , MerrillD , et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney International2000;57(4):1688-703. [MEDLINE: 10760105]KoppleJD , LeveyAS , GreeneT , ChumleaWC , GassmanJJ , HollingerDL , et al. Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. Kidney International1997;52(3):778-91. [MEDLINE: 9291200]KuE , GliddenDV , JohansenKL , SarnakM , TighiouartH , GrimesB , et al. Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease. Kidney International2015;87(5):1055-60. [MEDLINE: 25493952]KusekJW , CoyneT , deVelascoA , DrabikMJ , FinlayRA , GassmanJJ , et al. Recruitment experience in the full-scale phase of the Modification of Diet in Renal Disease Study. Controlled Clinical Trials1993;14(6):538-57. [MEDLINE: 8119068]KusekJW , CoyneT , deVelascoA , GassmanJ , KieferS , PowersS , et al. Recruitment experience in the full scale phase of the Modification of Diet in Renal Disease (MDRD) Study [abstract]. Controlled Clinical Trials1991;12:678. KwongYT , StevensLA , SelvinE , ZhangYL , GreeneT , Van LenteF , et al. Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. American Journal of Kidney Diseases2010;56(1):39-49. [MEDLINE: 20537455]LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , LeveyAS , MilasNC , et al. Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. Hypertension1997;29(2):641-50. [MEDLINE: 9040451]Leonberg-YooAK , TighiouartH , LeveyAS , BeckGJ , SarnakMJ . Urine potassium excretion, kidney failure, and mortality in CKD. American Journal of Kidney Diseases2017;69(3):341-9. [MEDLINE: 27233381]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , BoschJP , LewisJB , GreeneT , RogersN , RothD , et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of Internal Medicine1999;130(6):461-70. [MEDLINE: 10075613]LeveyAS , CoreshJ , GreeneT , StevensLA , ZhangYL , HendriksenS , et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate.[Erratum appears in Ann Intern Med. 2008 Oct 7;149(7):519]. Annals of Internal Medicine2006;145(4):247-54. [MEDLINE: 16908915]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study Group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]LeveyAS , GreeneT , SarnakM , WangX , BeckGJ , KusekJW , et al. Effect of low protein diet on progression of kidney disease in the Modification of Diet in Renal Disease study A: long-term follow-up [abstract no: SU-PO247]. Journal of the American Society of Nephrology2004;15(Oct):586A-7A. LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2006;48(6):879-88. [MEDLINE: 17162142]LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. The effect of very low protein diet on progression of kidney disease and mortality in Modification of Diet in Renal Disease Study B [abstract no: SU-PO246]. Journal of the American Society of Nephrology2004;15(Oct):586A. LeveyAS , GreeneT , SchluchterMD , ClearyPA , TeschanPE , LorenzRA , et al. Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. Journal of the American Society of Nephrology1993;4(5):1159-71. [MEDLINE: 8305642]MaderoM , SarnakM , WangX , GreeneT , CollinsA , BeckG , et al. Uric acid and development of kidney failure in chronic kidney disease [abstract no: F-PO1932]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):547A. MaderoM , SarnakMJ , WangX , GreeneT , BeckGJ , KusekJW , et al. Uric acid and long-term outcomes in CKD. American Journal of Kidney Diseases2009;53(5):796-803. [MEDLINE: 19303683]MaderoM , SarnakMJ , WangX , SceppaCC , GreeneT , BeckGJ , et al. Body mass index and mortality in CKD. American Journal of Kidney Diseases2007;50(3):404-11. [MEDLINE: 17720519]MaderoM , WangX , GreenT , HunsickerLG , BeckGJ , KusekJW , et al. Effect of trial participation on outcomes in the randomized and non-randomized cohorts of the Modification of Diet in Renal Disease study [abstract no: F-PO037]. Journal of the American Society of Nephrology2006;17(Abstracts):344A. MDRD Study Group, ChumleaWC , GassmanJJ , HollingerDL , MerrillD , ScherchLK , et al. Nutritional response to diet prescription in the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, HunsickerLG , AdlerS , CaggiulaAW , EnglandB , GreeneT , et al. Relationship among baseline proteinuria (p), mean arterial blood pressure (map) during follow-up, and decline in glomerular filtration rate (aGFR) in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, KoppleJD , ChumleaWC , GassmanJJ , HollingerDL , MaroniBJ , et al. Relationship between FGR and nutritional status - results from the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, KusekJW , AgodoaL , GreeneT , JonesC . Comparison of decline of GFR in blacks versus non-blacks in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , BoschJP , CaggiulaAW , GreeneT , et al. Short-term effects of protein intake, blood pressure, and antihypertensive therapy on GFR in the MDRD study. Journal of the American Society of Nephrology1995;6(3):395. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , HunsickerLG , et al. A hypothesis for the results of the Modification of Diet in Renal Disease (MDRD) study. [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , KusekJW , et al. Trends toward a beneficial effect of a low protein diet during additional follow-up in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1994;5(3):336. MDRD Study Group, LeveyAS , BeckGJ . Trends toward a beneficial effect of a low protein diet during additional follow-up in the modification of diet in renal disease study. MDRD Study Group. [abstract]. Nephrology Dialysis Transplantation1995;10(6):985. MDRD Study Group, LeveyAS , BoschJP , CogginsCH , GreeneT , MitchWE , et al. Effects of diet and blood pressure on creatinine clearance (CCr) and serum creatinine (PCr) in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, PetersonJC , BurkartJ , GreeneT , HebertL , KingA , et al. The effect of blood pressure control on progression of renal disease depends on level of proteinuria (p) at baseline evaluation [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, PetersonJC , GreeneT , KlahrS , BurkartJM , HebertL , et al. Effect of reducing proteinuria (PR) on subsequent glomerular filtration rate (GFR) decline in patients with chronic renal failure (CRF) [abstract]. Journal of the American Society of Nephrology1994;5(3):339. MDRD Study Group, PorushJG , LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , et al. Efficacy of anti-hypertensive interventions in reducing blood pressure in the MDRD study [abstract]. Journal of the American Society of Nephrology1995;6(3):400. MDRD Study Group, PowersSN , KurtzmanDA , PetotGJ , RaizmanDJ , WetsteinL . Promoting dietary compliance through computer-assisted education, assessment, and counseling. [abstract]. Kidney International1988;36(Suppl 27):S306. MDRD Study Group, RoccoMV , CoyneT , EastinS , FaubertJ , GassmanJJ , et al. Patient symptoms and quality of life in the MDRD study at enrollment-correlation with GFR [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group. The modification of diet in renal disease study: results from the full-scale trial [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:593. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Hemoglobin A1c and mortality in chronic kidney disease [abstract no: F-FC149]. Journal of the American Society of Nephrology2005;16:71A. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Insulin resistance as a predictor of all-cause and cardiovascular mortality (CVD) in chronic kidney disease (CKD) [abstract no: F-P0284]. Journal of the American Society of Nephrology2004;15(Oct):128A. MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. Journal of the American Society of Nephrology2005;16(11):3411-7. [MEDLINE: 16207824]MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD. American Journal of Kidney Diseases2005;46(3):455-63. [MEDLINE: 16129207]MenonV , GreeneT , WangX , PereiraAA , MarcovinaSM , BeckGJ , et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney International2005;68(2):766-72. [MEDLINE: 16014054]MenonV , GreenT , PereiraA , XueleiW , BeckG , KusekJ , et al. C-reactive protein (CRP) as a predictor of all-cause and cardiovascular (CVD) mortality in patients with chronic kidney disease (CKD) [abstract no: F-P0275]. Journal of the American Society of Nephrology2004;15(Oct):125A-6A. MenonV , KoppleJD , WangX , BeckGJ , CollinsAJ , KusekJW , et al. Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2009;53(2):208-17. [MEDLINE: 18950911]MenonV , LiL , GreeneT , WangX , ChandraP , BalakrishnanV , et al. Adiponectin and outcomes in chronic kidney disease [abstract no: TH-PO430]. Journal of the American Society of Nephrology2006;17(Abstracts):199A. MenonV , LiL , WangX , GreeneT , BalakrishnanV , MaderoM , et al. Adiponectin and mortality in patients with chronic kidney disease. Journal of the American Society of Nephrology2006;17(9):2599-606. [MEDLINE: 16885405]MenonV , SarnakMJ , GreeneT , WangX , PereiraAA , BeckGJ , et al. Relationship between homocysteine and mortality in chronic kidney disease. Circulation2006;113(12):1572-7. [MEDLINE: 16549639]MenonV , ShlipakMG , WangX , CoreshJ , GreeneT , StevensL , et al. Cystatin C as a risk factor for outcomes in chronic kidney disease. Annals of Internal Medicine2007;147(1):19-27. [MEDLINE: 17606957]MenonV , TighiouartH , VaughnNS , BeckGJ , KusekJW , CollinsAJ , et al. Serum bicarbonate and long-term outcomes in CKD. American Journal of Kidney Diseases2010;56(5):907-14. [MEDLINE: 20605301]MenonV , WangX , GreeneT , BeckGJ , KusekJW , MarcovinaSM , et al. Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. American Journal of Kidney Diseases2003;42(1):44-52. [MEDLINE: 12830455]MenonV , WangX , GreeneT , BeckGJ , KusekJW , SelhubJ , et al. Homocysteine in chronic kidney disease: effect of low protein diet and repletion with B vitamins. Kidney International2005;67(4):1539-46. [MEDLINE: 15780109]MenonV , WangX , SarnakMJ , HunsickerLH , MaderoM , BeckGJ , et al. Long-term outcomes in nondiabetic chronic kidney disease. Kidney International2008;73(11):1310-5. [MEDLINE: 18337713]MilasNC , NowalkMP , AkpeleL , CastaldoL , CoyneT , DoroshenkoL , et al. Factors associated with adherence to the dietary protein intervention in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1295-300. [MEDLINE: 7594126]NewsomeB , IxJH , TighiouartH , SarnakMJ , LeveyAS , BeckGJ , et al. Effect of protein restriction on serum and urine phosphate in the modification of diet in renal disease (MDRD) study. American Journal of Kidney Diseases2013;61(6):1045-6. [MEDLINE: 23415016]OlsonM , CoyneT , CaggiulaA , GregoryP . Patient satisfaction with a dietary intervention: the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):107S. OlsonM , CoyneT , CaggiulaA . Social factors influence dietary satisfaction in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1996;17(2 Suppl):133S. OlsonM , DolecekT , CaggiulaA , DwyerJ . Time required for the protein intervention in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):129S-30S. PetersonJC , AdlerS , BurkartJM , GreeneT , HebertLA , HunsickerLG , et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Annals of Internal Medicine1995;123(10):754-62. [MEDLINE: 7574193]PiccoliM , CodognottoM . Missing stratification by polycistic kidney disease (PKD) flaws risk estimates of GFR decline. Lesson from the MDRD Study [abstract no: F-PO175]. Journal of the American Society of Nephrology2004;15(Oct):103A. RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]RoccoMV , GassmanJJ , WangSR , KaplanRM . Cross-sectional study of quality of life and symptoms in chronic renal disease patients: the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1997;29(6):888-96. [MEDLINE: 9186075]SarnakMJ , GreeneT , WangX , BeckG , KusekJW , CollinsAJ , et al. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease study. Annals of Internal Medicine2005;142(5):342-51. [MEDLINE: 15738453]SarnakMJ , WangSR , BeckGJ , KusekJW , SelhubJ , GreeneT , et al. Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression. American Journal of Kidney Diseases2002;40(5):932-9. [MEDLINE: 12407637]SarnakMJ , WangX , GreeneT , GeraldJ , BeckJ , KusekJW , et al. Effect of strict blood pressure control on long-term outcome in the Modification of Diet in Renal Disease (MDRD) study [abstract no: F-P0599]. Journal of the American Society of Nephrology2003;14(Nov):192A. SchluchterMD . Estimating correlation between alternative measures of disease progression in a longitudinal study. Modification of Diet in Renal Disease Study. Statistics in Medicine1990;9(10):1175-88. [MEDLINE: 2247718]Short-term effects of protein intake, blood pressure, and antihypertensive therapy on glomerular filtration rate in the Modification of Diet in Renal Disease Study. Journal of the American Society of Nephrology1996;7(10):2097-109. [MEDLINE: 8915969]StollarC , ScherchL , AdlerS , KusekJ , CaggiulaA . Patterns of patient dietary compliance in the Modification of Diet in Renal Disease (MDRD) study, phase III. [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:609. TangriN , StevensLA , SchmidCH , ZhangYL , BeckGJ , GreeneT , et al. Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney International2011;79(4):471-7. [MEDLINE: 20980977]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]YamamotoME , OlsonMB , StollarC , MDRD Study Group. Effects of weight and Na+ change on blood pressures of hypertensive MDRD study patients [abstract]. Journal of the American Society of Nephrology1995;6(3):408. YoungJA , TerrinN , GreeneT , WangX , BeckG , KusekJ , et al. Asymmetric dimethylarginine and prevalent cardiovascular disease in patients with chronic kidney disease [abstract no: F-PO935]. Journal of the American Society of Nephrology2007;18(Abstracts):308A-9A. YoungJA , TerrinN , WangX , GreenT , BeckG , KusekJ , et al. ADMA and mortality in stage 3-4 chronic kidney disease [abstract no: TH-PO894]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A. ">MDRD 1 1989</a>; <a href="./references#CD001892-bbs2-0013" title="CogginsCH , DwyerJT , GreeneT , PetotG , SnetselaarLG , Van LenteF , et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):514-23. [MEDLINE: 8154486]KlahrS , LeveyAS , SandbergAM , WilliamsGW , MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International1989;35(1):195. KoppleJD , BergR , HouserH , SteinmanTI , TeschanP . Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S184-94. [MEDLINE: 2636655]LaidlawSA , BergRL , KoppleJD , NaitoH , WalkerWG , WalserM . Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):504-13. [MEDLINE: 8154485]LeveyAS , BergRL , GassmanJJ , HallPM , WalkerWG . Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S73-80. [MEDLINE: 2636677]LeveyAS , GassmanJJ , HallPM , WalkerWG , MDRD Study Group. Poor correlation of rates of change of creatinine clearance, reciprocal serum creatinine and GFR [abstract]. Kidney International1989;35(1):197. LeveyAS , GassmanJJ , HallPM , WalkerWG . Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. Journal of the American Society of Nephrology1991;1(9):1087-94. [MEDLINE: 1912407]MDRD Study Group, MitchME , SteinmanTI . Objectives and design of the cooperative study, Modification of Diet in Renal Disease [abstract]. Kidney International1987;31(1):210. PerroneR , SteinmanT , RoyalH , LawlorM , HunsickerL , Modification of Diet in Renal Disease Study Group. Markers of GFR: comparison of 99TC-DTPA (TC), 169YB-DTPA (YB) and 125I-Iothalamate (IO) to inulin (IN) [abstract]. Kidney International1987;31(1):213. PerroneRD , SteinmanTI , BeckGJ , SkibinskiCI , RoyalHD , LawlorM , et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1990;16(3):224-35. [MEDLINE: 2205098]TeschanPE , BeckGJ , DwyerJT , GreeneT , KlahrS , LevyAS , et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clinical Nephrology1998;50(5):273-83. [MEDLINE: 9840314]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]">MDRD Feasibility A 1989</a>; <a href="./references#CD001892-bbs2-0015" title="MeloniC , TatangeloP , CiprianiS , RossiV , SuraciC , TozzoC , et al. Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure. Journal of Renal Nutrition2004;14(4):208-13. [MEDLINE: 15483780]">Meloni 2004</a>; <a href="./references#CD001892-bbs2-0016" title="Milovanov IuS, LysenkoLV , MilovanovaLI , DobrosmyslovIA . The role of balanced low-protein diet in inhibition of predialysis chronic kidney disease progression in patients with systemic diseases. Terapevticheskii Arkhiv2009;81(8):52-7. [MEDLINE: 19799201]">Milovanov 2009</a>; <a href="./references#CD001892-bbs2-0018" title="BockHA , BrunnerFP . Dietary protein restriction in chronic renal failure. Lancet1985;1(8426):465-6. [MEDLINE: 2857845]DonkerAJ , Piers-BechtTP . Four-years follow-up of patients with chronic renal insufficiency randomly allocated to a protein-restricted diet and a control group [abstract]. Nephrology Dialysis Transplantation1989;4(5):455. DonkerAJ , RosmanJB , Piers-BechtTP , SluiterWJ . Effect of protein restriction in chronic renal insufficiency: a prospective randomized trial [abstract]. Kidney International1985;27:137. RosmanJB , DonkerAJ , MeijerS , SluiterWJ , Piers-BechtTP , van derHemGK . Two years' experience with protein restriction in chronic renal failure. Contributions to Nephrology1986;53:109-20. [MEDLINE: 3542377]RosmanJB , DonkerAJ . The response to a low-protein diet to retard the progression of renal failure is sex-dependent [abstract]. Nephrology Dialysis Transplantation1989;4(5):457. RosmanJB , LangerK , BrandlM , Piers-BechtTP , van derHemGK , ter WeePM , et al. Protein-restricted diets in chronic renal failure: a four year follow-up shows limited indications. Kidney International - Supplement1989;27:S96-S102. [MEDLINE: 2636680]RosmanJB , ter WeePM , MeijerS , Piers-BechtTP , SluiterWJ , DonkerAJ . Prospective randomised trial of early dietary protein restriction in chronic renal failure. Lancet1984;324(8415):1291-6. [MEDLINE: 6150320]RosmanJB , Ter WeePM , Piers-BechtGP , SluiterWJ , van derWoudeF , MeijerS , et al. Early protein restriction in chronic renal failure [abstract]. Kidney International1984;26(4):510. RosmanJB , ter WeePM , Piers-BechtGP , SluiterWJ , van derWoudeFJ , MeijerS , et al. Early protein restriction in chronic renal failure. Proceedings of the European Dialysis &amp; Transplant Association - European Renal Association1985;21:567-73. [MEDLINE: 3887375]RosmanJB , Ter WeePM , SluiterWJ , MeijerS , van derHemGK , DonkerAJ . Four years experience with dietary protein restriction in chronic renal failure [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:28. RosmanJB , ter WeePM . Relationship between proteinuria and response to low protein diets early in chronic renal failure. Blood Purification1989;7(1):52-7. [MEDLINE: 2645924]">Rosman 1 1984</a>; <a href="./references#CD001892-bbs2-0021" title="WilliamsP , StevensME , FassG , BoneJM . A randomised trial of the effect of protein and phosphate restriction on the progression of chronic renal failure [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:38. WilliamsPS , StevensM , FassG , BoneJM . A randomised trial of the effect of protein and phosphate restriction on the progression of chronic renal failure [abstract]. Nephrology Dialysis Transplantation1987;2(4):285. WilliamsPS , StevensM , IronsL , FassG , BoneJM . Failure of  dietary protein/phosphate restriction to slow the progression of chronic renal failure; a prospective randomised controlled trial [abstract]. Nephrology Dialysis Transplantation1990;5(8):674. WilliamsPS , StevensME , FassG , IronsL , BoneJM . Failure of dietary protein and phosphate restriction to retard the rate of progression of chronic renal failure: a prospective, randomized, controlled trial. Quarterly Journal of Medicine1991;81(294):837-55. [MEDLINE: 1801057]WilliamsPS , StevensME . A randomised trial of the effect of protein and phosphate restriction on the progression of chronic renal failure [abstract]. Nephrology Dialysis Transplantation1987;2(5):401. ">Williams 1991</a>), in which most participants had CKD category 3a or 3b (<a href="./references#CD001892-bbs2-0068" title="LevinA , StevensPE , BilousRW , CoreshJ , De FranciscoAL , De JongPE , et al. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney international - Supplement2013;3(1):1-150. [EMBASE: 369856107]">KDIGO 2012</a>), compared a prescribed low protein diet (0.5 to 0.6 g/kg/day) with a normal protein diet (≥ 1 g/kg/day). A tenth study (<a href="./references#CD001892-bbs2-0003" title="CianciarusoB , PotaA , BellizziV , Di GiuseppeD , Di MiccoL , MinutoloR , et al. Effect of a low- versus moderate-protein diet on progression of CKD: follow-up of a randomized controlled trial. American Journal of Kidney Diseases2009;54(6):1052-61. [MEDLINE: 19800722]CianciarusoB , PotaA , PisaniA , TorracaS , AnnecchiniR , LombardiP , et al. Metabolic effects of two low protein diets in chronic kidney disease stage 4-5--a randomized controlled trial. Nephrology Dialysis Transplantation2008;23(2):636-44. [MEDLINE: 17981885]CianciarusoB , PotaA , TorracaS , SommaG , NazzaroP , AnnecchiniR , et al. Comparison of two different protein intakes (0.3-0.6 vs 0.7-0.9 g/kg/day) on the metabolic control of advanced renal failure [abstract no: MP197]. In: 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal. 2004:295. PotaA , PisaniA , AnnecchiniR , Di GiuseppeD , CuccurulloP , CaputoDL , et al. Treatment of chronic renal failure (CRF) with two different low protein diets. Effects on the metabolic control and on the cardiovascular risk factors [abstract no: MP306]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv401. PotaA , PisaniA , RavaniP , Di MiccoL , Di GiuseppeD , SabbatiniM , et al. Impact of two different low protein diets on survival of CKD patients (stage4-5) [abstract no: TH-PO880]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):308A. ">Cianciaruso 2008a</a>), which included participants with CKD category 4 and randomised participants to a low protein diet (0.55 g/kg/day) or to the WHO recommended normal protein intake (0.8 g/kg/day), was included in the meta‐analyses with studies comparing low with normal protein intake. Protein intake was estimated from urinary urea nitrogen measurements (<a href="./references#CD001892-bbs2-0070" title="MaroniBJ , SteinmanTI , MitchWE . A method for estimating nitrogen intake of patients with chronic renal failure. Kidney International1985;27(1):58-65. [MEDLINE: 3981873]">Maroni 1985</a>). The mean calculated protein intake was 0.68 g/kg/day (range 0.49 to 0.85 g/kg/day) for the low protein intervention and 1.0 g/kg/day (range 0.61 to 1.54 g/kg/day) for the normal or free protein diet group. No data on calculated protein intake were available for <a href="./references#CD001892-bbs2-0018" title="BockHA , BrunnerFP . Dietary protein restriction in chronic renal failure. Lancet1985;1(8426):465-6. [MEDLINE: 2857845]DonkerAJ , Piers-BechtTP . Four-years follow-up of patients with chronic renal insufficiency randomly allocated to a protein-restricted diet and a control group [abstract]. Nephrology Dialysis Transplantation1989;4(5):455. DonkerAJ , RosmanJB , Piers-BechtTP , SluiterWJ . Effect of protein restriction in chronic renal insufficiency: a prospective randomized trial [abstract]. Kidney International1985;27:137. RosmanJB , DonkerAJ , MeijerS , SluiterWJ , Piers-BechtTP , van derHemGK . Two years' experience with protein restriction in chronic renal failure. Contributions to Nephrology1986;53:109-20. [MEDLINE: 3542377]RosmanJB , DonkerAJ . The response to a low-protein diet to retard the progression of renal failure is sex-dependent [abstract]. Nephrology Dialysis Transplantation1989;4(5):457. RosmanJB , LangerK , BrandlM , Piers-BechtTP , van derHemGK , ter WeePM , et al. Protein-restricted diets in chronic renal failure: a four year follow-up shows limited indications. Kidney International - Supplement1989;27:S96-S102. [MEDLINE: 2636680]RosmanJB , ter WeePM , MeijerS , Piers-BechtTP , SluiterWJ , DonkerAJ . Prospective randomised trial of early dietary protein restriction in chronic renal failure. Lancet1984;324(8415):1291-6. [MEDLINE: 6150320]RosmanJB , Ter WeePM , Piers-BechtGP , SluiterWJ , van derWoudeF , MeijerS , et al. Early protein restriction in chronic renal failure [abstract]. Kidney International1984;26(4):510. RosmanJB , ter WeePM , Piers-BechtGP , SluiterWJ , van derWoudeFJ , MeijerS , et al. Early protein restriction in chronic renal failure. Proceedings of the European Dialysis &amp; Transplant Association - European Renal Association1985;21:567-73. [MEDLINE: 3887375]RosmanJB , Ter WeePM , SluiterWJ , MeijerS , van derHemGK , DonkerAJ . Four years experience with dietary protein restriction in chronic renal failure [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:28. RosmanJB , ter WeePM . Relationship between proteinuria and response to low protein diets early in chronic renal failure. Blood Purification1989;7(1):52-7. [MEDLINE: 2645924]">Rosman 1 1984</a> since data on urea excretion were only provided graphically. </p> <p>Eight studies (<a href="./references#CD001892-bbs2-0004" title="Di IorioBR , BellizziV , MinutoloR , De NicolaL , IodiceC , ConteG . Supplemented very low-protein diet in advanced CRF: is it money saving?Kidney International2004;65(2):742. [MEDLINE: 14717953]Di IorioBR , MinutoloR , De NicolaL , BellizziV , CatapanoF , IodiceC , et al. Supplemented very low protein diet ameliorates responsiveness to erythropoietin in chronic renal failure. Kidney International2003;64(5):1822-8. [MEDLINE: 14717953]">Di Iorio 2003</a>; <a href="./references#CD001892-bbs2-0006" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 2 1990</a>; <a href="./references#CD001892-bbs2-0007" title="GarneataL , MircescuG . Effect of low-protein diet supplemented with keto acids on progression of chronic kidney disease. Journal of Renal Nutrition2013;23(3):210-3. [MEDLINE: 23611549]GarneataL , MocanuE , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues-effects on mineral bone metabolism disorders in advanced chronic kidney disease [abstract no: FP396]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i167-8. [EMBASE: 622605156]GarneataL , StancuA , DragomirD , MircescuG . Effect of very low protein diet supplemented with ketoanalogues of the essential amino acids on the progression of chronic kidney disease [abstract]. Nephrology Dialysis Transplantation2014;29(Suppl 3):iii39. [EMBASE: 71491557]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression. Journal of the American Society of Nephrology2016;27(7):2164-76. [MEDLINE: 26823552]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues in stage 5 CKD patients [abstract no: SP373]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i472. [EMBASE: 622606118]">Garneata 2013</a>; <a href="./references#CD001892-bbs2-0002" title="ChauveauP , LebkiriB , PloyardF , CiancioniC , ManNK , JungersP . Effect of keto analogs of essential amino acids on the progress of advanced renal insufficiency: controlled prospective study [Effet des cetoanalogues des acides amines essentiels sur la progression de l'insuffisance renale chronique avancee: etude prospective controlee]. Nephrologie1986;7(5):137-42. [MEDLINE: 3796783]JungersP , ChauveauP , PloyardF , LebkiriB , CiancioniC , ManNK . Comparison of ketoacids and low protein diet on advanced chronic renal failure progression. Kidney International - Supplement1987;22:S67-71. [MEDLINE: 3323621]">Chauveau 1986</a>; <a href="./references#CD001892-bbs2-0010" title="MalvyD , MaingourdC , PengloanJ , BagrosP , NivetH . Effects of severe protein restriction with ketoanalogues in advanced renal failure. Journal of the American College of Nutrition1999;18(5):481-6. [MEDLINE: 10511331]NivetH , MaingourdC , MalvyD , PengloanJ , BagrosPH . Effects of severe protein-restriction with ketoanalogues in advanced renal failure [abstract]. Journal of the American Society of Nephrology1992;3(3):286. ">Malvy 1999</a>; <a href="./references#CD001892-bbs2-0012" title="GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. KlahrS . The modification of diet in renal disease study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]">MDRD 2 1989</a>; <a href="./references#CD001892-bbs2-0014" title="CogginsCH , DwyerJT , GreeneT , PetotG , SnetselaarLG , Van LenteF , et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):514-23. [MEDLINE: 8154486]KlahrS , LeveyAS , SandbergAM , WilliamsGW , MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International1989;35(1):195. KoppleJD , BergR , HouserH , SteinmanTI , TeschanP . Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S184-94. [MEDLINE: 2636655]LaidlawSA , BergRL , KoppleJD , NaitoH , WalkerWG , WalserM . Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):504-13. [MEDLINE: 8154485]LeveyAS , BergRL , GassmanJJ , HallPM , WalkerWG . Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S73-80. [MEDLINE: 2636677]LeveyAS , GassmanJJ , HallPM , WalkerWG , Modification of Diet in Renal Disease Study. Poor correlation of rates of change of creatinine clearance, reciprocal serum creatinine and GFR [abstract]. Kidney International1989;35(1):197. LeveyAS , GassmanJJ , HallPM , WalkerWG . Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. Journal of the American Society of Nephrology1991;1(9):1087-94. [MEDLINE: 1912407]MDRD Study Group, MitchME , SteinmanTI . Objectives and design of the cooperative study, Modification of Diet in Renal Disease [abstract]. Kidney International1987;31(1):210. PerroneR , SteinmanT , RoyalH , LawlorM , HunsickerL , Modification of Diet in Renal Disease Study Group. Markers of GFR: comparison of 99TC-DTPA (TC), 169YB-DTPA (YB) and 125I-Iothalamate (IO) to inulin (IN) [abstract]. Kidney International1987;31(1):213. PerroneRD , SteinmanTI , BeckGJ , SkibinskiCI , RoyalHD , LawlorM , et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1990;16(3):224-35. [MEDLINE: 2205098]TeschanPE , BeckGJ , DwyerJT , GreeneT , KlahrS , LevyAS , et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clinical Nephrology1998;50(5):273-83. [MEDLINE: 9840314]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]">MDRD Feasibility B 1989</a>; <a href="./references#CD001892-bbs2-0017" title="MircescuG , GarneataL , StancuSH , CapusaC . Effects of a supplemented hypoproteic diet in chronic kidney disease. Journal of Renal Nutrition2007;17(3):179-88. [MEDLINE: 17462550]">Mircescu 2007</a>), in which participants had CKD stage 4/5 compared prescribed very low protein diets (0.3 to 0.4 g/kg/day with keto‐analogues) with low protein diets (0.58 to 0.65 g/kg/day). The mean calculated protein intake for the participants who received a very low protein diet was 0.4 g/kg/day (range 0.29 to 0.5 g/kg/day) and it was 0.64 g/kg/day (range 0.56 to 0.79 g/kg/day) for participants receiving the low protein diet. No data on calculated protein intake were available for <a href="./references#CD001892-bbs2-0002" title="ChauveauP , LebkiriB , PloyardF , CiancioniC , ManNK , JungersP . Effect of keto analogs of essential amino acids on the progress of advanced renal insufficiency: controlled prospective study [Effet des cetoanalogues des acides amines essentiels sur la progression de l'insuffisance renale chronique avancee: etude prospective controlee]. Nephrologie1986;7(5):137-42. [MEDLINE: 3796783]JungersP , ChauveauP , PloyardF , LebkiriB , CiancioniC , ManNK . Comparison of ketoacids and low protein diet on advanced chronic renal failure progression. Kidney International - Supplement1987;22:S67-71. [MEDLINE: 3323621]">Chauveau 1986</a> since data on urea excretion were not provided. <a href="./references#CD001892-bbs2-0008" title="BeckerGJ , WhitworthJA , IhleBU , ShahinfarS , Kincaid-SmithPS . Prevention of progression in non-diabetic chronic renal failure. Kidney International - Supplement1994;45(Suppl 45):S167-70. [MEDLINE: 8158888]IhleBU , BeckerGJ , WhithworthJA , CharlwoodRA , Kincaid-SmithPS . The effect of protein restriction on the progression of renal insufficiency. New England Journal of Medicine1989;321(26):1773-7. [MEDLINE: 2512486]">Ihle 1989</a> and <a href="./references#CD001892-bbs2-0019" title="BockHA , BrunnerFP . Dietary protein restriction in chronic renal failure. Lancet1985;1(8426):465-6. [MEDLINE: 2857845]DonkerAJ , Piers-BechtTP . Four-years follow-up of patients with chronic renal insufficiency randomly allocated to a protein-restricted diet and a control group [abstract]. Nephrology Dialysis Transplantation1989;4(5):455. DonkerAJ , RosmanJB , Piers-BechtTP , SluiterWJ . Effect of protein restriction in chronic renal insufficiency: a prospective randomized trial [abstract]. Kidney International1985;27:137. RosmanJB , DonkerAJ , MeijerS , SluiterWJ , Piers-BechtTP , van derHemGK . Two years' experience with protein restriction in chronic renal failure. Contributions to Nephrology1986;53:109-20. [MEDLINE: 3542377]RosmanJB , DonkerAJ . The response to a low-protein diet to retard the progression of renal failure is sex-dependent [abstract]. Nephrology Dialysis Transplantation1989;4(5):457. RosmanJB , LangerK , BrandlM , Piers-BechtTP , van derHemGK , ter WeePM , et al. Protein-restricted diets in chronic renal failure: a four year follow-up shows limited indications. Kidney International - Supplement1989;27:S96-102. [MEDLINE: 2636680]RosmanJB , ter WeePM , MeijerS , Piers-BechtTP , SluiterWJ , DonkerAJ . Prospective randomised trial of early dietary protein restriction in chronic renal failure. Lancet1984;324(8415):1291-6. [MEDLINE: 6150320]RosmanJB , Ter WeePM , Piers-BechtGP , SluiterWJ , van derWoudeF , MeijerS , et al. Early protein restriction in chronic renal failure [abstract]. Kidney International1984;26(4):510. RosmanJB , ter WeePM , Piers-BechtGP , SluiterWJ , van derWoudeFJ , MeijerS , et al. Early protein restriction in chronic renal failure. Proceedings of the European Dialysis &amp; Transplant Association - European Renal Association1985;21:567-73. [MEDLINE: 3887375]RosmanJB , Ter WeePM , SluiterWJ , MeijerS , van derHemGK , DonkerAJ . Four years experience with dietary protein restriction in chronic renal failure. [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:28. RosmanJB , ter WeePM . Relationship between proteinuria and response to low protein diets early in chronic renal failure. Blood Purification1989;7(1):52-7. [MEDLINE: 2645924]">Rosman 2 1984</a>, in which participants had CKD category 4 and which compared very low protein diets (0.4 g/kg/day) with normal protein diets, were included with the eight studies comparing very low with low protein intakes. Actual protein intake could not be calculated for these two studies. </p> <p>Seven studies were multicentre studies (<a href="./references#CD001892-bbs2-0005" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 1 1990</a>; <a href="./references#CD001892-bbs2-0006" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 2 1990</a>; <a href="./references#CD001892-bbs2-0009" title="D'AmicoG , GentileMG , FellinG , MannaG , CofanoF . Effect of dietary protein restriction on the progression of renal failure: a prospective randomized trial. Nephrology Dialysis Transplantation1994;9(11):1590-4. [MEDLINE: 7870348]LocatelliF , AlbertiD , GentileMG , GrazianiG , BucciantiG , CosciP , et al. Effects of two different protein prescriptions on chronic renal failure progression. Cooperative study. [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:20. LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA , et al. Blood pressure and chronic renal failure progression: results from a multicentre trial [abstract]. Nephrology Dialysis Transplantation1992;7(7):712. LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA , et al. Factors affecting chronic renal failure progression: results from a multicentre trial. The Northern Italian Cooperative Study Group. Mineral &amp; Electrolyte Metabolism1992;18(2-5):295-302. [MEDLINE: 1465079]LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA . Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group. Lancet1991;337(8753):1299-304. [MEDLINE: 1674294]LocatelliF , Del VecchioL , AndrulliS , MaraiP , TentoriF . The role of underlying nephropathy in the progression of renal disease. Kidney International - Supplement2000;75:S49-55. [MEDLINE: 10828762]LocatelliF , MarcelliD , et al. Factors affecting the progression of chronic renal failure: a multivariate analysis [abstract]. Nephrology Dialysis Transplantation1989;4(5):457. LocatelliF , MarcelliD , TentoriF , MaraiP . Hypertension and progression of chronic renal failure (CRF): a prospective study [abstract]. In: 11th International Congress of Nephrology; 1990 Jul 15-20; Tokyo, Japan. 1990:37A. LocatelliF . Controlled study of protein-restricted diet in chronic renal failure. Contributions to Nephrology1989;75:141-6. [MEDLINE: 2697498]LocatelliF . Dietary compliance in patients with chronic renal failure: experience in a northern Italy trial. Contributions to Nephrology1990;81:102-6. [MEDLINE: 2093485]TentoriF , MaraiP , MarcelliD , PontiR , LocatelliF . Monocentric prospective randomized controlled study on the progression rate of chronic renal failure (CRF) with two different protein intakes [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:20. TentoriF , MaraiP . Monocentric prospective randomised controlled study on the progression rate of chronic renal failure with two different protein intakes [abstract]. Nephrology Dialysis Transplantation1987;2(5):400-1. ">Locatelli 1989</a>; <a href="./references#CD001892-bbs2-0011" title="BeckGJ , BergRL , CogginsCH , GassmanJJ , HunsickerLG , SchluchterMD , et al. Design and statistical issues of the Modification of Diet in Renal Disease Trial. The Modification of Diet in Renal Disease Study Group. Controlled Clinical Trials1991;12(5):566-86. [MEDLINE: 1664792]Buckalew VM Jr, BergRL , WangSR , PorushJG , RauchS , SchulmanG . Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. American Journal of Kidney Diseases1996;28(6):811-21. [MEDLINE: 8957032]ChawlaV , WangX , GreeneJ , KusekJW , CollinsAJ , LeveyAS , et al. Dyslipidemia and mortality in chronic kidney disease [abstract no: TH-PO895]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A-2A. ChenJL , LernerD , RuthazerR , Castaneda-SceppaC , LeveyAS . Association of physical activity with mortality in chronic kidney disease. Journal of Nephrology2008;21(2):243-52. [MEDLINE: 18446720]ChenJL , SceppaC , RuthazerR , LeveyAS . Leisure time physical activity status and mortality in chronic kidney disease: preliminary findings from the MDRD study [abstract no: 21]. American Journal of Kidney Diseases2006;47(4):A24. CogginsCH , Breyer LewisJ , CaggiulaAW , CastaldoLS , KlahrS , WangSR . Differences between women and men with chronic renal disease. Nephrology Dialysis Transplantation1998;13(6):1430-7. [MEDLINE: 9641172]CoyneT , OlsonM , BradhamK , GarconM , GregoryP , ScherchL . Dietary satisfaction correlated with adherence in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1301-6. [MEDLINE: 7594127]DennisVW . Decoding the Modification of Diet in Renal Disease Study. Cleveland Clinic Journal of Medicine1994;61(4):254-7. [MEDLINE: 7923742]DolecekTA , OlsonMB , CaggiulaAW , DwyerJT , MilasNC , GillisBP , et al. Registered dietitian time requirements in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1307-12. [MEDLINE: 7594128]Effects of diet and antihypertensive therapy on creatinine clearance and serum creatinine concentration in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Aug;8(8):1354]. Journal of the American Society of Nephrology1996;7(4):556-66. [MEDLINE: 8724889]Effects of dietary protein restriction on the progression of moderate renal disease in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Mar;8(3):493]. Journal of the American Society of Nephrology1996;7(12):2616-26. [MEDLINE: 8989740]GassmanJJ , DrabikMJ , LeathermanJR , FaticaKJ , McPhersonJA , Modification of Diet in Renal Disease Study Group. Development and use of distributed data entry and electronic communication in a multi-center study of progressive renal disease [abstract]. Kidney International1989;35(1):226. GennariFJ , HoodVL , GreeneT , WangX , LeveyAS . Effect of Dietary Protein Intake on Serum Total CO2 Concentration in Chronic Kidney Disease: Modification of Diet in Renal Disease Study Findings. Clinical Journal of the American Society of Nephrology: CJASN2006;1(1):52-7. [MEDLINE: 17699190]GillisBP , AverbachFM , CaggiulaAW , JonesFL , NaujelisJ , MaurerE , et al. Features of the nutrient database and analysis system for the Modification of Diet in Renal Disease Study.[Erratum appears in Control Clin Trials 1994 Aug;15(4):326]. Controlled Clinical Trials1994;15(1):44-58. [MEDLINE: 8149770]GillisBP , CaggiulaAW , ChiavacciAT , CoyneT , DoroshenkoL , MilasNC , et al. Nutrition intervention program of the Modification of Diet in Renal Disease Study: a self-management approach. Journal of the American Dietetic Association1995;95(11):1288-94. [MEDLINE: 7594125]GramsME , CoreshJ , SegevDL , KucirkaLM , TighiouartH , SarnakMJ . Vascular disease, ESRD, and death: interpreting competing risk analyses. Clinical Journal of the American Society of Nephrology: CJASN2012;7(10):1606-14. [MEDLINE: 22859747]GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. GramsME , TinA , RebholzCM , ShafiT , KottgenA , PerroneRD , et al. Metabolomic alterations associated with cause of CKD. Clinical Journal of The American Society of Nephrology: CJASN2017;12(11):1787-94. [MEDLINE: 28971980]GreeneT , BeckG , WangS , KusekJ , LeveyA , Modification of Diet in Renal Disease Study Group. The effect of the low protein diet in the MDRD study A is dependent on the underlying rate of disease progression [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A. GreeneT , BourgoignieJJ , HabweV , KusekJW , SnetselaarLG , SoucieJM , et al. Baseline characteristics in the Modification of Diet in Renal Disease Study.[Republished from J Am Soc Nephrol 1993 May;3(11):1819-34]. Journal of the American Society of Nephrology1993;4(5):1221-36. [MEDLINE: 8305650]HebertLA , GreeneT , HunsickerLG , LeveyAS , WangS , MDRD Study Group. Relationship of urine volume (uv) and urine osmolality (Uosm) to the progression of renal disease in the Modification of Diet in Renal Disease (MDRD) study [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A-6A. HebertLA , KusekJW , GreeneT , AgodoaLY , JonesCA , LeveyAS , et al. Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group. Hypertension1997;30(3 (Pt 1)):428-35. [MEDLINE: 9314428]HunsickerLG , AdlerS , CaggiulaA , EnglandBK , GreeneT , KusekJW , et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney International1997;51(6):1908-19. [MEDLINE: 9186882]HunsickerLG , MDRD Study Group. Secondary analysis of the Modification of Diet in Renal Disease (MDRD) study [abstract]. In: 13th International Congress of Nephrology; 1995 Jul 2-6; Madrid, Spain. 1995:64. IxJH , ShlipakMG , SarnakMJ , BeckGJ , GreeneT , WangX , et al. Fetuin-A is not associated with all-cause or cardiovascular mortality in chronic kidney disease: data from the Modification of Diet in Renal Disease (MDRD) study [abstract no: SU-PO711]. Journal of the American Society of Nephrology2007;18(Abstracts Issue):741A. KlahrS , BreyerJA , BeckGJ , DennisVW , HartmanJA , RothD , et al. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group.[Erratum appears in J Am Soc Nephrol 1995 Oct;6(4):1318]. Journal of the American Society of Nephrology1995;5(12):2037-47. [MEDLINE: 7579052]KlahrS , LeveyAS , BeckGJ , CaggiulaAW , HunsickerL , KusekJW , et al. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. New England Journal of Medicine1994;330(13):877-84. [MEDLINE: 8114857]KlahrS , Modification of Diet in Renal Disease Study. The Modification of Diet in Renal Disease Study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]KlahrS . Primary and secondary results of the modification of diet in renal disease study. Mineral &amp; Electrolyte Metabolism1996;22(1-3):138-42. [MEDLINE: 8676806]KoppleJD , GreeneT , ChumleaWC , HollingerD , MaroniBJ , MerrillD , et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney International2000;57(4):1688-703. [MEDLINE: 10760105]KoppleJD , LeveyAS , GreeneT , ChumleaWC , GassmanJJ , HollingerDL , et al. Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. Kidney International1997;52(3):778-91. [MEDLINE: 9291200]KuE , GliddenDV , JohansenKL , SarnakM , TighiouartH , GrimesB , et al. Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease. Kidney International2015;87(5):1055-60. [MEDLINE: 25493952]KusekJW , CoyneT , deVelascoA , DrabikMJ , FinlayRA , GassmanJJ , et al. Recruitment experience in the full-scale phase of the Modification of Diet in Renal Disease Study. Controlled Clinical Trials1993;14(6):538-57. [MEDLINE: 8119068]KusekJW , CoyneT , deVelascoA , GassmanJ , KieferS , PowersS , et al. Recruitment experience in the full scale phase of the Modification of Diet in Renal Disease (MDRD) Study [abstract]. Controlled Clinical Trials1991;12:678. KwongYT , StevensLA , SelvinE , ZhangYL , GreeneT , Van LenteF , et al. Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. American Journal of Kidney Diseases2010;56(1):39-49. [MEDLINE: 20537455]LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , LeveyAS , MilasNC , et al. Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. Hypertension1997;29(2):641-50. [MEDLINE: 9040451]Leonberg-YooAK , TighiouartH , LeveyAS , BeckGJ , SarnakMJ . Urine potassium excretion, kidney failure, and mortality in CKD. American Journal of Kidney Diseases2017;69(3):341-9. [MEDLINE: 27233381]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , BoschJP , LewisJB , GreeneT , RogersN , RothD , et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of Internal Medicine1999;130(6):461-70. [MEDLINE: 10075613]LeveyAS , CoreshJ , GreeneT , StevensLA , ZhangYL , HendriksenS , et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate.[Erratum appears in Ann Intern Med. 2008 Oct 7;149(7):519]. Annals of Internal Medicine2006;145(4):247-54. [MEDLINE: 16908915]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study Group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]LeveyAS , GreeneT , SarnakM , WangX , BeckGJ , KusekJW , et al. Effect of low protein diet on progression of kidney disease in the Modification of Diet in Renal Disease study A: long-term follow-up [abstract no: SU-PO247]. Journal of the American Society of Nephrology2004;15(Oct):586A-7A. LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2006;48(6):879-88. [MEDLINE: 17162142]LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. The effect of very low protein diet on progression of kidney disease and mortality in Modification of Diet in Renal Disease Study B [abstract no: SU-PO246]. Journal of the American Society of Nephrology2004;15(Oct):586A. LeveyAS , GreeneT , SchluchterMD , ClearyPA , TeschanPE , LorenzRA , et al. Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. Journal of the American Society of Nephrology1993;4(5):1159-71. [MEDLINE: 8305642]MaderoM , SarnakM , WangX , GreeneT , CollinsA , BeckG , et al. Uric acid and development of kidney failure in chronic kidney disease [abstract no: F-PO1932]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):547A. MaderoM , SarnakMJ , WangX , GreeneT , BeckGJ , KusekJW , et al. Uric acid and long-term outcomes in CKD. American Journal of Kidney Diseases2009;53(5):796-803. [MEDLINE: 19303683]MaderoM , SarnakMJ , WangX , SceppaCC , GreeneT , BeckGJ , et al. Body mass index and mortality in CKD. American Journal of Kidney Diseases2007;50(3):404-11. [MEDLINE: 17720519]MaderoM , WangX , GreenT , HunsickerLG , BeckGJ , KusekJW , et al. Effect of trial participation on outcomes in the randomized and non-randomized cohorts of the Modification of Diet in Renal Disease study [abstract no: F-PO037]. Journal of the American Society of Nephrology2006;17(Abstracts):344A. MDRD Study Group, ChumleaWC , GassmanJJ , HollingerDL , MerrillD , ScherchLK , et al. Nutritional response to diet prescription in the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, HunsickerLG , AdlerS , CaggiulaAW , EnglandB , GreeneT , et al. Relationship among baseline proteinuria (p), mean arterial blood pressure (map) during follow-up, and decline in glomerular filtration rate (aGFR) in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, KoppleJD , ChumleaWC , GassmanJJ , HollingerDL , MaroniBJ , et al. Relationship between FGR and nutritional status - results from the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, KusekJW , AgodoaL , GreeneT , JonesC . Comparison of decline of GFR in blacks versus non-blacks in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , BoschJP , CaggiulaAW , GreeneT , et al. Short-term effects of protein intake, blood pressure, and antihypertensive therapy on GFR in the MDRD study. Journal of the American Society of Nephrology1995;6(3):395. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , HunsickerLG , et al. A hypothesis for the results of the Modification of Diet in Renal Disease (MDRD) study. [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , KusekJW , et al. Trends toward a beneficial effect of a low protein diet during additional follow-up in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1994;5(3):336. MDRD Study Group, LeveyAS , BeckGJ . Trends toward a beneficial effect of a low protein diet during additional follow-up in the modification of diet in renal disease study. MDRD Study Group. [abstract]. Nephrology Dialysis Transplantation1995;10(6):985. MDRD Study Group, LeveyAS , BoschJP , CogginsCH , GreeneT , MitchWE , et al. Effects of diet and blood pressure on creatinine clearance (CCr) and serum creatinine (PCr) in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, PetersonJC , BurkartJ , GreeneT , HebertL , KingA , et al. The effect of blood pressure control on progression of renal disease depends on level of proteinuria (p) at baseline evaluation [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, PetersonJC , GreeneT , KlahrS , BurkartJM , HebertL , et al. Effect of reducing proteinuria (PR) on subsequent glomerular filtration rate (GFR) decline in patients with chronic renal failure (CRF) [abstract]. Journal of the American Society of Nephrology1994;5(3):339. MDRD Study Group, PorushJG , LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , et al. Efficacy of anti-hypertensive interventions in reducing blood pressure in the MDRD study [abstract]. Journal of the American Society of Nephrology1995;6(3):400. MDRD Study Group, PowersSN , KurtzmanDA , PetotGJ , RaizmanDJ , WetsteinL . Promoting dietary compliance through computer-assisted education, assessment, and counseling. [abstract]. Kidney International1988;36(Suppl 27):S306. MDRD Study Group, RoccoMV , CoyneT , EastinS , FaubertJ , GassmanJJ , et al. Patient symptoms and quality of life in the MDRD study at enrollment-correlation with GFR [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group. The modification of diet in renal disease study: results from the full-scale trial [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:593. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Hemoglobin A1c and mortality in chronic kidney disease [abstract no: F-FC149]. Journal of the American Society of Nephrology2005;16:71A. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Insulin resistance as a predictor of all-cause and cardiovascular mortality (CVD) in chronic kidney disease (CKD) [abstract no: F-P0284]. Journal of the American Society of Nephrology2004;15(Oct):128A. MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. Journal of the American Society of Nephrology2005;16(11):3411-7. [MEDLINE: 16207824]MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD. American Journal of Kidney Diseases2005;46(3):455-63. [MEDLINE: 16129207]MenonV , GreeneT , WangX , PereiraAA , MarcovinaSM , BeckGJ , et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney International2005;68(2):766-72. [MEDLINE: 16014054]MenonV , GreenT , PereiraA , XueleiW , BeckG , KusekJ , et al. C-reactive protein (CRP) as a predictor of all-cause and cardiovascular (CVD) mortality in patients with chronic kidney disease (CKD) [abstract no: F-P0275]. Journal of the American Society of Nephrology2004;15(Oct):125A-6A. MenonV , KoppleJD , WangX , BeckGJ , CollinsAJ , KusekJW , et al. Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2009;53(2):208-17. [MEDLINE: 18950911]MenonV , LiL , GreeneT , WangX , ChandraP , BalakrishnanV , et al. Adiponectin and outcomes in chronic kidney disease [abstract no: TH-PO430]. Journal of the American Society of Nephrology2006;17(Abstracts):199A. MenonV , LiL , WangX , GreeneT , BalakrishnanV , MaderoM , et al. Adiponectin and mortality in patients with chronic kidney disease. Journal of the American Society of Nephrology2006;17(9):2599-606. [MEDLINE: 16885405]MenonV , SarnakMJ , GreeneT , WangX , PereiraAA , BeckGJ , et al. Relationship between homocysteine and mortality in chronic kidney disease. Circulation2006;113(12):1572-7. [MEDLINE: 16549639]MenonV , ShlipakMG , WangX , CoreshJ , GreeneT , StevensL , et al. Cystatin C as a risk factor for outcomes in chronic kidney disease. Annals of Internal Medicine2007;147(1):19-27. [MEDLINE: 17606957]MenonV , TighiouartH , VaughnNS , BeckGJ , KusekJW , CollinsAJ , et al. Serum bicarbonate and long-term outcomes in CKD. American Journal of Kidney Diseases2010;56(5):907-14. [MEDLINE: 20605301]MenonV , WangX , GreeneT , BeckGJ , KusekJW , MarcovinaSM , et al. Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. American Journal of Kidney Diseases2003;42(1):44-52. [MEDLINE: 12830455]MenonV , WangX , GreeneT , BeckGJ , KusekJW , SelhubJ , et al. Homocysteine in chronic kidney disease: effect of low protein diet and repletion with B vitamins. Kidney International2005;67(4):1539-46. [MEDLINE: 15780109]MenonV , WangX , SarnakMJ , HunsickerLH , MaderoM , BeckGJ , et al. Long-term outcomes in nondiabetic chronic kidney disease. Kidney International2008;73(11):1310-5. [MEDLINE: 18337713]MilasNC , NowalkMP , AkpeleL , CastaldoL , CoyneT , DoroshenkoL , et al. Factors associated with adherence to the dietary protein intervention in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1295-300. [MEDLINE: 7594126]NewsomeB , IxJH , TighiouartH , SarnakMJ , LeveyAS , BeckGJ , et al. Effect of protein restriction on serum and urine phosphate in the modification of diet in renal disease (MDRD) study. American Journal of Kidney Diseases2013;61(6):1045-6. [MEDLINE: 23415016]OlsonM , CoyneT , CaggiulaA , GregoryP . Patient satisfaction with a dietary intervention: the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):107S. OlsonM , CoyneT , CaggiulaA . Social factors influence dietary satisfaction in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1996;17(2 Suppl):133S. OlsonM , DolecekT , CaggiulaA , DwyerJ . Time required for the protein intervention in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):129S-30S. PetersonJC , AdlerS , BurkartJM , GreeneT , HebertLA , HunsickerLG , et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Annals of Internal Medicine1995;123(10):754-62. [MEDLINE: 7574193]PiccoliM , CodognottoM . Missing stratification by polycistic kidney disease (PKD) flaws risk estimates of GFR decline. Lesson from the MDRD Study [abstract no: F-PO175]. Journal of the American Society of Nephrology2004;15(Oct):103A. RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]RoccoMV , GassmanJJ , WangSR , KaplanRM . Cross-sectional study of quality of life and symptoms in chronic renal disease patients: the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1997;29(6):888-96. [MEDLINE: 9186075]SarnakMJ , GreeneT , WangX , BeckG , KusekJW , CollinsAJ , et al. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease study. Annals of Internal Medicine2005;142(5):342-51. [MEDLINE: 15738453]SarnakMJ , WangSR , BeckGJ , KusekJW , SelhubJ , GreeneT , et al. Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression. American Journal of Kidney Diseases2002;40(5):932-9. [MEDLINE: 12407637]SarnakMJ , WangX , GreeneT , GeraldJ , BeckJ , KusekJW , et al. Effect of strict blood pressure control on long-term outcome in the Modification of Diet in Renal Disease (MDRD) study [abstract no: F-P0599]. Journal of the American Society of Nephrology2003;14(Nov):192A. SchluchterMD . Estimating correlation between alternative measures of disease progression in a longitudinal study. Modification of Diet in Renal Disease Study. Statistics in Medicine1990;9(10):1175-88. [MEDLINE: 2247718]Short-term effects of protein intake, blood pressure, and antihypertensive therapy on glomerular filtration rate in the Modification of Diet in Renal Disease Study. Journal of the American Society of Nephrology1996;7(10):2097-109. [MEDLINE: 8915969]StollarC , ScherchL , AdlerS , KusekJ , CaggiulaA . Patterns of patient dietary compliance in the Modification of Diet in Renal Disease (MDRD) study, phase III. [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:609. TangriN , StevensLA , SchmidCH , ZhangYL , BeckGJ , GreeneT , et al. Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney International2011;79(4):471-7. [MEDLINE: 20980977]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]YamamotoME , OlsonMB , StollarC , MDRD Study Group. Effects of weight and Na+ change on blood pressures of hypertensive MDRD study patients [abstract]. Journal of the American Society of Nephrology1995;6(3):408. YoungJA , TerrinN , GreeneT , WangX , BeckG , KusekJ , et al. Asymmetric dimethylarginine and prevalent cardiovascular disease in patients with chronic kidney disease [abstract no: F-PO935]. Journal of the American Society of Nephrology2007;18(Abstracts):308A-9A. YoungJA , TerrinN , WangX , GreenT , BeckG , KusekJ , et al. ADMA and mortality in stage 3-4 chronic kidney disease [abstract no: TH-PO894]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A. ">MDRD 1 1989</a>; <a href="./references#CD001892-bbs2-0012" title="GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. KlahrS . The modification of diet in renal disease study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]">MDRD 2 1989</a>; <a href="./references#CD001892-bbs2-0013" title="CogginsCH , DwyerJT , GreeneT , PetotG , SnetselaarLG , Van LenteF , et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):514-23. [MEDLINE: 8154486]KlahrS , LeveyAS , SandbergAM , WilliamsGW , MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International1989;35(1):195. KoppleJD , BergR , HouserH , SteinmanTI , TeschanP . Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S184-94. [MEDLINE: 2636655]LaidlawSA , BergRL , KoppleJD , NaitoH , WalkerWG , WalserM . Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):504-13. [MEDLINE: 8154485]LeveyAS , BergRL , GassmanJJ , HallPM , WalkerWG . Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S73-80. [MEDLINE: 2636677]LeveyAS , GassmanJJ , HallPM , WalkerWG , MDRD Study Group. Poor correlation of rates of change of creatinine clearance, reciprocal serum creatinine and GFR [abstract]. Kidney International1989;35(1):197. LeveyAS , GassmanJJ , HallPM , WalkerWG . Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. Journal of the American Society of Nephrology1991;1(9):1087-94. [MEDLINE: 1912407]MDRD Study Group, MitchME , SteinmanTI . Objectives and design of the cooperative study, Modification of Diet in Renal Disease [abstract]. Kidney International1987;31(1):210. PerroneR , SteinmanT , RoyalH , LawlorM , HunsickerL , Modification of Diet in Renal Disease Study Group. Markers of GFR: comparison of 99TC-DTPA (TC), 169YB-DTPA (YB) and 125I-Iothalamate (IO) to inulin (IN) [abstract]. Kidney International1987;31(1):213. PerroneRD , SteinmanTI , BeckGJ , SkibinskiCI , RoyalHD , LawlorM , et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1990;16(3):224-35. [MEDLINE: 2205098]TeschanPE , BeckGJ , DwyerJT , GreeneT , KlahrS , LevyAS , et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clinical Nephrology1998;50(5):273-83. [MEDLINE: 9840314]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]">MDRD Feasibility A 1989</a>; <a href="./references#CD001892-bbs2-0014" title="CogginsCH , DwyerJT , GreeneT , PetotG , SnetselaarLG , Van LenteF , et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):514-23. [MEDLINE: 8154486]KlahrS , LeveyAS , SandbergAM , WilliamsGW , MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International1989;35(1):195. KoppleJD , BergR , HouserH , SteinmanTI , TeschanP . Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S184-94. [MEDLINE: 2636655]LaidlawSA , BergRL , KoppleJD , NaitoH , WalkerWG , WalserM . Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):504-13. [MEDLINE: 8154485]LeveyAS , BergRL , GassmanJJ , HallPM , WalkerWG . Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S73-80. [MEDLINE: 2636677]LeveyAS , GassmanJJ , HallPM , WalkerWG , Modification of Diet in Renal Disease Study. Poor correlation of rates of change of creatinine clearance, reciprocal serum creatinine and GFR [abstract]. Kidney International1989;35(1):197. LeveyAS , GassmanJJ , HallPM , WalkerWG . Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. Journal of the American Society of Nephrology1991;1(9):1087-94. [MEDLINE: 1912407]MDRD Study Group, MitchME , SteinmanTI . Objectives and design of the cooperative study, Modification of Diet in Renal Disease [abstract]. Kidney International1987;31(1):210. PerroneR , SteinmanT , RoyalH , LawlorM , HunsickerL , Modification of Diet in Renal Disease Study Group. Markers of GFR: comparison of 99TC-DTPA (TC), 169YB-DTPA (YB) and 125I-Iothalamate (IO) to inulin (IN) [abstract]. Kidney International1987;31(1):213. PerroneRD , SteinmanTI , BeckGJ , SkibinskiCI , RoyalHD , LawlorM , et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1990;16(3):224-35. [MEDLINE: 2205098]TeschanPE , BeckGJ , DwyerJT , GreeneT , KlahrS , LevyAS , et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clinical Nephrology1998;50(5):273-83. [MEDLINE: 9840314]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]">MDRD Feasibility B 1989</a>), two studies involved two sites (<a href="./references#CD001892-bbs2-0010" title="MalvyD , MaingourdC , PengloanJ , BagrosP , NivetH . Effects of severe protein restriction with ketoanalogues in advanced renal failure. Journal of the American College of Nutrition1999;18(5):481-6. [MEDLINE: 10511331]NivetH , MaingourdC , MalvyD , PengloanJ , BagrosPH . Effects of severe protein-restriction with ketoanalogues in advanced renal failure [abstract]. Journal of the American Society of Nephrology1992;3(3):286. ">Malvy 1999</a>; <a href="./references#CD001892-bbs2-0021" title="WilliamsP , StevensME , FassG , BoneJM . A randomised trial of the effect of protein and phosphate restriction on the progression of chronic renal failure [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:38. WilliamsPS , StevensM , FassG , BoneJM . A randomised trial of the effect of protein and phosphate restriction on the progression of chronic renal failure [abstract]. Nephrology Dialysis Transplantation1987;2(4):285. WilliamsPS , StevensM , IronsL , FassG , BoneJM . Failure of  dietary protein/phosphate restriction to slow the progression of chronic renal failure; a prospective randomised controlled trial [abstract]. Nephrology Dialysis Transplantation1990;5(8):674. WilliamsPS , StevensME , FassG , IronsL , BoneJM . Failure of dietary protein and phosphate restriction to retard the rate of progression of chronic renal failure: a prospective, randomized, controlled trial. Quarterly Journal of Medicine1991;81(294):837-55. [MEDLINE: 1801057]WilliamsPS , StevensME . A randomised trial of the effect of protein and phosphate restriction on the progression of chronic renal failure [abstract]. Nephrology Dialysis Transplantation1987;2(5):401. ">Williams 1991</a>) and the remainder were single centre studies. Participant numbers ranged from 19 to 840 with an age range of 15 to 75 years. Glomerulopathies accounted for CKD in between 23% (<a href="./references#CD001892-bbs2-0021" title="WilliamsP , StevensME , FassG , BoneJM . A randomised trial of the effect of protein and phosphate restriction on the progression of chronic renal failure [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:38. WilliamsPS , StevensM , FassG , BoneJM . A randomised trial of the effect of protein and phosphate restriction on the progression of chronic renal failure [abstract]. Nephrology Dialysis Transplantation1987;2(4):285. WilliamsPS , StevensM , IronsL , FassG , BoneJM . Failure of  dietary protein/phosphate restriction to slow the progression of chronic renal failure; a prospective randomised controlled trial [abstract]. Nephrology Dialysis Transplantation1990;5(8):674. WilliamsPS , StevensME , FassG , IronsL , BoneJM . Failure of dietary protein and phosphate restriction to retard the rate of progression of chronic renal failure: a prospective, randomized, controlled trial. Quarterly Journal of Medicine1991;81(294):837-55. [MEDLINE: 1801057]WilliamsPS , StevensME . A randomised trial of the effect of protein and phosphate restriction on the progression of chronic renal failure [abstract]. Nephrology Dialysis Transplantation1987;2(5):401. ">Williams 1991</a>) and 60% (<a href="./references#CD001892-bbs2-0015" title="MeloniC , TatangeloP , CiprianiS , RossiV , SuraciC , TozzoC , et al. Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure. Journal of Renal Nutrition2004;14(4):208-13. [MEDLINE: 15483780]">Meloni 2004</a>) of participants; the types of kidney disease included were not reported in <a href="./references#CD001892-bbs2-0001" title="AlvestrandA , BuchtH , GutierrezA , BergströmJ . Progression of chronic renal failure in man as influenced by frequency and quality of clinical follow-ups [abstract]. Kidney International1985;27(1):240. BergstromJ , AlvestrandA , BuchtH , GutierrezA . Progression of chronic renal failure in man is retarded with more frequent clinical follow-ups and better blood pressure control. Clinical Nephrology1986;25(1):1-6. [MEDLINE: 3955903]BergstromJ , AlvestrandA , BuchtH , GutierrezA . Stockholm clinical study on progression of chronic renal failure--an interim report. Kidney International - Supplement1989;36(Suppl 27):S110-4. [MEDLINE: 2636644]BergstromJ , AlvestrandA , BuchtH , GutierrezA . What is the role of controls in an outpatient department on progression of renal disease?Blood Purification1988;6(6):336-42. [MEDLINE: 3061400]">Bergstrom 1986</a>, while <a href="./references#CD001892-bbs2-0016" title="Milovanov IuS, LysenkoLV , MilovanovaLI , DobrosmyslovIA . The role of balanced low-protein diet in inhibition of predialysis chronic kidney disease progression in patients with systemic diseases. Terapevticheskii Arkhiv2009;81(8):52-7. [MEDLINE: 19799201]">Milovanov 2009</a> included only participants with lupus nephritis or other vasculitides. Six diabetic nephropathy participants (three in each group) were included in <a href="./references#CD001892-bbs2-0004" title="Di IorioBR , BellizziV , MinutoloR , De NicolaL , IodiceC , ConteG . Supplemented very low-protein diet in advanced CRF: is it money saving?Kidney International2004;65(2):742. [MEDLINE: 14717953]Di IorioBR , MinutoloR , De NicolaL , BellizziV , CatapanoF , IodiceC , et al. Supplemented very low protein diet ameliorates responsiveness to erythropoietin in chronic renal failure. Kidney International2003;64(5):1822-8. [MEDLINE: 14717953]">Di Iorio 2003</a>. <a href="./references#CD001892-bbs2-0005" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 1 1990</a> and <a href="./references#CD001892-bbs2-0006" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 2 1990</a> reported that fewer than 10% of diabetic participants were included among the 554 participants assessed for inclusion in the study though it was unclear whether any diabetic participants were included in the 336 randomised participants. No diabetic participants were included in the remaining studies. </p> <p>We chose to include <a href="./references#CD001892-bbs2-0005" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 1 1990</a> and <a href="./references#CD001892-bbs2-0006" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 2 1990</a> although there were known to be some participants from one centre, who were included in these studies and in <a href="./references#CD001892-bbs2-0009" title="D'AmicoG , GentileMG , FellinG , MannaG , CofanoF . Effect of dietary protein restriction on the progression of renal failure: a prospective randomized trial. Nephrology Dialysis Transplantation1994;9(11):1590-4. [MEDLINE: 7870348]LocatelliF , AlbertiD , GentileMG , GrazianiG , BucciantiG , CosciP , et al. Effects of two different protein prescriptions on chronic renal failure progression. Cooperative study. [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:20. LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA , et al. Blood pressure and chronic renal failure progression: results from a multicentre trial [abstract]. Nephrology Dialysis Transplantation1992;7(7):712. LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA , et al. Factors affecting chronic renal failure progression: results from a multicentre trial. The Northern Italian Cooperative Study Group. Mineral &amp; Electrolyte Metabolism1992;18(2-5):295-302. [MEDLINE: 1465079]LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA . Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group. Lancet1991;337(8753):1299-304. [MEDLINE: 1674294]LocatelliF , Del VecchioL , AndrulliS , MaraiP , TentoriF . The role of underlying nephropathy in the progression of renal disease. Kidney International - Supplement2000;75:S49-55. [MEDLINE: 10828762]LocatelliF , MarcelliD , et al. Factors affecting the progression of chronic renal failure: a multivariate analysis [abstract]. Nephrology Dialysis Transplantation1989;4(5):457. LocatelliF , MarcelliD , TentoriF , MaraiP . Hypertension and progression of chronic renal failure (CRF): a prospective study [abstract]. In: 11th International Congress of Nephrology; 1990 Jul 15-20; Tokyo, Japan. 1990:37A. LocatelliF . Controlled study of protein-restricted diet in chronic renal failure. Contributions to Nephrology1989;75:141-6. [MEDLINE: 2697498]LocatelliF . Dietary compliance in patients with chronic renal failure: experience in a northern Italy trial. Contributions to Nephrology1990;81:102-6. [MEDLINE: 2093485]TentoriF , MaraiP , MarcelliD , PontiR , LocatelliF . Monocentric prospective randomized controlled study on the progression rate of chronic renal failure (CRF) with two different protein intakes [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:20. TentoriF , MaraiP . Monocentric prospective randomised controlled study on the progression rate of chronic renal failure with two different protein intakes [abstract]. Nephrology Dialysis Transplantation1987;2(5):400-1. ">Locatelli 1989</a>. We were unable to obtain an exact number of participants included in both studies. However it appeared that only about 30 participants were included in both studies, which would be only 8.9% of 336 randomised participants in <a href="./references#CD001892-bbs2-0005" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 1 1990</a> and <a href="./references#CD001892-bbs2-0006" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 2 1990</a> and 6.6% of 456 randomised participants in <a href="./references#CD001892-bbs2-0009" title="D'AmicoG , GentileMG , FellinG , MannaG , CofanoF . Effect of dietary protein restriction on the progression of renal failure: a prospective randomized trial. Nephrology Dialysis Transplantation1994;9(11):1590-4. [MEDLINE: 7870348]LocatelliF , AlbertiD , GentileMG , GrazianiG , BucciantiG , CosciP , et al. Effects of two different protein prescriptions on chronic renal failure progression. Cooperative study. [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:20. LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA , et al. Blood pressure and chronic renal failure progression: results from a multicentre trial [abstract]. Nephrology Dialysis Transplantation1992;7(7):712. LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA , et al. Factors affecting chronic renal failure progression: results from a multicentre trial. The Northern Italian Cooperative Study Group. Mineral &amp; Electrolyte Metabolism1992;18(2-5):295-302. [MEDLINE: 1465079]LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA . Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group. Lancet1991;337(8753):1299-304. [MEDLINE: 1674294]LocatelliF , Del VecchioL , AndrulliS , MaraiP , TentoriF . The role of underlying nephropathy in the progression of renal disease. Kidney International - Supplement2000;75:S49-55. [MEDLINE: 10828762]LocatelliF , MarcelliD , et al. Factors affecting the progression of chronic renal failure: a multivariate analysis [abstract]. Nephrology Dialysis Transplantation1989;4(5):457. LocatelliF , MarcelliD , TentoriF , MaraiP . Hypertension and progression of chronic renal failure (CRF): a prospective study [abstract]. In: 11th International Congress of Nephrology; 1990 Jul 15-20; Tokyo, Japan. 1990:37A. LocatelliF . Controlled study of protein-restricted diet in chronic renal failure. Contributions to Nephrology1989;75:141-6. [MEDLINE: 2697498]LocatelliF . Dietary compliance in patients with chronic renal failure: experience in a northern Italy trial. Contributions to Nephrology1990;81:102-6. [MEDLINE: 2093485]TentoriF , MaraiP , MarcelliD , PontiR , LocatelliF . Monocentric prospective randomized controlled study on the progression rate of chronic renal failure (CRF) with two different protein intakes [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:20. TentoriF , MaraiP . Monocentric prospective randomised controlled study on the progression rate of chronic renal failure with two different protein intakes [abstract]. Nephrology Dialysis Transplantation1987;2(5):400-1. ">Locatelli 1989</a> (personal communication from Professor Norbert Gretz). </p> <p>Mean duration of follow up ranged from 12 to 50 months.</p> <p>See <a href="./references#CD001892-sec-0085" title="">Characteristics of included studies</a> </p> </section> <section id="CD001892-sec-0043"> <h4 class="title">Excluded studies</h4> <p>In the 2009 update, there were 53 excluded studies (67 reports). In the 2018 update we identified a total of 71 excluded studies (101 reports). Based on the Cochrane recommendations for dealing with excluded studies, we limited the excluded studies to randomised controlled trials (RCT) and removed all non‐randomised studies from excluded studies. Therefore in the 2018 update we excluded 29 studies. Of these 13 studies investigated ineligible interventions for this review, two studies included an ineligible population such as dialysis participants or participants with diabetes mellitus and in 14 studies the duration of follow‐up was less than one year. In 2020 we identified four new excluded studies (five reports) and an additional report of one already excluded study. Two new studies were excluded for ineligible interventions and two for a duration of follow‐up of less than one year. </p> <p>See <a href="./references#CD001892-sec-0086" title="">Characteristics of excluded studies</a>. </p> </section> </section> <section id="CD001892-sec-0044"> <h3 class="title">Risk of bias in included studies</h3> <p><a href="#CD001892-fig-0002">Figure 2</a>; <a href="#CD001892-fig-0003">Figure 3</a> </p> <div class="figure" id="CD001892-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD001892-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_n/nCD001892-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD001892-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD001892-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_n/nCD001892-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD001892-sec-0045"> <h4 class="title">Allocation</h4> <p>Random sequence generation was considered at low risk of bias in 11 studies (<a href="./references#CD001892-bbs2-0003" title="CianciarusoB , PotaA , BellizziV , Di GiuseppeD , Di MiccoL , MinutoloR , et al. Effect of a low- versus moderate-protein diet on progression of CKD: follow-up of a randomized controlled trial. American Journal of Kidney Diseases2009;54(6):1052-61. [MEDLINE: 19800722]CianciarusoB , PotaA , PisaniA , TorracaS , AnnecchiniR , LombardiP , et al. Metabolic effects of two low protein diets in chronic kidney disease stage 4-5--a randomized controlled trial. Nephrology Dialysis Transplantation2008;23(2):636-44. [MEDLINE: 17981885]CianciarusoB , PotaA , TorracaS , SommaG , NazzaroP , AnnecchiniR , et al. Comparison of two different protein intakes (0.3-0.6 vs 0.7-0.9 g/kg/day) on the metabolic control of advanced renal failure [abstract no: MP197]. In: 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal. 2004:295. PotaA , PisaniA , AnnecchiniR , Di GiuseppeD , CuccurulloP , CaputoDL , et al. Treatment of chronic renal failure (CRF) with two different low protein diets. Effects on the metabolic control and on the cardiovascular risk factors [abstract no: MP306]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv401. PotaA , PisaniA , RavaniP , Di MiccoL , Di GiuseppeD , SabbatiniM , et al. Impact of two different low protein diets on survival of CKD patients (stage4-5) [abstract no: TH-PO880]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):308A. ">Cianciaruso 2008a</a>; <a href="./references#CD001892-bbs2-0005" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 1 1990</a>; <a href="./references#CD001892-bbs2-0006" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 2 1990</a>; <a href="./references#CD001892-bbs2-0007" title="GarneataL , MircescuG . Effect of low-protein diet supplemented with keto acids on progression of chronic kidney disease. Journal of Renal Nutrition2013;23(3):210-3. [MEDLINE: 23611549]GarneataL , MocanuE , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues-effects on mineral bone metabolism disorders in advanced chronic kidney disease [abstract no: FP396]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i167-8. [EMBASE: 622605156]GarneataL , StancuA , DragomirD , MircescuG . Effect of very low protein diet supplemented with ketoanalogues of the essential amino acids on the progression of chronic kidney disease [abstract]. Nephrology Dialysis Transplantation2014;29(Suppl 3):iii39. [EMBASE: 71491557]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression. Journal of the American Society of Nephrology2016;27(7):2164-76. [MEDLINE: 26823552]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues in stage 5 CKD patients [abstract no: SP373]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i472. [EMBASE: 622606118]">Garneata 2013</a>; <a href="./references#CD001892-bbs2-0009" title="D'AmicoG , GentileMG , FellinG , MannaG , CofanoF . Effect of dietary protein restriction on the progression of renal failure: a prospective randomized trial. Nephrology Dialysis Transplantation1994;9(11):1590-4. [MEDLINE: 7870348]LocatelliF , AlbertiD , GentileMG , GrazianiG , BucciantiG , CosciP , et al. Effects of two different protein prescriptions on chronic renal failure progression. Cooperative study. [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:20. LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA , et al. Blood pressure and chronic renal failure progression: results from a multicentre trial [abstract]. Nephrology Dialysis Transplantation1992;7(7):712. LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA , et al. Factors affecting chronic renal failure progression: results from a multicentre trial. The Northern Italian Cooperative Study Group. Mineral &amp; Electrolyte Metabolism1992;18(2-5):295-302. [MEDLINE: 1465079]LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA . Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group. Lancet1991;337(8753):1299-304. [MEDLINE: 1674294]LocatelliF , Del VecchioL , AndrulliS , MaraiP , TentoriF . The role of underlying nephropathy in the progression of renal disease. Kidney International - Supplement2000;75:S49-55. [MEDLINE: 10828762]LocatelliF , MarcelliD , et al. Factors affecting the progression of chronic renal failure: a multivariate analysis [abstract]. Nephrology Dialysis Transplantation1989;4(5):457. LocatelliF , MarcelliD , TentoriF , MaraiP . Hypertension and progression of chronic renal failure (CRF): a prospective study [abstract]. In: 11th International Congress of Nephrology; 1990 Jul 15-20; Tokyo, Japan. 1990:37A. LocatelliF . Controlled study of protein-restricted diet in chronic renal failure. Contributions to Nephrology1989;75:141-6. [MEDLINE: 2697498]LocatelliF . Dietary compliance in patients with chronic renal failure: experience in a northern Italy trial. Contributions to Nephrology1990;81:102-6. [MEDLINE: 2093485]TentoriF , MaraiP , MarcelliD , PontiR , LocatelliF . Monocentric prospective randomized controlled study on the progression rate of chronic renal failure (CRF) with two different protein intakes [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:20. TentoriF , MaraiP . Monocentric prospective randomised controlled study on the progression rate of chronic renal failure with two different protein intakes [abstract]. Nephrology Dialysis Transplantation1987;2(5):400-1. ">Locatelli 1989</a>; <a href="./references#CD001892-bbs2-0011" title="BeckGJ , BergRL , CogginsCH , GassmanJJ , HunsickerLG , SchluchterMD , et al. Design and statistical issues of the Modification of Diet in Renal Disease Trial. The Modification of Diet in Renal Disease Study Group. Controlled Clinical Trials1991;12(5):566-86. [MEDLINE: 1664792]Buckalew VM Jr, BergRL , WangSR , PorushJG , RauchS , SchulmanG . Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. American Journal of Kidney Diseases1996;28(6):811-21. [MEDLINE: 8957032]ChawlaV , WangX , GreeneJ , KusekJW , CollinsAJ , LeveyAS , et al. Dyslipidemia and mortality in chronic kidney disease [abstract no: TH-PO895]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A-2A. ChenJL , LernerD , RuthazerR , Castaneda-SceppaC , LeveyAS . Association of physical activity with mortality in chronic kidney disease. Journal of Nephrology2008;21(2):243-52. [MEDLINE: 18446720]ChenJL , SceppaC , RuthazerR , LeveyAS . Leisure time physical activity status and mortality in chronic kidney disease: preliminary findings from the MDRD study [abstract no: 21]. American Journal of Kidney Diseases2006;47(4):A24. CogginsCH , Breyer LewisJ , CaggiulaAW , CastaldoLS , KlahrS , WangSR . Differences between women and men with chronic renal disease. Nephrology Dialysis Transplantation1998;13(6):1430-7. [MEDLINE: 9641172]CoyneT , OlsonM , BradhamK , GarconM , GregoryP , ScherchL . Dietary satisfaction correlated with adherence in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1301-6. [MEDLINE: 7594127]DennisVW . Decoding the Modification of Diet in Renal Disease Study. Cleveland Clinic Journal of Medicine1994;61(4):254-7. [MEDLINE: 7923742]DolecekTA , OlsonMB , CaggiulaAW , DwyerJT , MilasNC , GillisBP , et al. Registered dietitian time requirements in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1307-12. [MEDLINE: 7594128]Effects of diet and antihypertensive therapy on creatinine clearance and serum creatinine concentration in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Aug;8(8):1354]. Journal of the American Society of Nephrology1996;7(4):556-66. [MEDLINE: 8724889]Effects of dietary protein restriction on the progression of moderate renal disease in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Mar;8(3):493]. Journal of the American Society of Nephrology1996;7(12):2616-26. [MEDLINE: 8989740]GassmanJJ , DrabikMJ , LeathermanJR , FaticaKJ , McPhersonJA , Modification of Diet in Renal Disease Study Group. Development and use of distributed data entry and electronic communication in a multi-center study of progressive renal disease [abstract]. Kidney International1989;35(1):226. GennariFJ , HoodVL , GreeneT , WangX , LeveyAS . Effect of Dietary Protein Intake on Serum Total CO2 Concentration in Chronic Kidney Disease: Modification of Diet in Renal Disease Study Findings. Clinical Journal of the American Society of Nephrology: CJASN2006;1(1):52-7. [MEDLINE: 17699190]GillisBP , AverbachFM , CaggiulaAW , JonesFL , NaujelisJ , MaurerE , et al. Features of the nutrient database and analysis system for the Modification of Diet in Renal Disease Study.[Erratum appears in Control Clin Trials 1994 Aug;15(4):326]. Controlled Clinical Trials1994;15(1):44-58. [MEDLINE: 8149770]GillisBP , CaggiulaAW , ChiavacciAT , CoyneT , DoroshenkoL , MilasNC , et al. Nutrition intervention program of the Modification of Diet in Renal Disease Study: a self-management approach. Journal of the American Dietetic Association1995;95(11):1288-94. [MEDLINE: 7594125]GramsME , CoreshJ , SegevDL , KucirkaLM , TighiouartH , SarnakMJ . Vascular disease, ESRD, and death: interpreting competing risk analyses. Clinical Journal of the American Society of Nephrology: CJASN2012;7(10):1606-14. [MEDLINE: 22859747]GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. GramsME , TinA , RebholzCM , ShafiT , KottgenA , PerroneRD , et al. Metabolomic alterations associated with cause of CKD. Clinical Journal of The American Society of Nephrology: CJASN2017;12(11):1787-94. [MEDLINE: 28971980]GreeneT , BeckG , WangS , KusekJ , LeveyA , Modification of Diet in Renal Disease Study Group. The effect of the low protein diet in the MDRD study A is dependent on the underlying rate of disease progression [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A. GreeneT , BourgoignieJJ , HabweV , KusekJW , SnetselaarLG , SoucieJM , et al. Baseline characteristics in the Modification of Diet in Renal Disease Study.[Republished from J Am Soc Nephrol 1993 May;3(11):1819-34]. Journal of the American Society of Nephrology1993;4(5):1221-36. [MEDLINE: 8305650]HebertLA , GreeneT , HunsickerLG , LeveyAS , WangS , MDRD Study Group. Relationship of urine volume (uv) and urine osmolality (Uosm) to the progression of renal disease in the Modification of Diet in Renal Disease (MDRD) study [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A-6A. HebertLA , KusekJW , GreeneT , AgodoaLY , JonesCA , LeveyAS , et al. Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group. Hypertension1997;30(3 (Pt 1)):428-35. [MEDLINE: 9314428]HunsickerLG , AdlerS , CaggiulaA , EnglandBK , GreeneT , KusekJW , et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney International1997;51(6):1908-19. [MEDLINE: 9186882]HunsickerLG , MDRD Study Group. Secondary analysis of the Modification of Diet in Renal Disease (MDRD) study [abstract]. In: 13th International Congress of Nephrology; 1995 Jul 2-6; Madrid, Spain. 1995:64. IxJH , ShlipakMG , SarnakMJ , BeckGJ , GreeneT , WangX , et al. Fetuin-A is not associated with all-cause or cardiovascular mortality in chronic kidney disease: data from the Modification of Diet in Renal Disease (MDRD) study [abstract no: SU-PO711]. Journal of the American Society of Nephrology2007;18(Abstracts Issue):741A. KlahrS , BreyerJA , BeckGJ , DennisVW , HartmanJA , RothD , et al. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group.[Erratum appears in J Am Soc Nephrol 1995 Oct;6(4):1318]. Journal of the American Society of Nephrology1995;5(12):2037-47. [MEDLINE: 7579052]KlahrS , LeveyAS , BeckGJ , CaggiulaAW , HunsickerL , KusekJW , et al. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. New England Journal of Medicine1994;330(13):877-84. [MEDLINE: 8114857]KlahrS , Modification of Diet in Renal Disease Study. The Modification of Diet in Renal Disease Study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]KlahrS . Primary and secondary results of the modification of diet in renal disease study. Mineral &amp; Electrolyte Metabolism1996;22(1-3):138-42. [MEDLINE: 8676806]KoppleJD , GreeneT , ChumleaWC , HollingerD , MaroniBJ , MerrillD , et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney International2000;57(4):1688-703. [MEDLINE: 10760105]KoppleJD , LeveyAS , GreeneT , ChumleaWC , GassmanJJ , HollingerDL , et al. Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. Kidney International1997;52(3):778-91. [MEDLINE: 9291200]KuE , GliddenDV , JohansenKL , SarnakM , TighiouartH , GrimesB , et al. Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease. Kidney International2015;87(5):1055-60. [MEDLINE: 25493952]KusekJW , CoyneT , deVelascoA , DrabikMJ , FinlayRA , GassmanJJ , et al. Recruitment experience in the full-scale phase of the Modification of Diet in Renal Disease Study. Controlled Clinical Trials1993;14(6):538-57. [MEDLINE: 8119068]KusekJW , CoyneT , deVelascoA , GassmanJ , KieferS , PowersS , et al. Recruitment experience in the full scale phase of the Modification of Diet in Renal Disease (MDRD) Study [abstract]. Controlled Clinical Trials1991;12:678. KwongYT , StevensLA , SelvinE , ZhangYL , GreeneT , Van LenteF , et al. Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. American Journal of Kidney Diseases2010;56(1):39-49. [MEDLINE: 20537455]LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , LeveyAS , MilasNC , et al. Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. Hypertension1997;29(2):641-50. [MEDLINE: 9040451]Leonberg-YooAK , TighiouartH , LeveyAS , BeckGJ , SarnakMJ . Urine potassium excretion, kidney failure, and mortality in CKD. American Journal of Kidney Diseases2017;69(3):341-9. [MEDLINE: 27233381]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , BoschJP , LewisJB , GreeneT , RogersN , RothD , et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of Internal Medicine1999;130(6):461-70. [MEDLINE: 10075613]LeveyAS , CoreshJ , GreeneT , StevensLA , ZhangYL , HendriksenS , et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate.[Erratum appears in Ann Intern Med. 2008 Oct 7;149(7):519]. Annals of Internal Medicine2006;145(4):247-54. [MEDLINE: 16908915]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study Group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]LeveyAS , GreeneT , SarnakM , WangX , BeckGJ , KusekJW , et al. Effect of low protein diet on progression of kidney disease in the Modification of Diet in Renal Disease study A: long-term follow-up [abstract no: SU-PO247]. Journal of the American Society of Nephrology2004;15(Oct):586A-7A. LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2006;48(6):879-88. [MEDLINE: 17162142]LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. The effect of very low protein diet on progression of kidney disease and mortality in Modification of Diet in Renal Disease Study B [abstract no: SU-PO246]. Journal of the American Society of Nephrology2004;15(Oct):586A. LeveyAS , GreeneT , SchluchterMD , ClearyPA , TeschanPE , LorenzRA , et al. Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. Journal of the American Society of Nephrology1993;4(5):1159-71. [MEDLINE: 8305642]MaderoM , SarnakM , WangX , GreeneT , CollinsA , BeckG , et al. Uric acid and development of kidney failure in chronic kidney disease [abstract no: F-PO1932]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):547A. MaderoM , SarnakMJ , WangX , GreeneT , BeckGJ , KusekJW , et al. Uric acid and long-term outcomes in CKD. American Journal of Kidney Diseases2009;53(5):796-803. [MEDLINE: 19303683]MaderoM , SarnakMJ , WangX , SceppaCC , GreeneT , BeckGJ , et al. Body mass index and mortality in CKD. American Journal of Kidney Diseases2007;50(3):404-11. [MEDLINE: 17720519]MaderoM , WangX , GreenT , HunsickerLG , BeckGJ , KusekJW , et al. Effect of trial participation on outcomes in the randomized and non-randomized cohorts of the Modification of Diet in Renal Disease study [abstract no: F-PO037]. Journal of the American Society of Nephrology2006;17(Abstracts):344A. MDRD Study Group, ChumleaWC , GassmanJJ , HollingerDL , MerrillD , ScherchLK , et al. Nutritional response to diet prescription in the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, HunsickerLG , AdlerS , CaggiulaAW , EnglandB , GreeneT , et al. Relationship among baseline proteinuria (p), mean arterial blood pressure (map) during follow-up, and decline in glomerular filtration rate (aGFR) in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, KoppleJD , ChumleaWC , GassmanJJ , HollingerDL , MaroniBJ , et al. Relationship between FGR and nutritional status - results from the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, KusekJW , AgodoaL , GreeneT , JonesC . Comparison of decline of GFR in blacks versus non-blacks in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , BoschJP , CaggiulaAW , GreeneT , et al. Short-term effects of protein intake, blood pressure, and antihypertensive therapy on GFR in the MDRD study. Journal of the American Society of Nephrology1995;6(3):395. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , HunsickerLG , et al. A hypothesis for the results of the Modification of Diet in Renal Disease (MDRD) study. [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , KusekJW , et al. Trends toward a beneficial effect of a low protein diet during additional follow-up in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1994;5(3):336. MDRD Study Group, LeveyAS , BeckGJ . Trends toward a beneficial effect of a low protein diet during additional follow-up in the modification of diet in renal disease study. MDRD Study Group. [abstract]. Nephrology Dialysis Transplantation1995;10(6):985. MDRD Study Group, LeveyAS , BoschJP , CogginsCH , GreeneT , MitchWE , et al. Effects of diet and blood pressure on creatinine clearance (CCr) and serum creatinine (PCr) in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, PetersonJC , BurkartJ , GreeneT , HebertL , KingA , et al. The effect of blood pressure control on progression of renal disease depends on level of proteinuria (p) at baseline evaluation [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, PetersonJC , GreeneT , KlahrS , BurkartJM , HebertL , et al. Effect of reducing proteinuria (PR) on subsequent glomerular filtration rate (GFR) decline in patients with chronic renal failure (CRF) [abstract]. Journal of the American Society of Nephrology1994;5(3):339. MDRD Study Group, PorushJG , LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , et al. Efficacy of anti-hypertensive interventions in reducing blood pressure in the MDRD study [abstract]. Journal of the American Society of Nephrology1995;6(3):400. MDRD Study Group, PowersSN , KurtzmanDA , PetotGJ , RaizmanDJ , WetsteinL . Promoting dietary compliance through computer-assisted education, assessment, and counseling. [abstract]. Kidney International1988;36(Suppl 27):S306. MDRD Study Group, RoccoMV , CoyneT , EastinS , FaubertJ , GassmanJJ , et al. Patient symptoms and quality of life in the MDRD study at enrollment-correlation with GFR [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group. The modification of diet in renal disease study: results from the full-scale trial [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:593. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Hemoglobin A1c and mortality in chronic kidney disease [abstract no: F-FC149]. Journal of the American Society of Nephrology2005;16:71A. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Insulin resistance as a predictor of all-cause and cardiovascular mortality (CVD) in chronic kidney disease (CKD) [abstract no: F-P0284]. Journal of the American Society of Nephrology2004;15(Oct):128A. MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. Journal of the American Society of Nephrology2005;16(11):3411-7. [MEDLINE: 16207824]MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD. American Journal of Kidney Diseases2005;46(3):455-63. [MEDLINE: 16129207]MenonV , GreeneT , WangX , PereiraAA , MarcovinaSM , BeckGJ , et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney International2005;68(2):766-72. [MEDLINE: 16014054]MenonV , GreenT , PereiraA , XueleiW , BeckG , KusekJ , et al. C-reactive protein (CRP) as a predictor of all-cause and cardiovascular (CVD) mortality in patients with chronic kidney disease (CKD) [abstract no: F-P0275]. Journal of the American Society of Nephrology2004;15(Oct):125A-6A. MenonV , KoppleJD , WangX , BeckGJ , CollinsAJ , KusekJW , et al. Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2009;53(2):208-17. [MEDLINE: 18950911]MenonV , LiL , GreeneT , WangX , ChandraP , BalakrishnanV , et al. Adiponectin and outcomes in chronic kidney disease [abstract no: TH-PO430]. Journal of the American Society of Nephrology2006;17(Abstracts):199A. MenonV , LiL , WangX , GreeneT , BalakrishnanV , MaderoM , et al. Adiponectin and mortality in patients with chronic kidney disease. Journal of the American Society of Nephrology2006;17(9):2599-606. [MEDLINE: 16885405]MenonV , SarnakMJ , GreeneT , WangX , PereiraAA , BeckGJ , et al. Relationship between homocysteine and mortality in chronic kidney disease. Circulation2006;113(12):1572-7. [MEDLINE: 16549639]MenonV , ShlipakMG , WangX , CoreshJ , GreeneT , StevensL , et al. Cystatin C as a risk factor for outcomes in chronic kidney disease. Annals of Internal Medicine2007;147(1):19-27. [MEDLINE: 17606957]MenonV , TighiouartH , VaughnNS , BeckGJ , KusekJW , CollinsAJ , et al. Serum bicarbonate and long-term outcomes in CKD. American Journal of Kidney Diseases2010;56(5):907-14. [MEDLINE: 20605301]MenonV , WangX , GreeneT , BeckGJ , KusekJW , MarcovinaSM , et al. Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. American Journal of Kidney Diseases2003;42(1):44-52. [MEDLINE: 12830455]MenonV , WangX , GreeneT , BeckGJ , KusekJW , SelhubJ , et al. Homocysteine in chronic kidney disease: effect of low protein diet and repletion with B vitamins. Kidney International2005;67(4):1539-46. [MEDLINE: 15780109]MenonV , WangX , SarnakMJ , HunsickerLH , MaderoM , BeckGJ , et al. Long-term outcomes in nondiabetic chronic kidney disease. Kidney International2008;73(11):1310-5. [MEDLINE: 18337713]MilasNC , NowalkMP , AkpeleL , CastaldoL , CoyneT , DoroshenkoL , et al. Factors associated with adherence to the dietary protein intervention in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1295-300. [MEDLINE: 7594126]NewsomeB , IxJH , TighiouartH , SarnakMJ , LeveyAS , BeckGJ , et al. Effect of protein restriction on serum and urine phosphate in the modification of diet in renal disease (MDRD) study. American Journal of Kidney Diseases2013;61(6):1045-6. [MEDLINE: 23415016]OlsonM , CoyneT , CaggiulaA , GregoryP . Patient satisfaction with a dietary intervention: the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):107S. OlsonM , CoyneT , CaggiulaA . Social factors influence dietary satisfaction in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1996;17(2 Suppl):133S. OlsonM , DolecekT , CaggiulaA , DwyerJ . Time required for the protein intervention in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):129S-30S. PetersonJC , AdlerS , BurkartJM , GreeneT , HebertLA , HunsickerLG , et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Annals of Internal Medicine1995;123(10):754-62. [MEDLINE: 7574193]PiccoliM , CodognottoM . Missing stratification by polycistic kidney disease (PKD) flaws risk estimates of GFR decline. Lesson from the MDRD Study [abstract no: F-PO175]. Journal of the American Society of Nephrology2004;15(Oct):103A. RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]RoccoMV , GassmanJJ , WangSR , KaplanRM . Cross-sectional study of quality of life and symptoms in chronic renal disease patients: the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1997;29(6):888-96. [MEDLINE: 9186075]SarnakMJ , GreeneT , WangX , BeckG , KusekJW , CollinsAJ , et al. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease study. Annals of Internal Medicine2005;142(5):342-51. [MEDLINE: 15738453]SarnakMJ , WangSR , BeckGJ , KusekJW , SelhubJ , GreeneT , et al. Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression. American Journal of Kidney Diseases2002;40(5):932-9. [MEDLINE: 12407637]SarnakMJ , WangX , GreeneT , GeraldJ , BeckJ , KusekJW , et al. Effect of strict blood pressure control on long-term outcome in the Modification of Diet in Renal Disease (MDRD) study [abstract no: F-P0599]. Journal of the American Society of Nephrology2003;14(Nov):192A. SchluchterMD . Estimating correlation between alternative measures of disease progression in a longitudinal study. Modification of Diet in Renal Disease Study. Statistics in Medicine1990;9(10):1175-88. [MEDLINE: 2247718]Short-term effects of protein intake, blood pressure, and antihypertensive therapy on glomerular filtration rate in the Modification of Diet in Renal Disease Study. Journal of the American Society of Nephrology1996;7(10):2097-109. [MEDLINE: 8915969]StollarC , ScherchL , AdlerS , KusekJ , CaggiulaA . Patterns of patient dietary compliance in the Modification of Diet in Renal Disease (MDRD) study, phase III. [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:609. TangriN , StevensLA , SchmidCH , ZhangYL , BeckGJ , GreeneT , et al. Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney International2011;79(4):471-7. [MEDLINE: 20980977]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]YamamotoME , OlsonMB , StollarC , MDRD Study Group. Effects of weight and Na+ change on blood pressures of hypertensive MDRD study patients [abstract]. Journal of the American Society of Nephrology1995;6(3):408. YoungJA , TerrinN , GreeneT , WangX , BeckG , KusekJ , et al. Asymmetric dimethylarginine and prevalent cardiovascular disease in patients with chronic kidney disease [abstract no: F-PO935]. Journal of the American Society of Nephrology2007;18(Abstracts):308A-9A. YoungJA , TerrinN , WangX , GreenT , BeckG , KusekJ , et al. ADMA and mortality in stage 3-4 chronic kidney disease [abstract no: TH-PO894]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A. ">MDRD 1 1989</a>; <a href="./references#CD001892-bbs2-0012" title="GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. KlahrS . The modification of diet in renal disease study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]">MDRD 2 1989</a>; <a href="./references#CD001892-bbs2-0013" title="CogginsCH , DwyerJT , GreeneT , PetotG , SnetselaarLG , Van LenteF , et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):514-23. [MEDLINE: 8154486]KlahrS , LeveyAS , SandbergAM , WilliamsGW , MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International1989;35(1):195. KoppleJD , BergR , HouserH , SteinmanTI , TeschanP . Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S184-94. [MEDLINE: 2636655]LaidlawSA , BergRL , KoppleJD , NaitoH , WalkerWG , WalserM . Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):504-13. [MEDLINE: 8154485]LeveyAS , BergRL , GassmanJJ , HallPM , WalkerWG . Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S73-80. [MEDLINE: 2636677]LeveyAS , GassmanJJ , HallPM , WalkerWG , MDRD Study Group. Poor correlation of rates of change of creatinine clearance, reciprocal serum creatinine and GFR [abstract]. Kidney International1989;35(1):197. LeveyAS , GassmanJJ , HallPM , WalkerWG . Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. Journal of the American Society of Nephrology1991;1(9):1087-94. [MEDLINE: 1912407]MDRD Study Group, MitchME , SteinmanTI . Objectives and design of the cooperative study, Modification of Diet in Renal Disease [abstract]. Kidney International1987;31(1):210. PerroneR , SteinmanT , RoyalH , LawlorM , HunsickerL , Modification of Diet in Renal Disease Study Group. Markers of GFR: comparison of 99TC-DTPA (TC), 169YB-DTPA (YB) and 125I-Iothalamate (IO) to inulin (IN) [abstract]. Kidney International1987;31(1):213. PerroneRD , SteinmanTI , BeckGJ , SkibinskiCI , RoyalHD , LawlorM , et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1990;16(3):224-35. [MEDLINE: 2205098]TeschanPE , BeckGJ , DwyerJT , GreeneT , KlahrS , LevyAS , et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clinical Nephrology1998;50(5):273-83. [MEDLINE: 9840314]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]">MDRD Feasibility A 1989</a>; <a href="./references#CD001892-bbs2-0014" title="CogginsCH , DwyerJT , GreeneT , PetotG , SnetselaarLG , Van LenteF , et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):514-23. [MEDLINE: 8154486]KlahrS , LeveyAS , SandbergAM , WilliamsGW , MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International1989;35(1):195. KoppleJD , BergR , HouserH , SteinmanTI , TeschanP . Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S184-94. [MEDLINE: 2636655]LaidlawSA , BergRL , KoppleJD , NaitoH , WalkerWG , WalserM . Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):504-13. [MEDLINE: 8154485]LeveyAS , BergRL , GassmanJJ , HallPM , WalkerWG . Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S73-80. [MEDLINE: 2636677]LeveyAS , GassmanJJ , HallPM , WalkerWG , Modification of Diet in Renal Disease Study. Poor correlation of rates of change of creatinine clearance, reciprocal serum creatinine and GFR [abstract]. Kidney International1989;35(1):197. LeveyAS , GassmanJJ , HallPM , WalkerWG . Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. Journal of the American Society of Nephrology1991;1(9):1087-94. [MEDLINE: 1912407]MDRD Study Group, MitchME , SteinmanTI . Objectives and design of the cooperative study, Modification of Diet in Renal Disease [abstract]. Kidney International1987;31(1):210. PerroneR , SteinmanT , RoyalH , LawlorM , HunsickerL , Modification of Diet in Renal Disease Study Group. Markers of GFR: comparison of 99TC-DTPA (TC), 169YB-DTPA (YB) and 125I-Iothalamate (IO) to inulin (IN) [abstract]. Kidney International1987;31(1):213. PerroneRD , SteinmanTI , BeckGJ , SkibinskiCI , RoyalHD , LawlorM , et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1990;16(3):224-35. [MEDLINE: 2205098]TeschanPE , BeckGJ , DwyerJT , GreeneT , KlahrS , LevyAS , et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clinical Nephrology1998;50(5):273-83. [MEDLINE: 9840314]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]">MDRD Feasibility B 1989</a>; <a href="./references#CD001892-bbs2-0015" title="MeloniC , TatangeloP , CiprianiS , RossiV , SuraciC , TozzoC , et al. Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure. Journal of Renal Nutrition2004;14(4):208-13. [MEDLINE: 15483780]">Meloni 2004</a>; <a href="./references#CD001892-bbs2-0021" title="WilliamsP , StevensME , FassG , BoneJM . A randomised trial of the effect of protein and phosphate restriction on the progression of chronic renal failure [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:38. WilliamsPS , StevensM , FassG , BoneJM . A randomised trial of the effect of protein and phosphate restriction on the progression of chronic renal failure [abstract]. Nephrology Dialysis Transplantation1987;2(4):285. WilliamsPS , StevensM , IronsL , FassG , BoneJM . Failure of  dietary protein/phosphate restriction to slow the progression of chronic renal failure; a prospective randomised controlled trial [abstract]. Nephrology Dialysis Transplantation1990;5(8):674. WilliamsPS , StevensME , FassG , IronsL , BoneJM . Failure of dietary protein and phosphate restriction to retard the rate of progression of chronic renal failure: a prospective, randomized, controlled trial. Quarterly Journal of Medicine1991;81(294):837-55. [MEDLINE: 1801057]WilliamsPS , StevensME . A randomised trial of the effect of protein and phosphate restriction on the progression of chronic renal failure [abstract]. Nephrology Dialysis Transplantation1987;2(5):401. ">Williams 1991</a>) and unclear in the remaining studies. </p> <p>Allocation concealment was considered to be at low risk of bias in nine studies (<a href="./references#CD001892-bbs2-0003" title="CianciarusoB , PotaA , BellizziV , Di GiuseppeD , Di MiccoL , MinutoloR , et al. Effect of a low- versus moderate-protein diet on progression of CKD: follow-up of a randomized controlled trial. American Journal of Kidney Diseases2009;54(6):1052-61. [MEDLINE: 19800722]CianciarusoB , PotaA , PisaniA , TorracaS , AnnecchiniR , LombardiP , et al. Metabolic effects of two low protein diets in chronic kidney disease stage 4-5--a randomized controlled trial. Nephrology Dialysis Transplantation2008;23(2):636-44. [MEDLINE: 17981885]CianciarusoB , PotaA , TorracaS , SommaG , NazzaroP , AnnecchiniR , et al. Comparison of two different protein intakes (0.3-0.6 vs 0.7-0.9 g/kg/day) on the metabolic control of advanced renal failure [abstract no: MP197]. In: 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal. 2004:295. PotaA , PisaniA , AnnecchiniR , Di GiuseppeD , CuccurulloP , CaputoDL , et al. Treatment of chronic renal failure (CRF) with two different low protein diets. Effects on the metabolic control and on the cardiovascular risk factors [abstract no: MP306]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv401. PotaA , PisaniA , RavaniP , Di MiccoL , Di GiuseppeD , SabbatiniM , et al. Impact of two different low protein diets on survival of CKD patients (stage4-5) [abstract no: TH-PO880]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):308A. ">Cianciaruso 2008a</a>; <a href="./references#CD001892-bbs2-0005" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 1 1990</a>; <a href="./references#CD001892-bbs2-0006" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 2 1990</a>; <a href="./references#CD001892-bbs2-0007" title="GarneataL , MircescuG . Effect of low-protein diet supplemented with keto acids on progression of chronic kidney disease. Journal of Renal Nutrition2013;23(3):210-3. [MEDLINE: 23611549]GarneataL , MocanuE , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues-effects on mineral bone metabolism disorders in advanced chronic kidney disease [abstract no: FP396]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i167-8. [EMBASE: 622605156]GarneataL , StancuA , DragomirD , MircescuG . Effect of very low protein diet supplemented with ketoanalogues of the essential amino acids on the progression of chronic kidney disease [abstract]. Nephrology Dialysis Transplantation2014;29(Suppl 3):iii39. [EMBASE: 71491557]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression. Journal of the American Society of Nephrology2016;27(7):2164-76. [MEDLINE: 26823552]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues in stage 5 CKD patients [abstract no: SP373]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i472. [EMBASE: 622606118]">Garneata 2013</a>; <a href="./references#CD001892-bbs2-0009" title="D'AmicoG , GentileMG , FellinG , MannaG , CofanoF . Effect of dietary protein restriction on the progression of renal failure: a prospective randomized trial. Nephrology Dialysis Transplantation1994;9(11):1590-4. [MEDLINE: 7870348]LocatelliF , AlbertiD , GentileMG , GrazianiG , BucciantiG , CosciP , et al. Effects of two different protein prescriptions on chronic renal failure progression. Cooperative study. [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:20. LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA , et al. Blood pressure and chronic renal failure progression: results from a multicentre trial [abstract]. Nephrology Dialysis Transplantation1992;7(7):712. LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA , et al. Factors affecting chronic renal failure progression: results from a multicentre trial. The Northern Italian Cooperative Study Group. Mineral &amp; Electrolyte Metabolism1992;18(2-5):295-302. [MEDLINE: 1465079]LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA . Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group. Lancet1991;337(8753):1299-304. [MEDLINE: 1674294]LocatelliF , Del VecchioL , AndrulliS , MaraiP , TentoriF . The role of underlying nephropathy in the progression of renal disease. Kidney International - Supplement2000;75:S49-55. [MEDLINE: 10828762]LocatelliF , MarcelliD , et al. Factors affecting the progression of chronic renal failure: a multivariate analysis [abstract]. Nephrology Dialysis Transplantation1989;4(5):457. LocatelliF , MarcelliD , TentoriF , MaraiP . Hypertension and progression of chronic renal failure (CRF): a prospective study [abstract]. In: 11th International Congress of Nephrology; 1990 Jul 15-20; Tokyo, Japan. 1990:37A. LocatelliF . Controlled study of protein-restricted diet in chronic renal failure. Contributions to Nephrology1989;75:141-6. [MEDLINE: 2697498]LocatelliF . Dietary compliance in patients with chronic renal failure: experience in a northern Italy trial. Contributions to Nephrology1990;81:102-6. [MEDLINE: 2093485]TentoriF , MaraiP , MarcelliD , PontiR , LocatelliF . Monocentric prospective randomized controlled study on the progression rate of chronic renal failure (CRF) with two different protein intakes [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:20. TentoriF , MaraiP . Monocentric prospective randomised controlled study on the progression rate of chronic renal failure with two different protein intakes [abstract]. Nephrology Dialysis Transplantation1987;2(5):400-1. ">Locatelli 1989</a>; <a href="./references#CD001892-bbs2-0011" title="BeckGJ , BergRL , CogginsCH , GassmanJJ , HunsickerLG , SchluchterMD , et al. Design and statistical issues of the Modification of Diet in Renal Disease Trial. The Modification of Diet in Renal Disease Study Group. Controlled Clinical Trials1991;12(5):566-86. [MEDLINE: 1664792]Buckalew VM Jr, BergRL , WangSR , PorushJG , RauchS , SchulmanG . Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. American Journal of Kidney Diseases1996;28(6):811-21. [MEDLINE: 8957032]ChawlaV , WangX , GreeneJ , KusekJW , CollinsAJ , LeveyAS , et al. Dyslipidemia and mortality in chronic kidney disease [abstract no: TH-PO895]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A-2A. ChenJL , LernerD , RuthazerR , Castaneda-SceppaC , LeveyAS . Association of physical activity with mortality in chronic kidney disease. Journal of Nephrology2008;21(2):243-52. [MEDLINE: 18446720]ChenJL , SceppaC , RuthazerR , LeveyAS . Leisure time physical activity status and mortality in chronic kidney disease: preliminary findings from the MDRD study [abstract no: 21]. American Journal of Kidney Diseases2006;47(4):A24. CogginsCH , Breyer LewisJ , CaggiulaAW , CastaldoLS , KlahrS , WangSR . Differences between women and men with chronic renal disease. Nephrology Dialysis Transplantation1998;13(6):1430-7. [MEDLINE: 9641172]CoyneT , OlsonM , BradhamK , GarconM , GregoryP , ScherchL . Dietary satisfaction correlated with adherence in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1301-6. [MEDLINE: 7594127]DennisVW . Decoding the Modification of Diet in Renal Disease Study. Cleveland Clinic Journal of Medicine1994;61(4):254-7. [MEDLINE: 7923742]DolecekTA , OlsonMB , CaggiulaAW , DwyerJT , MilasNC , GillisBP , et al. Registered dietitian time requirements in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1307-12. [MEDLINE: 7594128]Effects of diet and antihypertensive therapy on creatinine clearance and serum creatinine concentration in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Aug;8(8):1354]. Journal of the American Society of Nephrology1996;7(4):556-66. [MEDLINE: 8724889]Effects of dietary protein restriction on the progression of moderate renal disease in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Mar;8(3):493]. Journal of the American Society of Nephrology1996;7(12):2616-26. [MEDLINE: 8989740]GassmanJJ , DrabikMJ , LeathermanJR , FaticaKJ , McPhersonJA , Modification of Diet in Renal Disease Study Group. Development and use of distributed data entry and electronic communication in a multi-center study of progressive renal disease [abstract]. Kidney International1989;35(1):226. GennariFJ , HoodVL , GreeneT , WangX , LeveyAS . Effect of Dietary Protein Intake on Serum Total CO2 Concentration in Chronic Kidney Disease: Modification of Diet in Renal Disease Study Findings. Clinical Journal of the American Society of Nephrology: CJASN2006;1(1):52-7. [MEDLINE: 17699190]GillisBP , AverbachFM , CaggiulaAW , JonesFL , NaujelisJ , MaurerE , et al. Features of the nutrient database and analysis system for the Modification of Diet in Renal Disease Study.[Erratum appears in Control Clin Trials 1994 Aug;15(4):326]. Controlled Clinical Trials1994;15(1):44-58. [MEDLINE: 8149770]GillisBP , CaggiulaAW , ChiavacciAT , CoyneT , DoroshenkoL , MilasNC , et al. Nutrition intervention program of the Modification of Diet in Renal Disease Study: a self-management approach. Journal of the American Dietetic Association1995;95(11):1288-94. [MEDLINE: 7594125]GramsME , CoreshJ , SegevDL , KucirkaLM , TighiouartH , SarnakMJ . Vascular disease, ESRD, and death: interpreting competing risk analyses. Clinical Journal of the American Society of Nephrology: CJASN2012;7(10):1606-14. [MEDLINE: 22859747]GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. GramsME , TinA , RebholzCM , ShafiT , KottgenA , PerroneRD , et al. Metabolomic alterations associated with cause of CKD. Clinical Journal of The American Society of Nephrology: CJASN2017;12(11):1787-94. [MEDLINE: 28971980]GreeneT , BeckG , WangS , KusekJ , LeveyA , Modification of Diet in Renal Disease Study Group. The effect of the low protein diet in the MDRD study A is dependent on the underlying rate of disease progression [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A. GreeneT , BourgoignieJJ , HabweV , KusekJW , SnetselaarLG , SoucieJM , et al. Baseline characteristics in the Modification of Diet in Renal Disease Study.[Republished from J Am Soc Nephrol 1993 May;3(11):1819-34]. Journal of the American Society of Nephrology1993;4(5):1221-36. [MEDLINE: 8305650]HebertLA , GreeneT , HunsickerLG , LeveyAS , WangS , MDRD Study Group. Relationship of urine volume (uv) and urine osmolality (Uosm) to the progression of renal disease in the Modification of Diet in Renal Disease (MDRD) study [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A-6A. HebertLA , KusekJW , GreeneT , AgodoaLY , JonesCA , LeveyAS , et al. Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group. Hypertension1997;30(3 (Pt 1)):428-35. [MEDLINE: 9314428]HunsickerLG , AdlerS , CaggiulaA , EnglandBK , GreeneT , KusekJW , et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney International1997;51(6):1908-19. [MEDLINE: 9186882]HunsickerLG , MDRD Study Group. Secondary analysis of the Modification of Diet in Renal Disease (MDRD) study [abstract]. In: 13th International Congress of Nephrology; 1995 Jul 2-6; Madrid, Spain. 1995:64. IxJH , ShlipakMG , SarnakMJ , BeckGJ , GreeneT , WangX , et al. Fetuin-A is not associated with all-cause or cardiovascular mortality in chronic kidney disease: data from the Modification of Diet in Renal Disease (MDRD) study [abstract no: SU-PO711]. Journal of the American Society of Nephrology2007;18(Abstracts Issue):741A. KlahrS , BreyerJA , BeckGJ , DennisVW , HartmanJA , RothD , et al. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group.[Erratum appears in J Am Soc Nephrol 1995 Oct;6(4):1318]. Journal of the American Society of Nephrology1995;5(12):2037-47. [MEDLINE: 7579052]KlahrS , LeveyAS , BeckGJ , CaggiulaAW , HunsickerL , KusekJW , et al. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. New England Journal of Medicine1994;330(13):877-84. [MEDLINE: 8114857]KlahrS , Modification of Diet in Renal Disease Study. The Modification of Diet in Renal Disease Study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]KlahrS . Primary and secondary results of the modification of diet in renal disease study. Mineral &amp; Electrolyte Metabolism1996;22(1-3):138-42. [MEDLINE: 8676806]KoppleJD , GreeneT , ChumleaWC , HollingerD , MaroniBJ , MerrillD , et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney International2000;57(4):1688-703. [MEDLINE: 10760105]KoppleJD , LeveyAS , GreeneT , ChumleaWC , GassmanJJ , HollingerDL , et al. Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. Kidney International1997;52(3):778-91. [MEDLINE: 9291200]KuE , GliddenDV , JohansenKL , SarnakM , TighiouartH , GrimesB , et al. Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease. Kidney International2015;87(5):1055-60. [MEDLINE: 25493952]KusekJW , CoyneT , deVelascoA , DrabikMJ , FinlayRA , GassmanJJ , et al. Recruitment experience in the full-scale phase of the Modification of Diet in Renal Disease Study. Controlled Clinical Trials1993;14(6):538-57. [MEDLINE: 8119068]KusekJW , CoyneT , deVelascoA , GassmanJ , KieferS , PowersS , et al. Recruitment experience in the full scale phase of the Modification of Diet in Renal Disease (MDRD) Study [abstract]. Controlled Clinical Trials1991;12:678. KwongYT , StevensLA , SelvinE , ZhangYL , GreeneT , Van LenteF , et al. Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. American Journal of Kidney Diseases2010;56(1):39-49. [MEDLINE: 20537455]LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , LeveyAS , MilasNC , et al. Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. Hypertension1997;29(2):641-50. [MEDLINE: 9040451]Leonberg-YooAK , TighiouartH , LeveyAS , BeckGJ , SarnakMJ . Urine potassium excretion, kidney failure, and mortality in CKD. American Journal of Kidney Diseases2017;69(3):341-9. [MEDLINE: 27233381]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , BoschJP , LewisJB , GreeneT , RogersN , RothD , et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of Internal Medicine1999;130(6):461-70. [MEDLINE: 10075613]LeveyAS , CoreshJ , GreeneT , StevensLA , ZhangYL , HendriksenS , et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate.[Erratum appears in Ann Intern Med. 2008 Oct 7;149(7):519]. Annals of Internal Medicine2006;145(4):247-54. [MEDLINE: 16908915]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study Group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]LeveyAS , GreeneT , SarnakM , WangX , BeckGJ , KusekJW , et al. Effect of low protein diet on progression of kidney disease in the Modification of Diet in Renal Disease study A: long-term follow-up [abstract no: SU-PO247]. Journal of the American Society of Nephrology2004;15(Oct):586A-7A. LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2006;48(6):879-88. [MEDLINE: 17162142]LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. The effect of very low protein diet on progression of kidney disease and mortality in Modification of Diet in Renal Disease Study B [abstract no: SU-PO246]. Journal of the American Society of Nephrology2004;15(Oct):586A. LeveyAS , GreeneT , SchluchterMD , ClearyPA , TeschanPE , LorenzRA , et al. Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. Journal of the American Society of Nephrology1993;4(5):1159-71. [MEDLINE: 8305642]MaderoM , SarnakM , WangX , GreeneT , CollinsA , BeckG , et al. Uric acid and development of kidney failure in chronic kidney disease [abstract no: F-PO1932]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):547A. MaderoM , SarnakMJ , WangX , GreeneT , BeckGJ , KusekJW , et al. Uric acid and long-term outcomes in CKD. American Journal of Kidney Diseases2009;53(5):796-803. [MEDLINE: 19303683]MaderoM , SarnakMJ , WangX , SceppaCC , GreeneT , BeckGJ , et al. Body mass index and mortality in CKD. American Journal of Kidney Diseases2007;50(3):404-11. [MEDLINE: 17720519]MaderoM , WangX , GreenT , HunsickerLG , BeckGJ , KusekJW , et al. Effect of trial participation on outcomes in the randomized and non-randomized cohorts of the Modification of Diet in Renal Disease study [abstract no: F-PO037]. Journal of the American Society of Nephrology2006;17(Abstracts):344A. MDRD Study Group, ChumleaWC , GassmanJJ , HollingerDL , MerrillD , ScherchLK , et al. Nutritional response to diet prescription in the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, HunsickerLG , AdlerS , CaggiulaAW , EnglandB , GreeneT , et al. Relationship among baseline proteinuria (p), mean arterial blood pressure (map) during follow-up, and decline in glomerular filtration rate (aGFR) in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, KoppleJD , ChumleaWC , GassmanJJ , HollingerDL , MaroniBJ , et al. Relationship between FGR and nutritional status - results from the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, KusekJW , AgodoaL , GreeneT , JonesC . Comparison of decline of GFR in blacks versus non-blacks in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , BoschJP , CaggiulaAW , GreeneT , et al. Short-term effects of protein intake, blood pressure, and antihypertensive therapy on GFR in the MDRD study. Journal of the American Society of Nephrology1995;6(3):395. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , HunsickerLG , et al. A hypothesis for the results of the Modification of Diet in Renal Disease (MDRD) study. [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , KusekJW , et al. Trends toward a beneficial effect of a low protein diet during additional follow-up in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1994;5(3):336. MDRD Study Group, LeveyAS , BeckGJ . Trends toward a beneficial effect of a low protein diet during additional follow-up in the modification of diet in renal disease study. MDRD Study Group. [abstract]. Nephrology Dialysis Transplantation1995;10(6):985. MDRD Study Group, LeveyAS , BoschJP , CogginsCH , GreeneT , MitchWE , et al. Effects of diet and blood pressure on creatinine clearance (CCr) and serum creatinine (PCr) in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, PetersonJC , BurkartJ , GreeneT , HebertL , KingA , et al. The effect of blood pressure control on progression of renal disease depends on level of proteinuria (p) at baseline evaluation [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, PetersonJC , GreeneT , KlahrS , BurkartJM , HebertL , et al. Effect of reducing proteinuria (PR) on subsequent glomerular filtration rate (GFR) decline in patients with chronic renal failure (CRF) [abstract]. Journal of the American Society of Nephrology1994;5(3):339. MDRD Study Group, PorushJG , LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , et al. Efficacy of anti-hypertensive interventions in reducing blood pressure in the MDRD study [abstract]. Journal of the American Society of Nephrology1995;6(3):400. MDRD Study Group, PowersSN , KurtzmanDA , PetotGJ , RaizmanDJ , WetsteinL . Promoting dietary compliance through computer-assisted education, assessment, and counseling. [abstract]. Kidney International1988;36(Suppl 27):S306. MDRD Study Group, RoccoMV , CoyneT , EastinS , FaubertJ , GassmanJJ , et al. Patient symptoms and quality of life in the MDRD study at enrollment-correlation with GFR [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group. The modification of diet in renal disease study: results from the full-scale trial [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:593. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Hemoglobin A1c and mortality in chronic kidney disease [abstract no: F-FC149]. Journal of the American Society of Nephrology2005;16:71A. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Insulin resistance as a predictor of all-cause and cardiovascular mortality (CVD) in chronic kidney disease (CKD) [abstract no: F-P0284]. Journal of the American Society of Nephrology2004;15(Oct):128A. MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. Journal of the American Society of Nephrology2005;16(11):3411-7. [MEDLINE: 16207824]MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD. American Journal of Kidney Diseases2005;46(3):455-63. [MEDLINE: 16129207]MenonV , GreeneT , WangX , PereiraAA , MarcovinaSM , BeckGJ , et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney International2005;68(2):766-72. [MEDLINE: 16014054]MenonV , GreenT , PereiraA , XueleiW , BeckG , KusekJ , et al. C-reactive protein (CRP) as a predictor of all-cause and cardiovascular (CVD) mortality in patients with chronic kidney disease (CKD) [abstract no: F-P0275]. Journal of the American Society of Nephrology2004;15(Oct):125A-6A. MenonV , KoppleJD , WangX , BeckGJ , CollinsAJ , KusekJW , et al. Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2009;53(2):208-17. [MEDLINE: 18950911]MenonV , LiL , GreeneT , WangX , ChandraP , BalakrishnanV , et al. Adiponectin and outcomes in chronic kidney disease [abstract no: TH-PO430]. Journal of the American Society of Nephrology2006;17(Abstracts):199A. MenonV , LiL , WangX , GreeneT , BalakrishnanV , MaderoM , et al. Adiponectin and mortality in patients with chronic kidney disease. Journal of the American Society of Nephrology2006;17(9):2599-606. [MEDLINE: 16885405]MenonV , SarnakMJ , GreeneT , WangX , PereiraAA , BeckGJ , et al. Relationship between homocysteine and mortality in chronic kidney disease. Circulation2006;113(12):1572-7. [MEDLINE: 16549639]MenonV , ShlipakMG , WangX , CoreshJ , GreeneT , StevensL , et al. Cystatin C as a risk factor for outcomes in chronic kidney disease. Annals of Internal Medicine2007;147(1):19-27. [MEDLINE: 17606957]MenonV , TighiouartH , VaughnNS , BeckGJ , KusekJW , CollinsAJ , et al. Serum bicarbonate and long-term outcomes in CKD. American Journal of Kidney Diseases2010;56(5):907-14. [MEDLINE: 20605301]MenonV , WangX , GreeneT , BeckGJ , KusekJW , MarcovinaSM , et al. Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. American Journal of Kidney Diseases2003;42(1):44-52. [MEDLINE: 12830455]MenonV , WangX , GreeneT , BeckGJ , KusekJW , SelhubJ , et al. Homocysteine in chronic kidney disease: effect of low protein diet and repletion with B vitamins. Kidney International2005;67(4):1539-46. [MEDLINE: 15780109]MenonV , WangX , SarnakMJ , HunsickerLH , MaderoM , BeckGJ , et al. Long-term outcomes in nondiabetic chronic kidney disease. Kidney International2008;73(11):1310-5. [MEDLINE: 18337713]MilasNC , NowalkMP , AkpeleL , CastaldoL , CoyneT , DoroshenkoL , et al. Factors associated with adherence to the dietary protein intervention in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1295-300. [MEDLINE: 7594126]NewsomeB , IxJH , TighiouartH , SarnakMJ , LeveyAS , BeckGJ , et al. Effect of protein restriction on serum and urine phosphate in the modification of diet in renal disease (MDRD) study. American Journal of Kidney Diseases2013;61(6):1045-6. [MEDLINE: 23415016]OlsonM , CoyneT , CaggiulaA , GregoryP . Patient satisfaction with a dietary intervention: the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):107S. OlsonM , CoyneT , CaggiulaA . Social factors influence dietary satisfaction in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1996;17(2 Suppl):133S. OlsonM , DolecekT , CaggiulaA , DwyerJ . Time required for the protein intervention in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):129S-30S. PetersonJC , AdlerS , BurkartJM , GreeneT , HebertLA , HunsickerLG , et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Annals of Internal Medicine1995;123(10):754-62. [MEDLINE: 7574193]PiccoliM , CodognottoM . Missing stratification by polycistic kidney disease (PKD) flaws risk estimates of GFR decline. Lesson from the MDRD Study [abstract no: F-PO175]. Journal of the American Society of Nephrology2004;15(Oct):103A. RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]RoccoMV , GassmanJJ , WangSR , KaplanRM . Cross-sectional study of quality of life and symptoms in chronic renal disease patients: the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1997;29(6):888-96. [MEDLINE: 9186075]SarnakMJ , GreeneT , WangX , BeckG , KusekJW , CollinsAJ , et al. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease study. Annals of Internal Medicine2005;142(5):342-51. [MEDLINE: 15738453]SarnakMJ , WangSR , BeckGJ , KusekJW , SelhubJ , GreeneT , et al. Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression. American Journal of Kidney Diseases2002;40(5):932-9. [MEDLINE: 12407637]SarnakMJ , WangX , GreeneT , GeraldJ , BeckJ , KusekJW , et al. Effect of strict blood pressure control on long-term outcome in the Modification of Diet in Renal Disease (MDRD) study [abstract no: F-P0599]. Journal of the American Society of Nephrology2003;14(Nov):192A. SchluchterMD . Estimating correlation between alternative measures of disease progression in a longitudinal study. Modification of Diet in Renal Disease Study. Statistics in Medicine1990;9(10):1175-88. [MEDLINE: 2247718]Short-term effects of protein intake, blood pressure, and antihypertensive therapy on glomerular filtration rate in the Modification of Diet in Renal Disease Study. Journal of the American Society of Nephrology1996;7(10):2097-109. [MEDLINE: 8915969]StollarC , ScherchL , AdlerS , KusekJ , CaggiulaA . Patterns of patient dietary compliance in the Modification of Diet in Renal Disease (MDRD) study, phase III. [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:609. TangriN , StevensLA , SchmidCH , ZhangYL , BeckGJ , GreeneT , et al. Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney International2011;79(4):471-7. [MEDLINE: 20980977]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]YamamotoME , OlsonMB , StollarC , MDRD Study Group. Effects of weight and Na+ change on blood pressures of hypertensive MDRD study patients [abstract]. Journal of the American Society of Nephrology1995;6(3):408. YoungJA , TerrinN , GreeneT , WangX , BeckG , KusekJ , et al. Asymmetric dimethylarginine and prevalent cardiovascular disease in patients with chronic kidney disease [abstract no: F-PO935]. Journal of the American Society of Nephrology2007;18(Abstracts):308A-9A. YoungJA , TerrinN , WangX , GreenT , BeckG , KusekJ , et al. ADMA and mortality in stage 3-4 chronic kidney disease [abstract no: TH-PO894]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A. ">MDRD 1 1989</a>; <a href="./references#CD001892-bbs2-0012" title="GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. KlahrS . The modification of diet in renal disease study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]">MDRD 2 1989</a>; <a href="./references#CD001892-bbs2-0013" title="CogginsCH , DwyerJT , GreeneT , PetotG , SnetselaarLG , Van LenteF , et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):514-23. [MEDLINE: 8154486]KlahrS , LeveyAS , SandbergAM , WilliamsGW , MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International1989;35(1):195. KoppleJD , BergR , HouserH , SteinmanTI , TeschanP . Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S184-94. [MEDLINE: 2636655]LaidlawSA , BergRL , KoppleJD , NaitoH , WalkerWG , WalserM . Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):504-13. [MEDLINE: 8154485]LeveyAS , BergRL , GassmanJJ , HallPM , WalkerWG . Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S73-80. [MEDLINE: 2636677]LeveyAS , GassmanJJ , HallPM , WalkerWG , MDRD Study Group. Poor correlation of rates of change of creatinine clearance, reciprocal serum creatinine and GFR [abstract]. Kidney International1989;35(1):197. LeveyAS , GassmanJJ , HallPM , WalkerWG . Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. Journal of the American Society of Nephrology1991;1(9):1087-94. [MEDLINE: 1912407]MDRD Study Group, MitchME , SteinmanTI . Objectives and design of the cooperative study, Modification of Diet in Renal Disease [abstract]. Kidney International1987;31(1):210. PerroneR , SteinmanT , RoyalH , LawlorM , HunsickerL , Modification of Diet in Renal Disease Study Group. Markers of GFR: comparison of 99TC-DTPA (TC), 169YB-DTPA (YB) and 125I-Iothalamate (IO) to inulin (IN) [abstract]. Kidney International1987;31(1):213. PerroneRD , SteinmanTI , BeckGJ , SkibinskiCI , RoyalHD , LawlorM , et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1990;16(3):224-35. [MEDLINE: 2205098]TeschanPE , BeckGJ , DwyerJT , GreeneT , KlahrS , LevyAS , et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clinical Nephrology1998;50(5):273-83. [MEDLINE: 9840314]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]">MDRD Feasibility A 1989</a>; <a href="./references#CD001892-bbs2-0014" title="CogginsCH , DwyerJT , GreeneT , PetotG , SnetselaarLG , Van LenteF , et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):514-23. [MEDLINE: 8154486]KlahrS , LeveyAS , SandbergAM , WilliamsGW , MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International1989;35(1):195. KoppleJD , BergR , HouserH , SteinmanTI , TeschanP . Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S184-94. [MEDLINE: 2636655]LaidlawSA , BergRL , KoppleJD , NaitoH , WalkerWG , WalserM . Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):504-13. [MEDLINE: 8154485]LeveyAS , BergRL , GassmanJJ , HallPM , WalkerWG . Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S73-80. [MEDLINE: 2636677]LeveyAS , GassmanJJ , HallPM , WalkerWG , Modification of Diet in Renal Disease Study. Poor correlation of rates of change of creatinine clearance, reciprocal serum creatinine and GFR [abstract]. Kidney International1989;35(1):197. LeveyAS , GassmanJJ , HallPM , WalkerWG . Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. Journal of the American Society of Nephrology1991;1(9):1087-94. [MEDLINE: 1912407]MDRD Study Group, MitchME , SteinmanTI . Objectives and design of the cooperative study, Modification of Diet in Renal Disease [abstract]. Kidney International1987;31(1):210. PerroneR , SteinmanT , RoyalH , LawlorM , HunsickerL , Modification of Diet in Renal Disease Study Group. Markers of GFR: comparison of 99TC-DTPA (TC), 169YB-DTPA (YB) and 125I-Iothalamate (IO) to inulin (IN) [abstract]. Kidney International1987;31(1):213. PerroneRD , SteinmanTI , BeckGJ , SkibinskiCI , RoyalHD , LawlorM , et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1990;16(3):224-35. [MEDLINE: 2205098]TeschanPE , BeckGJ , DwyerJT , GreeneT , KlahrS , LevyAS , et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clinical Nephrology1998;50(5):273-83. [MEDLINE: 9840314]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]">MDRD Feasibility B 1989</a>) and assessed as unclear in the remaining studies with insufficient information available to permit judgement. </p> </section> <section id="CD001892-sec-0046"> <h4 class="title">Blinding</h4> <p>All 20 studies were open‐label studies and so were considered at high risk for performance bias. </p> <p>Detection bias (outcome assessment) was recorded separately for GFR and for the need to commence dialysis. All studies which reported this outcome were assessed to be at low risk for detection bias for GFR measurement as the outcomes were laboratory‐based and unlikely to be influenced by lack of blinding. Nine studies were assessed as at low risk of bias for need to commence dialysis as they provided information to indicate that the onset of ESKD with the start of dialysis treatment was assessed independently of the study investigators (<a href="./references#CD001892-bbs2-0002" title="ChauveauP , LebkiriB , PloyardF , CiancioniC , ManNK , JungersP . Effect of keto analogs of essential amino acids on the progress of advanced renal insufficiency: controlled prospective study [Effet des cetoanalogues des acides amines essentiels sur la progression de l'insuffisance renale chronique avancee: etude prospective controlee]. Nephrologie1986;7(5):137-42. [MEDLINE: 3796783]JungersP , ChauveauP , PloyardF , LebkiriB , CiancioniC , ManNK . Comparison of ketoacids and low protein diet on advanced chronic renal failure progression. Kidney International - Supplement1987;22:S67-71. [MEDLINE: 3323621]">Chauveau 1986</a>; <a href="./references#CD001892-bbs2-0003" title="CianciarusoB , PotaA , BellizziV , Di GiuseppeD , Di MiccoL , MinutoloR , et al. Effect of a low- versus moderate-protein diet on progression of CKD: follow-up of a randomized controlled trial. American Journal of Kidney Diseases2009;54(6):1052-61. [MEDLINE: 19800722]CianciarusoB , PotaA , PisaniA , TorracaS , AnnecchiniR , LombardiP , et al. Metabolic effects of two low protein diets in chronic kidney disease stage 4-5--a randomized controlled trial. Nephrology Dialysis Transplantation2008;23(2):636-44. [MEDLINE: 17981885]CianciarusoB , PotaA , TorracaS , SommaG , NazzaroP , AnnecchiniR , et al. Comparison of two different protein intakes (0.3-0.6 vs 0.7-0.9 g/kg/day) on the metabolic control of advanced renal failure [abstract no: MP197]. In: 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal. 2004:295. PotaA , PisaniA , AnnecchiniR , Di GiuseppeD , CuccurulloP , CaputoDL , et al. Treatment of chronic renal failure (CRF) with two different low protein diets. Effects on the metabolic control and on the cardiovascular risk factors [abstract no: MP306]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv401. PotaA , PisaniA , RavaniP , Di MiccoL , Di GiuseppeD , SabbatiniM , et al. Impact of two different low protein diets on survival of CKD patients (stage4-5) [abstract no: TH-PO880]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):308A. ">Cianciaruso 2008a</a>; <a href="./references#CD001892-bbs2-0007" title="GarneataL , MircescuG . Effect of low-protein diet supplemented with keto acids on progression of chronic kidney disease. Journal of Renal Nutrition2013;23(3):210-3. [MEDLINE: 23611549]GarneataL , MocanuE , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues-effects on mineral bone metabolism disorders in advanced chronic kidney disease [abstract no: FP396]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i167-8. [EMBASE: 622605156]GarneataL , StancuA , DragomirD , MircescuG . Effect of very low protein diet supplemented with ketoanalogues of the essential amino acids on the progression of chronic kidney disease [abstract]. Nephrology Dialysis Transplantation2014;29(Suppl 3):iii39. [EMBASE: 71491557]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression. Journal of the American Society of Nephrology2016;27(7):2164-76. [MEDLINE: 26823552]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues in stage 5 CKD patients [abstract no: SP373]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i472. [EMBASE: 622606118]">Garneata 2013</a>; <a href="./references#CD001892-bbs2-0010" title="MalvyD , MaingourdC , PengloanJ , BagrosP , NivetH . Effects of severe protein restriction with ketoanalogues in advanced renal failure. Journal of the American College of Nutrition1999;18(5):481-6. [MEDLINE: 10511331]NivetH , MaingourdC , MalvyD , PengloanJ , BagrosPH . Effects of severe protein-restriction with ketoanalogues in advanced renal failure [abstract]. Journal of the American Society of Nephrology1992;3(3):286. ">Malvy 1999</a>; <a href="./references#CD001892-bbs2-0013" title="CogginsCH , DwyerJT , GreeneT , PetotG , SnetselaarLG , Van LenteF , et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):514-23. [MEDLINE: 8154486]KlahrS , LeveyAS , SandbergAM , WilliamsGW , MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International1989;35(1):195. KoppleJD , BergR , HouserH , SteinmanTI , TeschanP . Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S184-94. [MEDLINE: 2636655]LaidlawSA , BergRL , KoppleJD , NaitoH , WalkerWG , WalserM . Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):504-13. [MEDLINE: 8154485]LeveyAS , BergRL , GassmanJJ , HallPM , WalkerWG . Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S73-80. [MEDLINE: 2636677]LeveyAS , GassmanJJ , HallPM , WalkerWG , MDRD Study Group. Poor correlation of rates of change of creatinine clearance, reciprocal serum creatinine and GFR [abstract]. Kidney International1989;35(1):197. LeveyAS , GassmanJJ , HallPM , WalkerWG . Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. Journal of the American Society of Nephrology1991;1(9):1087-94. [MEDLINE: 1912407]MDRD Study Group, MitchME , SteinmanTI . Objectives and design of the cooperative study, Modification of Diet in Renal Disease [abstract]. Kidney International1987;31(1):210. PerroneR , SteinmanT , RoyalH , LawlorM , HunsickerL , Modification of Diet in Renal Disease Study Group. Markers of GFR: comparison of 99TC-DTPA (TC), 169YB-DTPA (YB) and 125I-Iothalamate (IO) to inulin (IN) [abstract]. Kidney International1987;31(1):213. PerroneRD , SteinmanTI , BeckGJ , SkibinskiCI , RoyalHD , LawlorM , et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1990;16(3):224-35. [MEDLINE: 2205098]TeschanPE , BeckGJ , DwyerJT , GreeneT , KlahrS , LevyAS , et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clinical Nephrology1998;50(5):273-83. [MEDLINE: 9840314]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]">MDRD Feasibility A 1989</a>; <a href="./references#CD001892-bbs2-0014" title="CogginsCH , DwyerJT , GreeneT , PetotG , SnetselaarLG , Van LenteF , et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):514-23. [MEDLINE: 8154486]KlahrS , LeveyAS , SandbergAM , WilliamsGW , MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International1989;35(1):195. KoppleJD , BergR , HouserH , SteinmanTI , TeschanP . Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S184-94. [MEDLINE: 2636655]LaidlawSA , BergRL , KoppleJD , NaitoH , WalkerWG , WalserM . Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):504-13. [MEDLINE: 8154485]LeveyAS , BergRL , GassmanJJ , HallPM , WalkerWG . Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S73-80. [MEDLINE: 2636677]LeveyAS , GassmanJJ , HallPM , WalkerWG , Modification of Diet in Renal Disease Study. Poor correlation of rates of change of creatinine clearance, reciprocal serum creatinine and GFR [abstract]. Kidney International1989;35(1):197. LeveyAS , GassmanJJ , HallPM , WalkerWG . Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. Journal of the American Society of Nephrology1991;1(9):1087-94. [MEDLINE: 1912407]MDRD Study Group, MitchME , SteinmanTI . Objectives and design of the cooperative study, Modification of Diet in Renal Disease [abstract]. Kidney International1987;31(1):210. PerroneR , SteinmanT , RoyalH , LawlorM , HunsickerL , Modification of Diet in Renal Disease Study Group. Markers of GFR: comparison of 99TC-DTPA (TC), 169YB-DTPA (YB) and 125I-Iothalamate (IO) to inulin (IN) [abstract]. Kidney International1987;31(1):213. PerroneRD , SteinmanTI , BeckGJ , SkibinskiCI , RoyalHD , LawlorM , et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1990;16(3):224-35. [MEDLINE: 2205098]TeschanPE , BeckGJ , DwyerJT , GreeneT , KlahrS , LevyAS , et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clinical Nephrology1998;50(5):273-83. [MEDLINE: 9840314]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]">MDRD Feasibility B 1989</a>; <a href="./references#CD001892-bbs2-0017" title="MircescuG , GarneataL , StancuSH , CapusaC . Effects of a supplemented hypoproteic diet in chronic kidney disease. Journal of Renal Nutrition2007;17(3):179-88. [MEDLINE: 17462550]">Mircescu 2007</a>; <a href="./references#CD001892-bbs2-0018" title="BockHA , BrunnerFP . Dietary protein restriction in chronic renal failure. Lancet1985;1(8426):465-6. [MEDLINE: 2857845]DonkerAJ , Piers-BechtTP . Four-years follow-up of patients with chronic renal insufficiency randomly allocated to a protein-restricted diet and a control group [abstract]. Nephrology Dialysis Transplantation1989;4(5):455. DonkerAJ , RosmanJB , Piers-BechtTP , SluiterWJ . Effect of protein restriction in chronic renal insufficiency: a prospective randomized trial [abstract]. Kidney International1985;27:137. RosmanJB , DonkerAJ , MeijerS , SluiterWJ , Piers-BechtTP , van derHemGK . Two years' experience with protein restriction in chronic renal failure. Contributions to Nephrology1986;53:109-20. [MEDLINE: 3542377]RosmanJB , DonkerAJ . The response to a low-protein diet to retard the progression of renal failure is sex-dependent [abstract]. Nephrology Dialysis Transplantation1989;4(5):457. RosmanJB , LangerK , BrandlM , Piers-BechtTP , van derHemGK , ter WeePM , et al. Protein-restricted diets in chronic renal failure: a four year follow-up shows limited indications. Kidney International - Supplement1989;27:S96-S102. [MEDLINE: 2636680]RosmanJB , ter WeePM , MeijerS , Piers-BechtTP , SluiterWJ , DonkerAJ . Prospective randomised trial of early dietary protein restriction in chronic renal failure. Lancet1984;324(8415):1291-6. [MEDLINE: 6150320]RosmanJB , Ter WeePM , Piers-BechtGP , SluiterWJ , van derWoudeF , MeijerS , et al. Early protein restriction in chronic renal failure [abstract]. Kidney International1984;26(4):510. RosmanJB , ter WeePM , Piers-BechtGP , SluiterWJ , van derWoudeFJ , MeijerS , et al. Early protein restriction in chronic renal failure. Proceedings of the European Dialysis &amp; Transplant Association - European Renal Association1985;21:567-73. [MEDLINE: 3887375]RosmanJB , Ter WeePM , SluiterWJ , MeijerS , van derHemGK , DonkerAJ . Four years experience with dietary protein restriction in chronic renal failure [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:28. RosmanJB , ter WeePM . Relationship between proteinuria and response to low protein diets early in chronic renal failure. Blood Purification1989;7(1):52-7. [MEDLINE: 2645924]">Rosman 1 1984</a>; <a href="./references#CD001892-bbs2-0019" title="BockHA , BrunnerFP . Dietary protein restriction in chronic renal failure. Lancet1985;1(8426):465-6. [MEDLINE: 2857845]DonkerAJ , Piers-BechtTP . Four-years follow-up of patients with chronic renal insufficiency randomly allocated to a protein-restricted diet and a control group [abstract]. Nephrology Dialysis Transplantation1989;4(5):455. DonkerAJ , RosmanJB , Piers-BechtTP , SluiterWJ . Effect of protein restriction in chronic renal insufficiency: a prospective randomized trial [abstract]. Kidney International1985;27:137. RosmanJB , DonkerAJ , MeijerS , SluiterWJ , Piers-BechtTP , van derHemGK . Two years' experience with protein restriction in chronic renal failure. Contributions to Nephrology1986;53:109-20. [MEDLINE: 3542377]RosmanJB , DonkerAJ . The response to a low-protein diet to retard the progression of renal failure is sex-dependent [abstract]. Nephrology Dialysis Transplantation1989;4(5):457. RosmanJB , LangerK , BrandlM , Piers-BechtTP , van derHemGK , ter WeePM , et al. Protein-restricted diets in chronic renal failure: a four year follow-up shows limited indications. Kidney International - Supplement1989;27:S96-102. [MEDLINE: 2636680]RosmanJB , ter WeePM , MeijerS , Piers-BechtTP , SluiterWJ , DonkerAJ . Prospective randomised trial of early dietary protein restriction in chronic renal failure. Lancet1984;324(8415):1291-6. [MEDLINE: 6150320]RosmanJB , Ter WeePM , Piers-BechtGP , SluiterWJ , van derWoudeF , MeijerS , et al. Early protein restriction in chronic renal failure [abstract]. Kidney International1984;26(4):510. RosmanJB , ter WeePM , Piers-BechtGP , SluiterWJ , van derWoudeFJ , MeijerS , et al. Early protein restriction in chronic renal failure. Proceedings of the European Dialysis &amp; Transplant Association - European Renal Association1985;21:567-73. [MEDLINE: 3887375]RosmanJB , Ter WeePM , SluiterWJ , MeijerS , van derHemGK , DonkerAJ . Four years experience with dietary protein restriction in chronic renal failure. [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:28. RosmanJB , ter WeePM . Relationship between proteinuria and response to low protein diets early in chronic renal failure. Blood Purification1989;7(1):52-7. [MEDLINE: 2645924]">Rosman 2 1984</a>). One study was at high risk (<a href="./references#CD001892-bbs2-0008" title="BeckerGJ , WhitworthJA , IhleBU , ShahinfarS , Kincaid-SmithPS . Prevention of progression in non-diabetic chronic renal failure. Kidney International - Supplement1994;45(Suppl 45):S167-70. [MEDLINE: 8158888]IhleBU , BeckerGJ , WhithworthJA , CharlwoodRA , Kincaid-SmithPS . The effect of protein restriction on the progression of renal insufficiency. New England Journal of Medicine1989;321(26):1773-7. [MEDLINE: 2512486]">Ihle 1989</a>) and the remaining studies did not provide any information on how the onset of ESKD was assessed. </p> </section> <section id="CD001892-sec-0047"> <h4 class="title">Incomplete outcome data</h4> <p>Five studies were considered at high risk of attrition bias as more than 10% of participants were lost to follow up or excluded from the analysis (<a href="./references#CD001892-bbs2-0001" title="AlvestrandA , BuchtH , GutierrezA , BergströmJ . Progression of chronic renal failure in man as influenced by frequency and quality of clinical follow-ups [abstract]. Kidney International1985;27(1):240. BergstromJ , AlvestrandA , BuchtH , GutierrezA . Progression of chronic renal failure in man is retarded with more frequent clinical follow-ups and better blood pressure control. Clinical Nephrology1986;25(1):1-6. [MEDLINE: 3955903]BergstromJ , AlvestrandA , BuchtH , GutierrezA . Stockholm clinical study on progression of chronic renal failure--an interim report. Kidney International - Supplement1989;36(Suppl 27):S110-4. [MEDLINE: 2636644]BergstromJ , AlvestrandA , BuchtH , GutierrezA . What is the role of controls in an outpatient department on progression of renal disease?Blood Purification1988;6(6):336-42. [MEDLINE: 3061400]">Bergstrom 1986</a>; <a href="./references#CD001892-bbs2-0002" title="ChauveauP , LebkiriB , PloyardF , CiancioniC , ManNK , JungersP . Effect of keto analogs of essential amino acids on the progress of advanced renal insufficiency: controlled prospective study [Effet des cetoanalogues des acides amines essentiels sur la progression de l'insuffisance renale chronique avancee: etude prospective controlee]. Nephrologie1986;7(5):137-42. [MEDLINE: 3796783]JungersP , ChauveauP , PloyardF , LebkiriB , CiancioniC , ManNK . Comparison of ketoacids and low protein diet on advanced chronic renal failure progression. Kidney International - Supplement1987;22:S67-71. [MEDLINE: 3323621]">Chauveau 1986</a>; <a href="./references#CD001892-bbs2-0008" title="BeckerGJ , WhitworthJA , IhleBU , ShahinfarS , Kincaid-SmithPS . Prevention of progression in non-diabetic chronic renal failure. Kidney International - Supplement1994;45(Suppl 45):S167-70. [MEDLINE: 8158888]IhleBU , BeckerGJ , WhithworthJA , CharlwoodRA , Kincaid-SmithPS . The effect of protein restriction on the progression of renal insufficiency. New England Journal of Medicine1989;321(26):1773-7. [MEDLINE: 2512486]">Ihle 1989</a>; <a href="./references#CD001892-bbs2-0009" title="D'AmicoG , GentileMG , FellinG , MannaG , CofanoF . Effect of dietary protein restriction on the progression of renal failure: a prospective randomized trial. Nephrology Dialysis Transplantation1994;9(11):1590-4. [MEDLINE: 7870348]LocatelliF , AlbertiD , GentileMG , GrazianiG , BucciantiG , CosciP , et al. Effects of two different protein prescriptions on chronic renal failure progression. Cooperative study. [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:20. LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA , et al. Blood pressure and chronic renal failure progression: results from a multicentre trial [abstract]. Nephrology Dialysis Transplantation1992;7(7):712. LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA , et al. Factors affecting chronic renal failure progression: results from a multicentre trial. The Northern Italian Cooperative Study Group. Mineral &amp; Electrolyte Metabolism1992;18(2-5):295-302. [MEDLINE: 1465079]LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA . Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group. Lancet1991;337(8753):1299-304. [MEDLINE: 1674294]LocatelliF , Del VecchioL , AndrulliS , MaraiP , TentoriF . The role of underlying nephropathy in the progression of renal disease. Kidney International - Supplement2000;75:S49-55. [MEDLINE: 10828762]LocatelliF , MarcelliD , et al. Factors affecting the progression of chronic renal failure: a multivariate analysis [abstract]. Nephrology Dialysis Transplantation1989;4(5):457. LocatelliF , MarcelliD , TentoriF , MaraiP . Hypertension and progression of chronic renal failure (CRF): a prospective study [abstract]. In: 11th International Congress of Nephrology; 1990 Jul 15-20; Tokyo, Japan. 1990:37A. LocatelliF . Controlled study of protein-restricted diet in chronic renal failure. Contributions to Nephrology1989;75:141-6. [MEDLINE: 2697498]LocatelliF . Dietary compliance in patients with chronic renal failure: experience in a northern Italy trial. Contributions to Nephrology1990;81:102-6. [MEDLINE: 2093485]TentoriF , MaraiP , MarcelliD , PontiR , LocatelliF . Monocentric prospective randomized controlled study on the progression rate of chronic renal failure (CRF) with two different protein intakes [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:20. TentoriF , MaraiP . Monocentric prospective randomised controlled study on the progression rate of chronic renal failure with two different protein intakes [abstract]. Nephrology Dialysis Transplantation1987;2(5):400-1. ">Locatelli 1989</a>; <a href="./references#CD001892-bbs2-0021" title="WilliamsP , StevensME , FassG , BoneJM . A randomised trial of the effect of protein and phosphate restriction on the progression of chronic renal failure [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:38. WilliamsPS , StevensM , FassG , BoneJM . A randomised trial of the effect of protein and phosphate restriction on the progression of chronic renal failure [abstract]. Nephrology Dialysis Transplantation1987;2(4):285. WilliamsPS , StevensM , IronsL , FassG , BoneJM . Failure of  dietary protein/phosphate restriction to slow the progression of chronic renal failure; a prospective randomised controlled trial [abstract]. Nephrology Dialysis Transplantation1990;5(8):674. WilliamsPS , StevensME , FassG , IronsL , BoneJM . Failure of dietary protein and phosphate restriction to retard the rate of progression of chronic renal failure: a prospective, randomized, controlled trial. Quarterly Journal of Medicine1991;81(294):837-55. [MEDLINE: 1801057]WilliamsPS , StevensME . A randomised trial of the effect of protein and phosphate restriction on the progression of chronic renal failure [abstract]. Nephrology Dialysis Transplantation1987;2(5):401. ">Williams 1991</a>). Eleven studies (<a href="./references#CD001892-bbs2-0003" title="CianciarusoB , PotaA , BellizziV , Di GiuseppeD , Di MiccoL , MinutoloR , et al. Effect of a low- versus moderate-protein diet on progression of CKD: follow-up of a randomized controlled trial. American Journal of Kidney Diseases2009;54(6):1052-61. [MEDLINE: 19800722]CianciarusoB , PotaA , PisaniA , TorracaS , AnnecchiniR , LombardiP , et al. Metabolic effects of two low protein diets in chronic kidney disease stage 4-5--a randomized controlled trial. Nephrology Dialysis Transplantation2008;23(2):636-44. [MEDLINE: 17981885]CianciarusoB , PotaA , TorracaS , SommaG , NazzaroP , AnnecchiniR , et al. Comparison of two different protein intakes (0.3-0.6 vs 0.7-0.9 g/kg/day) on the metabolic control of advanced renal failure [abstract no: MP197]. In: 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal. 2004:295. PotaA , PisaniA , AnnecchiniR , Di GiuseppeD , CuccurulloP , CaputoDL , et al. Treatment of chronic renal failure (CRF) with two different low protein diets. Effects on the metabolic control and on the cardiovascular risk factors [abstract no: MP306]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv401. PotaA , PisaniA , RavaniP , Di MiccoL , Di GiuseppeD , SabbatiniM , et al. Impact of two different low protein diets on survival of CKD patients (stage4-5) [abstract no: TH-PO880]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):308A. ">Cianciaruso 2008a</a>; <a href="./references#CD001892-bbs2-0004" title="Di IorioBR , BellizziV , MinutoloR , De NicolaL , IodiceC , ConteG . Supplemented very low-protein diet in advanced CRF: is it money saving?Kidney International2004;65(2):742. [MEDLINE: 14717953]Di IorioBR , MinutoloR , De NicolaL , BellizziV , CatapanoF , IodiceC , et al. Supplemented very low protein diet ameliorates responsiveness to erythropoietin in chronic renal failure. Kidney International2003;64(5):1822-8. [MEDLINE: 14717953]">Di Iorio 2003</a>; <a href="./references#CD001892-bbs2-0007" title="GarneataL , MircescuG . Effect of low-protein diet supplemented with keto acids on progression of chronic kidney disease. Journal of Renal Nutrition2013;23(3):210-3. [MEDLINE: 23611549]GarneataL , MocanuE , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues-effects on mineral bone metabolism disorders in advanced chronic kidney disease [abstract no: FP396]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i167-8. [EMBASE: 622605156]GarneataL , StancuA , DragomirD , MircescuG . Effect of very low protein diet supplemented with ketoanalogues of the essential amino acids on the progression of chronic kidney disease [abstract]. Nephrology Dialysis Transplantation2014;29(Suppl 3):iii39. [EMBASE: 71491557]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression. Journal of the American Society of Nephrology2016;27(7):2164-76. [MEDLINE: 26823552]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues in stage 5 CKD patients [abstract no: SP373]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i472. [EMBASE: 622606118]">Garneata 2013</a>; <a href="./references#CD001892-bbs2-0013" title="CogginsCH , DwyerJT , GreeneT , PetotG , SnetselaarLG , Van LenteF , et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):514-23. [MEDLINE: 8154486]KlahrS , LeveyAS , SandbergAM , WilliamsGW , MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International1989;35(1):195. KoppleJD , BergR , HouserH , SteinmanTI , TeschanP . Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S184-94. [MEDLINE: 2636655]LaidlawSA , BergRL , KoppleJD , NaitoH , WalkerWG , WalserM . Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):504-13. [MEDLINE: 8154485]LeveyAS , BergRL , GassmanJJ , HallPM , WalkerWG . Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S73-80. [MEDLINE: 2636677]LeveyAS , GassmanJJ , HallPM , WalkerWG , MDRD Study Group. Poor correlation of rates of change of creatinine clearance, reciprocal serum creatinine and GFR [abstract]. Kidney International1989;35(1):197. LeveyAS , GassmanJJ , HallPM , WalkerWG . Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. Journal of the American Society of Nephrology1991;1(9):1087-94. [MEDLINE: 1912407]MDRD Study Group, MitchME , SteinmanTI . Objectives and design of the cooperative study, Modification of Diet in Renal Disease [abstract]. Kidney International1987;31(1):210. PerroneR , SteinmanT , RoyalH , LawlorM , HunsickerL , Modification of Diet in Renal Disease Study Group. Markers of GFR: comparison of 99TC-DTPA (TC), 169YB-DTPA (YB) and 125I-Iothalamate (IO) to inulin (IN) [abstract]. Kidney International1987;31(1):213. PerroneRD , SteinmanTI , BeckGJ , SkibinskiCI , RoyalHD , LawlorM , et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1990;16(3):224-35. [MEDLINE: 2205098]TeschanPE , BeckGJ , DwyerJT , GreeneT , KlahrS , LevyAS , et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clinical Nephrology1998;50(5):273-83. [MEDLINE: 9840314]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]">MDRD Feasibility A 1989</a>; <a href="./references#CD001892-bbs2-0014" title="CogginsCH , DwyerJT , GreeneT , PetotG , SnetselaarLG , Van LenteF , et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):514-23. [MEDLINE: 8154486]KlahrS , LeveyAS , SandbergAM , WilliamsGW , MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International1989;35(1):195. KoppleJD , BergR , HouserH , SteinmanTI , TeschanP . Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S184-94. [MEDLINE: 2636655]LaidlawSA , BergRL , KoppleJD , NaitoH , WalkerWG , WalserM . Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):504-13. [MEDLINE: 8154485]LeveyAS , BergRL , GassmanJJ , HallPM , WalkerWG . Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S73-80. [MEDLINE: 2636677]LeveyAS , GassmanJJ , HallPM , WalkerWG , Modification of Diet in Renal Disease Study. Poor correlation of rates of change of creatinine clearance, reciprocal serum creatinine and GFR [abstract]. Kidney International1989;35(1):197. LeveyAS , GassmanJJ , HallPM , WalkerWG . Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. Journal of the American Society of Nephrology1991;1(9):1087-94. [MEDLINE: 1912407]MDRD Study Group, MitchME , SteinmanTI . Objectives and design of the cooperative study, Modification of Diet in Renal Disease [abstract]. Kidney International1987;31(1):210. PerroneR , SteinmanT , RoyalH , LawlorM , HunsickerL , Modification of Diet in Renal Disease Study Group. Markers of GFR: comparison of 99TC-DTPA (TC), 169YB-DTPA (YB) and 125I-Iothalamate (IO) to inulin (IN) [abstract]. Kidney International1987;31(1):213. PerroneRD , SteinmanTI , BeckGJ , SkibinskiCI , RoyalHD , LawlorM , et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1990;16(3):224-35. [MEDLINE: 2205098]TeschanPE , BeckGJ , DwyerJT , GreeneT , KlahrS , LevyAS , et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clinical Nephrology1998;50(5):273-83. [MEDLINE: 9840314]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]">MDRD Feasibility B 1989</a>; <a href="./references#CD001892-bbs2-0011" title="BeckGJ , BergRL , CogginsCH , GassmanJJ , HunsickerLG , SchluchterMD , et al. Design and statistical issues of the Modification of Diet in Renal Disease Trial. The Modification of Diet in Renal Disease Study Group. Controlled Clinical Trials1991;12(5):566-86. [MEDLINE: 1664792]Buckalew VM Jr, BergRL , WangSR , PorushJG , RauchS , SchulmanG . Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. American Journal of Kidney Diseases1996;28(6):811-21. [MEDLINE: 8957032]ChawlaV , WangX , GreeneJ , KusekJW , CollinsAJ , LeveyAS , et al. Dyslipidemia and mortality in chronic kidney disease [abstract no: TH-PO895]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A-2A. ChenJL , LernerD , RuthazerR , Castaneda-SceppaC , LeveyAS . Association of physical activity with mortality in chronic kidney disease. Journal of Nephrology2008;21(2):243-52. [MEDLINE: 18446720]ChenJL , SceppaC , RuthazerR , LeveyAS . Leisure time physical activity status and mortality in chronic kidney disease: preliminary findings from the MDRD study [abstract no: 21]. American Journal of Kidney Diseases2006;47(4):A24. CogginsCH , Breyer LewisJ , CaggiulaAW , CastaldoLS , KlahrS , WangSR . Differences between women and men with chronic renal disease. Nephrology Dialysis Transplantation1998;13(6):1430-7. [MEDLINE: 9641172]CoyneT , OlsonM , BradhamK , GarconM , GregoryP , ScherchL . Dietary satisfaction correlated with adherence in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1301-6. [MEDLINE: 7594127]DennisVW . Decoding the Modification of Diet in Renal Disease Study. Cleveland Clinic Journal of Medicine1994;61(4):254-7. [MEDLINE: 7923742]DolecekTA , OlsonMB , CaggiulaAW , DwyerJT , MilasNC , GillisBP , et al. Registered dietitian time requirements in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1307-12. [MEDLINE: 7594128]Effects of diet and antihypertensive therapy on creatinine clearance and serum creatinine concentration in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Aug;8(8):1354]. Journal of the American Society of Nephrology1996;7(4):556-66. [MEDLINE: 8724889]Effects of dietary protein restriction on the progression of moderate renal disease in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Mar;8(3):493]. Journal of the American Society of Nephrology1996;7(12):2616-26. [MEDLINE: 8989740]GassmanJJ , DrabikMJ , LeathermanJR , FaticaKJ , McPhersonJA , Modification of Diet in Renal Disease Study Group. Development and use of distributed data entry and electronic communication in a multi-center study of progressive renal disease [abstract]. Kidney International1989;35(1):226. GennariFJ , HoodVL , GreeneT , WangX , LeveyAS . Effect of Dietary Protein Intake on Serum Total CO2 Concentration in Chronic Kidney Disease: Modification of Diet in Renal Disease Study Findings. Clinical Journal of the American Society of Nephrology: CJASN2006;1(1):52-7. [MEDLINE: 17699190]GillisBP , AverbachFM , CaggiulaAW , JonesFL , NaujelisJ , MaurerE , et al. Features of the nutrient database and analysis system for the Modification of Diet in Renal Disease Study.[Erratum appears in Control Clin Trials 1994 Aug;15(4):326]. Controlled Clinical Trials1994;15(1):44-58. [MEDLINE: 8149770]GillisBP , CaggiulaAW , ChiavacciAT , CoyneT , DoroshenkoL , MilasNC , et al. Nutrition intervention program of the Modification of Diet in Renal Disease Study: a self-management approach. Journal of the American Dietetic Association1995;95(11):1288-94. [MEDLINE: 7594125]GramsME , CoreshJ , SegevDL , KucirkaLM , TighiouartH , SarnakMJ . Vascular disease, ESRD, and death: interpreting competing risk analyses. Clinical Journal of the American Society of Nephrology: CJASN2012;7(10):1606-14. [MEDLINE: 22859747]GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. GramsME , TinA , RebholzCM , ShafiT , KottgenA , PerroneRD , et al. Metabolomic alterations associated with cause of CKD. Clinical Journal of The American Society of Nephrology: CJASN2017;12(11):1787-94. [MEDLINE: 28971980]GreeneT , BeckG , WangS , KusekJ , LeveyA , Modification of Diet in Renal Disease Study Group. The effect of the low protein diet in the MDRD study A is dependent on the underlying rate of disease progression [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A. GreeneT , BourgoignieJJ , HabweV , KusekJW , SnetselaarLG , SoucieJM , et al. Baseline characteristics in the Modification of Diet in Renal Disease Study.[Republished from J Am Soc Nephrol 1993 May;3(11):1819-34]. Journal of the American Society of Nephrology1993;4(5):1221-36. [MEDLINE: 8305650]HebertLA , GreeneT , HunsickerLG , LeveyAS , WangS , MDRD Study Group. Relationship of urine volume (uv) and urine osmolality (Uosm) to the progression of renal disease in the Modification of Diet in Renal Disease (MDRD) study [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A-6A. HebertLA , KusekJW , GreeneT , AgodoaLY , JonesCA , LeveyAS , et al. Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group. Hypertension1997;30(3 (Pt 1)):428-35. [MEDLINE: 9314428]HunsickerLG , AdlerS , CaggiulaA , EnglandBK , GreeneT , KusekJW , et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney International1997;51(6):1908-19. [MEDLINE: 9186882]HunsickerLG , MDRD Study Group. Secondary analysis of the Modification of Diet in Renal Disease (MDRD) study [abstract]. In: 13th International Congress of Nephrology; 1995 Jul 2-6; Madrid, Spain. 1995:64. IxJH , ShlipakMG , SarnakMJ , BeckGJ , GreeneT , WangX , et al. Fetuin-A is not associated with all-cause or cardiovascular mortality in chronic kidney disease: data from the Modification of Diet in Renal Disease (MDRD) study [abstract no: SU-PO711]. Journal of the American Society of Nephrology2007;18(Abstracts Issue):741A. KlahrS , BreyerJA , BeckGJ , DennisVW , HartmanJA , RothD , et al. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group.[Erratum appears in J Am Soc Nephrol 1995 Oct;6(4):1318]. Journal of the American Society of Nephrology1995;5(12):2037-47. [MEDLINE: 7579052]KlahrS , LeveyAS , BeckGJ , CaggiulaAW , HunsickerL , KusekJW , et al. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. New England Journal of Medicine1994;330(13):877-84. [MEDLINE: 8114857]KlahrS , Modification of Diet in Renal Disease Study. The Modification of Diet in Renal Disease Study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]KlahrS . Primary and secondary results of the modification of diet in renal disease study. Mineral &amp; Electrolyte Metabolism1996;22(1-3):138-42. [MEDLINE: 8676806]KoppleJD , GreeneT , ChumleaWC , HollingerD , MaroniBJ , MerrillD , et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney International2000;57(4):1688-703. [MEDLINE: 10760105]KoppleJD , LeveyAS , GreeneT , ChumleaWC , GassmanJJ , HollingerDL , et al. Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. Kidney International1997;52(3):778-91. [MEDLINE: 9291200]KuE , GliddenDV , JohansenKL , SarnakM , TighiouartH , GrimesB , et al. Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease. Kidney International2015;87(5):1055-60. [MEDLINE: 25493952]KusekJW , CoyneT , deVelascoA , DrabikMJ , FinlayRA , GassmanJJ , et al. Recruitment experience in the full-scale phase of the Modification of Diet in Renal Disease Study. Controlled Clinical Trials1993;14(6):538-57. [MEDLINE: 8119068]KusekJW , CoyneT , deVelascoA , GassmanJ , KieferS , PowersS , et al. Recruitment experience in the full scale phase of the Modification of Diet in Renal Disease (MDRD) Study [abstract]. Controlled Clinical Trials1991;12:678. KwongYT , StevensLA , SelvinE , ZhangYL , GreeneT , Van LenteF , et al. Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. American Journal of Kidney Diseases2010;56(1):39-49. [MEDLINE: 20537455]LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , LeveyAS , MilasNC , et al. Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. Hypertension1997;29(2):641-50. [MEDLINE: 9040451]Leonberg-YooAK , TighiouartH , LeveyAS , BeckGJ , SarnakMJ . Urine potassium excretion, kidney failure, and mortality in CKD. American Journal of Kidney Diseases2017;69(3):341-9. [MEDLINE: 27233381]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , BoschJP , LewisJB , GreeneT , RogersN , RothD , et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of Internal Medicine1999;130(6):461-70. [MEDLINE: 10075613]LeveyAS , CoreshJ , GreeneT , StevensLA , ZhangYL , HendriksenS , et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate.[Erratum appears in Ann Intern Med. 2008 Oct 7;149(7):519]. Annals of Internal Medicine2006;145(4):247-54. [MEDLINE: 16908915]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study Group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]LeveyAS , GreeneT , SarnakM , WangX , BeckGJ , KusekJW , et al. Effect of low protein diet on progression of kidney disease in the Modification of Diet in Renal Disease study A: long-term follow-up [abstract no: SU-PO247]. Journal of the American Society of Nephrology2004;15(Oct):586A-7A. LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2006;48(6):879-88. [MEDLINE: 17162142]LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. The effect of very low protein diet on progression of kidney disease and mortality in Modification of Diet in Renal Disease Study B [abstract no: SU-PO246]. Journal of the American Society of Nephrology2004;15(Oct):586A. LeveyAS , GreeneT , SchluchterMD , ClearyPA , TeschanPE , LorenzRA , et al. Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. Journal of the American Society of Nephrology1993;4(5):1159-71. [MEDLINE: 8305642]MaderoM , SarnakM , WangX , GreeneT , CollinsA , BeckG , et al. Uric acid and development of kidney failure in chronic kidney disease [abstract no: F-PO1932]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):547A. MaderoM , SarnakMJ , WangX , GreeneT , BeckGJ , KusekJW , et al. Uric acid and long-term outcomes in CKD. American Journal of Kidney Diseases2009;53(5):796-803. [MEDLINE: 19303683]MaderoM , SarnakMJ , WangX , SceppaCC , GreeneT , BeckGJ , et al. Body mass index and mortality in CKD. American Journal of Kidney Diseases2007;50(3):404-11. [MEDLINE: 17720519]MaderoM , WangX , GreenT , HunsickerLG , BeckGJ , KusekJW , et al. Effect of trial participation on outcomes in the randomized and non-randomized cohorts of the Modification of Diet in Renal Disease study [abstract no: F-PO037]. Journal of the American Society of Nephrology2006;17(Abstracts):344A. MDRD Study Group, ChumleaWC , GassmanJJ , HollingerDL , MerrillD , ScherchLK , et al. Nutritional response to diet prescription in the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, HunsickerLG , AdlerS , CaggiulaAW , EnglandB , GreeneT , et al. Relationship among baseline proteinuria (p), mean arterial blood pressure (map) during follow-up, and decline in glomerular filtration rate (aGFR) in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, KoppleJD , ChumleaWC , GassmanJJ , HollingerDL , MaroniBJ , et al. Relationship between FGR and nutritional status - results from the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, KusekJW , AgodoaL , GreeneT , JonesC . Comparison of decline of GFR in blacks versus non-blacks in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , BoschJP , CaggiulaAW , GreeneT , et al. Short-term effects of protein intake, blood pressure, and antihypertensive therapy on GFR in the MDRD study. Journal of the American Society of Nephrology1995;6(3):395. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , HunsickerLG , et al. A hypothesis for the results of the Modification of Diet in Renal Disease (MDRD) study. [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , KusekJW , et al. Trends toward a beneficial effect of a low protein diet during additional follow-up in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1994;5(3):336. MDRD Study Group, LeveyAS , BeckGJ . Trends toward a beneficial effect of a low protein diet during additional follow-up in the modification of diet in renal disease study. MDRD Study Group. [abstract]. Nephrology Dialysis Transplantation1995;10(6):985. MDRD Study Group, LeveyAS , BoschJP , CogginsCH , GreeneT , MitchWE , et al. Effects of diet and blood pressure on creatinine clearance (CCr) and serum creatinine (PCr) in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, PetersonJC , BurkartJ , GreeneT , HebertL , KingA , et al. The effect of blood pressure control on progression of renal disease depends on level of proteinuria (p) at baseline evaluation [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, PetersonJC , GreeneT , KlahrS , BurkartJM , HebertL , et al. Effect of reducing proteinuria (PR) on subsequent glomerular filtration rate (GFR) decline in patients with chronic renal failure (CRF) [abstract]. Journal of the American Society of Nephrology1994;5(3):339. MDRD Study Group, PorushJG , LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , et al. Efficacy of anti-hypertensive interventions in reducing blood pressure in the MDRD study [abstract]. Journal of the American Society of Nephrology1995;6(3):400. MDRD Study Group, PowersSN , KurtzmanDA , PetotGJ , RaizmanDJ , WetsteinL . Promoting dietary compliance through computer-assisted education, assessment, and counseling. [abstract]. Kidney International1988;36(Suppl 27):S306. MDRD Study Group, RoccoMV , CoyneT , EastinS , FaubertJ , GassmanJJ , et al. Patient symptoms and quality of life in the MDRD study at enrollment-correlation with GFR [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group. The modification of diet in renal disease study: results from the full-scale trial [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:593. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Hemoglobin A1c and mortality in chronic kidney disease [abstract no: F-FC149]. Journal of the American Society of Nephrology2005;16:71A. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Insulin resistance as a predictor of all-cause and cardiovascular mortality (CVD) in chronic kidney disease (CKD) [abstract no: F-P0284]. Journal of the American Society of Nephrology2004;15(Oct):128A. MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. Journal of the American Society of Nephrology2005;16(11):3411-7. [MEDLINE: 16207824]MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD. American Journal of Kidney Diseases2005;46(3):455-63. [MEDLINE: 16129207]MenonV , GreeneT , WangX , PereiraAA , MarcovinaSM , BeckGJ , et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney International2005;68(2):766-72. [MEDLINE: 16014054]MenonV , GreenT , PereiraA , XueleiW , BeckG , KusekJ , et al. C-reactive protein (CRP) as a predictor of all-cause and cardiovascular (CVD) mortality in patients with chronic kidney disease (CKD) [abstract no: F-P0275]. Journal of the American Society of Nephrology2004;15(Oct):125A-6A. MenonV , KoppleJD , WangX , BeckGJ , CollinsAJ , KusekJW , et al. Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2009;53(2):208-17. [MEDLINE: 18950911]MenonV , LiL , GreeneT , WangX , ChandraP , BalakrishnanV , et al. Adiponectin and outcomes in chronic kidney disease [abstract no: TH-PO430]. Journal of the American Society of Nephrology2006;17(Abstracts):199A. MenonV , LiL , WangX , GreeneT , BalakrishnanV , MaderoM , et al. Adiponectin and mortality in patients with chronic kidney disease. Journal of the American Society of Nephrology2006;17(9):2599-606. [MEDLINE: 16885405]MenonV , SarnakMJ , GreeneT , WangX , PereiraAA , BeckGJ , et al. Relationship between homocysteine and mortality in chronic kidney disease. Circulation2006;113(12):1572-7. [MEDLINE: 16549639]MenonV , ShlipakMG , WangX , CoreshJ , GreeneT , StevensL , et al. Cystatin C as a risk factor for outcomes in chronic kidney disease. Annals of Internal Medicine2007;147(1):19-27. [MEDLINE: 17606957]MenonV , TighiouartH , VaughnNS , BeckGJ , KusekJW , CollinsAJ , et al. Serum bicarbonate and long-term outcomes in CKD. American Journal of Kidney Diseases2010;56(5):907-14. [MEDLINE: 20605301]MenonV , WangX , GreeneT , BeckGJ , KusekJW , MarcovinaSM , et al. Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. American Journal of Kidney Diseases2003;42(1):44-52. [MEDLINE: 12830455]MenonV , WangX , GreeneT , BeckGJ , KusekJW , SelhubJ , et al. Homocysteine in chronic kidney disease: effect of low protein diet and repletion with B vitamins. Kidney International2005;67(4):1539-46. [MEDLINE: 15780109]MenonV , WangX , SarnakMJ , HunsickerLH , MaderoM , BeckGJ , et al. Long-term outcomes in nondiabetic chronic kidney disease. Kidney International2008;73(11):1310-5. [MEDLINE: 18337713]MilasNC , NowalkMP , AkpeleL , CastaldoL , CoyneT , DoroshenkoL , et al. Factors associated with adherence to the dietary protein intervention in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1295-300. [MEDLINE: 7594126]NewsomeB , IxJH , TighiouartH , SarnakMJ , LeveyAS , BeckGJ , et al. Effect of protein restriction on serum and urine phosphate in the modification of diet in renal disease (MDRD) study. American Journal of Kidney Diseases2013;61(6):1045-6. [MEDLINE: 23415016]OlsonM , CoyneT , CaggiulaA , GregoryP . Patient satisfaction with a dietary intervention: the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):107S. OlsonM , CoyneT , CaggiulaA . Social factors influence dietary satisfaction in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1996;17(2 Suppl):133S. OlsonM , DolecekT , CaggiulaA , DwyerJ . Time required for the protein intervention in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):129S-30S. PetersonJC , AdlerS , BurkartJM , GreeneT , HebertLA , HunsickerLG , et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Annals of Internal Medicine1995;123(10):754-62. [MEDLINE: 7574193]PiccoliM , CodognottoM . Missing stratification by polycistic kidney disease (PKD) flaws risk estimates of GFR decline. Lesson from the MDRD Study [abstract no: F-PO175]. Journal of the American Society of Nephrology2004;15(Oct):103A. RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]RoccoMV , GassmanJJ , WangSR , KaplanRM . Cross-sectional study of quality of life and symptoms in chronic renal disease patients: the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1997;29(6):888-96. [MEDLINE: 9186075]SarnakMJ , GreeneT , WangX , BeckG , KusekJW , CollinsAJ , et al. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease study. Annals of Internal Medicine2005;142(5):342-51. [MEDLINE: 15738453]SarnakMJ , WangSR , BeckGJ , KusekJW , SelhubJ , GreeneT , et al. Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression. American Journal of Kidney Diseases2002;40(5):932-9. [MEDLINE: 12407637]SarnakMJ , WangX , GreeneT , GeraldJ , BeckJ , KusekJW , et al. Effect of strict blood pressure control on long-term outcome in the Modification of Diet in Renal Disease (MDRD) study [abstract no: F-P0599]. Journal of the American Society of Nephrology2003;14(Nov):192A. SchluchterMD . Estimating correlation between alternative measures of disease progression in a longitudinal study. Modification of Diet in Renal Disease Study. Statistics in Medicine1990;9(10):1175-88. [MEDLINE: 2247718]Short-term effects of protein intake, blood pressure, and antihypertensive therapy on glomerular filtration rate in the Modification of Diet in Renal Disease Study. Journal of the American Society of Nephrology1996;7(10):2097-109. [MEDLINE: 8915969]StollarC , ScherchL , AdlerS , KusekJ , CaggiulaA . Patterns of patient dietary compliance in the Modification of Diet in Renal Disease (MDRD) study, phase III. [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:609. TangriN , StevensLA , SchmidCH , ZhangYL , BeckGJ , GreeneT , et al. Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney International2011;79(4):471-7. [MEDLINE: 20980977]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]YamamotoME , OlsonMB , StollarC , MDRD Study Group. Effects of weight and Na+ change on blood pressures of hypertensive MDRD study patients [abstract]. Journal of the American Society of Nephrology1995;6(3):408. YoungJA , TerrinN , GreeneT , WangX , BeckG , KusekJ , et al. Asymmetric dimethylarginine and prevalent cardiovascular disease in patients with chronic kidney disease [abstract no: F-PO935]. Journal of the American Society of Nephrology2007;18(Abstracts):308A-9A. YoungJA , TerrinN , WangX , GreenT , BeckG , KusekJ , et al. ADMA and mortality in stage 3-4 chronic kidney disease [abstract no: TH-PO894]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A. ">MDRD 1 1989</a>; <a href="./references#CD001892-bbs2-0012" title="GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. KlahrS . The modification of diet in renal disease study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]">MDRD 2 1989</a>; <a href="./references#CD001892-bbs2-0015" title="MeloniC , TatangeloP , CiprianiS , RossiV , SuraciC , TozzoC , et al. Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure. Journal of Renal Nutrition2004;14(4):208-13. [MEDLINE: 15483780]">Meloni 2004</a>; <a href="./references#CD001892-bbs2-0017" title="MircescuG , GarneataL , StancuSH , CapusaC . Effects of a supplemented hypoproteic diet in chronic kidney disease. Journal of Renal Nutrition2007;17(3):179-88. [MEDLINE: 17462550]">Mircescu 2007</a>; <a href="./references#CD001892-bbs2-0018" title="BockHA , BrunnerFP . Dietary protein restriction in chronic renal failure. Lancet1985;1(8426):465-6. [MEDLINE: 2857845]DonkerAJ , Piers-BechtTP . Four-years follow-up of patients with chronic renal insufficiency randomly allocated to a protein-restricted diet and a control group [abstract]. Nephrology Dialysis Transplantation1989;4(5):455. DonkerAJ , RosmanJB , Piers-BechtTP , SluiterWJ . Effect of protein restriction in chronic renal insufficiency: a prospective randomized trial [abstract]. Kidney International1985;27:137. RosmanJB , DonkerAJ , MeijerS , SluiterWJ , Piers-BechtTP , van derHemGK . Two years' experience with protein restriction in chronic renal failure. Contributions to Nephrology1986;53:109-20. [MEDLINE: 3542377]RosmanJB , DonkerAJ . The response to a low-protein diet to retard the progression of renal failure is sex-dependent [abstract]. Nephrology Dialysis Transplantation1989;4(5):457. RosmanJB , LangerK , BrandlM , Piers-BechtTP , van derHemGK , ter WeePM , et al. Protein-restricted diets in chronic renal failure: a four year follow-up shows limited indications. Kidney International - Supplement1989;27:S96-S102. [MEDLINE: 2636680]RosmanJB , ter WeePM , MeijerS , Piers-BechtTP , SluiterWJ , DonkerAJ . Prospective randomised trial of early dietary protein restriction in chronic renal failure. Lancet1984;324(8415):1291-6. [MEDLINE: 6150320]RosmanJB , Ter WeePM , Piers-BechtGP , SluiterWJ , van derWoudeF , MeijerS , et al. Early protein restriction in chronic renal failure [abstract]. Kidney International1984;26(4):510. RosmanJB , ter WeePM , Piers-BechtGP , SluiterWJ , van derWoudeFJ , MeijerS , et al. Early protein restriction in chronic renal failure. Proceedings of the European Dialysis &amp; Transplant Association - European Renal Association1985;21:567-73. [MEDLINE: 3887375]RosmanJB , Ter WeePM , SluiterWJ , MeijerS , van derHemGK , DonkerAJ . Four years experience with dietary protein restriction in chronic renal failure [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:28. RosmanJB , ter WeePM . Relationship between proteinuria and response to low protein diets early in chronic renal failure. Blood Purification1989;7(1):52-7. [MEDLINE: 2645924]">Rosman 1 1984</a>; <a href="./references#CD001892-bbs2-0019" title="BockHA , BrunnerFP . Dietary protein restriction in chronic renal failure. Lancet1985;1(8426):465-6. [MEDLINE: 2857845]DonkerAJ , Piers-BechtTP . Four-years follow-up of patients with chronic renal insufficiency randomly allocated to a protein-restricted diet and a control group [abstract]. Nephrology Dialysis Transplantation1989;4(5):455. DonkerAJ , RosmanJB , Piers-BechtTP , SluiterWJ . Effect of protein restriction in chronic renal insufficiency: a prospective randomized trial [abstract]. Kidney International1985;27:137. RosmanJB , DonkerAJ , MeijerS , SluiterWJ , Piers-BechtTP , van derHemGK . Two years' experience with protein restriction in chronic renal failure. Contributions to Nephrology1986;53:109-20. [MEDLINE: 3542377]RosmanJB , DonkerAJ . The response to a low-protein diet to retard the progression of renal failure is sex-dependent [abstract]. Nephrology Dialysis Transplantation1989;4(5):457. RosmanJB , LangerK , BrandlM , Piers-BechtTP , van derHemGK , ter WeePM , et al. Protein-restricted diets in chronic renal failure: a four year follow-up shows limited indications. Kidney International - Supplement1989;27:S96-102. [MEDLINE: 2636680]RosmanJB , ter WeePM , MeijerS , Piers-BechtTP , SluiterWJ , DonkerAJ . Prospective randomised trial of early dietary protein restriction in chronic renal failure. Lancet1984;324(8415):1291-6. [MEDLINE: 6150320]RosmanJB , Ter WeePM , Piers-BechtGP , SluiterWJ , van derWoudeF , MeijerS , et al. Early protein restriction in chronic renal failure [abstract]. Kidney International1984;26(4):510. RosmanJB , ter WeePM , Piers-BechtGP , SluiterWJ , van derWoudeFJ , MeijerS , et al. Early protein restriction in chronic renal failure. Proceedings of the European Dialysis &amp; Transplant Association - European Renal Association1985;21:567-73. [MEDLINE: 3887375]RosmanJB , Ter WeePM , SluiterWJ , MeijerS , van derHemGK , DonkerAJ . Four years experience with dietary protein restriction in chronic renal failure. [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:28. RosmanJB , ter WeePM . Relationship between proteinuria and response to low protein diets early in chronic renal failure. Blood Purification1989;7(1):52-7. [MEDLINE: 2645924]">Rosman 2 1984</a>) were assessed as at low risk of detection bias and in the remaining four studies, it was unclear how many participants were lost to follow‐up. </p> </section> <section id="CD001892-sec-0048"> <h4 class="title">Selective reporting</h4> <p>Studies were considered to be at high risk of bias if data were provided in a format, which could not be entered into the meta‐analyses or if the study did not provide data on death, requirement for dialysis or the nutritional status of the participants. We assessed 11 studies at high risk of selective reporting (<a href="./references#CD001892-bbs2-0005" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 1 1990</a>; <a href="./references#CD001892-bbs2-0006" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 2 1990</a>; <a href="./references#CD001892-bbs2-0008" title="BeckerGJ , WhitworthJA , IhleBU , ShahinfarS , Kincaid-SmithPS . Prevention of progression in non-diabetic chronic renal failure. Kidney International - Supplement1994;45(Suppl 45):S167-70. [MEDLINE: 8158888]IhleBU , BeckerGJ , WhithworthJA , CharlwoodRA , Kincaid-SmithPS . The effect of protein restriction on the progression of renal insufficiency. New England Journal of Medicine1989;321(26):1773-7. [MEDLINE: 2512486]">Ihle 1989</a>; <a href="./references#CD001892-bbs2-0009" title="D'AmicoG , GentileMG , FellinG , MannaG , CofanoF . Effect of dietary protein restriction on the progression of renal failure: a prospective randomized trial. Nephrology Dialysis Transplantation1994;9(11):1590-4. [MEDLINE: 7870348]LocatelliF , AlbertiD , GentileMG , GrazianiG , BucciantiG , CosciP , et al. Effects of two different protein prescriptions on chronic renal failure progression. Cooperative study. [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:20. LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA , et al. Blood pressure and chronic renal failure progression: results from a multicentre trial [abstract]. Nephrology Dialysis Transplantation1992;7(7):712. LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA , et al. Factors affecting chronic renal failure progression: results from a multicentre trial. The Northern Italian Cooperative Study Group. Mineral &amp; Electrolyte Metabolism1992;18(2-5):295-302. [MEDLINE: 1465079]LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA . Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group. Lancet1991;337(8753):1299-304. [MEDLINE: 1674294]LocatelliF , Del VecchioL , AndrulliS , MaraiP , TentoriF . The role of underlying nephropathy in the progression of renal disease. Kidney International - Supplement2000;75:S49-55. [MEDLINE: 10828762]LocatelliF , MarcelliD , et al. Factors affecting the progression of chronic renal failure: a multivariate analysis [abstract]. Nephrology Dialysis Transplantation1989;4(5):457. LocatelliF , MarcelliD , TentoriF , MaraiP . Hypertension and progression of chronic renal failure (CRF): a prospective study [abstract]. In: 11th International Congress of Nephrology; 1990 Jul 15-20; Tokyo, Japan. 1990:37A. LocatelliF . Controlled study of protein-restricted diet in chronic renal failure. Contributions to Nephrology1989;75:141-6. [MEDLINE: 2697498]LocatelliF . Dietary compliance in patients with chronic renal failure: experience in a northern Italy trial. Contributions to Nephrology1990;81:102-6. [MEDLINE: 2093485]TentoriF , MaraiP , MarcelliD , PontiR , LocatelliF . Monocentric prospective randomized controlled study on the progression rate of chronic renal failure (CRF) with two different protein intakes [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:20. TentoriF , MaraiP . Monocentric prospective randomised controlled study on the progression rate of chronic renal failure with two different protein intakes [abstract]. Nephrology Dialysis Transplantation1987;2(5):400-1. ">Locatelli 1989</a>; <a href="./references#CD001892-bbs2-0010" title="MalvyD , MaingourdC , PengloanJ , BagrosP , NivetH . Effects of severe protein restriction with ketoanalogues in advanced renal failure. Journal of the American College of Nutrition1999;18(5):481-6. [MEDLINE: 10511331]NivetH , MaingourdC , MalvyD , PengloanJ , BagrosPH . Effects of severe protein-restriction with ketoanalogues in advanced renal failure [abstract]. Journal of the American Society of Nephrology1992;3(3):286. ">Malvy 1999</a>; <a href="./references#CD001892-bbs2-0011" title="BeckGJ , BergRL , CogginsCH , GassmanJJ , HunsickerLG , SchluchterMD , et al. Design and statistical issues of the Modification of Diet in Renal Disease Trial. The Modification of Diet in Renal Disease Study Group. Controlled Clinical Trials1991;12(5):566-86. [MEDLINE: 1664792]Buckalew VM Jr, BergRL , WangSR , PorushJG , RauchS , SchulmanG . Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. American Journal of Kidney Diseases1996;28(6):811-21. [MEDLINE: 8957032]ChawlaV , WangX , GreeneJ , KusekJW , CollinsAJ , LeveyAS , et al. Dyslipidemia and mortality in chronic kidney disease [abstract no: TH-PO895]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A-2A. ChenJL , LernerD , RuthazerR , Castaneda-SceppaC , LeveyAS . Association of physical activity with mortality in chronic kidney disease. Journal of Nephrology2008;21(2):243-52. [MEDLINE: 18446720]ChenJL , SceppaC , RuthazerR , LeveyAS . Leisure time physical activity status and mortality in chronic kidney disease: preliminary findings from the MDRD study [abstract no: 21]. American Journal of Kidney Diseases2006;47(4):A24. CogginsCH , Breyer LewisJ , CaggiulaAW , CastaldoLS , KlahrS , WangSR . Differences between women and men with chronic renal disease. Nephrology Dialysis Transplantation1998;13(6):1430-7. [MEDLINE: 9641172]CoyneT , OlsonM , BradhamK , GarconM , GregoryP , ScherchL . Dietary satisfaction correlated with adherence in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1301-6. [MEDLINE: 7594127]DennisVW . Decoding the Modification of Diet in Renal Disease Study. Cleveland Clinic Journal of Medicine1994;61(4):254-7. [MEDLINE: 7923742]DolecekTA , OlsonMB , CaggiulaAW , DwyerJT , MilasNC , GillisBP , et al. Registered dietitian time requirements in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1307-12. [MEDLINE: 7594128]Effects of diet and antihypertensive therapy on creatinine clearance and serum creatinine concentration in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Aug;8(8):1354]. Journal of the American Society of Nephrology1996;7(4):556-66. [MEDLINE: 8724889]Effects of dietary protein restriction on the progression of moderate renal disease in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Mar;8(3):493]. Journal of the American Society of Nephrology1996;7(12):2616-26. [MEDLINE: 8989740]GassmanJJ , DrabikMJ , LeathermanJR , FaticaKJ , McPhersonJA , Modification of Diet in Renal Disease Study Group. Development and use of distributed data entry and electronic communication in a multi-center study of progressive renal disease [abstract]. Kidney International1989;35(1):226. GennariFJ , HoodVL , GreeneT , WangX , LeveyAS . Effect of Dietary Protein Intake on Serum Total CO2 Concentration in Chronic Kidney Disease: Modification of Diet in Renal Disease Study Findings. Clinical Journal of the American Society of Nephrology: CJASN2006;1(1):52-7. [MEDLINE: 17699190]GillisBP , AverbachFM , CaggiulaAW , JonesFL , NaujelisJ , MaurerE , et al. Features of the nutrient database and analysis system for the Modification of Diet in Renal Disease Study.[Erratum appears in Control Clin Trials 1994 Aug;15(4):326]. Controlled Clinical Trials1994;15(1):44-58. [MEDLINE: 8149770]GillisBP , CaggiulaAW , ChiavacciAT , CoyneT , DoroshenkoL , MilasNC , et al. Nutrition intervention program of the Modification of Diet in Renal Disease Study: a self-management approach. Journal of the American Dietetic Association1995;95(11):1288-94. [MEDLINE: 7594125]GramsME , CoreshJ , SegevDL , KucirkaLM , TighiouartH , SarnakMJ . Vascular disease, ESRD, and death: interpreting competing risk analyses. Clinical Journal of the American Society of Nephrology: CJASN2012;7(10):1606-14. [MEDLINE: 22859747]GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. GramsME , TinA , RebholzCM , ShafiT , KottgenA , PerroneRD , et al. Metabolomic alterations associated with cause of CKD. Clinical Journal of The American Society of Nephrology: CJASN2017;12(11):1787-94. [MEDLINE: 28971980]GreeneT , BeckG , WangS , KusekJ , LeveyA , Modification of Diet in Renal Disease Study Group. The effect of the low protein diet in the MDRD study A is dependent on the underlying rate of disease progression [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A. GreeneT , BourgoignieJJ , HabweV , KusekJW , SnetselaarLG , SoucieJM , et al. Baseline characteristics in the Modification of Diet in Renal Disease Study.[Republished from J Am Soc Nephrol 1993 May;3(11):1819-34]. Journal of the American Society of Nephrology1993;4(5):1221-36. [MEDLINE: 8305650]HebertLA , GreeneT , HunsickerLG , LeveyAS , WangS , MDRD Study Group. Relationship of urine volume (uv) and urine osmolality (Uosm) to the progression of renal disease in the Modification of Diet in Renal Disease (MDRD) study [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A-6A. HebertLA , KusekJW , GreeneT , AgodoaLY , JonesCA , LeveyAS , et al. Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group. Hypertension1997;30(3 (Pt 1)):428-35. [MEDLINE: 9314428]HunsickerLG , AdlerS , CaggiulaA , EnglandBK , GreeneT , KusekJW , et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney International1997;51(6):1908-19. [MEDLINE: 9186882]HunsickerLG , MDRD Study Group. Secondary analysis of the Modification of Diet in Renal Disease (MDRD) study [abstract]. In: 13th International Congress of Nephrology; 1995 Jul 2-6; Madrid, Spain. 1995:64. IxJH , ShlipakMG , SarnakMJ , BeckGJ , GreeneT , WangX , et al. Fetuin-A is not associated with all-cause or cardiovascular mortality in chronic kidney disease: data from the Modification of Diet in Renal Disease (MDRD) study [abstract no: SU-PO711]. Journal of the American Society of Nephrology2007;18(Abstracts Issue):741A. KlahrS , BreyerJA , BeckGJ , DennisVW , HartmanJA , RothD , et al. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group.[Erratum appears in J Am Soc Nephrol 1995 Oct;6(4):1318]. Journal of the American Society of Nephrology1995;5(12):2037-47. [MEDLINE: 7579052]KlahrS , LeveyAS , BeckGJ , CaggiulaAW , HunsickerL , KusekJW , et al. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. New England Journal of Medicine1994;330(13):877-84. [MEDLINE: 8114857]KlahrS , Modification of Diet in Renal Disease Study. The Modification of Diet in Renal Disease Study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]KlahrS . Primary and secondary results of the modification of diet in renal disease study. Mineral &amp; Electrolyte Metabolism1996;22(1-3):138-42. [MEDLINE: 8676806]KoppleJD , GreeneT , ChumleaWC , HollingerD , MaroniBJ , MerrillD , et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney International2000;57(4):1688-703. [MEDLINE: 10760105]KoppleJD , LeveyAS , GreeneT , ChumleaWC , GassmanJJ , HollingerDL , et al. Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. Kidney International1997;52(3):778-91. [MEDLINE: 9291200]KuE , GliddenDV , JohansenKL , SarnakM , TighiouartH , GrimesB , et al. Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease. Kidney International2015;87(5):1055-60. [MEDLINE: 25493952]KusekJW , CoyneT , deVelascoA , DrabikMJ , FinlayRA , GassmanJJ , et al. Recruitment experience in the full-scale phase of the Modification of Diet in Renal Disease Study. Controlled Clinical Trials1993;14(6):538-57. [MEDLINE: 8119068]KusekJW , CoyneT , deVelascoA , GassmanJ , KieferS , PowersS , et al. Recruitment experience in the full scale phase of the Modification of Diet in Renal Disease (MDRD) Study [abstract]. Controlled Clinical Trials1991;12:678. KwongYT , StevensLA , SelvinE , ZhangYL , GreeneT , Van LenteF , et al. Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. American Journal of Kidney Diseases2010;56(1):39-49. [MEDLINE: 20537455]LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , LeveyAS , MilasNC , et al. Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. Hypertension1997;29(2):641-50. [MEDLINE: 9040451]Leonberg-YooAK , TighiouartH , LeveyAS , BeckGJ , SarnakMJ . Urine potassium excretion, kidney failure, and mortality in CKD. American Journal of Kidney Diseases2017;69(3):341-9. [MEDLINE: 27233381]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , BoschJP , LewisJB , GreeneT , RogersN , RothD , et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of Internal Medicine1999;130(6):461-70. [MEDLINE: 10075613]LeveyAS , CoreshJ , GreeneT , StevensLA , ZhangYL , HendriksenS , et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate.[Erratum appears in Ann Intern Med. 2008 Oct 7;149(7):519]. Annals of Internal Medicine2006;145(4):247-54. [MEDLINE: 16908915]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study Group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]LeveyAS , GreeneT , SarnakM , WangX , BeckGJ , KusekJW , et al. Effect of low protein diet on progression of kidney disease in the Modification of Diet in Renal Disease study A: long-term follow-up [abstract no: SU-PO247]. Journal of the American Society of Nephrology2004;15(Oct):586A-7A. LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2006;48(6):879-88. [MEDLINE: 17162142]LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. The effect of very low protein diet on progression of kidney disease and mortality in Modification of Diet in Renal Disease Study B [abstract no: SU-PO246]. Journal of the American Society of Nephrology2004;15(Oct):586A. LeveyAS , GreeneT , SchluchterMD , ClearyPA , TeschanPE , LorenzRA , et al. Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. Journal of the American Society of Nephrology1993;4(5):1159-71. [MEDLINE: 8305642]MaderoM , SarnakM , WangX , GreeneT , CollinsA , BeckG , et al. Uric acid and development of kidney failure in chronic kidney disease [abstract no: F-PO1932]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):547A. MaderoM , SarnakMJ , WangX , GreeneT , BeckGJ , KusekJW , et al. Uric acid and long-term outcomes in CKD. American Journal of Kidney Diseases2009;53(5):796-803. [MEDLINE: 19303683]MaderoM , SarnakMJ , WangX , SceppaCC , GreeneT , BeckGJ , et al. Body mass index and mortality in CKD. American Journal of Kidney Diseases2007;50(3):404-11. [MEDLINE: 17720519]MaderoM , WangX , GreenT , HunsickerLG , BeckGJ , KusekJW , et al. Effect of trial participation on outcomes in the randomized and non-randomized cohorts of the Modification of Diet in Renal Disease study [abstract no: F-PO037]. Journal of the American Society of Nephrology2006;17(Abstracts):344A. MDRD Study Group, ChumleaWC , GassmanJJ , HollingerDL , MerrillD , ScherchLK , et al. Nutritional response to diet prescription in the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, HunsickerLG , AdlerS , CaggiulaAW , EnglandB , GreeneT , et al. Relationship among baseline proteinuria (p), mean arterial blood pressure (map) during follow-up, and decline in glomerular filtration rate (aGFR) in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, KoppleJD , ChumleaWC , GassmanJJ , HollingerDL , MaroniBJ , et al. Relationship between FGR and nutritional status - results from the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, KusekJW , AgodoaL , GreeneT , JonesC . Comparison of decline of GFR in blacks versus non-blacks in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , BoschJP , CaggiulaAW , GreeneT , et al. Short-term effects of protein intake, blood pressure, and antihypertensive therapy on GFR in the MDRD study. Journal of the American Society of Nephrology1995;6(3):395. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , HunsickerLG , et al. A hypothesis for the results of the Modification of Diet in Renal Disease (MDRD) study. [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , KusekJW , et al. Trends toward a beneficial effect of a low protein diet during additional follow-up in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1994;5(3):336. MDRD Study Group, LeveyAS , BeckGJ . Trends toward a beneficial effect of a low protein diet during additional follow-up in the modification of diet in renal disease study. MDRD Study Group. [abstract]. Nephrology Dialysis Transplantation1995;10(6):985. MDRD Study Group, LeveyAS , BoschJP , CogginsCH , GreeneT , MitchWE , et al. Effects of diet and blood pressure on creatinine clearance (CCr) and serum creatinine (PCr) in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, PetersonJC , BurkartJ , GreeneT , HebertL , KingA , et al. The effect of blood pressure control on progression of renal disease depends on level of proteinuria (p) at baseline evaluation [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, PetersonJC , GreeneT , KlahrS , BurkartJM , HebertL , et al. Effect of reducing proteinuria (PR) on subsequent glomerular filtration rate (GFR) decline in patients with chronic renal failure (CRF) [abstract]. Journal of the American Society of Nephrology1994;5(3):339. MDRD Study Group, PorushJG , LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , et al. Efficacy of anti-hypertensive interventions in reducing blood pressure in the MDRD study [abstract]. Journal of the American Society of Nephrology1995;6(3):400. MDRD Study Group, PowersSN , KurtzmanDA , PetotGJ , RaizmanDJ , WetsteinL . Promoting dietary compliance through computer-assisted education, assessment, and counseling. [abstract]. Kidney International1988;36(Suppl 27):S306. MDRD Study Group, RoccoMV , CoyneT , EastinS , FaubertJ , GassmanJJ , et al. Patient symptoms and quality of life in the MDRD study at enrollment-correlation with GFR [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group. The modification of diet in renal disease study: results from the full-scale trial [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:593. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Hemoglobin A1c and mortality in chronic kidney disease [abstract no: F-FC149]. Journal of the American Society of Nephrology2005;16:71A. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Insulin resistance as a predictor of all-cause and cardiovascular mortality (CVD) in chronic kidney disease (CKD) [abstract no: F-P0284]. Journal of the American Society of Nephrology2004;15(Oct):128A. MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. Journal of the American Society of Nephrology2005;16(11):3411-7. [MEDLINE: 16207824]MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD. American Journal of Kidney Diseases2005;46(3):455-63. [MEDLINE: 16129207]MenonV , GreeneT , WangX , PereiraAA , MarcovinaSM , BeckGJ , et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney International2005;68(2):766-72. [MEDLINE: 16014054]MenonV , GreenT , PereiraA , XueleiW , BeckG , KusekJ , et al. C-reactive protein (CRP) as a predictor of all-cause and cardiovascular (CVD) mortality in patients with chronic kidney disease (CKD) [abstract no: F-P0275]. Journal of the American Society of Nephrology2004;15(Oct):125A-6A. MenonV , KoppleJD , WangX , BeckGJ , CollinsAJ , KusekJW , et al. Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2009;53(2):208-17. [MEDLINE: 18950911]MenonV , LiL , GreeneT , WangX , ChandraP , BalakrishnanV , et al. Adiponectin and outcomes in chronic kidney disease [abstract no: TH-PO430]. Journal of the American Society of Nephrology2006;17(Abstracts):199A. MenonV , LiL , WangX , GreeneT , BalakrishnanV , MaderoM , et al. Adiponectin and mortality in patients with chronic kidney disease. Journal of the American Society of Nephrology2006;17(9):2599-606. [MEDLINE: 16885405]MenonV , SarnakMJ , GreeneT , WangX , PereiraAA , BeckGJ , et al. Relationship between homocysteine and mortality in chronic kidney disease. Circulation2006;113(12):1572-7. [MEDLINE: 16549639]MenonV , ShlipakMG , WangX , CoreshJ , GreeneT , StevensL , et al. Cystatin C as a risk factor for outcomes in chronic kidney disease. Annals of Internal Medicine2007;147(1):19-27. [MEDLINE: 17606957]MenonV , TighiouartH , VaughnNS , BeckGJ , KusekJW , CollinsAJ , et al. Serum bicarbonate and long-term outcomes in CKD. American Journal of Kidney Diseases2010;56(5):907-14. [MEDLINE: 20605301]MenonV , WangX , GreeneT , BeckGJ , KusekJW , MarcovinaSM , et al. Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. American Journal of Kidney Diseases2003;42(1):44-52. [MEDLINE: 12830455]MenonV , WangX , GreeneT , BeckGJ , KusekJW , SelhubJ , et al. Homocysteine in chronic kidney disease: effect of low protein diet and repletion with B vitamins. Kidney International2005;67(4):1539-46. [MEDLINE: 15780109]MenonV , WangX , SarnakMJ , HunsickerLH , MaderoM , BeckGJ , et al. Long-term outcomes in nondiabetic chronic kidney disease. Kidney International2008;73(11):1310-5. [MEDLINE: 18337713]MilasNC , NowalkMP , AkpeleL , CastaldoL , CoyneT , DoroshenkoL , et al. Factors associated with adherence to the dietary protein intervention in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1295-300. [MEDLINE: 7594126]NewsomeB , IxJH , TighiouartH , SarnakMJ , LeveyAS , BeckGJ , et al. Effect of protein restriction on serum and urine phosphate in the modification of diet in renal disease (MDRD) study. American Journal of Kidney Diseases2013;61(6):1045-6. [MEDLINE: 23415016]OlsonM , CoyneT , CaggiulaA , GregoryP . Patient satisfaction with a dietary intervention: the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):107S. OlsonM , CoyneT , CaggiulaA . Social factors influence dietary satisfaction in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1996;17(2 Suppl):133S. OlsonM , DolecekT , CaggiulaA , DwyerJ . Time required for the protein intervention in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):129S-30S. PetersonJC , AdlerS , BurkartJM , GreeneT , HebertLA , HunsickerLG , et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Annals of Internal Medicine1995;123(10):754-62. [MEDLINE: 7574193]PiccoliM , CodognottoM . Missing stratification by polycistic kidney disease (PKD) flaws risk estimates of GFR decline. Lesson from the MDRD Study [abstract no: F-PO175]. Journal of the American Society of Nephrology2004;15(Oct):103A. RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]RoccoMV , GassmanJJ , WangSR , KaplanRM . Cross-sectional study of quality of life and symptoms in chronic renal disease patients: the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1997;29(6):888-96. [MEDLINE: 9186075]SarnakMJ , GreeneT , WangX , BeckG , KusekJW , CollinsAJ , et al. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease study. Annals of Internal Medicine2005;142(5):342-51. [MEDLINE: 15738453]SarnakMJ , WangSR , BeckGJ , KusekJW , SelhubJ , GreeneT , et al. Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression. American Journal of Kidney Diseases2002;40(5):932-9. [MEDLINE: 12407637]SarnakMJ , WangX , GreeneT , GeraldJ , BeckJ , KusekJW , et al. Effect of strict blood pressure control on long-term outcome in the Modification of Diet in Renal Disease (MDRD) study [abstract no: F-P0599]. Journal of the American Society of Nephrology2003;14(Nov):192A. SchluchterMD . Estimating correlation between alternative measures of disease progression in a longitudinal study. Modification of Diet in Renal Disease Study. Statistics in Medicine1990;9(10):1175-88. [MEDLINE: 2247718]Short-term effects of protein intake, blood pressure, and antihypertensive therapy on glomerular filtration rate in the Modification of Diet in Renal Disease Study. Journal of the American Society of Nephrology1996;7(10):2097-109. [MEDLINE: 8915969]StollarC , ScherchL , AdlerS , KusekJ , CaggiulaA . Patterns of patient dietary compliance in the Modification of Diet in Renal Disease (MDRD) study, phase III. [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:609. TangriN , StevensLA , SchmidCH , ZhangYL , BeckGJ , GreeneT , et al. Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney International2011;79(4):471-7. [MEDLINE: 20980977]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]YamamotoME , OlsonMB , StollarC , MDRD Study Group. Effects of weight and Na+ change on blood pressures of hypertensive MDRD study patients [abstract]. Journal of the American Society of Nephrology1995;6(3):408. YoungJA , TerrinN , GreeneT , WangX , BeckG , KusekJ , et al. Asymmetric dimethylarginine and prevalent cardiovascular disease in patients with chronic kidney disease [abstract no: F-PO935]. Journal of the American Society of Nephrology2007;18(Abstracts):308A-9A. YoungJA , TerrinN , WangX , GreenT , BeckG , KusekJ , et al. ADMA and mortality in stage 3-4 chronic kidney disease [abstract no: TH-PO894]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A. ">MDRD 1 1989</a>; <a href="./references#CD001892-bbs2-0012" title="GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. KlahrS . The modification of diet in renal disease study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]">MDRD 2 1989</a>; <a href="./references#CD001892-bbs2-0013" title="CogginsCH , DwyerJT , GreeneT , PetotG , SnetselaarLG , Van LenteF , et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):514-23. [MEDLINE: 8154486]KlahrS , LeveyAS , SandbergAM , WilliamsGW , MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International1989;35(1):195. KoppleJD , BergR , HouserH , SteinmanTI , TeschanP . Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S184-94. [MEDLINE: 2636655]LaidlawSA , BergRL , KoppleJD , NaitoH , WalkerWG , WalserM . Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):504-13. [MEDLINE: 8154485]LeveyAS , BergRL , GassmanJJ , HallPM , WalkerWG . Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S73-80. [MEDLINE: 2636677]LeveyAS , GassmanJJ , HallPM , WalkerWG , MDRD Study Group. Poor correlation of rates of change of creatinine clearance, reciprocal serum creatinine and GFR [abstract]. Kidney International1989;35(1):197. LeveyAS , GassmanJJ , HallPM , WalkerWG . Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. Journal of the American Society of Nephrology1991;1(9):1087-94. [MEDLINE: 1912407]MDRD Study Group, MitchME , SteinmanTI . Objectives and design of the cooperative study, Modification of Diet in Renal Disease [abstract]. Kidney International1987;31(1):210. PerroneR , SteinmanT , RoyalH , LawlorM , HunsickerL , Modification of Diet in Renal Disease Study Group. Markers of GFR: comparison of 99TC-DTPA (TC), 169YB-DTPA (YB) and 125I-Iothalamate (IO) to inulin (IN) [abstract]. Kidney International1987;31(1):213. PerroneRD , SteinmanTI , BeckGJ , SkibinskiCI , RoyalHD , LawlorM , et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1990;16(3):224-35. [MEDLINE: 2205098]TeschanPE , BeckGJ , DwyerJT , GreeneT , KlahrS , LevyAS , et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clinical Nephrology1998;50(5):273-83. [MEDLINE: 9840314]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]">MDRD Feasibility A 1989</a>; <a href="./references#CD001892-bbs2-0014" title="CogginsCH , DwyerJT , GreeneT , PetotG , SnetselaarLG , Van LenteF , et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):514-23. [MEDLINE: 8154486]KlahrS , LeveyAS , SandbergAM , WilliamsGW , MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International1989;35(1):195. KoppleJD , BergR , HouserH , SteinmanTI , TeschanP . Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S184-94. [MEDLINE: 2636655]LaidlawSA , BergRL , KoppleJD , NaitoH , WalkerWG , WalserM . Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):504-13. [MEDLINE: 8154485]LeveyAS , BergRL , GassmanJJ , HallPM , WalkerWG . Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S73-80. [MEDLINE: 2636677]LeveyAS , GassmanJJ , HallPM , WalkerWG , Modification of Diet in Renal Disease Study. Poor correlation of rates of change of creatinine clearance, reciprocal serum creatinine and GFR [abstract]. Kidney International1989;35(1):197. LeveyAS , GassmanJJ , HallPM , WalkerWG . Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. Journal of the American Society of Nephrology1991;1(9):1087-94. [MEDLINE: 1912407]MDRD Study Group, MitchME , SteinmanTI . Objectives and design of the cooperative study, Modification of Diet in Renal Disease [abstract]. Kidney International1987;31(1):210. PerroneR , SteinmanT , RoyalH , LawlorM , HunsickerL , Modification of Diet in Renal Disease Study Group. Markers of GFR: comparison of 99TC-DTPA (TC), 169YB-DTPA (YB) and 125I-Iothalamate (IO) to inulin (IN) [abstract]. Kidney International1987;31(1):213. PerroneRD , SteinmanTI , BeckGJ , SkibinskiCI , RoyalHD , LawlorM , et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1990;16(3):224-35. [MEDLINE: 2205098]TeschanPE , BeckGJ , DwyerJT , GreeneT , KlahrS , LevyAS , et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clinical Nephrology1998;50(5):273-83. [MEDLINE: 9840314]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]">MDRD Feasibility B 1989</a>; <a href="./references#CD001892-bbs2-0015" title="MeloniC , TatangeloP , CiprianiS , RossiV , SuraciC , TozzoC , et al. Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure. Journal of Renal Nutrition2004;14(4):208-13. [MEDLINE: 15483780]">Meloni 2004</a>; <a href="./references#CD001892-bbs2-0020" title="TeplanV , SchuckO , BubenicekP , MengerovaO , TesarovaZ , HajnyJ , et al. The effect of long-term administration of a low-protein diet on the metabolic status and progression of chronic renal failure: a multicentre study [abstract]. Nephrology Dialysis Transplantation1998;13:820. [CENTRAL: CN-00301551] ">Teplan 1998</a>). Eight studies were assessed as low risk of selective reporting (<a href="./references#CD001892-bbs2-0003" title="CianciarusoB , PotaA , BellizziV , Di GiuseppeD , Di MiccoL , MinutoloR , et al. Effect of a low- versus moderate-protein diet on progression of CKD: follow-up of a randomized controlled trial. American Journal of Kidney Diseases2009;54(6):1052-61. [MEDLINE: 19800722]CianciarusoB , PotaA , PisaniA , TorracaS , AnnecchiniR , LombardiP , et al. Metabolic effects of two low protein diets in chronic kidney disease stage 4-5--a randomized controlled trial. Nephrology Dialysis Transplantation2008;23(2):636-44. [MEDLINE: 17981885]CianciarusoB , PotaA , TorracaS , SommaG , NazzaroP , AnnecchiniR , et al. Comparison of two different protein intakes (0.3-0.6 vs 0.7-0.9 g/kg/day) on the metabolic control of advanced renal failure [abstract no: MP197]. In: 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal. 2004:295. PotaA , PisaniA , AnnecchiniR , Di GiuseppeD , CuccurulloP , CaputoDL , et al. Treatment of chronic renal failure (CRF) with two different low protein diets. Effects on the metabolic control and on the cardiovascular risk factors [abstract no: MP306]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv401. PotaA , PisaniA , RavaniP , Di MiccoL , Di GiuseppeD , SabbatiniM , et al. Impact of two different low protein diets on survival of CKD patients (stage4-5) [abstract no: TH-PO880]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):308A. ">Cianciaruso 2008a</a>; <a href="./references#CD001892-bbs2-0002" title="ChauveauP , LebkiriB , PloyardF , CiancioniC , ManNK , JungersP . Effect of keto analogs of essential amino acids on the progress of advanced renal insufficiency: controlled prospective study [Effet des cetoanalogues des acides amines essentiels sur la progression de l'insuffisance renale chronique avancee: etude prospective controlee]. Nephrologie1986;7(5):137-42. [MEDLINE: 3796783]JungersP , ChauveauP , PloyardF , LebkiriB , CiancioniC , ManNK . Comparison of ketoacids and low protein diet on advanced chronic renal failure progression. Kidney International - Supplement1987;22:S67-71. [MEDLINE: 3323621]">Chauveau 1986</a>; <a href="./references#CD001892-bbs2-0004" title="Di IorioBR , BellizziV , MinutoloR , De NicolaL , IodiceC , ConteG . Supplemented very low-protein diet in advanced CRF: is it money saving?Kidney International2004;65(2):742. [MEDLINE: 14717953]Di IorioBR , MinutoloR , De NicolaL , BellizziV , CatapanoF , IodiceC , et al. Supplemented very low protein diet ameliorates responsiveness to erythropoietin in chronic renal failure. Kidney International2003;64(5):1822-8. [MEDLINE: 14717953]">Di Iorio 2003</a>; <a href="./references#CD001892-bbs2-0007" title="GarneataL , MircescuG . Effect of low-protein diet supplemented with keto acids on progression of chronic kidney disease. Journal of Renal Nutrition2013;23(3):210-3. [MEDLINE: 23611549]GarneataL , MocanuE , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues-effects on mineral bone metabolism disorders in advanced chronic kidney disease [abstract no: FP396]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i167-8. [EMBASE: 622605156]GarneataL , StancuA , DragomirD , MircescuG . Effect of very low protein diet supplemented with ketoanalogues of the essential amino acids on the progression of chronic kidney disease [abstract]. Nephrology Dialysis Transplantation2014;29(Suppl 3):iii39. [EMBASE: 71491557]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression. Journal of the American Society of Nephrology2016;27(7):2164-76. [MEDLINE: 26823552]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues in stage 5 CKD patients [abstract no: SP373]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i472. [EMBASE: 622606118]">Garneata 2013</a>; <a href="./references#CD001892-bbs2-0017" title="MircescuG , GarneataL , StancuSH , CapusaC . Effects of a supplemented hypoproteic diet in chronic kidney disease. Journal of Renal Nutrition2007;17(3):179-88. [MEDLINE: 17462550]">Mircescu 2007</a>; <a href="./references#CD001892-bbs2-0018" title="BockHA , BrunnerFP . Dietary protein restriction in chronic renal failure. Lancet1985;1(8426):465-6. [MEDLINE: 2857845]DonkerAJ , Piers-BechtTP . Four-years follow-up of patients with chronic renal insufficiency randomly allocated to a protein-restricted diet and a control group [abstract]. Nephrology Dialysis Transplantation1989;4(5):455. DonkerAJ , RosmanJB , Piers-BechtTP , SluiterWJ . Effect of protein restriction in chronic renal insufficiency: a prospective randomized trial [abstract]. Kidney International1985;27:137. RosmanJB , DonkerAJ , MeijerS , SluiterWJ , Piers-BechtTP , van derHemGK . Two years' experience with protein restriction in chronic renal failure. Contributions to Nephrology1986;53:109-20. [MEDLINE: 3542377]RosmanJB , DonkerAJ . The response to a low-protein diet to retard the progression of renal failure is sex-dependent [abstract]. Nephrology Dialysis Transplantation1989;4(5):457. RosmanJB , LangerK , BrandlM , Piers-BechtTP , van derHemGK , ter WeePM , et al. Protein-restricted diets in chronic renal failure: a four year follow-up shows limited indications. Kidney International - Supplement1989;27:S96-S102. [MEDLINE: 2636680]RosmanJB , ter WeePM , MeijerS , Piers-BechtTP , SluiterWJ , DonkerAJ . Prospective randomised trial of early dietary protein restriction in chronic renal failure. Lancet1984;324(8415):1291-6. [MEDLINE: 6150320]RosmanJB , Ter WeePM , Piers-BechtGP , SluiterWJ , van derWoudeF , MeijerS , et al. Early protein restriction in chronic renal failure [abstract]. Kidney International1984;26(4):510. RosmanJB , ter WeePM , Piers-BechtGP , SluiterWJ , van derWoudeFJ , MeijerS , et al. Early protein restriction in chronic renal failure. Proceedings of the European Dialysis &amp; Transplant Association - European Renal Association1985;21:567-73. [MEDLINE: 3887375]RosmanJB , Ter WeePM , SluiterWJ , MeijerS , van derHemGK , DonkerAJ . Four years experience with dietary protein restriction in chronic renal failure [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:28. RosmanJB , ter WeePM . Relationship between proteinuria and response to low protein diets early in chronic renal failure. Blood Purification1989;7(1):52-7. [MEDLINE: 2645924]">Rosman 1 1984</a>; <a href="./references#CD001892-bbs2-0019" title="BockHA , BrunnerFP . Dietary protein restriction in chronic renal failure. Lancet1985;1(8426):465-6. [MEDLINE: 2857845]DonkerAJ , Piers-BechtTP . Four-years follow-up of patients with chronic renal insufficiency randomly allocated to a protein-restricted diet and a control group [abstract]. Nephrology Dialysis Transplantation1989;4(5):455. DonkerAJ , RosmanJB , Piers-BechtTP , SluiterWJ . Effect of protein restriction in chronic renal insufficiency: a prospective randomized trial [abstract]. Kidney International1985;27:137. RosmanJB , DonkerAJ , MeijerS , SluiterWJ , Piers-BechtTP , van derHemGK . Two years' experience with protein restriction in chronic renal failure. Contributions to Nephrology1986;53:109-20. [MEDLINE: 3542377]RosmanJB , DonkerAJ . The response to a low-protein diet to retard the progression of renal failure is sex-dependent [abstract]. Nephrology Dialysis Transplantation1989;4(5):457. RosmanJB , LangerK , BrandlM , Piers-BechtTP , van derHemGK , ter WeePM , et al. Protein-restricted diets in chronic renal failure: a four year follow-up shows limited indications. Kidney International - Supplement1989;27:S96-102. [MEDLINE: 2636680]RosmanJB , ter WeePM , MeijerS , Piers-BechtTP , SluiterWJ , DonkerAJ . Prospective randomised trial of early dietary protein restriction in chronic renal failure. Lancet1984;324(8415):1291-6. [MEDLINE: 6150320]RosmanJB , Ter WeePM , Piers-BechtGP , SluiterWJ , van derWoudeF , MeijerS , et al. Early protein restriction in chronic renal failure [abstract]. Kidney International1984;26(4):510. RosmanJB , ter WeePM , Piers-BechtGP , SluiterWJ , van derWoudeFJ , MeijerS , et al. Early protein restriction in chronic renal failure. Proceedings of the European Dialysis &amp; Transplant Association - European Renal Association1985;21:567-73. [MEDLINE: 3887375]RosmanJB , Ter WeePM , SluiterWJ , MeijerS , van derHemGK , DonkerAJ . Four years experience with dietary protein restriction in chronic renal failure. [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:28. RosmanJB , ter WeePM . Relationship between proteinuria and response to low protein diets early in chronic renal failure. Blood Purification1989;7(1):52-7. [MEDLINE: 2645924]">Rosman 2 1984</a>; <a href="./references#CD001892-bbs2-0021" title="WilliamsP , StevensME , FassG , BoneJM . A randomised trial of the effect of protein and phosphate restriction on the progression of chronic renal failure [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:38. WilliamsPS , StevensM , FassG , BoneJM . A randomised trial of the effect of protein and phosphate restriction on the progression of chronic renal failure [abstract]. Nephrology Dialysis Transplantation1987;2(4):285. WilliamsPS , StevensM , IronsL , FassG , BoneJM . Failure of  dietary protein/phosphate restriction to slow the progression of chronic renal failure; a prospective randomised controlled trial [abstract]. Nephrology Dialysis Transplantation1990;5(8):674. WilliamsPS , StevensME , FassG , IronsL , BoneJM . Failure of dietary protein and phosphate restriction to retard the rate of progression of chronic renal failure: a prospective, randomized, controlled trial. Quarterly Journal of Medicine1991;81(294):837-55. [MEDLINE: 1801057]WilliamsPS , StevensME . A randomised trial of the effect of protein and phosphate restriction on the progression of chronic renal failure [abstract]. Nephrology Dialysis Transplantation1987;2(5):401. ">Williams 1991</a>) and two studies were judged as unclear. </p> </section> <section id="CD001892-sec-0049"> <h4 class="title">Other potential sources of bias</h4> <p>We assessed eight studies (<a href="./references#CD001892-bbs2-0003" title="CianciarusoB , PotaA , BellizziV , Di GiuseppeD , Di MiccoL , MinutoloR , et al. Effect of a low- versus moderate-protein diet on progression of CKD: follow-up of a randomized controlled trial. American Journal of Kidney Diseases2009;54(6):1052-61. [MEDLINE: 19800722]CianciarusoB , PotaA , PisaniA , TorracaS , AnnecchiniR , LombardiP , et al. Metabolic effects of two low protein diets in chronic kidney disease stage 4-5--a randomized controlled trial. Nephrology Dialysis Transplantation2008;23(2):636-44. [MEDLINE: 17981885]CianciarusoB , PotaA , TorracaS , SommaG , NazzaroP , AnnecchiniR , et al. Comparison of two different protein intakes (0.3-0.6 vs 0.7-0.9 g/kg/day) on the metabolic control of advanced renal failure [abstract no: MP197]. In: 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal. 2004:295. PotaA , PisaniA , AnnecchiniR , Di GiuseppeD , CuccurulloP , CaputoDL , et al. Treatment of chronic renal failure (CRF) with two different low protein diets. Effects on the metabolic control and on the cardiovascular risk factors [abstract no: MP306]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv401. PotaA , PisaniA , RavaniP , Di MiccoL , Di GiuseppeD , SabbatiniM , et al. Impact of two different low protein diets on survival of CKD patients (stage4-5) [abstract no: TH-PO880]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):308A. ">Cianciaruso 2008a</a>; <a href="./references#CD001892-bbs2-0005" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 1 1990</a>; <a href="./references#CD001892-bbs2-0006" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 2 1990</a>; <a href="./references#CD001892-bbs2-0007" title="GarneataL , MircescuG . Effect of low-protein diet supplemented with keto acids on progression of chronic kidney disease. Journal of Renal Nutrition2013;23(3):210-3. [MEDLINE: 23611549]GarneataL , MocanuE , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues-effects on mineral bone metabolism disorders in advanced chronic kidney disease [abstract no: FP396]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i167-8. [EMBASE: 622605156]GarneataL , StancuA , DragomirD , MircescuG . Effect of very low protein diet supplemented with ketoanalogues of the essential amino acids on the progression of chronic kidney disease [abstract]. Nephrology Dialysis Transplantation2014;29(Suppl 3):iii39. [EMBASE: 71491557]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression. Journal of the American Society of Nephrology2016;27(7):2164-76. [MEDLINE: 26823552]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues in stage 5 CKD patients [abstract no: SP373]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i472. [EMBASE: 622606118]">Garneata 2013</a>; <a href="./references#CD001892-bbs2-0011" title="BeckGJ , BergRL , CogginsCH , GassmanJJ , HunsickerLG , SchluchterMD , et al. Design and statistical issues of the Modification of Diet in Renal Disease Trial. The Modification of Diet in Renal Disease Study Group. Controlled Clinical Trials1991;12(5):566-86. [MEDLINE: 1664792]Buckalew VM Jr, BergRL , WangSR , PorushJG , RauchS , SchulmanG . Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. American Journal of Kidney Diseases1996;28(6):811-21. [MEDLINE: 8957032]ChawlaV , WangX , GreeneJ , KusekJW , CollinsAJ , LeveyAS , et al. Dyslipidemia and mortality in chronic kidney disease [abstract no: TH-PO895]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A-2A. ChenJL , LernerD , RuthazerR , Castaneda-SceppaC , LeveyAS . Association of physical activity with mortality in chronic kidney disease. Journal of Nephrology2008;21(2):243-52. [MEDLINE: 18446720]ChenJL , SceppaC , RuthazerR , LeveyAS . Leisure time physical activity status and mortality in chronic kidney disease: preliminary findings from the MDRD study [abstract no: 21]. American Journal of Kidney Diseases2006;47(4):A24. CogginsCH , Breyer LewisJ , CaggiulaAW , CastaldoLS , KlahrS , WangSR . Differences between women and men with chronic renal disease. Nephrology Dialysis Transplantation1998;13(6):1430-7. [MEDLINE: 9641172]CoyneT , OlsonM , BradhamK , GarconM , GregoryP , ScherchL . Dietary satisfaction correlated with adherence in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1301-6. [MEDLINE: 7594127]DennisVW . Decoding the Modification of Diet in Renal Disease Study. Cleveland Clinic Journal of Medicine1994;61(4):254-7. [MEDLINE: 7923742]DolecekTA , OlsonMB , CaggiulaAW , DwyerJT , MilasNC , GillisBP , et al. Registered dietitian time requirements in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1307-12. [MEDLINE: 7594128]Effects of diet and antihypertensive therapy on creatinine clearance and serum creatinine concentration in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Aug;8(8):1354]. Journal of the American Society of Nephrology1996;7(4):556-66. [MEDLINE: 8724889]Effects of dietary protein restriction on the progression of moderate renal disease in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Mar;8(3):493]. Journal of the American Society of Nephrology1996;7(12):2616-26. [MEDLINE: 8989740]GassmanJJ , DrabikMJ , LeathermanJR , FaticaKJ , McPhersonJA , Modification of Diet in Renal Disease Study Group. Development and use of distributed data entry and electronic communication in a multi-center study of progressive renal disease [abstract]. Kidney International1989;35(1):226. GennariFJ , HoodVL , GreeneT , WangX , LeveyAS . Effect of Dietary Protein Intake on Serum Total CO2 Concentration in Chronic Kidney Disease: Modification of Diet in Renal Disease Study Findings. Clinical Journal of the American Society of Nephrology: CJASN2006;1(1):52-7. [MEDLINE: 17699190]GillisBP , AverbachFM , CaggiulaAW , JonesFL , NaujelisJ , MaurerE , et al. Features of the nutrient database and analysis system for the Modification of Diet in Renal Disease Study.[Erratum appears in Control Clin Trials 1994 Aug;15(4):326]. Controlled Clinical Trials1994;15(1):44-58. [MEDLINE: 8149770]GillisBP , CaggiulaAW , ChiavacciAT , CoyneT , DoroshenkoL , MilasNC , et al. Nutrition intervention program of the Modification of Diet in Renal Disease Study: a self-management approach. Journal of the American Dietetic Association1995;95(11):1288-94. [MEDLINE: 7594125]GramsME , CoreshJ , SegevDL , KucirkaLM , TighiouartH , SarnakMJ . Vascular disease, ESRD, and death: interpreting competing risk analyses. Clinical Journal of the American Society of Nephrology: CJASN2012;7(10):1606-14. [MEDLINE: 22859747]GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. GramsME , TinA , RebholzCM , ShafiT , KottgenA , PerroneRD , et al. Metabolomic alterations associated with cause of CKD. Clinical Journal of The American Society of Nephrology: CJASN2017;12(11):1787-94. [MEDLINE: 28971980]GreeneT , BeckG , WangS , KusekJ , LeveyA , Modification of Diet in Renal Disease Study Group. The effect of the low protein diet in the MDRD study A is dependent on the underlying rate of disease progression [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A. GreeneT , BourgoignieJJ , HabweV , KusekJW , SnetselaarLG , SoucieJM , et al. Baseline characteristics in the Modification of Diet in Renal Disease Study.[Republished from J Am Soc Nephrol 1993 May;3(11):1819-34]. Journal of the American Society of Nephrology1993;4(5):1221-36. [MEDLINE: 8305650]HebertLA , GreeneT , HunsickerLG , LeveyAS , WangS , MDRD Study Group. Relationship of urine volume (uv) and urine osmolality (Uosm) to the progression of renal disease in the Modification of Diet in Renal Disease (MDRD) study [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A-6A. HebertLA , KusekJW , GreeneT , AgodoaLY , JonesCA , LeveyAS , et al. Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group. Hypertension1997;30(3 (Pt 1)):428-35. [MEDLINE: 9314428]HunsickerLG , AdlerS , CaggiulaA , EnglandBK , GreeneT , KusekJW , et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney International1997;51(6):1908-19. [MEDLINE: 9186882]HunsickerLG , MDRD Study Group. Secondary analysis of the Modification of Diet in Renal Disease (MDRD) study [abstract]. In: 13th International Congress of Nephrology; 1995 Jul 2-6; Madrid, Spain. 1995:64. IxJH , ShlipakMG , SarnakMJ , BeckGJ , GreeneT , WangX , et al. Fetuin-A is not associated with all-cause or cardiovascular mortality in chronic kidney disease: data from the Modification of Diet in Renal Disease (MDRD) study [abstract no: SU-PO711]. Journal of the American Society of Nephrology2007;18(Abstracts Issue):741A. KlahrS , BreyerJA , BeckGJ , DennisVW , HartmanJA , RothD , et al. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group.[Erratum appears in J Am Soc Nephrol 1995 Oct;6(4):1318]. Journal of the American Society of Nephrology1995;5(12):2037-47. [MEDLINE: 7579052]KlahrS , LeveyAS , BeckGJ , CaggiulaAW , HunsickerL , KusekJW , et al. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. New England Journal of Medicine1994;330(13):877-84. [MEDLINE: 8114857]KlahrS , Modification of Diet in Renal Disease Study. The Modification of Diet in Renal Disease Study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]KlahrS . Primary and secondary results of the modification of diet in renal disease study. Mineral &amp; Electrolyte Metabolism1996;22(1-3):138-42. [MEDLINE: 8676806]KoppleJD , GreeneT , ChumleaWC , HollingerD , MaroniBJ , MerrillD , et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney International2000;57(4):1688-703. [MEDLINE: 10760105]KoppleJD , LeveyAS , GreeneT , ChumleaWC , GassmanJJ , HollingerDL , et al. Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. Kidney International1997;52(3):778-91. [MEDLINE: 9291200]KuE , GliddenDV , JohansenKL , SarnakM , TighiouartH , GrimesB , et al. Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease. Kidney International2015;87(5):1055-60. [MEDLINE: 25493952]KusekJW , CoyneT , deVelascoA , DrabikMJ , FinlayRA , GassmanJJ , et al. Recruitment experience in the full-scale phase of the Modification of Diet in Renal Disease Study. Controlled Clinical Trials1993;14(6):538-57. [MEDLINE: 8119068]KusekJW , CoyneT , deVelascoA , GassmanJ , KieferS , PowersS , et al. Recruitment experience in the full scale phase of the Modification of Diet in Renal Disease (MDRD) Study [abstract]. Controlled Clinical Trials1991;12:678. KwongYT , StevensLA , SelvinE , ZhangYL , GreeneT , Van LenteF , et al. Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. American Journal of Kidney Diseases2010;56(1):39-49. [MEDLINE: 20537455]LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , LeveyAS , MilasNC , et al. Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. Hypertension1997;29(2):641-50. [MEDLINE: 9040451]Leonberg-YooAK , TighiouartH , LeveyAS , BeckGJ , SarnakMJ . Urine potassium excretion, kidney failure, and mortality in CKD. American Journal of Kidney Diseases2017;69(3):341-9. [MEDLINE: 27233381]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , BoschJP , LewisJB , GreeneT , RogersN , RothD , et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of Internal Medicine1999;130(6):461-70. [MEDLINE: 10075613]LeveyAS , CoreshJ , GreeneT , StevensLA , ZhangYL , HendriksenS , et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate.[Erratum appears in Ann Intern Med. 2008 Oct 7;149(7):519]. Annals of Internal Medicine2006;145(4):247-54. [MEDLINE: 16908915]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study Group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]LeveyAS , GreeneT , SarnakM , WangX , BeckGJ , KusekJW , et al. Effect of low protein diet on progression of kidney disease in the Modification of Diet in Renal Disease study A: long-term follow-up [abstract no: SU-PO247]. Journal of the American Society of Nephrology2004;15(Oct):586A-7A. LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2006;48(6):879-88. [MEDLINE: 17162142]LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. The effect of very low protein diet on progression of kidney disease and mortality in Modification of Diet in Renal Disease Study B [abstract no: SU-PO246]. Journal of the American Society of Nephrology2004;15(Oct):586A. LeveyAS , GreeneT , SchluchterMD , ClearyPA , TeschanPE , LorenzRA , et al. Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. Journal of the American Society of Nephrology1993;4(5):1159-71. [MEDLINE: 8305642]MaderoM , SarnakM , WangX , GreeneT , CollinsA , BeckG , et al. Uric acid and development of kidney failure in chronic kidney disease [abstract no: F-PO1932]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):547A. MaderoM , SarnakMJ , WangX , GreeneT , BeckGJ , KusekJW , et al. Uric acid and long-term outcomes in CKD. American Journal of Kidney Diseases2009;53(5):796-803. [MEDLINE: 19303683]MaderoM , SarnakMJ , WangX , SceppaCC , GreeneT , BeckGJ , et al. Body mass index and mortality in CKD. American Journal of Kidney Diseases2007;50(3):404-11. [MEDLINE: 17720519]MaderoM , WangX , GreenT , HunsickerLG , BeckGJ , KusekJW , et al. Effect of trial participation on outcomes in the randomized and non-randomized cohorts of the Modification of Diet in Renal Disease study [abstract no: F-PO037]. Journal of the American Society of Nephrology2006;17(Abstracts):344A. MDRD Study Group, ChumleaWC , GassmanJJ , HollingerDL , MerrillD , ScherchLK , et al. Nutritional response to diet prescription in the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, HunsickerLG , AdlerS , CaggiulaAW , EnglandB , GreeneT , et al. Relationship among baseline proteinuria (p), mean arterial blood pressure (map) during follow-up, and decline in glomerular filtration rate (aGFR) in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, KoppleJD , ChumleaWC , GassmanJJ , HollingerDL , MaroniBJ , et al. Relationship between FGR and nutritional status - results from the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, KusekJW , AgodoaL , GreeneT , JonesC . Comparison of decline of GFR in blacks versus non-blacks in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , BoschJP , CaggiulaAW , GreeneT , et al. Short-term effects of protein intake, blood pressure, and antihypertensive therapy on GFR in the MDRD study. Journal of the American Society of Nephrology1995;6(3):395. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , HunsickerLG , et al. A hypothesis for the results of the Modification of Diet in Renal Disease (MDRD) study. [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , KusekJW , et al. Trends toward a beneficial effect of a low protein diet during additional follow-up in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1994;5(3):336. MDRD Study Group, LeveyAS , BeckGJ . Trends toward a beneficial effect of a low protein diet during additional follow-up in the modification of diet in renal disease study. MDRD Study Group. [abstract]. Nephrology Dialysis Transplantation1995;10(6):985. MDRD Study Group, LeveyAS , BoschJP , CogginsCH , GreeneT , MitchWE , et al. Effects of diet and blood pressure on creatinine clearance (CCr) and serum creatinine (PCr) in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, PetersonJC , BurkartJ , GreeneT , HebertL , KingA , et al. The effect of blood pressure control on progression of renal disease depends on level of proteinuria (p) at baseline evaluation [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, PetersonJC , GreeneT , KlahrS , BurkartJM , HebertL , et al. Effect of reducing proteinuria (PR) on subsequent glomerular filtration rate (GFR) decline in patients with chronic renal failure (CRF) [abstract]. Journal of the American Society of Nephrology1994;5(3):339. MDRD Study Group, PorushJG , LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , et al. Efficacy of anti-hypertensive interventions in reducing blood pressure in the MDRD study [abstract]. Journal of the American Society of Nephrology1995;6(3):400. MDRD Study Group, PowersSN , KurtzmanDA , PetotGJ , RaizmanDJ , WetsteinL . Promoting dietary compliance through computer-assisted education, assessment, and counseling. [abstract]. Kidney International1988;36(Suppl 27):S306. MDRD Study Group, RoccoMV , CoyneT , EastinS , FaubertJ , GassmanJJ , et al. Patient symptoms and quality of life in the MDRD study at enrollment-correlation with GFR [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group. The modification of diet in renal disease study: results from the full-scale trial [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:593. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Hemoglobin A1c and mortality in chronic kidney disease [abstract no: F-FC149]. Journal of the American Society of Nephrology2005;16:71A. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Insulin resistance as a predictor of all-cause and cardiovascular mortality (CVD) in chronic kidney disease (CKD) [abstract no: F-P0284]. Journal of the American Society of Nephrology2004;15(Oct):128A. MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. Journal of the American Society of Nephrology2005;16(11):3411-7. [MEDLINE: 16207824]MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD. American Journal of Kidney Diseases2005;46(3):455-63. [MEDLINE: 16129207]MenonV , GreeneT , WangX , PereiraAA , MarcovinaSM , BeckGJ , et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney International2005;68(2):766-72. [MEDLINE: 16014054]MenonV , GreenT , PereiraA , XueleiW , BeckG , KusekJ , et al. C-reactive protein (CRP) as a predictor of all-cause and cardiovascular (CVD) mortality in patients with chronic kidney disease (CKD) [abstract no: F-P0275]. Journal of the American Society of Nephrology2004;15(Oct):125A-6A. MenonV , KoppleJD , WangX , BeckGJ , CollinsAJ , KusekJW , et al. Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2009;53(2):208-17. [MEDLINE: 18950911]MenonV , LiL , GreeneT , WangX , ChandraP , BalakrishnanV , et al. Adiponectin and outcomes in chronic kidney disease [abstract no: TH-PO430]. Journal of the American Society of Nephrology2006;17(Abstracts):199A. MenonV , LiL , WangX , GreeneT , BalakrishnanV , MaderoM , et al. Adiponectin and mortality in patients with chronic kidney disease. Journal of the American Society of Nephrology2006;17(9):2599-606. [MEDLINE: 16885405]MenonV , SarnakMJ , GreeneT , WangX , PereiraAA , BeckGJ , et al. Relationship between homocysteine and mortality in chronic kidney disease. Circulation2006;113(12):1572-7. [MEDLINE: 16549639]MenonV , ShlipakMG , WangX , CoreshJ , GreeneT , StevensL , et al. Cystatin C as a risk factor for outcomes in chronic kidney disease. Annals of Internal Medicine2007;147(1):19-27. [MEDLINE: 17606957]MenonV , TighiouartH , VaughnNS , BeckGJ , KusekJW , CollinsAJ , et al. Serum bicarbonate and long-term outcomes in CKD. American Journal of Kidney Diseases2010;56(5):907-14. [MEDLINE: 20605301]MenonV , WangX , GreeneT , BeckGJ , KusekJW , MarcovinaSM , et al. Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. American Journal of Kidney Diseases2003;42(1):44-52. [MEDLINE: 12830455]MenonV , WangX , GreeneT , BeckGJ , KusekJW , SelhubJ , et al. Homocysteine in chronic kidney disease: effect of low protein diet and repletion with B vitamins. Kidney International2005;67(4):1539-46. [MEDLINE: 15780109]MenonV , WangX , SarnakMJ , HunsickerLH , MaderoM , BeckGJ , et al. Long-term outcomes in nondiabetic chronic kidney disease. Kidney International2008;73(11):1310-5. [MEDLINE: 18337713]MilasNC , NowalkMP , AkpeleL , CastaldoL , CoyneT , DoroshenkoL , et al. Factors associated with adherence to the dietary protein intervention in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1295-300. [MEDLINE: 7594126]NewsomeB , IxJH , TighiouartH , SarnakMJ , LeveyAS , BeckGJ , et al. Effect of protein restriction on serum and urine phosphate in the modification of diet in renal disease (MDRD) study. American Journal of Kidney Diseases2013;61(6):1045-6. [MEDLINE: 23415016]OlsonM , CoyneT , CaggiulaA , GregoryP . Patient satisfaction with a dietary intervention: the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):107S. OlsonM , CoyneT , CaggiulaA . Social factors influence dietary satisfaction in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1996;17(2 Suppl):133S. OlsonM , DolecekT , CaggiulaA , DwyerJ . Time required for the protein intervention in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):129S-30S. PetersonJC , AdlerS , BurkartJM , GreeneT , HebertLA , HunsickerLG , et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Annals of Internal Medicine1995;123(10):754-62. [MEDLINE: 7574193]PiccoliM , CodognottoM . Missing stratification by polycistic kidney disease (PKD) flaws risk estimates of GFR decline. Lesson from the MDRD Study [abstract no: F-PO175]. Journal of the American Society of Nephrology2004;15(Oct):103A. RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]RoccoMV , GassmanJJ , WangSR , KaplanRM . Cross-sectional study of quality of life and symptoms in chronic renal disease patients: the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1997;29(6):888-96. [MEDLINE: 9186075]SarnakMJ , GreeneT , WangX , BeckG , KusekJW , CollinsAJ , et al. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease study. Annals of Internal Medicine2005;142(5):342-51. [MEDLINE: 15738453]SarnakMJ , WangSR , BeckGJ , KusekJW , SelhubJ , GreeneT , et al. Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression. American Journal of Kidney Diseases2002;40(5):932-9. [MEDLINE: 12407637]SarnakMJ , WangX , GreeneT , GeraldJ , BeckJ , KusekJW , et al. Effect of strict blood pressure control on long-term outcome in the Modification of Diet in Renal Disease (MDRD) study [abstract no: F-P0599]. Journal of the American Society of Nephrology2003;14(Nov):192A. SchluchterMD . Estimating correlation between alternative measures of disease progression in a longitudinal study. Modification of Diet in Renal Disease Study. Statistics in Medicine1990;9(10):1175-88. [MEDLINE: 2247718]Short-term effects of protein intake, blood pressure, and antihypertensive therapy on glomerular filtration rate in the Modification of Diet in Renal Disease Study. Journal of the American Society of Nephrology1996;7(10):2097-109. [MEDLINE: 8915969]StollarC , ScherchL , AdlerS , KusekJ , CaggiulaA . Patterns of patient dietary compliance in the Modification of Diet in Renal Disease (MDRD) study, phase III. [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:609. TangriN , StevensLA , SchmidCH , ZhangYL , BeckGJ , GreeneT , et al. Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney International2011;79(4):471-7. [MEDLINE: 20980977]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]YamamotoME , OlsonMB , StollarC , MDRD Study Group. Effects of weight and Na+ change on blood pressures of hypertensive MDRD study patients [abstract]. Journal of the American Society of Nephrology1995;6(3):408. YoungJA , TerrinN , GreeneT , WangX , BeckG , KusekJ , et al. Asymmetric dimethylarginine and prevalent cardiovascular disease in patients with chronic kidney disease [abstract no: F-PO935]. Journal of the American Society of Nephrology2007;18(Abstracts):308A-9A. YoungJA , TerrinN , WangX , GreenT , BeckG , KusekJ , et al. ADMA and mortality in stage 3-4 chronic kidney disease [abstract no: TH-PO894]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A. ">MDRD 1 1989</a>; <a href="./references#CD001892-bbs2-0012" title="GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. KlahrS . The modification of diet in renal disease study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]">MDRD 2 1989</a>; <a href="./references#CD001892-bbs2-0013" title="CogginsCH , DwyerJT , GreeneT , PetotG , SnetselaarLG , Van LenteF , et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):514-23. [MEDLINE: 8154486]KlahrS , LeveyAS , SandbergAM , WilliamsGW , MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International1989;35(1):195. KoppleJD , BergR , HouserH , SteinmanTI , TeschanP . Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S184-94. [MEDLINE: 2636655]LaidlawSA , BergRL , KoppleJD , NaitoH , WalkerWG , WalserM . Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):504-13. [MEDLINE: 8154485]LeveyAS , BergRL , GassmanJJ , HallPM , WalkerWG . Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S73-80. [MEDLINE: 2636677]LeveyAS , GassmanJJ , HallPM , WalkerWG , MDRD Study Group. Poor correlation of rates of change of creatinine clearance, reciprocal serum creatinine and GFR [abstract]. Kidney International1989;35(1):197. LeveyAS , GassmanJJ , HallPM , WalkerWG . Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. Journal of the American Society of Nephrology1991;1(9):1087-94. [MEDLINE: 1912407]MDRD Study Group, MitchME , SteinmanTI . Objectives and design of the cooperative study, Modification of Diet in Renal Disease [abstract]. Kidney International1987;31(1):210. PerroneR , SteinmanT , RoyalH , LawlorM , HunsickerL , Modification of Diet in Renal Disease Study Group. Markers of GFR: comparison of 99TC-DTPA (TC), 169YB-DTPA (YB) and 125I-Iothalamate (IO) to inulin (IN) [abstract]. Kidney International1987;31(1):213. PerroneRD , SteinmanTI , BeckGJ , SkibinskiCI , RoyalHD , LawlorM , et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1990;16(3):224-35. [MEDLINE: 2205098]TeschanPE , BeckGJ , DwyerJT , GreeneT , KlahrS , LevyAS , et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clinical Nephrology1998;50(5):273-83. [MEDLINE: 9840314]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]">MDRD Feasibility A 1989</a>; <a href="./references#CD001892-bbs2-0014" title="CogginsCH , DwyerJT , GreeneT , PetotG , SnetselaarLG , Van LenteF , et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):514-23. [MEDLINE: 8154486]KlahrS , LeveyAS , SandbergAM , WilliamsGW , MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International1989;35(1):195. KoppleJD , BergR , HouserH , SteinmanTI , TeschanP . Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S184-94. [MEDLINE: 2636655]LaidlawSA , BergRL , KoppleJD , NaitoH , WalkerWG , WalserM . Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):504-13. [MEDLINE: 8154485]LeveyAS , BergRL , GassmanJJ , HallPM , WalkerWG . Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S73-80. [MEDLINE: 2636677]LeveyAS , GassmanJJ , HallPM , WalkerWG , Modification of Diet in Renal Disease Study. Poor correlation of rates of change of creatinine clearance, reciprocal serum creatinine and GFR [abstract]. Kidney International1989;35(1):197. LeveyAS , GassmanJJ , HallPM , WalkerWG . Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. Journal of the American Society of Nephrology1991;1(9):1087-94. [MEDLINE: 1912407]MDRD Study Group, MitchME , SteinmanTI . Objectives and design of the cooperative study, Modification of Diet in Renal Disease [abstract]. Kidney International1987;31(1):210. PerroneR , SteinmanT , RoyalH , LawlorM , HunsickerL , Modification of Diet in Renal Disease Study Group. Markers of GFR: comparison of 99TC-DTPA (TC), 169YB-DTPA (YB) and 125I-Iothalamate (IO) to inulin (IN) [abstract]. Kidney International1987;31(1):213. PerroneRD , SteinmanTI , BeckGJ , SkibinskiCI , RoyalHD , LawlorM , et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1990;16(3):224-35. [MEDLINE: 2205098]TeschanPE , BeckGJ , DwyerJT , GreeneT , KlahrS , LevyAS , et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clinical Nephrology1998;50(5):273-83. [MEDLINE: 9840314]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]">MDRD Feasibility B 1989</a>) to be at low risk of potential bias as they were funded by educational or philanthropic organisations and the remaining fourteen studies were considered as unclear as there was insufficient information to permit judgement regarding funding sources. </p> </section> </section> <section id="CD001892-sec-0050"> <h3 class="title" id="CD001892-sec-0050">Effects of interventions</h3> <p>See: <a href="./full#CD001892-tbl-0001"><b>Summary of findings 1</b> Low protein diet versus normal protein diet for non‐diabetic adults with chronic kidney disease (CKD)</a>; <a href="./full#CD001892-tbl-0002"><b>Summary of findings 2</b> Very low protein diet versus low or normal protein diet for non‐diabetic adults with chronic kidney disease (CKD)</a>; <a href="./full#CD001892-tbl-0003"><b>Summary of findings 3</b> Nutritional measures for non‐diabetic adults with chronic kidney disease (CKD)</a> </p> <section id="CD001892-sec-0051"> <h4 class="title">Low protein diets versus normal or free protein diet</h4> <p>Eleven studies compared low protein diets (0.55 to 0.6 g/kg/day) with a normal or free protein diet (0.8 to 1 g/kg/day). Nine studies enrolled participants with category 3a and 3b CKD while one study (<a href="./references#CD001892-bbs2-0003" title="CianciarusoB , PotaA , BellizziV , Di GiuseppeD , Di MiccoL , MinutoloR , et al. Effect of a low- versus moderate-protein diet on progression of CKD: follow-up of a randomized controlled trial. American Journal of Kidney Diseases2009;54(6):1052-61. [MEDLINE: 19800722]CianciarusoB , PotaA , PisaniA , TorracaS , AnnecchiniR , LombardiP , et al. Metabolic effects of two low protein diets in chronic kidney disease stage 4-5--a randomized controlled trial. Nephrology Dialysis Transplantation2008;23(2):636-44. [MEDLINE: 17981885]CianciarusoB , PotaA , TorracaS , SommaG , NazzaroP , AnnecchiniR , et al. Comparison of two different protein intakes (0.3-0.6 vs 0.7-0.9 g/kg/day) on the metabolic control of advanced renal failure [abstract no: MP197]. In: 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal. 2004:295. PotaA , PisaniA , AnnecchiniR , Di GiuseppeD , CuccurulloP , CaputoDL , et al. Treatment of chronic renal failure (CRF) with two different low protein diets. Effects on the metabolic control and on the cardiovascular risk factors [abstract no: MP306]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv401. PotaA , PisaniA , RavaniP , Di MiccoL , Di GiuseppeD , SabbatiniM , et al. Impact of two different low protein diets on survival of CKD patients (stage4-5) [abstract no: TH-PO880]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):308A. ">Cianciaruso 2008a</a>) enrolled participants with CKD category 4 and 5. </p> <section id="CD001892-sec-0052"> <h5 class="title">Death (all causes)</h5> <p>Five of 10 studies reported data on death (all causes), which could be included in a meta‐analysis. The certainty of the evidence was considered as moderate (<a href="./full#CD001892-tbl-0001">summary of findings Table 1</a>) because of imprecision. Thus a low protein intake probably leads to little or no difference in death between participants, who received a lower protein diet, and those receiving a normal or free protein diet (<a href="./references#CD001892-fig-0004" title="">Analysis 1.1</a> (5 studies, 1680 participants): RR 0.77, 95% CI 0.51 to 1.18; I<sup>2</sup> = 0%). There were 13 fewer deaths per 1000 in the low protein group (27 fewer to 10 more deaths). Five studies did not report this outcome. </p> </section> <section id="CD001892-sec-0053"> <h5 class="title">End‐stage kidney disease</h5> <p>Six of 10 studies reported data on this outcome, which could be included in a meta‐analysis. The certainty of the evidence was considered as low (<a href="./full#CD001892-tbl-0001">summary of findings Table 1</a>) because of imprecision and moderate heterogeneity. A low protein diet may make little or no difference in the number of participants who reached ESKD compared with a normal protein diet (<a href="./references#CD001892-fig-0005" title="">Analysis 1.2</a> (6 studies, 1814 participants): RR 1.05, 95% CI 0.73 to 1.53; I<sup>2</sup> = 62%). There were 7 participants more per 1000 reaching ESKD in the low protein group (39 fewer to 76 more) compared with the normal protein group. Removal of <a href="./references#CD001892-bbs2-0003" title="CianciarusoB , PotaA , BellizziV , Di GiuseppeD , Di MiccoL , MinutoloR , et al. Effect of a low- versus moderate-protein diet on progression of CKD: follow-up of a randomized controlled trial. American Journal of Kidney Diseases2009;54(6):1052-61. [MEDLINE: 19800722]CianciarusoB , PotaA , PisaniA , TorracaS , AnnecchiniR , LombardiP , et al. Metabolic effects of two low protein diets in chronic kidney disease stage 4-5--a randomized controlled trial. Nephrology Dialysis Transplantation2008;23(2):636-44. [MEDLINE: 17981885]CianciarusoB , PotaA , TorracaS , SommaG , NazzaroP , AnnecchiniR , et al. Comparison of two different protein intakes (0.3-0.6 vs 0.7-0.9 g/kg/day) on the metabolic control of advanced renal failure [abstract no: MP197]. In: 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal. 2004:295. PotaA , PisaniA , AnnecchiniR , Di GiuseppeD , CuccurulloP , CaputoDL , et al. Treatment of chronic renal failure (CRF) with two different low protein diets. Effects on the metabolic control and on the cardiovascular risk factors [abstract no: MP306]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv401. PotaA , PisaniA , RavaniP , Di MiccoL , Di GiuseppeD , SabbatiniM , et al. Impact of two different low protein diets on survival of CKD patients (stage4-5) [abstract no: TH-PO880]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):308A. ">Cianciaruso 2008a</a>, which included participants with CKD category 4, did not influence the heterogeneity. Exclusion of <a href="./references#CD001892-bbs2-0005" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 1 1990</a> reduced this heterogeneity (I<sup>2</sup> = 26%). <a href="./references#CD001892-bbs2-0005" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 1 1990</a> did not report information which allowed us to determine whether there was detection bias or selective reporting in this study so it is possible that increased risk of bias in these domains in this study contributed to the heterogeneity. Four studies (<a href="./references#CD001892-bbs2-0001" title="AlvestrandA , BuchtH , GutierrezA , BergströmJ . Progression of chronic renal failure in man as influenced by frequency and quality of clinical follow-ups [abstract]. Kidney International1985;27(1):240. BergstromJ , AlvestrandA , BuchtH , GutierrezA . Progression of chronic renal failure in man is retarded with more frequent clinical follow-ups and better blood pressure control. Clinical Nephrology1986;25(1):1-6. [MEDLINE: 3955903]BergstromJ , AlvestrandA , BuchtH , GutierrezA . Stockholm clinical study on progression of chronic renal failure--an interim report. Kidney International - Supplement1989;36(Suppl 27):S110-4. [MEDLINE: 2636644]BergstromJ , AlvestrandA , BuchtH , GutierrezA . What is the role of controls in an outpatient department on progression of renal disease?Blood Purification1988;6(6):336-42. [MEDLINE: 3061400]">Bergstrom 1986</a>, <a href="./references#CD001892-bbs2-0013" title="CogginsCH , DwyerJT , GreeneT , PetotG , SnetselaarLG , Van LenteF , et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):514-23. [MEDLINE: 8154486]KlahrS , LeveyAS , SandbergAM , WilliamsGW , MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International1989;35(1):195. KoppleJD , BergR , HouserH , SteinmanTI , TeschanP . Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S184-94. [MEDLINE: 2636655]LaidlawSA , BergRL , KoppleJD , NaitoH , WalkerWG , WalserM . Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):504-13. [MEDLINE: 8154485]LeveyAS , BergRL , GassmanJJ , HallPM , WalkerWG . Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S73-80. [MEDLINE: 2636677]LeveyAS , GassmanJJ , HallPM , WalkerWG , MDRD Study Group. Poor correlation of rates of change of creatinine clearance, reciprocal serum creatinine and GFR [abstract]. Kidney International1989;35(1):197. LeveyAS , GassmanJJ , HallPM , WalkerWG . Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. Journal of the American Society of Nephrology1991;1(9):1087-94. [MEDLINE: 1912407]MDRD Study Group, MitchME , SteinmanTI . Objectives and design of the cooperative study, Modification of Diet in Renal Disease [abstract]. Kidney International1987;31(1):210. PerroneR , SteinmanT , RoyalH , LawlorM , HunsickerL , Modification of Diet in Renal Disease Study Group. Markers of GFR: comparison of 99TC-DTPA (TC), 169YB-DTPA (YB) and 125I-Iothalamate (IO) to inulin (IN) [abstract]. Kidney International1987;31(1):213. PerroneRD , SteinmanTI , BeckGJ , SkibinskiCI , RoyalHD , LawlorM , et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1990;16(3):224-35. [MEDLINE: 2205098]TeschanPE , BeckGJ , DwyerJT , GreeneT , KlahrS , LevyAS , et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clinical Nephrology1998;50(5):273-83. [MEDLINE: 9840314]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]">MDRD Feasibility A 1989</a>; <a href="./references#CD001892-bbs2-0015" title="MeloniC , TatangeloP , CiprianiS , RossiV , SuraciC , TozzoC , et al. Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure. Journal of Renal Nutrition2004;14(4):208-13. [MEDLINE: 15483780]">Meloni 2004</a>; <a href="./references#CD001892-bbs2-0016" title="Milovanov IuS, LysenkoLV , MilovanovaLI , DobrosmyslovIA . The role of balanced low-protein diet in inhibition of predialysis chronic kidney disease progression in patients with systemic diseases. Terapevticheskii Arkhiv2009;81(8):52-7. [MEDLINE: 19799201]">Milovanov 2009</a>) did not report on this outcome. </p> </section> <section id="CD001892-sec-0054"> <h5 class="title">End or change in GFR</h5> <p>Eight of 10 studies reported data on this outcome, which could be included in a meta‐analysis. Studies used different methods to express the final GFR or the change in GFR. Because of imprecision, use of a surrogate outcome and substantial heterogeneity (Summary of findings table 1), the certainty of the evidence was considered to be very low. It therefore remains uncertain whether a low protein diet influences the final or change in GFR compared with a normal protein diet (<a href="./references#CD001892-fig-0006" title="">Analysis 1.3</a>; 8 studies, 1680 participants): SMD ‐0.18, 95% CI ‐0.75 to 0.38; I<sup>2</sup> = 96%). Heterogeneity was reduced by exclusion of the studies by <a href="./references#CD001892-bbs2-0009" title="D'AmicoG , GentileMG , FellinG , MannaG , CofanoF . Effect of dietary protein restriction on the progression of renal failure: a prospective randomized trial. Nephrology Dialysis Transplantation1994;9(11):1590-4. [MEDLINE: 7870348]LocatelliF , AlbertiD , GentileMG , GrazianiG , BucciantiG , CosciP , et al. Effects of two different protein prescriptions on chronic renal failure progression. Cooperative study. [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:20. LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA , et al. Blood pressure and chronic renal failure progression: results from a multicentre trial [abstract]. Nephrology Dialysis Transplantation1992;7(7):712. LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA , et al. Factors affecting chronic renal failure progression: results from a multicentre trial. The Northern Italian Cooperative Study Group. Mineral &amp; Electrolyte Metabolism1992;18(2-5):295-302. [MEDLINE: 1465079]LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA . Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group. Lancet1991;337(8753):1299-304. [MEDLINE: 1674294]LocatelliF , Del VecchioL , AndrulliS , MaraiP , TentoriF . The role of underlying nephropathy in the progression of renal disease. Kidney International - Supplement2000;75:S49-55. [MEDLINE: 10828762]LocatelliF , MarcelliD , et al. Factors affecting the progression of chronic renal failure: a multivariate analysis [abstract]. Nephrology Dialysis Transplantation1989;4(5):457. LocatelliF , MarcelliD , TentoriF , MaraiP . Hypertension and progression of chronic renal failure (CRF): a prospective study [abstract]. In: 11th International Congress of Nephrology; 1990 Jul 15-20; Tokyo, Japan. 1990:37A. LocatelliF . Controlled study of protein-restricted diet in chronic renal failure. Contributions to Nephrology1989;75:141-6. [MEDLINE: 2697498]LocatelliF . Dietary compliance in patients with chronic renal failure: experience in a northern Italy trial. Contributions to Nephrology1990;81:102-6. [MEDLINE: 2093485]TentoriF , MaraiP , MarcelliD , PontiR , LocatelliF . Monocentric prospective randomized controlled study on the progression rate of chronic renal failure (CRF) with two different protein intakes [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:20. TentoriF , MaraiP . Monocentric prospective randomised controlled study on the progression rate of chronic renal failure with two different protein intakes [abstract]. Nephrology Dialysis Transplantation1987;2(5):400-1. ">Locatelli 1989</a> and <a href="./references#CD001892-bbs2-0015" title="MeloniC , TatangeloP , CiprianiS , RossiV , SuraciC , TozzoC , et al. Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure. Journal of Renal Nutrition2004;14(4):208-13. [MEDLINE: 15483780]">Meloni 2004</a> but it was not clear why these studies should provide data that differed from other studies. <a href="./references#CD001892-bbs2-0005" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 1 1990</a> did not report this outcome while <a href="./references#CD001892-bbs2-0018" title="BockHA , BrunnerFP . Dietary protein restriction in chronic renal failure. Lancet1985;1(8426):465-6. [MEDLINE: 2857845]DonkerAJ , Piers-BechtTP . Four-years follow-up of patients with chronic renal insufficiency randomly allocated to a protein-restricted diet and a control group [abstract]. Nephrology Dialysis Transplantation1989;4(5):455. DonkerAJ , RosmanJB , Piers-BechtTP , SluiterWJ . Effect of protein restriction in chronic renal insufficiency: a prospective randomized trial [abstract]. Kidney International1985;27:137. RosmanJB , DonkerAJ , MeijerS , SluiterWJ , Piers-BechtTP , van derHemGK . Two years' experience with protein restriction in chronic renal failure. Contributions to Nephrology1986;53:109-20. [MEDLINE: 3542377]RosmanJB , DonkerAJ . The response to a low-protein diet to retard the progression of renal failure is sex-dependent [abstract]. Nephrology Dialysis Transplantation1989;4(5):457. RosmanJB , LangerK , BrandlM , Piers-BechtTP , van derHemGK , ter WeePM , et al. Protein-restricted diets in chronic renal failure: a four year follow-up shows limited indications. Kidney International - Supplement1989;27:S96-S102. [MEDLINE: 2636680]RosmanJB , ter WeePM , MeijerS , Piers-BechtTP , SluiterWJ , DonkerAJ . Prospective randomised trial of early dietary protein restriction in chronic renal failure. Lancet1984;324(8415):1291-6. [MEDLINE: 6150320]RosmanJB , Ter WeePM , Piers-BechtGP , SluiterWJ , van derWoudeF , MeijerS , et al. Early protein restriction in chronic renal failure [abstract]. Kidney International1984;26(4):510. RosmanJB , ter WeePM , Piers-BechtGP , SluiterWJ , van derWoudeFJ , MeijerS , et al. Early protein restriction in chronic renal failure. Proceedings of the European Dialysis &amp; Transplant Association - European Renal Association1985;21:567-73. [MEDLINE: 3887375]RosmanJB , Ter WeePM , SluiterWJ , MeijerS , van derHemGK , DonkerAJ . Four years experience with dietary protein restriction in chronic renal failure [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:28. RosmanJB , ter WeePM . Relationship between proteinuria and response to low protein diets early in chronic renal failure. Blood Purification1989;7(1):52-7. [MEDLINE: 2645924]">Rosman 1 1984</a> only reported the data as medians, which could not be included in the meta‐analysis. </p> </section> </section> <section id="CD001892-sec-0055"> <h4 class="title">Very low protein diet versus low protein diet</h4> <p>Eight studies compared a very low protein diet (0.3 to 0.4 g/kg/day) with a low protein diet (0.58 to 0.65 g/kg/day) while two studies compared a very low protein diet with a normal protein diet. All studies enrolled participants with CKD category 4. </p> <section id="CD001892-sec-0056"> <h5 class="title">Death (all causes)</h5> <p>Six of 10 studies reported data for this outcome, which could be included in a meta‐analysis. Because of imprecision in the results, the certainty of the evidence was considered to be moderate (<a href="./full#CD001892-tbl-0002">summary of findings Table 2</a>). Thus a very low protein intake probably leads to little or no difference in death between participants, who received a lower protein diet, and those receiving a normal or free protein diet (<a href="./references#CD001892-fig-0007" title="">Analysis 2.1</a> (6 studies, 681 participants): RR 1.26, 95% CI 0.62 to 2.54; I<sup>2</sup> = 0%). There were 10 more deaths per 1000 in the very low protein group (15 fewer to 60 more) compared with the normal or low protein group. Four studies (<a href="./references#CD001892-bbs2-0004" title="Di IorioBR , BellizziV , MinutoloR , De NicolaL , IodiceC , ConteG . Supplemented very low-protein diet in advanced CRF: is it money saving?Kidney International2004;65(2):742. [MEDLINE: 14717953]Di IorioBR , MinutoloR , De NicolaL , BellizziV , CatapanoF , IodiceC , et al. Supplemented very low protein diet ameliorates responsiveness to erythropoietin in chronic renal failure. Kidney International2003;64(5):1822-8. [MEDLINE: 14717953]">Di Iorio 2003</a>; <a href="./references#CD001892-bbs2-0006" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 2 1990</a>; <a href="./references#CD001892-bbs2-0008" title="BeckerGJ , WhitworthJA , IhleBU , ShahinfarS , Kincaid-SmithPS . Prevention of progression in non-diabetic chronic renal failure. Kidney International - Supplement1994;45(Suppl 45):S167-70. [MEDLINE: 8158888]IhleBU , BeckerGJ , WhithworthJA , CharlwoodRA , Kincaid-SmithPS . The effect of protein restriction on the progression of renal insufficiency. New England Journal of Medicine1989;321(26):1773-7. [MEDLINE: 2512486]">Ihle 1989</a>; <a href="./references#CD001892-bbs2-0014" title="CogginsCH , DwyerJT , GreeneT , PetotG , SnetselaarLG , Van LenteF , et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):514-23. [MEDLINE: 8154486]KlahrS , LeveyAS , SandbergAM , WilliamsGW , MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International1989;35(1):195. KoppleJD , BergR , HouserH , SteinmanTI , TeschanP . Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S184-94. [MEDLINE: 2636655]LaidlawSA , BergRL , KoppleJD , NaitoH , WalkerWG , WalserM . Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):504-13. [MEDLINE: 8154485]LeveyAS , BergRL , GassmanJJ , HallPM , WalkerWG . Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S73-80. [MEDLINE: 2636677]LeveyAS , GassmanJJ , HallPM , WalkerWG , Modification of Diet in Renal Disease Study. Poor correlation of rates of change of creatinine clearance, reciprocal serum creatinine and GFR [abstract]. Kidney International1989;35(1):197. LeveyAS , GassmanJJ , HallPM , WalkerWG . Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. Journal of the American Society of Nephrology1991;1(9):1087-94. [MEDLINE: 1912407]MDRD Study Group, MitchME , SteinmanTI . Objectives and design of the cooperative study, Modification of Diet in Renal Disease [abstract]. Kidney International1987;31(1):210. PerroneR , SteinmanT , RoyalH , LawlorM , HunsickerL , Modification of Diet in Renal Disease Study Group. Markers of GFR: comparison of 99TC-DTPA (TC), 169YB-DTPA (YB) and 125I-Iothalamate (IO) to inulin (IN) [abstract]. Kidney International1987;31(1):213. PerroneRD , SteinmanTI , BeckGJ , SkibinskiCI , RoyalHD , LawlorM , et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1990;16(3):224-35. [MEDLINE: 2205098]TeschanPE , BeckGJ , DwyerJT , GreeneT , KlahrS , LevyAS , et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clinical Nephrology1998;50(5):273-83. [MEDLINE: 9840314]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]">MDRD Feasibility B 1989</a>) did not report data for this outcome. </p> </section> <section id="CD001892-sec-0057"> <h5 class="title">End‐stage kidney disease</h5> <p>All ten studies reported data on this outcome, which could be included in a meta‐analysis. Because of moderate heterogeneity, the certainty of the evidence was considered to be moderate (<a href="./full#CD001892-tbl-0002">summary of findings Table 2</a>). Thus a very low protein diet probably reduces the number of participants, who reach ESKD, compared with a low or normal protein intake (<a href="./references#CD001892-fig-0008" title="">Analysis 2.2</a> (10 studies, 1010 participants): RR 0.64, 95% CI 0.49 to 0.85; I<sup>2</sup> = 56%). There were 165 fewer participants per 1000, who reached ESKD with a very low protein diet compared with a low or normal protein diet (69 to 233 fewer). Exclusion of <a href="./references#CD001892-bbs2-0014" title="CogginsCH , DwyerJT , GreeneT , PetotG , SnetselaarLG , Van LenteF , et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):514-23. [MEDLINE: 8154486]KlahrS , LeveyAS , SandbergAM , WilliamsGW , MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International1989;35(1):195. KoppleJD , BergR , HouserH , SteinmanTI , TeschanP . Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S184-94. [MEDLINE: 2636655]LaidlawSA , BergRL , KoppleJD , NaitoH , WalkerWG , WalserM . Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):504-13. [MEDLINE: 8154485]LeveyAS , BergRL , GassmanJJ , HallPM , WalkerWG . Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S73-80. [MEDLINE: 2636677]LeveyAS , GassmanJJ , HallPM , WalkerWG , Modification of Diet in Renal Disease Study. Poor correlation of rates of change of creatinine clearance, reciprocal serum creatinine and GFR [abstract]. Kidney International1989;35(1):197. LeveyAS , GassmanJJ , HallPM , WalkerWG . Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. Journal of the American Society of Nephrology1991;1(9):1087-94. [MEDLINE: 1912407]MDRD Study Group, MitchME , SteinmanTI . Objectives and design of the cooperative study, Modification of Diet in Renal Disease [abstract]. Kidney International1987;31(1):210. PerroneR , SteinmanT , RoyalH , LawlorM , HunsickerL , Modification of Diet in Renal Disease Study Group. Markers of GFR: comparison of 99TC-DTPA (TC), 169YB-DTPA (YB) and 125I-Iothalamate (IO) to inulin (IN) [abstract]. Kidney International1987;31(1):213. PerroneRD , SteinmanTI , BeckGJ , SkibinskiCI , RoyalHD , LawlorM , et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1990;16(3):224-35. [MEDLINE: 2205098]TeschanPE , BeckGJ , DwyerJT , GreeneT , KlahrS , LevyAS , et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clinical Nephrology1998;50(5):273-83. [MEDLINE: 9840314]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]">MDRD Feasibility B 1989</a> reduced heterogeneity slightly though it remains unclear why this study's results differed from those of the other studies. Exclusion of <a href="./references#CD001892-bbs2-0008" title="BeckerGJ , WhitworthJA , IhleBU , ShahinfarS , Kincaid-SmithPS . Prevention of progression in non-diabetic chronic renal failure. Kidney International - Supplement1994;45(Suppl 45):S167-70. [MEDLINE: 8158888]IhleBU , BeckerGJ , WhithworthJA , CharlwoodRA , Kincaid-SmithPS . The effect of protein restriction on the progression of renal insufficiency. New England Journal of Medicine1989;321(26):1773-7. [MEDLINE: 2512486]">Ihle 1989</a> and <a href="./references#CD001892-bbs2-0019" title="BockHA , BrunnerFP . Dietary protein restriction in chronic renal failure. Lancet1985;1(8426):465-6. [MEDLINE: 2857845]DonkerAJ , Piers-BechtTP . Four-years follow-up of patients with chronic renal insufficiency randomly allocated to a protein-restricted diet and a control group [abstract]. Nephrology Dialysis Transplantation1989;4(5):455. DonkerAJ , RosmanJB , Piers-BechtTP , SluiterWJ . Effect of protein restriction in chronic renal insufficiency: a prospective randomized trial [abstract]. Kidney International1985;27:137. RosmanJB , DonkerAJ , MeijerS , SluiterWJ , Piers-BechtTP , van derHemGK . Two years' experience with protein restriction in chronic renal failure. Contributions to Nephrology1986;53:109-20. [MEDLINE: 3542377]RosmanJB , DonkerAJ . The response to a low-protein diet to retard the progression of renal failure is sex-dependent [abstract]. Nephrology Dialysis Transplantation1989;4(5):457. RosmanJB , LangerK , BrandlM , Piers-BechtTP , van derHemGK , ter WeePM , et al. Protein-restricted diets in chronic renal failure: a four year follow-up shows limited indications. Kidney International - Supplement1989;27:S96-102. [MEDLINE: 2636680]RosmanJB , ter WeePM , MeijerS , Piers-BechtTP , SluiterWJ , DonkerAJ . Prospective randomised trial of early dietary protein restriction in chronic renal failure. Lancet1984;324(8415):1291-6. [MEDLINE: 6150320]RosmanJB , Ter WeePM , Piers-BechtGP , SluiterWJ , van derWoudeF , MeijerS , et al. Early protein restriction in chronic renal failure [abstract]. Kidney International1984;26(4):510. RosmanJB , ter WeePM , Piers-BechtGP , SluiterWJ , van derWoudeFJ , MeijerS , et al. Early protein restriction in chronic renal failure. Proceedings of the European Dialysis &amp; Transplant Association - European Renal Association1985;21:567-73. [MEDLINE: 3887375]RosmanJB , Ter WeePM , SluiterWJ , MeijerS , van derHemGK , DonkerAJ . Four years experience with dietary protein restriction in chronic renal failure. [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:28. RosmanJB , ter WeePM . Relationship between proteinuria and response to low protein diets early in chronic renal failure. Blood Purification1989;7(1):52-7. [MEDLINE: 2645924]">Rosman 2 1984</a>, which compared a very low protein intake with a normal protein intake, did not influence the degree of heterogeneity. </p> </section> <section id="CD001892-sec-0058"> <h5 class="title">End or change in GFR</h5> <p>Six of 10 studies reported data on this outcome, which could be included in a meta‐analysis. Because of substantial heterogeneity, use of a surrogate outcome and a high risk of bias in some included studies, the certainty of the evidence was considered to be very low (<a href="./full#CD001892-tbl-0002">summary of findings Table 2</a>). It therefore remains uncertain whether a low protein diet influences the final or change in GFR compared with a normal protein diet (<a href="./references#CD001892-fig-0009" title="">Analysis 2.3</a> (6 studies, 456 participants): SMD 0.12, 95% CI ‐0.27 to 0.52; I<sup>2</sup> = 68%). Heterogeneity was reduced with the exclusion of <a href="./references#CD001892-bbs2-0012" title="GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. KlahrS . The modification of diet in renal disease study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]">MDRD 2 1989</a> and <a href="./references#CD001892-bbs2-0014" title="CogginsCH , DwyerJT , GreeneT , PetotG , SnetselaarLG , Van LenteF , et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):514-23. [MEDLINE: 8154486]KlahrS , LeveyAS , SandbergAM , WilliamsGW , MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International1989;35(1):195. KoppleJD , BergR , HouserH , SteinmanTI , TeschanP . Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S184-94. [MEDLINE: 2636655]LaidlawSA , BergRL , KoppleJD , NaitoH , WalkerWG , WalserM . Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):504-13. [MEDLINE: 8154485]LeveyAS , BergRL , GassmanJJ , HallPM , WalkerWG . Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S73-80. [MEDLINE: 2636677]LeveyAS , GassmanJJ , HallPM , WalkerWG , Modification of Diet in Renal Disease Study. Poor correlation of rates of change of creatinine clearance, reciprocal serum creatinine and GFR [abstract]. Kidney International1989;35(1):197. LeveyAS , GassmanJJ , HallPM , WalkerWG . Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. Journal of the American Society of Nephrology1991;1(9):1087-94. [MEDLINE: 1912407]MDRD Study Group, MitchME , SteinmanTI . Objectives and design of the cooperative study, Modification of Diet in Renal Disease [abstract]. Kidney International1987;31(1):210. PerroneR , SteinmanT , RoyalH , LawlorM , HunsickerL , Modification of Diet in Renal Disease Study Group. Markers of GFR: comparison of 99TC-DTPA (TC), 169YB-DTPA (YB) and 125I-Iothalamate (IO) to inulin (IN) [abstract]. Kidney International1987;31(1):213. PerroneRD , SteinmanTI , BeckGJ , SkibinskiCI , RoyalHD , LawlorM , et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1990;16(3):224-35. [MEDLINE: 2205098]TeschanPE , BeckGJ , DwyerJT , GreeneT , KlahrS , LevyAS , et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clinical Nephrology1998;50(5):273-83. [MEDLINE: 9840314]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]">MDRD Feasibility B 1989</a>. Both of these studies were at low risk of bias for selection bias unlike the other studies included in the analysis but the reason for the heterogeneity remains unclear. <a href="./references#CD001892-bbs2-0007" title="GarneataL , MircescuG . Effect of low-protein diet supplemented with keto acids on progression of chronic kidney disease. Journal of Renal Nutrition2013;23(3):210-3. [MEDLINE: 23611549]GarneataL , MocanuE , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues-effects on mineral bone metabolism disorders in advanced chronic kidney disease [abstract no: FP396]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i167-8. [EMBASE: 622605156]GarneataL , StancuA , DragomirD , MircescuG . Effect of very low protein diet supplemented with ketoanalogues of the essential amino acids on the progression of chronic kidney disease [abstract]. Nephrology Dialysis Transplantation2014;29(Suppl 3):iii39. [EMBASE: 71491557]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression. Journal of the American Society of Nephrology2016;27(7):2164-76. [MEDLINE: 26823552]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues in stage 5 CKD patients [abstract no: SP373]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i472. [EMBASE: 622606118]">Garneata 2013</a> reported the data on GFR as medians with 95% confidence intervals and these data could not be included in the meta‐analysis. The study found a significantly higher GFR in the very low protein group compared with the low protein group after 15 months (P &lt; 0.01). Three studies did not report the outcome (<a href="./references#CD001892-bbs2-0006" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 2 1990</a>; <a href="./references#CD001892-bbs2-0010" title="MalvyD , MaingourdC , PengloanJ , BagrosP , NivetH . Effects of severe protein restriction with ketoanalogues in advanced renal failure. Journal of the American College of Nutrition1999;18(5):481-6. [MEDLINE: 10511331]NivetH , MaingourdC , MalvyD , PengloanJ , BagrosPH . Effects of severe protein-restriction with ketoanalogues in advanced renal failure [abstract]. Journal of the American Society of Nephrology1992;3(3):286. ">Malvy 1999</a>; <a href="./references#CD001892-bbs2-0019" title="BockHA , BrunnerFP . Dietary protein restriction in chronic renal failure. Lancet1985;1(8426):465-6. [MEDLINE: 2857845]DonkerAJ , Piers-BechtTP . Four-years follow-up of patients with chronic renal insufficiency randomly allocated to a protein-restricted diet and a control group [abstract]. Nephrology Dialysis Transplantation1989;4(5):455. DonkerAJ , RosmanJB , Piers-BechtTP , SluiterWJ . Effect of protein restriction in chronic renal insufficiency: a prospective randomized trial [abstract]. Kidney International1985;27:137. RosmanJB , DonkerAJ , MeijerS , SluiterWJ , Piers-BechtTP , van derHemGK . Two years' experience with protein restriction in chronic renal failure. Contributions to Nephrology1986;53:109-20. [MEDLINE: 3542377]RosmanJB , DonkerAJ . The response to a low-protein diet to retard the progression of renal failure is sex-dependent [abstract]. Nephrology Dialysis Transplantation1989;4(5):457. RosmanJB , LangerK , BrandlM , Piers-BechtTP , van derHemGK , ter WeePM , et al. Protein-restricted diets in chronic renal failure: a four year follow-up shows limited indications. Kidney International - Supplement1989;27:S96-102. [MEDLINE: 2636680]RosmanJB , ter WeePM , MeijerS , Piers-BechtTP , SluiterWJ , DonkerAJ . Prospective randomised trial of early dietary protein restriction in chronic renal failure. Lancet1984;324(8415):1291-6. [MEDLINE: 6150320]RosmanJB , Ter WeePM , Piers-BechtGP , SluiterWJ , van derWoudeF , MeijerS , et al. Early protein restriction in chronic renal failure [abstract]. Kidney International1984;26(4):510. RosmanJB , ter WeePM , Piers-BechtGP , SluiterWJ , van derWoudeFJ , MeijerS , et al. Early protein restriction in chronic renal failure. Proceedings of the European Dialysis &amp; Transplant Association - European Renal Association1985;21:567-73. [MEDLINE: 3887375]RosmanJB , Ter WeePM , SluiterWJ , MeijerS , van derHemGK , DonkerAJ . Four years experience with dietary protein restriction in chronic renal failure. [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:28. RosmanJB , ter WeePM . Relationship between proteinuria and response to low protein diets early in chronic renal failure. Blood Purification1989;7(1):52-7. [MEDLINE: 2645924]">Rosman 2 1984</a>). </p> </section> </section> <section id="CD001892-sec-0059"> <h4 class="title">Other outcomes</h4> <p>Most studies did not discuss adverse events. However all the studies reported that body weight, BMI and mid arm circumferences were measured though most studies did not provide numerical data that could be included in meta‐analyses. </p> <p>Most studies reported on dietary adherence and measured this at one to three monthly intervals using urine nitrogen excretion to calculate protein intake and/or by dietary recall or interviews, facilitated by dietitians. The differences between prescribed protein intakes and actual protein intakes are shown in <a href="#CD001892-tbl-0004">Table 1</a> and <a href="#CD001892-tbl-0005">Table 2</a>. While most studies reported that adherence to diet was satisfactory, studies of participants with CKD 3a and 3b tended to have larger differences between actual protein intakes and prescribed protein intakes (<a href="#CD001892-tbl-0004">Table 1</a>). <a href="./references#CD001892-bbs2-0005" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 1 1990</a> and <a href="./references#CD001892-bbs2-0006" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 2 1990</a> reported large SD for actual protein intakes because of the wide variation among participants in adherence to diet. Two studies (<a href="./references#CD001892-bbs2-0002" title="ChauveauP , LebkiriB , PloyardF , CiancioniC , ManNK , JungersP . Effect of keto analogs of essential amino acids on the progress of advanced renal insufficiency: controlled prospective study [Effet des cetoanalogues des acides amines essentiels sur la progression de l'insuffisance renale chronique avancee: etude prospective controlee]. Nephrologie1986;7(5):137-42. [MEDLINE: 3796783]JungersP , ChauveauP , PloyardF , LebkiriB , CiancioniC , ManNK . Comparison of ketoacids and low protein diet on advanced chronic renal failure progression. Kidney International - Supplement1987;22:S67-71. [MEDLINE: 3323621]">Chauveau 1986</a>; <a href="./references#CD001892-bbs2-0009" title="D'AmicoG , GentileMG , FellinG , MannaG , CofanoF . Effect of dietary protein restriction on the progression of renal failure: a prospective randomized trial. Nephrology Dialysis Transplantation1994;9(11):1590-4. [MEDLINE: 7870348]LocatelliF , AlbertiD , GentileMG , GrazianiG , BucciantiG , CosciP , et al. Effects of two different protein prescriptions on chronic renal failure progression. Cooperative study. [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:20. LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA , et al. Blood pressure and chronic renal failure progression: results from a multicentre trial [abstract]. Nephrology Dialysis Transplantation1992;7(7):712. LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA , et al. Factors affecting chronic renal failure progression: results from a multicentre trial. The Northern Italian Cooperative Study Group. Mineral &amp; Electrolyte Metabolism1992;18(2-5):295-302. [MEDLINE: 1465079]LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA . Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group. Lancet1991;337(8753):1299-304. [MEDLINE: 1674294]LocatelliF , Del VecchioL , AndrulliS , MaraiP , TentoriF . The role of underlying nephropathy in the progression of renal disease. Kidney International - Supplement2000;75:S49-55. [MEDLINE: 10828762]LocatelliF , MarcelliD , et al. Factors affecting the progression of chronic renal failure: a multivariate analysis [abstract]. Nephrology Dialysis Transplantation1989;4(5):457. LocatelliF , MarcelliD , TentoriF , MaraiP . Hypertension and progression of chronic renal failure (CRF): a prospective study [abstract]. In: 11th International Congress of Nephrology; 1990 Jul 15-20; Tokyo, Japan. 1990:37A. LocatelliF . Controlled study of protein-restricted diet in chronic renal failure. Contributions to Nephrology1989;75:141-6. [MEDLINE: 2697498]LocatelliF . Dietary compliance in patients with chronic renal failure: experience in a northern Italy trial. Contributions to Nephrology1990;81:102-6. [MEDLINE: 2093485]TentoriF , MaraiP , MarcelliD , PontiR , LocatelliF . Monocentric prospective randomized controlled study on the progression rate of chronic renal failure (CRF) with two different protein intakes [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:20. TentoriF , MaraiP . Monocentric prospective randomised controlled study on the progression rate of chronic renal failure with two different protein intakes [abstract]. Nephrology Dialysis Transplantation1987;2(5):400-1. ">Locatelli 1989</a>) specifically reported difficulty in maintaining dietary adherence with the low protein diet. <a href="./references#CD001892-bbs2-0007" title="GarneataL , MircescuG . Effect of low-protein diet supplemented with keto acids on progression of chronic kidney disease. Journal of Renal Nutrition2013;23(3):210-3. [MEDLINE: 23611549]GarneataL , MocanuE , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues-effects on mineral bone metabolism disorders in advanced chronic kidney disease [abstract no: FP396]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i167-8. [EMBASE: 622605156]GarneataL , StancuA , DragomirD , MircescuG . Effect of very low protein diet supplemented with ketoanalogues of the essential amino acids on the progression of chronic kidney disease [abstract]. Nephrology Dialysis Transplantation2014;29(Suppl 3):iii39. [EMBASE: 71491557]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression. Journal of the American Society of Nephrology2016;27(7):2164-76. [MEDLINE: 26823552]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues in stage 5 CKD patients [abstract no: SP373]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i472. [EMBASE: 622606118]">Garneata 2013</a> excluded people who were not able to agree to adhere to protein restriction. No study formally assessed quality of life. </p> <div class="table" id="CD001892-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Prescribed versus calculated differences in protein intake in studies comparing low with normal or free protein diets</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Difference in prescribed protein intake</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Difference in actual protein intake</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Difference between prescribed and actual protein intake</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0005" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 1 1990</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.4 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.12 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.28 g/kg/day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0001" title="AlvestrandA , BuchtH , GutierrezA , BergströmJ . Progression of chronic renal failure in man as influenced by frequency and quality of clinical follow-ups [abstract]. Kidney International1985;27(1):240. BergstromJ , AlvestrandA , BuchtH , GutierrezA . Progression of chronic renal failure in man is retarded with more frequent clinical follow-ups and better blood pressure control. Clinical Nephrology1986;25(1):1-6. [MEDLINE: 3955903]BergstromJ , AlvestrandA , BuchtH , GutierrezA . Stockholm clinical study on progression of chronic renal failure--an interim report. Kidney International - Supplement1989;36(Suppl 27):S110-4. [MEDLINE: 2636644]BergstromJ , AlvestrandA , BuchtH , GutierrezA . What is the role of controls in an outpatient department on progression of renal disease?Blood Purification1988;6(6):336-42. [MEDLINE: 3061400]">Bergstrom 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.45 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.21 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.24 g/kg/day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0003" title="CianciarusoB , PotaA , BellizziV , Di GiuseppeD , Di MiccoL , MinutoloR , et al. Effect of a low- versus moderate-protein diet on progression of CKD: follow-up of a randomized controlled trial. American Journal of Kidney Diseases2009;54(6):1052-61. [MEDLINE: 19800722]CianciarusoB , PotaA , PisaniA , TorracaS , AnnecchiniR , LombardiP , et al. Metabolic effects of two low protein diets in chronic kidney disease stage 4-5--a randomized controlled trial. Nephrology Dialysis Transplantation2008;23(2):636-44. [MEDLINE: 17981885]CianciarusoB , PotaA , TorracaS , SommaG , NazzaroP , AnnecchiniR , et al. Comparison of two different protein intakes (0.3-0.6 vs 0.7-0.9 g/kg/day) on the metabolic control of advanced renal failure [abstract no: MP197]. In: 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal. 2004:295. PotaA , PisaniA , AnnecchiniR , Di GiuseppeD , CuccurulloP , CaputoDL , et al. Treatment of chronic renal failure (CRF) with two different low protein diets. Effects on the metabolic control and on the cardiovascular risk factors [abstract no: MP306]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv401. PotaA , PisaniA , RavaniP , Di MiccoL , Di GiuseppeD , SabbatiniM , et al. Impact of two different low protein diets on survival of CKD patients (stage4-5) [abstract no: TH-PO880]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):308A. ">Cianciaruso 2008a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.25 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.17 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.08 g/kg/day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0002" title="ChauveauP , LebkiriB , PloyardF , CiancioniC , ManNK , JungersP . Effect of keto analogs of essential amino acids on the progress of advanced renal insufficiency: controlled prospective study [Effet des cetoanalogues des acides amines essentiels sur la progression de l'insuffisance renale chronique avancee: etude prospective controlee]. Nephrologie1986;7(5):137-42. [MEDLINE: 3796783]JungersP , ChauveauP , PloyardF , LebkiriB , CiancioniC , ManNK . Comparison of ketoacids and low protein diet on advanced chronic renal failure progression. Kidney International - Supplement1987;22:S67-71. [MEDLINE: 3323621]">Chauveau 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.2 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.2 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 g/kg/day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0009" title="D'AmicoG , GentileMG , FellinG , MannaG , CofanoF . Effect of dietary protein restriction on the progression of renal failure: a prospective randomized trial. Nephrology Dialysis Transplantation1994;9(11):1590-4. [MEDLINE: 7870348]LocatelliF , AlbertiD , GentileMG , GrazianiG , BucciantiG , CosciP , et al. Effects of two different protein prescriptions on chronic renal failure progression. Cooperative study. [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:20. LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA , et al. Blood pressure and chronic renal failure progression: results from a multicentre trial [abstract]. Nephrology Dialysis Transplantation1992;7(7):712. LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA , et al. Factors affecting chronic renal failure progression: results from a multicentre trial. The Northern Italian Cooperative Study Group. Mineral &amp; Electrolyte Metabolism1992;18(2-5):295-302. [MEDLINE: 1465079]LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA . Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group. Lancet1991;337(8753):1299-304. [MEDLINE: 1674294]LocatelliF , Del VecchioL , AndrulliS , MaraiP , TentoriF . The role of underlying nephropathy in the progression of renal disease. Kidney International - Supplement2000;75:S49-55. [MEDLINE: 10828762]LocatelliF , MarcelliD , et al. Factors affecting the progression of chronic renal failure: a multivariate analysis [abstract]. Nephrology Dialysis Transplantation1989;4(5):457. LocatelliF , MarcelliD , TentoriF , MaraiP . Hypertension and progression of chronic renal failure (CRF): a prospective study [abstract]. In: 11th International Congress of Nephrology; 1990 Jul 15-20; Tokyo, Japan. 1990:37A. LocatelliF . Controlled study of protein-restricted diet in chronic renal failure. Contributions to Nephrology1989;75:141-6. [MEDLINE: 2697498]LocatelliF . Dietary compliance in patients with chronic renal failure: experience in a northern Italy trial. Contributions to Nephrology1990;81:102-6. [MEDLINE: 2093485]TentoriF , MaraiP , MarcelliD , PontiR , LocatelliF . Monocentric prospective randomized controlled study on the progression rate of chronic renal failure (CRF) with two different protein intakes [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:20. TentoriF , MaraiP . Monocentric prospective randomised controlled study on the progression rate of chronic renal failure with two different protein intakes [abstract]. Nephrology Dialysis Transplantation1987;2(5):400-1. ">Locatelli 1989</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.4 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.18 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.22 g/kg/day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0013" title="CogginsCH , DwyerJT , GreeneT , PetotG , SnetselaarLG , Van LenteF , et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):514-23. [MEDLINE: 8154486]KlahrS , LeveyAS , SandbergAM , WilliamsGW , MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International1989;35(1):195. KoppleJD , BergR , HouserH , SteinmanTI , TeschanP . Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S184-94. [MEDLINE: 2636655]LaidlawSA , BergRL , KoppleJD , NaitoH , WalkerWG , WalserM . Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):504-13. [MEDLINE: 8154485]LeveyAS , BergRL , GassmanJJ , HallPM , WalkerWG . Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S73-80. [MEDLINE: 2636677]LeveyAS , GassmanJJ , HallPM , WalkerWG , MDRD Study Group. Poor correlation of rates of change of creatinine clearance, reciprocal serum creatinine and GFR [abstract]. Kidney International1989;35(1):197. LeveyAS , GassmanJJ , HallPM , WalkerWG . Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. Journal of the American Society of Nephrology1991;1(9):1087-94. [MEDLINE: 1912407]MDRD Study Group, MitchME , SteinmanTI . Objectives and design of the cooperative study, Modification of Diet in Renal Disease [abstract]. Kidney International1987;31(1):210. PerroneR , SteinmanT , RoyalH , LawlorM , HunsickerL , Modification of Diet in Renal Disease Study Group. Markers of GFR: comparison of 99TC-DTPA (TC), 169YB-DTPA (YB) and 125I-Iothalamate (IO) to inulin (IN) [abstract]. Kidney International1987;31(1):213. PerroneRD , SteinmanTI , BeckGJ , SkibinskiCI , RoyalHD , LawlorM , et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1990;16(3):224-35. [MEDLINE: 2205098]TeschanPE , BeckGJ , DwyerJT , GreeneT , KlahrS , LevyAS , et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clinical Nephrology1998;50(5):273-83. [MEDLINE: 9840314]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]">MDRD Feasibility A 1989</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.625 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.19 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.435 g/kg/day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0011" title="BeckGJ , BergRL , CogginsCH , GassmanJJ , HunsickerLG , SchluchterMD , et al. Design and statistical issues of the Modification of Diet in Renal Disease Trial. The Modification of Diet in Renal Disease Study Group. Controlled Clinical Trials1991;12(5):566-86. [MEDLINE: 1664792]Buckalew VM Jr, BergRL , WangSR , PorushJG , RauchS , SchulmanG . Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. American Journal of Kidney Diseases1996;28(6):811-21. [MEDLINE: 8957032]ChawlaV , WangX , GreeneJ , KusekJW , CollinsAJ , LeveyAS , et al. Dyslipidemia and mortality in chronic kidney disease [abstract no: TH-PO895]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A-2A. ChenJL , LernerD , RuthazerR , Castaneda-SceppaC , LeveyAS . Association of physical activity with mortality in chronic kidney disease. Journal of Nephrology2008;21(2):243-52. [MEDLINE: 18446720]ChenJL , SceppaC , RuthazerR , LeveyAS . Leisure time physical activity status and mortality in chronic kidney disease: preliminary findings from the MDRD study [abstract no: 21]. American Journal of Kidney Diseases2006;47(4):A24. CogginsCH , Breyer LewisJ , CaggiulaAW , CastaldoLS , KlahrS , WangSR . Differences between women and men with chronic renal disease. Nephrology Dialysis Transplantation1998;13(6):1430-7. [MEDLINE: 9641172]CoyneT , OlsonM , BradhamK , GarconM , GregoryP , ScherchL . Dietary satisfaction correlated with adherence in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1301-6. [MEDLINE: 7594127]DennisVW . Decoding the Modification of Diet in Renal Disease Study. Cleveland Clinic Journal of Medicine1994;61(4):254-7. [MEDLINE: 7923742]DolecekTA , OlsonMB , CaggiulaAW , DwyerJT , MilasNC , GillisBP , et al. Registered dietitian time requirements in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1307-12. [MEDLINE: 7594128]Effects of diet and antihypertensive therapy on creatinine clearance and serum creatinine concentration in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Aug;8(8):1354]. Journal of the American Society of Nephrology1996;7(4):556-66. [MEDLINE: 8724889]Effects of dietary protein restriction on the progression of moderate renal disease in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Mar;8(3):493]. Journal of the American Society of Nephrology1996;7(12):2616-26. [MEDLINE: 8989740]GassmanJJ , DrabikMJ , LeathermanJR , FaticaKJ , McPhersonJA , Modification of Diet in Renal Disease Study Group. Development and use of distributed data entry and electronic communication in a multi-center study of progressive renal disease [abstract]. Kidney International1989;35(1):226. GennariFJ , HoodVL , GreeneT , WangX , LeveyAS . Effect of Dietary Protein Intake on Serum Total CO2 Concentration in Chronic Kidney Disease: Modification of Diet in Renal Disease Study Findings. Clinical Journal of the American Society of Nephrology: CJASN2006;1(1):52-7. [MEDLINE: 17699190]GillisBP , AverbachFM , CaggiulaAW , JonesFL , NaujelisJ , MaurerE , et al. Features of the nutrient database and analysis system for the Modification of Diet in Renal Disease Study.[Erratum appears in Control Clin Trials 1994 Aug;15(4):326]. Controlled Clinical Trials1994;15(1):44-58. [MEDLINE: 8149770]GillisBP , CaggiulaAW , ChiavacciAT , CoyneT , DoroshenkoL , MilasNC , et al. Nutrition intervention program of the Modification of Diet in Renal Disease Study: a self-management approach. Journal of the American Dietetic Association1995;95(11):1288-94. [MEDLINE: 7594125]GramsME , CoreshJ , SegevDL , KucirkaLM , TighiouartH , SarnakMJ . Vascular disease, ESRD, and death: interpreting competing risk analyses. Clinical Journal of the American Society of Nephrology: CJASN2012;7(10):1606-14. [MEDLINE: 22859747]GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. GramsME , TinA , RebholzCM , ShafiT , KottgenA , PerroneRD , et al. Metabolomic alterations associated with cause of CKD. Clinical Journal of The American Society of Nephrology: CJASN2017;12(11):1787-94. [MEDLINE: 28971980]GreeneT , BeckG , WangS , KusekJ , LeveyA , Modification of Diet in Renal Disease Study Group. The effect of the low protein diet in the MDRD study A is dependent on the underlying rate of disease progression [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A. GreeneT , BourgoignieJJ , HabweV , KusekJW , SnetselaarLG , SoucieJM , et al. Baseline characteristics in the Modification of Diet in Renal Disease Study.[Republished from J Am Soc Nephrol 1993 May;3(11):1819-34]. Journal of the American Society of Nephrology1993;4(5):1221-36. [MEDLINE: 8305650]HebertLA , GreeneT , HunsickerLG , LeveyAS , WangS , MDRD Study Group. Relationship of urine volume (uv) and urine osmolality (Uosm) to the progression of renal disease in the Modification of Diet in Renal Disease (MDRD) study [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A-6A. HebertLA , KusekJW , GreeneT , AgodoaLY , JonesCA , LeveyAS , et al. Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group. Hypertension1997;30(3 (Pt 1)):428-35. [MEDLINE: 9314428]HunsickerLG , AdlerS , CaggiulaA , EnglandBK , GreeneT , KusekJW , et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney International1997;51(6):1908-19. [MEDLINE: 9186882]HunsickerLG , MDRD Study Group. Secondary analysis of the Modification of Diet in Renal Disease (MDRD) study [abstract]. In: 13th International Congress of Nephrology; 1995 Jul 2-6; Madrid, Spain. 1995:64. IxJH , ShlipakMG , SarnakMJ , BeckGJ , GreeneT , WangX , et al. Fetuin-A is not associated with all-cause or cardiovascular mortality in chronic kidney disease: data from the Modification of Diet in Renal Disease (MDRD) study [abstract no: SU-PO711]. Journal of the American Society of Nephrology2007;18(Abstracts Issue):741A. KlahrS , BreyerJA , BeckGJ , DennisVW , HartmanJA , RothD , et al. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group.[Erratum appears in J Am Soc Nephrol 1995 Oct;6(4):1318]. Journal of the American Society of Nephrology1995;5(12):2037-47. [MEDLINE: 7579052]KlahrS , LeveyAS , BeckGJ , CaggiulaAW , HunsickerL , KusekJW , et al. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. New England Journal of Medicine1994;330(13):877-84. [MEDLINE: 8114857]KlahrS , Modification of Diet in Renal Disease Study. The Modification of Diet in Renal Disease Study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]KlahrS . Primary and secondary results of the modification of diet in renal disease study. Mineral &amp; Electrolyte Metabolism1996;22(1-3):138-42. [MEDLINE: 8676806]KoppleJD , GreeneT , ChumleaWC , HollingerD , MaroniBJ , MerrillD , et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney International2000;57(4):1688-703. [MEDLINE: 10760105]KoppleJD , LeveyAS , GreeneT , ChumleaWC , GassmanJJ , HollingerDL , et al. Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. Kidney International1997;52(3):778-91. [MEDLINE: 9291200]KuE , GliddenDV , JohansenKL , SarnakM , TighiouartH , GrimesB , et al. Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease. Kidney International2015;87(5):1055-60. [MEDLINE: 25493952]KusekJW , CoyneT , deVelascoA , DrabikMJ , FinlayRA , GassmanJJ , et al. Recruitment experience in the full-scale phase of the Modification of Diet in Renal Disease Study. Controlled Clinical Trials1993;14(6):538-57. [MEDLINE: 8119068]KusekJW , CoyneT , deVelascoA , GassmanJ , KieferS , PowersS , et al. Recruitment experience in the full scale phase of the Modification of Diet in Renal Disease (MDRD) Study [abstract]. Controlled Clinical Trials1991;12:678. KwongYT , StevensLA , SelvinE , ZhangYL , GreeneT , Van LenteF , et al. Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. American Journal of Kidney Diseases2010;56(1):39-49. [MEDLINE: 20537455]LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , LeveyAS , MilasNC , et al. Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. Hypertension1997;29(2):641-50. [MEDLINE: 9040451]Leonberg-YooAK , TighiouartH , LeveyAS , BeckGJ , SarnakMJ . Urine potassium excretion, kidney failure, and mortality in CKD. American Journal of Kidney Diseases2017;69(3):341-9. [MEDLINE: 27233381]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , BoschJP , LewisJB , GreeneT , RogersN , RothD , et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of Internal Medicine1999;130(6):461-70. [MEDLINE: 10075613]LeveyAS , CoreshJ , GreeneT , StevensLA , ZhangYL , HendriksenS , et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate.[Erratum appears in Ann Intern Med. 2008 Oct 7;149(7):519]. Annals of Internal Medicine2006;145(4):247-54. [MEDLINE: 16908915]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study Group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]LeveyAS , GreeneT , SarnakM , WangX , BeckGJ , KusekJW , et al. Effect of low protein diet on progression of kidney disease in the Modification of Diet in Renal Disease study A: long-term follow-up [abstract no: SU-PO247]. Journal of the American Society of Nephrology2004;15(Oct):586A-7A. LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2006;48(6):879-88. [MEDLINE: 17162142]LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. The effect of very low protein diet on progression of kidney disease and mortality in Modification of Diet in Renal Disease Study B [abstract no: SU-PO246]. Journal of the American Society of Nephrology2004;15(Oct):586A. LeveyAS , GreeneT , SchluchterMD , ClearyPA , TeschanPE , LorenzRA , et al. Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. Journal of the American Society of Nephrology1993;4(5):1159-71. [MEDLINE: 8305642]MaderoM , SarnakM , WangX , GreeneT , CollinsA , BeckG , et al. Uric acid and development of kidney failure in chronic kidney disease [abstract no: F-PO1932]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):547A. MaderoM , SarnakMJ , WangX , GreeneT , BeckGJ , KusekJW , et al. Uric acid and long-term outcomes in CKD. American Journal of Kidney Diseases2009;53(5):796-803. [MEDLINE: 19303683]MaderoM , SarnakMJ , WangX , SceppaCC , GreeneT , BeckGJ , et al. Body mass index and mortality in CKD. American Journal of Kidney Diseases2007;50(3):404-11. [MEDLINE: 17720519]MaderoM , WangX , GreenT , HunsickerLG , BeckGJ , KusekJW , et al. Effect of trial participation on outcomes in the randomized and non-randomized cohorts of the Modification of Diet in Renal Disease study [abstract no: F-PO037]. Journal of the American Society of Nephrology2006;17(Abstracts):344A. MDRD Study Group, ChumleaWC , GassmanJJ , HollingerDL , MerrillD , ScherchLK , et al. Nutritional response to diet prescription in the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, HunsickerLG , AdlerS , CaggiulaAW , EnglandB , GreeneT , et al. Relationship among baseline proteinuria (p), mean arterial blood pressure (map) during follow-up, and decline in glomerular filtration rate (aGFR) in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, KoppleJD , ChumleaWC , GassmanJJ , HollingerDL , MaroniBJ , et al. Relationship between FGR and nutritional status - results from the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, KusekJW , AgodoaL , GreeneT , JonesC . Comparison of decline of GFR in blacks versus non-blacks in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , BoschJP , CaggiulaAW , GreeneT , et al. Short-term effects of protein intake, blood pressure, and antihypertensive therapy on GFR in the MDRD study. Journal of the American Society of Nephrology1995;6(3):395. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , HunsickerLG , et al. A hypothesis for the results of the Modification of Diet in Renal Disease (MDRD) study. [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , KusekJW , et al. Trends toward a beneficial effect of a low protein diet during additional follow-up in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1994;5(3):336. MDRD Study Group, LeveyAS , BeckGJ . Trends toward a beneficial effect of a low protein diet during additional follow-up in the modification of diet in renal disease study. MDRD Study Group. [abstract]. Nephrology Dialysis Transplantation1995;10(6):985. MDRD Study Group, LeveyAS , BoschJP , CogginsCH , GreeneT , MitchWE , et al. Effects of diet and blood pressure on creatinine clearance (CCr) and serum creatinine (PCr) in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, PetersonJC , BurkartJ , GreeneT , HebertL , KingA , et al. The effect of blood pressure control on progression of renal disease depends on level of proteinuria (p) at baseline evaluation [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, PetersonJC , GreeneT , KlahrS , BurkartJM , HebertL , et al. Effect of reducing proteinuria (PR) on subsequent glomerular filtration rate (GFR) decline in patients with chronic renal failure (CRF) [abstract]. Journal of the American Society of Nephrology1994;5(3):339. MDRD Study Group, PorushJG , LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , et al. Efficacy of anti-hypertensive interventions in reducing blood pressure in the MDRD study [abstract]. Journal of the American Society of Nephrology1995;6(3):400. MDRD Study Group, PowersSN , KurtzmanDA , PetotGJ , RaizmanDJ , WetsteinL . Promoting dietary compliance through computer-assisted education, assessment, and counseling. [abstract]. Kidney International1988;36(Suppl 27):S306. MDRD Study Group, RoccoMV , CoyneT , EastinS , FaubertJ , GassmanJJ , et al. Patient symptoms and quality of life in the MDRD study at enrollment-correlation with GFR [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group. The modification of diet in renal disease study: results from the full-scale trial [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:593. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Hemoglobin A1c and mortality in chronic kidney disease [abstract no: F-FC149]. Journal of the American Society of Nephrology2005;16:71A. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Insulin resistance as a predictor of all-cause and cardiovascular mortality (CVD) in chronic kidney disease (CKD) [abstract no: F-P0284]. Journal of the American Society of Nephrology2004;15(Oct):128A. MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. Journal of the American Society of Nephrology2005;16(11):3411-7. [MEDLINE: 16207824]MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD. American Journal of Kidney Diseases2005;46(3):455-63. [MEDLINE: 16129207]MenonV , GreeneT , WangX , PereiraAA , MarcovinaSM , BeckGJ , et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney International2005;68(2):766-72. [MEDLINE: 16014054]MenonV , GreenT , PereiraA , XueleiW , BeckG , KusekJ , et al. C-reactive protein (CRP) as a predictor of all-cause and cardiovascular (CVD) mortality in patients with chronic kidney disease (CKD) [abstract no: F-P0275]. Journal of the American Society of Nephrology2004;15(Oct):125A-6A. MenonV , KoppleJD , WangX , BeckGJ , CollinsAJ , KusekJW , et al. Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2009;53(2):208-17. [MEDLINE: 18950911]MenonV , LiL , GreeneT , WangX , ChandraP , BalakrishnanV , et al. Adiponectin and outcomes in chronic kidney disease [abstract no: TH-PO430]. Journal of the American Society of Nephrology2006;17(Abstracts):199A. MenonV , LiL , WangX , GreeneT , BalakrishnanV , MaderoM , et al. Adiponectin and mortality in patients with chronic kidney disease. Journal of the American Society of Nephrology2006;17(9):2599-606. [MEDLINE: 16885405]MenonV , SarnakMJ , GreeneT , WangX , PereiraAA , BeckGJ , et al. Relationship between homocysteine and mortality in chronic kidney disease. Circulation2006;113(12):1572-7. [MEDLINE: 16549639]MenonV , ShlipakMG , WangX , CoreshJ , GreeneT , StevensL , et al. Cystatin C as a risk factor for outcomes in chronic kidney disease. Annals of Internal Medicine2007;147(1):19-27. [MEDLINE: 17606957]MenonV , TighiouartH , VaughnNS , BeckGJ , KusekJW , CollinsAJ , et al. Serum bicarbonate and long-term outcomes in CKD. American Journal of Kidney Diseases2010;56(5):907-14. [MEDLINE: 20605301]MenonV , WangX , GreeneT , BeckGJ , KusekJW , MarcovinaSM , et al. Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. American Journal of Kidney Diseases2003;42(1):44-52. [MEDLINE: 12830455]MenonV , WangX , GreeneT , BeckGJ , KusekJW , SelhubJ , et al. Homocysteine in chronic kidney disease: effect of low protein diet and repletion with B vitamins. Kidney International2005;67(4):1539-46. [MEDLINE: 15780109]MenonV , WangX , SarnakMJ , HunsickerLH , MaderoM , BeckGJ , et al. Long-term outcomes in nondiabetic chronic kidney disease. Kidney International2008;73(11):1310-5. [MEDLINE: 18337713]MilasNC , NowalkMP , AkpeleL , CastaldoL , CoyneT , DoroshenkoL , et al. Factors associated with adherence to the dietary protein intervention in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1295-300. [MEDLINE: 7594126]NewsomeB , IxJH , TighiouartH , SarnakMJ , LeveyAS , BeckGJ , et al. Effect of protein restriction on serum and urine phosphate in the modification of diet in renal disease (MDRD) study. American Journal of Kidney Diseases2013;61(6):1045-6. [MEDLINE: 23415016]OlsonM , CoyneT , CaggiulaA , GregoryP . Patient satisfaction with a dietary intervention: the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):107S. OlsonM , CoyneT , CaggiulaA . Social factors influence dietary satisfaction in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1996;17(2 Suppl):133S. OlsonM , DolecekT , CaggiulaA , DwyerJ . Time required for the protein intervention in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):129S-30S. PetersonJC , AdlerS , BurkartJM , GreeneT , HebertLA , HunsickerLG , et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Annals of Internal Medicine1995;123(10):754-62. [MEDLINE: 7574193]PiccoliM , CodognottoM . Missing stratification by polycistic kidney disease (PKD) flaws risk estimates of GFR decline. Lesson from the MDRD Study [abstract no: F-PO175]. Journal of the American Society of Nephrology2004;15(Oct):103A. RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]RoccoMV , GassmanJJ , WangSR , KaplanRM . Cross-sectional study of quality of life and symptoms in chronic renal disease patients: the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1997;29(6):888-96. [MEDLINE: 9186075]SarnakMJ , GreeneT , WangX , BeckG , KusekJW , CollinsAJ , et al. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease study. Annals of Internal Medicine2005;142(5):342-51. [MEDLINE: 15738453]SarnakMJ , WangSR , BeckGJ , KusekJW , SelhubJ , GreeneT , et al. Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression. American Journal of Kidney Diseases2002;40(5):932-9. [MEDLINE: 12407637]SarnakMJ , WangX , GreeneT , GeraldJ , BeckJ , KusekJW , et al. Effect of strict blood pressure control on long-term outcome in the Modification of Diet in Renal Disease (MDRD) study [abstract no: F-P0599]. Journal of the American Society of Nephrology2003;14(Nov):192A. SchluchterMD . Estimating correlation between alternative measures of disease progression in a longitudinal study. Modification of Diet in Renal Disease Study. Statistics in Medicine1990;9(10):1175-88. [MEDLINE: 2247718]Short-term effects of protein intake, blood pressure, and antihypertensive therapy on glomerular filtration rate in the Modification of Diet in Renal Disease Study. Journal of the American Society of Nephrology1996;7(10):2097-109. [MEDLINE: 8915969]StollarC , ScherchL , AdlerS , KusekJ , CaggiulaA . Patterns of patient dietary compliance in the Modification of Diet in Renal Disease (MDRD) study, phase III. [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:609. TangriN , StevensLA , SchmidCH , ZhangYL , BeckGJ , GreeneT , et al. Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney International2011;79(4):471-7. [MEDLINE: 20980977]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]YamamotoME , OlsonMB , StollarC , MDRD Study Group. Effects of weight and Na+ change on blood pressures of hypertensive MDRD study patients [abstract]. Journal of the American Society of Nephrology1995;6(3):408. YoungJA , TerrinN , GreeneT , WangX , BeckG , KusekJ , et al. Asymmetric dimethylarginine and prevalent cardiovascular disease in patients with chronic kidney disease [abstract no: F-PO935]. Journal of the American Society of Nephrology2007;18(Abstracts):308A-9A. YoungJA , TerrinN , WangX , GreenT , BeckG , KusekJ , et al. ADMA and mortality in stage 3-4 chronic kidney disease [abstract no: TH-PO894]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A. ">MDRD 1 1989</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.72 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.4 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.32 g/kg/day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0015" title="MeloniC , TatangeloP , CiprianiS , RossiV , SuraciC , TozzoC , et al. Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure. Journal of Renal Nutrition2004;14(4):208-13. [MEDLINE: 15483780]">Meloni 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.4 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.87 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.47 g/kg/day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0021" title="WilliamsP , StevensME , FassG , BoneJM . A randomised trial of the effect of protein and phosphate restriction on the progression of chronic renal failure [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:38. WilliamsPS , StevensM , FassG , BoneJM . A randomised trial of the effect of protein and phosphate restriction on the progression of chronic renal failure [abstract]. Nephrology Dialysis Transplantation1987;2(4):285. WilliamsPS , StevensM , IronsL , FassG , BoneJM . Failure of  dietary protein/phosphate restriction to slow the progression of chronic renal failure; a prospective randomised controlled trial [abstract]. Nephrology Dialysis Transplantation1990;5(8):674. WilliamsPS , StevensME , FassG , IronsL , BoneJM . Failure of dietary protein and phosphate restriction to retard the rate of progression of chronic renal failure: a prospective, randomized, controlled trial. Quarterly Journal of Medicine1991;81(294):837-55. [MEDLINE: 1801057]WilliamsPS , StevensME . A randomised trial of the effect of protein and phosphate restriction on the progression of chronic renal failure [abstract]. Nephrology Dialysis Transplantation1987;2(5):401. ">Williams 1991</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.4 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.45 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.05 g/kg/day</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD001892-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Prescribed versus calculated differences in protein intake in studies comparing very low with low protein diets</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Difference in prescribed protein intake</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Difference in actual protein intake</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0006" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 2 1990</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.21 g/kg/day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0004" title="Di IorioBR , BellizziV , MinutoloR , De NicolaL , IodiceC , ConteG . Supplemented very low-protein diet in advanced CRF: is it money saving?Kidney International2004;65(2):742. [MEDLINE: 14717953]Di IorioBR , MinutoloR , De NicolaL , BellizziV , CatapanoF , IodiceC , et al. Supplemented very low protein diet ameliorates responsiveness to erythropoietin in chronic renal failure. Kidney International2003;64(5):1822-8. [MEDLINE: 14717953]">Di Iorio 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.29 g/kg/day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0007" title="GarneataL , MircescuG . Effect of low-protein diet supplemented with keto acids on progression of chronic kidney disease. Journal of Renal Nutrition2013;23(3):210-3. [MEDLINE: 23611549]GarneataL , MocanuE , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues-effects on mineral bone metabolism disorders in advanced chronic kidney disease [abstract no: FP396]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i167-8. [EMBASE: 622605156]GarneataL , StancuA , DragomirD , MircescuG . Effect of very low protein diet supplemented with ketoanalogues of the essential amino acids on the progression of chronic kidney disease [abstract]. Nephrology Dialysis Transplantation2014;29(Suppl 3):iii39. [EMBASE: 71491557]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression. Journal of the American Society of Nephrology2016;27(7):2164-76. [MEDLINE: 26823552]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues in stage 5 CKD patients [abstract no: SP373]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i472. [EMBASE: 622606118]">Garneata 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.29 g/kg/day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0010" title="MalvyD , MaingourdC , PengloanJ , BagrosP , NivetH . Effects of severe protein restriction with ketoanalogues in advanced renal failure. Journal of the American College of Nutrition1999;18(5):481-6. [MEDLINE: 10511331]NivetH , MaingourdC , MalvyD , PengloanJ , BagrosPH . Effects of severe protein-restriction with ketoanalogues in advanced renal failure [abstract]. Journal of the American Society of Nephrology1992;3(3):286. ">Malvy 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.21 g/kg/day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0014" title="CogginsCH , DwyerJT , GreeneT , PetotG , SnetselaarLG , Van LenteF , et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):514-23. [MEDLINE: 8154486]KlahrS , LeveyAS , SandbergAM , WilliamsGW , MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International1989;35(1):195. KoppleJD , BergR , HouserH , SteinmanTI , TeschanP . Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S184-94. [MEDLINE: 2636655]LaidlawSA , BergRL , KoppleJD , NaitoH , WalkerWG , WalserM . Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):504-13. [MEDLINE: 8154485]LeveyAS , BergRL , GassmanJJ , HallPM , WalkerWG . Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S73-80. [MEDLINE: 2636677]LeveyAS , GassmanJJ , HallPM , WalkerWG , Modification of Diet in Renal Disease Study. Poor correlation of rates of change of creatinine clearance, reciprocal serum creatinine and GFR [abstract]. Kidney International1989;35(1):197. LeveyAS , GassmanJJ , HallPM , WalkerWG . Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. Journal of the American Society of Nephrology1991;1(9):1087-94. [MEDLINE: 1912407]MDRD Study Group, MitchME , SteinmanTI . Objectives and design of the cooperative study, Modification of Diet in Renal Disease [abstract]. Kidney International1987;31(1):210. PerroneR , SteinmanT , RoyalH , LawlorM , HunsickerL , Modification of Diet in Renal Disease Study Group. Markers of GFR: comparison of 99TC-DTPA (TC), 169YB-DTPA (YB) and 125I-Iothalamate (IO) to inulin (IN) [abstract]. Kidney International1987;31(1):213. PerroneRD , SteinmanTI , BeckGJ , SkibinskiCI , RoyalHD , LawlorM , et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1990;16(3):224-35. [MEDLINE: 2205098]TeschanPE , BeckGJ , DwyerJT , GreeneT , KlahrS , LevyAS , et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clinical Nephrology1998;50(5):273-83. [MEDLINE: 9840314]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]">MDRD Feasibility B 1989</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.295 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.22 g/kg/day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0012" title="GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. KlahrS . The modification of diet in renal disease study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]">MDRD 2 1989</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3 g/kg/day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0017" title="MircescuG , GarneataL , StancuSH , CapusaC . Effects of a supplemented hypoproteic diet in chronic kidney disease. Journal of Renal Nutrition2007;17(3):179-88. [MEDLINE: 17462550]">Mircescu 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.27 g/kg/day</p> </td> </tr> </tbody> </table> </div> <section id="CD001892-sec-0060"> <h5 class="title">Body weight</h5> <p>Seven studies in total reported data on end of study body weight. The data were subgrouped according to protein intakes. Because of small numbers, imprecision and a high risk of bias, the certainty of the evidence was considered to be very low (<a href="./full#CD001892-tbl-0003">summary of findings Table 3</a>). </p> <p>In two studies which compared low protein diets with normal protein diets, the certainty of the evidence was considered very low because of increased risk of bias and imprecision, and therefore it is uncertain whether a low protein diet reduces the final body weight (<a href="./references#CD001892-fig-0010" title="">Analysis 3.1</a>.1 (2 studies, 223 participants): MD ‐3.09 kg, 95% CI ‐5.02 to ‐1.16; I<sup>2</sup> = 0%). <a href="./references#CD001892-bbs2-0003" title="CianciarusoB , PotaA , BellizziV , Di GiuseppeD , Di MiccoL , MinutoloR , et al. Effect of a low- versus moderate-protein diet on progression of CKD: follow-up of a randomized controlled trial. American Journal of Kidney Diseases2009;54(6):1052-61. [MEDLINE: 19800722]CianciarusoB , PotaA , PisaniA , TorracaS , AnnecchiniR , LombardiP , et al. Metabolic effects of two low protein diets in chronic kidney disease stage 4-5--a randomized controlled trial. Nephrology Dialysis Transplantation2008;23(2):636-44. [MEDLINE: 17981885]CianciarusoB , PotaA , TorracaS , SommaG , NazzaroP , AnnecchiniR , et al. Comparison of two different protein intakes (0.3-0.6 vs 0.7-0.9 g/kg/day) on the metabolic control of advanced renal failure [abstract no: MP197]. In: 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal. 2004:295. PotaA , PisaniA , AnnecchiniR , Di GiuseppeD , CuccurulloP , CaputoDL , et al. Treatment of chronic renal failure (CRF) with two different low protein diets. Effects on the metabolic control and on the cardiovascular risk factors [abstract no: MP306]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv401. PotaA , PisaniA , RavaniP , Di MiccoL , Di GiuseppeD , SabbatiniM , et al. Impact of two different low protein diets on survival of CKD patients (stage4-5) [abstract no: TH-PO880]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):308A. ">Cianciaruso 2008a</a> reported final body weights as a percentage of the baseline; actual weights could not be calculated as baseline weights were provided separately for men and women. At 12 months, the final body weights were 99.8% or more of baseline weights. </p> <p>In four studies which compared very low protein diets with low protein diets, the certainty of the evidence was considered very low because of increased risk of bias and imprecision, and therefore it is uncertain whether a low protein diet reduces the final body weight (<a href="./references#CD001892-fig-0010" title="">Analysis 3.1</a>.2 (4 studies, 291 participants): MD 1.4 kg, 95% CI 3.40 to 6.21; I<sup>2</sup> = 56%). </p> <p>Thus it is uncertain whether the intervention alters final body weight. The data for <a href="./references#CD001892-bbs2-0011" title="BeckGJ , BergRL , CogginsCH , GassmanJJ , HunsickerLG , SchluchterMD , et al. Design and statistical issues of the Modification of Diet in Renal Disease Trial. The Modification of Diet in Renal Disease Study Group. Controlled Clinical Trials1991;12(5):566-86. [MEDLINE: 1664792]Buckalew VM Jr, BergRL , WangSR , PorushJG , RauchS , SchulmanG . Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. American Journal of Kidney Diseases1996;28(6):811-21. [MEDLINE: 8957032]ChawlaV , WangX , GreeneJ , KusekJW , CollinsAJ , LeveyAS , et al. Dyslipidemia and mortality in chronic kidney disease [abstract no: TH-PO895]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A-2A. ChenJL , LernerD , RuthazerR , Castaneda-SceppaC , LeveyAS . Association of physical activity with mortality in chronic kidney disease. Journal of Nephrology2008;21(2):243-52. [MEDLINE: 18446720]ChenJL , SceppaC , RuthazerR , LeveyAS . Leisure time physical activity status and mortality in chronic kidney disease: preliminary findings from the MDRD study [abstract no: 21]. American Journal of Kidney Diseases2006;47(4):A24. CogginsCH , Breyer LewisJ , CaggiulaAW , CastaldoLS , KlahrS , WangSR . Differences between women and men with chronic renal disease. Nephrology Dialysis Transplantation1998;13(6):1430-7. [MEDLINE: 9641172]CoyneT , OlsonM , BradhamK , GarconM , GregoryP , ScherchL . Dietary satisfaction correlated with adherence in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1301-6. [MEDLINE: 7594127]DennisVW . Decoding the Modification of Diet in Renal Disease Study. Cleveland Clinic Journal of Medicine1994;61(4):254-7. [MEDLINE: 7923742]DolecekTA , OlsonMB , CaggiulaAW , DwyerJT , MilasNC , GillisBP , et al. Registered dietitian time requirements in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1307-12. [MEDLINE: 7594128]Effects of diet and antihypertensive therapy on creatinine clearance and serum creatinine concentration in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Aug;8(8):1354]. Journal of the American Society of Nephrology1996;7(4):556-66. [MEDLINE: 8724889]Effects of dietary protein restriction on the progression of moderate renal disease in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Mar;8(3):493]. Journal of the American Society of Nephrology1996;7(12):2616-26. [MEDLINE: 8989740]GassmanJJ , DrabikMJ , LeathermanJR , FaticaKJ , McPhersonJA , Modification of Diet in Renal Disease Study Group. Development and use of distributed data entry and electronic communication in a multi-center study of progressive renal disease [abstract]. Kidney International1989;35(1):226. GennariFJ , HoodVL , GreeneT , WangX , LeveyAS . Effect of Dietary Protein Intake on Serum Total CO2 Concentration in Chronic Kidney Disease: Modification of Diet in Renal Disease Study Findings. Clinical Journal of the American Society of Nephrology: CJASN2006;1(1):52-7. [MEDLINE: 17699190]GillisBP , AverbachFM , CaggiulaAW , JonesFL , NaujelisJ , MaurerE , et al. Features of the nutrient database and analysis system for the Modification of Diet in Renal Disease Study.[Erratum appears in Control Clin Trials 1994 Aug;15(4):326]. Controlled Clinical Trials1994;15(1):44-58. [MEDLINE: 8149770]GillisBP , CaggiulaAW , ChiavacciAT , CoyneT , DoroshenkoL , MilasNC , et al. Nutrition intervention program of the Modification of Diet in Renal Disease Study: a self-management approach. Journal of the American Dietetic Association1995;95(11):1288-94. [MEDLINE: 7594125]GramsME , CoreshJ , SegevDL , KucirkaLM , TighiouartH , SarnakMJ . Vascular disease, ESRD, and death: interpreting competing risk analyses. Clinical Journal of the American Society of Nephrology: CJASN2012;7(10):1606-14. [MEDLINE: 22859747]GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. GramsME , TinA , RebholzCM , ShafiT , KottgenA , PerroneRD , et al. Metabolomic alterations associated with cause of CKD. Clinical Journal of The American Society of Nephrology: CJASN2017;12(11):1787-94. [MEDLINE: 28971980]GreeneT , BeckG , WangS , KusekJ , LeveyA , Modification of Diet in Renal Disease Study Group. The effect of the low protein diet in the MDRD study A is dependent on the underlying rate of disease progression [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A. GreeneT , BourgoignieJJ , HabweV , KusekJW , SnetselaarLG , SoucieJM , et al. Baseline characteristics in the Modification of Diet in Renal Disease Study.[Republished from J Am Soc Nephrol 1993 May;3(11):1819-34]. Journal of the American Society of Nephrology1993;4(5):1221-36. [MEDLINE: 8305650]HebertLA , GreeneT , HunsickerLG , LeveyAS , WangS , MDRD Study Group. Relationship of urine volume (uv) and urine osmolality (Uosm) to the progression of renal disease in the Modification of Diet in Renal Disease (MDRD) study [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A-6A. HebertLA , KusekJW , GreeneT , AgodoaLY , JonesCA , LeveyAS , et al. Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group. Hypertension1997;30(3 (Pt 1)):428-35. [MEDLINE: 9314428]HunsickerLG , AdlerS , CaggiulaA , EnglandBK , GreeneT , KusekJW , et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney International1997;51(6):1908-19. [MEDLINE: 9186882]HunsickerLG , MDRD Study Group. Secondary analysis of the Modification of Diet in Renal Disease (MDRD) study [abstract]. In: 13th International Congress of Nephrology; 1995 Jul 2-6; Madrid, Spain. 1995:64. IxJH , ShlipakMG , SarnakMJ , BeckGJ , GreeneT , WangX , et al. Fetuin-A is not associated with all-cause or cardiovascular mortality in chronic kidney disease: data from the Modification of Diet in Renal Disease (MDRD) study [abstract no: SU-PO711]. Journal of the American Society of Nephrology2007;18(Abstracts Issue):741A. KlahrS , BreyerJA , BeckGJ , DennisVW , HartmanJA , RothD , et al. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group.[Erratum appears in J Am Soc Nephrol 1995 Oct;6(4):1318]. Journal of the American Society of Nephrology1995;5(12):2037-47. [MEDLINE: 7579052]KlahrS , LeveyAS , BeckGJ , CaggiulaAW , HunsickerL , KusekJW , et al. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. New England Journal of Medicine1994;330(13):877-84. [MEDLINE: 8114857]KlahrS , Modification of Diet in Renal Disease Study. The Modification of Diet in Renal Disease Study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]KlahrS . Primary and secondary results of the modification of diet in renal disease study. Mineral &amp; Electrolyte Metabolism1996;22(1-3):138-42. [MEDLINE: 8676806]KoppleJD , GreeneT , ChumleaWC , HollingerD , MaroniBJ , MerrillD , et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney International2000;57(4):1688-703. [MEDLINE: 10760105]KoppleJD , LeveyAS , GreeneT , ChumleaWC , GassmanJJ , HollingerDL , et al. Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. Kidney International1997;52(3):778-91. [MEDLINE: 9291200]KuE , GliddenDV , JohansenKL , SarnakM , TighiouartH , GrimesB , et al. Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease. Kidney International2015;87(5):1055-60. [MEDLINE: 25493952]KusekJW , CoyneT , deVelascoA , DrabikMJ , FinlayRA , GassmanJJ , et al. Recruitment experience in the full-scale phase of the Modification of Diet in Renal Disease Study. Controlled Clinical Trials1993;14(6):538-57. [MEDLINE: 8119068]KusekJW , CoyneT , deVelascoA , GassmanJ , KieferS , PowersS , et al. Recruitment experience in the full scale phase of the Modification of Diet in Renal Disease (MDRD) Study [abstract]. Controlled Clinical Trials1991;12:678. KwongYT , StevensLA , SelvinE , ZhangYL , GreeneT , Van LenteF , et al. Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. American Journal of Kidney Diseases2010;56(1):39-49. [MEDLINE: 20537455]LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , LeveyAS , MilasNC , et al. Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. Hypertension1997;29(2):641-50. [MEDLINE: 9040451]Leonberg-YooAK , TighiouartH , LeveyAS , BeckGJ , SarnakMJ . Urine potassium excretion, kidney failure, and mortality in CKD. American Journal of Kidney Diseases2017;69(3):341-9. [MEDLINE: 27233381]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , BoschJP , LewisJB , GreeneT , RogersN , RothD , et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of Internal Medicine1999;130(6):461-70. [MEDLINE: 10075613]LeveyAS , CoreshJ , GreeneT , StevensLA , ZhangYL , HendriksenS , et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate.[Erratum appears in Ann Intern Med. 2008 Oct 7;149(7):519]. Annals of Internal Medicine2006;145(4):247-54. [MEDLINE: 16908915]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study Group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]LeveyAS , GreeneT , SarnakM , WangX , BeckGJ , KusekJW , et al. Effect of low protein diet on progression of kidney disease in the Modification of Diet in Renal Disease study A: long-term follow-up [abstract no: SU-PO247]. Journal of the American Society of Nephrology2004;15(Oct):586A-7A. LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2006;48(6):879-88. [MEDLINE: 17162142]LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. The effect of very low protein diet on progression of kidney disease and mortality in Modification of Diet in Renal Disease Study B [abstract no: SU-PO246]. Journal of the American Society of Nephrology2004;15(Oct):586A. LeveyAS , GreeneT , SchluchterMD , ClearyPA , TeschanPE , LorenzRA , et al. Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. Journal of the American Society of Nephrology1993;4(5):1159-71. [MEDLINE: 8305642]MaderoM , SarnakM , WangX , GreeneT , CollinsA , BeckG , et al. Uric acid and development of kidney failure in chronic kidney disease [abstract no: F-PO1932]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):547A. MaderoM , SarnakMJ , WangX , GreeneT , BeckGJ , KusekJW , et al. Uric acid and long-term outcomes in CKD. American Journal of Kidney Diseases2009;53(5):796-803. [MEDLINE: 19303683]MaderoM , SarnakMJ , WangX , SceppaCC , GreeneT , BeckGJ , et al. Body mass index and mortality in CKD. American Journal of Kidney Diseases2007;50(3):404-11. [MEDLINE: 17720519]MaderoM , WangX , GreenT , HunsickerLG , BeckGJ , KusekJW , et al. Effect of trial participation on outcomes in the randomized and non-randomized cohorts of the Modification of Diet in Renal Disease study [abstract no: F-PO037]. Journal of the American Society of Nephrology2006;17(Abstracts):344A. MDRD Study Group, ChumleaWC , GassmanJJ , HollingerDL , MerrillD , ScherchLK , et al. Nutritional response to diet prescription in the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, HunsickerLG , AdlerS , CaggiulaAW , EnglandB , GreeneT , et al. Relationship among baseline proteinuria (p), mean arterial blood pressure (map) during follow-up, and decline in glomerular filtration rate (aGFR) in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, KoppleJD , ChumleaWC , GassmanJJ , HollingerDL , MaroniBJ , et al. Relationship between FGR and nutritional status - results from the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, KusekJW , AgodoaL , GreeneT , JonesC . Comparison of decline of GFR in blacks versus non-blacks in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , BoschJP , CaggiulaAW , GreeneT , et al. Short-term effects of protein intake, blood pressure, and antihypertensive therapy on GFR in the MDRD study. Journal of the American Society of Nephrology1995;6(3):395. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , HunsickerLG , et al. A hypothesis for the results of the Modification of Diet in Renal Disease (MDRD) study. [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , KusekJW , et al. Trends toward a beneficial effect of a low protein diet during additional follow-up in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1994;5(3):336. MDRD Study Group, LeveyAS , BeckGJ . Trends toward a beneficial effect of a low protein diet during additional follow-up in the modification of diet in renal disease study. MDRD Study Group. [abstract]. Nephrology Dialysis Transplantation1995;10(6):985. MDRD Study Group, LeveyAS , BoschJP , CogginsCH , GreeneT , MitchWE , et al. Effects of diet and blood pressure on creatinine clearance (CCr) and serum creatinine (PCr) in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, PetersonJC , BurkartJ , GreeneT , HebertL , KingA , et al. The effect of blood pressure control on progression of renal disease depends on level of proteinuria (p) at baseline evaluation [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, PetersonJC , GreeneT , KlahrS , BurkartJM , HebertL , et al. Effect of reducing proteinuria (PR) on subsequent glomerular filtration rate (GFR) decline in patients with chronic renal failure (CRF) [abstract]. Journal of the American Society of Nephrology1994;5(3):339. MDRD Study Group, PorushJG , LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , et al. Efficacy of anti-hypertensive interventions in reducing blood pressure in the MDRD study [abstract]. Journal of the American Society of Nephrology1995;6(3):400. MDRD Study Group, PowersSN , KurtzmanDA , PetotGJ , RaizmanDJ , WetsteinL . Promoting dietary compliance through computer-assisted education, assessment, and counseling. [abstract]. Kidney International1988;36(Suppl 27):S306. MDRD Study Group, RoccoMV , CoyneT , EastinS , FaubertJ , GassmanJJ , et al. Patient symptoms and quality of life in the MDRD study at enrollment-correlation with GFR [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group. The modification of diet in renal disease study: results from the full-scale trial [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:593. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Hemoglobin A1c and mortality in chronic kidney disease [abstract no: F-FC149]. Journal of the American Society of Nephrology2005;16:71A. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Insulin resistance as a predictor of all-cause and cardiovascular mortality (CVD) in chronic kidney disease (CKD) [abstract no: F-P0284]. Journal of the American Society of Nephrology2004;15(Oct):128A. MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. Journal of the American Society of Nephrology2005;16(11):3411-7. [MEDLINE: 16207824]MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD. American Journal of Kidney Diseases2005;46(3):455-63. [MEDLINE: 16129207]MenonV , GreeneT , WangX , PereiraAA , MarcovinaSM , BeckGJ , et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney International2005;68(2):766-72. [MEDLINE: 16014054]MenonV , GreenT , PereiraA , XueleiW , BeckG , KusekJ , et al. C-reactive protein (CRP) as a predictor of all-cause and cardiovascular (CVD) mortality in patients with chronic kidney disease (CKD) [abstract no: F-P0275]. Journal of the American Society of Nephrology2004;15(Oct):125A-6A. MenonV , KoppleJD , WangX , BeckGJ , CollinsAJ , KusekJW , et al. Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2009;53(2):208-17. [MEDLINE: 18950911]MenonV , LiL , GreeneT , WangX , ChandraP , BalakrishnanV , et al. Adiponectin and outcomes in chronic kidney disease [abstract no: TH-PO430]. Journal of the American Society of Nephrology2006;17(Abstracts):199A. MenonV , LiL , WangX , GreeneT , BalakrishnanV , MaderoM , et al. Adiponectin and mortality in patients with chronic kidney disease. Journal of the American Society of Nephrology2006;17(9):2599-606. [MEDLINE: 16885405]MenonV , SarnakMJ , GreeneT , WangX , PereiraAA , BeckGJ , et al. Relationship between homocysteine and mortality in chronic kidney disease. Circulation2006;113(12):1572-7. [MEDLINE: 16549639]MenonV , ShlipakMG , WangX , CoreshJ , GreeneT , StevensL , et al. Cystatin C as a risk factor for outcomes in chronic kidney disease. Annals of Internal Medicine2007;147(1):19-27. [MEDLINE: 17606957]MenonV , TighiouartH , VaughnNS , BeckGJ , KusekJW , CollinsAJ , et al. Serum bicarbonate and long-term outcomes in CKD. American Journal of Kidney Diseases2010;56(5):907-14. [MEDLINE: 20605301]MenonV , WangX , GreeneT , BeckGJ , KusekJW , MarcovinaSM , et al. Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. American Journal of Kidney Diseases2003;42(1):44-52. [MEDLINE: 12830455]MenonV , WangX , GreeneT , BeckGJ , KusekJW , SelhubJ , et al. Homocysteine in chronic kidney disease: effect of low protein diet and repletion with B vitamins. Kidney International2005;67(4):1539-46. [MEDLINE: 15780109]MenonV , WangX , SarnakMJ , HunsickerLH , MaderoM , BeckGJ , et al. Long-term outcomes in nondiabetic chronic kidney disease. Kidney International2008;73(11):1310-5. [MEDLINE: 18337713]MilasNC , NowalkMP , AkpeleL , CastaldoL , CoyneT , DoroshenkoL , et al. Factors associated with adherence to the dietary protein intervention in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1295-300. [MEDLINE: 7594126]NewsomeB , IxJH , TighiouartH , SarnakMJ , LeveyAS , BeckGJ , et al. Effect of protein restriction on serum and urine phosphate in the modification of diet in renal disease (MDRD) study. American Journal of Kidney Diseases2013;61(6):1045-6. [MEDLINE: 23415016]OlsonM , CoyneT , CaggiulaA , GregoryP . Patient satisfaction with a dietary intervention: the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):107S. OlsonM , CoyneT , CaggiulaA . Social factors influence dietary satisfaction in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1996;17(2 Suppl):133S. OlsonM , DolecekT , CaggiulaA , DwyerJ . Time required for the protein intervention in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):129S-30S. PetersonJC , AdlerS , BurkartJM , GreeneT , HebertLA , HunsickerLG , et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Annals of Internal Medicine1995;123(10):754-62. [MEDLINE: 7574193]PiccoliM , CodognottoM . Missing stratification by polycistic kidney disease (PKD) flaws risk estimates of GFR decline. Lesson from the MDRD Study [abstract no: F-PO175]. Journal of the American Society of Nephrology2004;15(Oct):103A. RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]RoccoMV , GassmanJJ , WangSR , KaplanRM . Cross-sectional study of quality of life and symptoms in chronic renal disease patients: the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1997;29(6):888-96. [MEDLINE: 9186075]SarnakMJ , GreeneT , WangX , BeckG , KusekJW , CollinsAJ , et al. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease study. Annals of Internal Medicine2005;142(5):342-51. [MEDLINE: 15738453]SarnakMJ , WangSR , BeckGJ , KusekJW , SelhubJ , GreeneT , et al. Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression. American Journal of Kidney Diseases2002;40(5):932-9. [MEDLINE: 12407637]SarnakMJ , WangX , GreeneT , GeraldJ , BeckJ , KusekJW , et al. Effect of strict blood pressure control on long-term outcome in the Modification of Diet in Renal Disease (MDRD) study [abstract no: F-P0599]. Journal of the American Society of Nephrology2003;14(Nov):192A. SchluchterMD . Estimating correlation between alternative measures of disease progression in a longitudinal study. Modification of Diet in Renal Disease Study. Statistics in Medicine1990;9(10):1175-88. [MEDLINE: 2247718]Short-term effects of protein intake, blood pressure, and antihypertensive therapy on glomerular filtration rate in the Modification of Diet in Renal Disease Study. Journal of the American Society of Nephrology1996;7(10):2097-109. [MEDLINE: 8915969]StollarC , ScherchL , AdlerS , KusekJ , CaggiulaA . Patterns of patient dietary compliance in the Modification of Diet in Renal Disease (MDRD) study, phase III. [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:609. TangriN , StevensLA , SchmidCH , ZhangYL , BeckGJ , GreeneT , et al. Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney International2011;79(4):471-7. [MEDLINE: 20980977]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]YamamotoME , OlsonMB , StollarC , MDRD Study Group. Effects of weight and Na+ change on blood pressures of hypertensive MDRD study patients [abstract]. Journal of the American Society of Nephrology1995;6(3):408. YoungJA , TerrinN , GreeneT , WangX , BeckG , KusekJ , et al. Asymmetric dimethylarginine and prevalent cardiovascular disease in patients with chronic kidney disease [abstract no: F-PO935]. Journal of the American Society of Nephrology2007;18(Abstracts):308A-9A. YoungJA , TerrinN , WangX , GreenT , BeckG , KusekJ , et al. ADMA and mortality in stage 3-4 chronic kidney disease [abstract no: TH-PO894]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A. ">MDRD 1 1989</a>; <a href="./references#CD001892-bbs2-0012" title="GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. KlahrS . The modification of diet in renal disease study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]">MDRD 2 1989</a> are shown in <a href="#CD001892-tbl-0006">Table 3</a> as data were reported separately for men and women so could not be added to the meta‐analysis. Three studies reported that body weight dropped during the first few months of commencing a low protein diet but that subsequently weight stabilised (<a href="./references#CD001892-bbs2-0008" title="BeckerGJ , WhitworthJA , IhleBU , ShahinfarS , Kincaid-SmithPS . Prevention of progression in non-diabetic chronic renal failure. Kidney International - Supplement1994;45(Suppl 45):S167-70. [MEDLINE: 8158888]IhleBU , BeckerGJ , WhithworthJA , CharlwoodRA , Kincaid-SmithPS . The effect of protein restriction on the progression of renal insufficiency. New England Journal of Medicine1989;321(26):1773-7. [MEDLINE: 2512486]">Ihle 1989</a>; <a href="./references#CD001892-bbs2-0010" title="MalvyD , MaingourdC , PengloanJ , BagrosP , NivetH . Effects of severe protein restriction with ketoanalogues in advanced renal failure. Journal of the American College of Nutrition1999;18(5):481-6. [MEDLINE: 10511331]NivetH , MaingourdC , MalvyD , PengloanJ , BagrosPH . Effects of severe protein-restriction with ketoanalogues in advanced renal failure [abstract]. Journal of the American Society of Nephrology1992;3(3):286. ">Malvy 1999</a>; <a href="./references#CD001892-bbs2-0015" title="MeloniC , TatangeloP , CiprianiS , RossiV , SuraciC , TozzoC , et al. Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure. Journal of Renal Nutrition2004;14(4):208-13. [MEDLINE: 15483780]">Meloni 2004</a>). </p> <div class="table" id="CD001892-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Final body weight in participants in MDRD studies 1 and 2</span></div> <tbody> <tr> <td align="" class="headercell" colspan="1" rowspan="3" valign=""></td> <th align="center" class="headercell" colspan="4" rowspan="1" scope="col" valign=""> <p><b>MDRD Study 1</b> </p> </th> <th align="center" class="headercell" colspan="4" rowspan="1" scope="col" valign=""> <p><b>MDRD Study 2</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign=""> <p><b>Usual protein diet</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign=""> <p><b>Low protein diet</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign=""> <p><b>Low protein diet</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign=""> <p><b>Very low protein diet</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Final body weight (kg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Final body weight (kg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Final body weight (kg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Final body weight (kg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Men</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>88.5 ± 14.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>179 to 183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83.2 ± 12.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>165 to 170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79.6 ± 11.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74 to 77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79.3 ± 10.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69 to 71</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Women</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72.2 ± 14.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98 to 105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69.3 ± 13.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>107 to 115</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65.9 ± 11.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49 to 51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65.0 ± 14.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49 to 52</p> </td> </tr> </tbody> </table> </div> </section> <section id="CD001892-sec-0061"> <h5 class="title">Protein energy wasting (malnutrition)</h5> <p>Fifteen studies made reference to protein energy wasting. Of these 12 studies reported no evidence of malnutrition while three studies reported small numbers of participants with protein energy wasting in both groups (<a href="./references#CD001892-fig-0011" title="">Analysis 3.2</a> (15 studies, 2373 participants): RR 1.31, 95% CI 0.42 to 4.13; I<sup>2</sup> = 0%; low certainty evidence). </p> </section> <section id="CD001892-sec-0062"> <h5 class="title">Body mass index</h5> <p>Four studies reported on this outcome. Two studies (<a href="./references#CD001892-bbs2-0005" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 1 1990</a>; <a href="./references#CD001892-bbs2-0015" title="MeloniC , TatangeloP , CiprianiS , RossiV , SuraciC , TozzoC , et al. Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure. Journal of Renal Nutrition2004;14(4):208-13. [MEDLINE: 15483780]">Meloni 2004</a>) comparing a low protein with a normal protein diet, found no difference in BMI between groups. Two studies (<a href="./references#CD001892-bbs2-0006" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 2 1990</a>; <a href="./references#CD001892-bbs2-0007" title="GarneataL , MircescuG . Effect of low-protein diet supplemented with keto acids on progression of chronic kidney disease. Journal of Renal Nutrition2013;23(3):210-3. [MEDLINE: 23611549]GarneataL , MocanuE , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues-effects on mineral bone metabolism disorders in advanced chronic kidney disease [abstract no: FP396]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i167-8. [EMBASE: 622605156]GarneataL , StancuA , DragomirD , MircescuG . Effect of very low protein diet supplemented with ketoanalogues of the essential amino acids on the progression of chronic kidney disease [abstract]. Nephrology Dialysis Transplantation2014;29(Suppl 3):iii39. [EMBASE: 71491557]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression. Journal of the American Society of Nephrology2016;27(7):2164-76. [MEDLINE: 26823552]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues in stage 5 CKD patients [abstract no: SP373]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i472. [EMBASE: 622606118]">Garneata 2013</a>) comparing very low protein with a low protein diet, also demonstrated no difference between diet groups. Studies were not combined in a meta‐analysis as three studies (<a href="./references#CD001892-bbs2-0005" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 1 1990</a>; <a href="./references#CD001892-bbs2-0006" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 2 1990</a>; <a href="./references#CD001892-bbs2-0007" title="GarneataL , MircescuG . Effect of low-protein diet supplemented with keto acids on progression of chronic kidney disease. Journal of Renal Nutrition2013;23(3):210-3. [MEDLINE: 23611549]GarneataL , MocanuE , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues-effects on mineral bone metabolism disorders in advanced chronic kidney disease [abstract no: FP396]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i167-8. [EMBASE: 622605156]GarneataL , StancuA , DragomirD , MircescuG . Effect of very low protein diet supplemented with ketoanalogues of the essential amino acids on the progression of chronic kidney disease [abstract]. Nephrology Dialysis Transplantation2014;29(Suppl 3):iii39. [EMBASE: 71491557]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression. Journal of the American Society of Nephrology2016;27(7):2164-76. [MEDLINE: 26823552]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues in stage 5 CKD patients [abstract no: SP373]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i472. [EMBASE: 622606118]">Garneata 2013</a>) provided the data as medians and ranges. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD001892-sec-0063" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD001892-sec-0063"></div> <section id="CD001892-sec-0064"> <h3 class="title" id="CD001892-sec-0064">Summary of main results</h3> <p>For this update we identified six additional studies to provide a total of 17 studies (21 data sets) with 3100 participants (2996 analysed participants) so we were able to report separately on the outcomes of death (all causes), numbers with ESKD, and final or change in GFR. We could also report data separately for studies which compared low with normal protein intakes and those which compared very low with low protein intakes. We sub‐divided four studies which compared different protein intakes in participants with different stages of CKD so that 20 studies were included in this review. </p> <p>Ten studies, mainly evaluating participants with CKD categories 3a and 3b, compared a low prescribed protein diet (0.55 to 0.6 g/kg/day) with a normal protein diet (0.8 to ≥ 1.0 g/kg/day). The difference in calculated protein intake was 0.32 g/kg/day between the intervention groups. A low protein diet compared with a normal protein diet probably makes little or no difference in the numbers of participants who died (moderate certainty evidence) and may make little or no difference in the number of participants who progressed to ESKD (low certainty evidence). It remains uncertain whether a low protein diet compared with a normal protein intake impacts on the final or change in GFR (very low certainty evidence) (<a href="./full#CD001892-tbl-0001">summary of findings Table 1</a>). </p> <p>Ten studies, which evaluated participants with CKD 4 or 5, compared a prescribed very low protein diet (0.3 to 0.4 g/kg/day) with a low protein diet (0.58 to 0.65 g/kg/day) (eight studies) or with a normal protein diet (two studies). The difference in calculated protein intake was 0.25 g/kg/day between the intervention groups. A very low protein intake compared with a low protein intake probably makes little or no difference to death but it probably reduces the number of participants, who reach ESKD (moderate certainty evidence). It remains uncertain whether a very low protein diet compared with a low or normal protein intake influences the final or change in GFR (very low certainty evidence) (<a href="./full#CD001892-tbl-0002">summary of findings Table 2</a>). </p> <p>Fifteen studies reported on the numbers of participants with protein energy wasting (malnutrition); 12 studies had no participants with protein energy wasting while three studies reported small numbers in both treatment groups. Only eight studies provided numerical data for body weight although most studies reported that weight was measured. Only three of the 15 studies reported any evidence of protein energy wasting. No study formally assessed quality of life in the participants. Most studies reported that adherence to diet was satisfactory though studies of participants with CKD 3a and 3b tended to have smaller differences between actual protein intakes, as measured by urinary nitrogen excretion, and prescribed protein intakes. </p> </section> <section id="CD001892-sec-0065"> <h3 class="title" id="CD001892-sec-0065">Overall completeness and applicability of evidence</h3> <p>For this review we identified 16 studies (reported as 20 studies) which evaluated the efficacy and safety of low protein diets in non‐diabetic CKD. Several studies, particularly the older and smaller studies, were of low methodological quality. The primary outcomes of this review (death and ESKD) were not reported in 10 and 4 studies respectively. Numerical data on weight difference and protein energy wasting were provided in few studies though all the studies reported that participants' body weight, BMI and mid arm circumference were measured. Adherence was reported in all the studies and was measured at one to three monthly intervals utilising urine nitrogen excretion for calculated protein intake or dietary recall. While most studies reported satisfactory adherence, difficulty in maintaining adherence was reported in two studies. No studies reported any assessment of quality of life although one study commented that quality of life would be improved if participants were not restricted in their dietary protein intake. Quality of life is significantly reduced in patients who require dialysis. Quality of life should be assessed with dietary interventions, aimed at delaying the onset of ESKD, to confirm that any impact of diet on quality of life is minimal compared with the impact of dialysis treatment. </p> <p>Although <a href="./references#CD001892-bbs2-0001" title="AlvestrandA , BuchtH , GutierrezA , BergströmJ . Progression of chronic renal failure in man as influenced by frequency and quality of clinical follow-ups [abstract]. Kidney International1985;27(1):240. BergstromJ , AlvestrandA , BuchtH , GutierrezA . Progression of chronic renal failure in man is retarded with more frequent clinical follow-ups and better blood pressure control. Clinical Nephrology1986;25(1):1-6. [MEDLINE: 3955903]BergstromJ , AlvestrandA , BuchtH , GutierrezA . Stockholm clinical study on progression of chronic renal failure--an interim report. Kidney International - Supplement1989;36(Suppl 27):S110-4. [MEDLINE: 2636644]BergstromJ , AlvestrandA , BuchtH , GutierrezA . What is the role of controls in an outpatient department on progression of renal disease?Blood Purification1988;6(6):336-42. [MEDLINE: 3061400]">Bergstrom 1986</a>, <a href="./references#CD001892-bbs2-0005" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 1 1990</a> and <a href="./references#CD001892-bbs2-0006" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 2 1990</a> were reported as full text journal articles, these articles only provided preliminary results and our updated search and contact with authors did not identify a publication of the full results for the studies. Most studies were small with only five studies enrolling more than 100 participants in each treatment group. Although we identified six studies not previously included in this review, only <a href="./references#CD001892-bbs2-0007" title="GarneataL , MircescuG . Effect of low-protein diet supplemented with keto acids on progression of chronic kidney disease. Journal of Renal Nutrition2013;23(3):210-3. [MEDLINE: 23611549]GarneataL , MocanuE , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues-effects on mineral bone metabolism disorders in advanced chronic kidney disease [abstract no: FP396]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i167-8. [EMBASE: 622605156]GarneataL , StancuA , DragomirD , MircescuG . Effect of very low protein diet supplemented with ketoanalogues of the essential amino acids on the progression of chronic kidney disease [abstract]. Nephrology Dialysis Transplantation2014;29(Suppl 3):iii39. [EMBASE: 71491557]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression. Journal of the American Society of Nephrology2016;27(7):2164-76. [MEDLINE: 26823552]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues in stage 5 CKD patients [abstract no: SP373]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i472. [EMBASE: 622606118]">Garneata 2013</a> was a large, well reported and high quality study. Only two new studies (<a href="./references#CD001892-bbs2-0007" title="GarneataL , MircescuG . Effect of low-protein diet supplemented with keto acids on progression of chronic kidney disease. Journal of Renal Nutrition2013;23(3):210-3. [MEDLINE: 23611549]GarneataL , MocanuE , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues-effects on mineral bone metabolism disorders in advanced chronic kidney disease [abstract no: FP396]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i167-8. [EMBASE: 622605156]GarneataL , StancuA , DragomirD , MircescuG . Effect of very low protein diet supplemented with ketoanalogues of the essential amino acids on the progression of chronic kidney disease [abstract]. Nephrology Dialysis Transplantation2014;29(Suppl 3):iii39. [EMBASE: 71491557]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression. Journal of the American Society of Nephrology2016;27(7):2164-76. [MEDLINE: 26823552]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues in stage 5 CKD patients [abstract no: SP373]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i472. [EMBASE: 622606118]">Garneata 2013</a>; <a href="./references#CD001892-bbs2-0016" title="Milovanov IuS, LysenkoLV , MilovanovaLI , DobrosmyslovIA . The role of balanced low-protein diet in inhibition of predialysis chronic kidney disease progression in patients with systemic diseases. Terapevticheskii Arkhiv2009;81(8):52-7. [MEDLINE: 19799201]">Milovanov 2009</a>) and the full text publication of <a href="./references#CD001892-bbs2-0003" title="CianciarusoB , PotaA , BellizziV , Di GiuseppeD , Di MiccoL , MinutoloR , et al. Effect of a low- versus moderate-protein diet on progression of CKD: follow-up of a randomized controlled trial. American Journal of Kidney Diseases2009;54(6):1052-61. [MEDLINE: 19800722]CianciarusoB , PotaA , PisaniA , TorracaS , AnnecchiniR , LombardiP , et al. Metabolic effects of two low protein diets in chronic kidney disease stage 4-5--a randomized controlled trial. Nephrology Dialysis Transplantation2008;23(2):636-44. [MEDLINE: 17981885]CianciarusoB , PotaA , TorracaS , SommaG , NazzaroP , AnnecchiniR , et al. Comparison of two different protein intakes (0.3-0.6 vs 0.7-0.9 g/kg/day) on the metabolic control of advanced renal failure [abstract no: MP197]. In: 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal. 2004:295. PotaA , PisaniA , AnnecchiniR , Di GiuseppeD , CuccurulloP , CaputoDL , et al. Treatment of chronic renal failure (CRF) with two different low protein diets. Effects on the metabolic control and on the cardiovascular risk factors [abstract no: MP306]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv401. PotaA , PisaniA , RavaniP , Di MiccoL , Di GiuseppeD , SabbatiniM , et al. Impact of two different low protein diets on survival of CKD patients (stage4-5) [abstract no: TH-PO880]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):308A. ">Cianciaruso 2008a</a> were published since the 2009 update. The other four new studies identified for this update had been published before 2009. </p> </section> <section id="CD001892-sec-0066"> <h3 class="title" id="CD001892-sec-0066">Quality of the evidence</h3> <p>For all the studies included in the review, full length journal articles were available. However included studies were commonly reported incompletely and were of poor methodological quality and this may reflect pre‐2001 CONSORT (Consolidated Standards of Reporting Trials) practices in the older studies (<a href="http://www.consort-statement.org" target="_blank">www.consort-statement.org</a>). Random sequence generation and allocation concealment were considered at low risk of bias in 11 and nine studies respectively. All studies were considered at high risk for performance bias as they were open‐label studies. We assessed bias for outcome assessment (detection bias) for GFR and ESKD separately. As the outcome measurement for GFR measurement was a laboratory outcome all studies were assessed at low risk of detection bias. We felt it important to include a separate assessment of bias for outcome assessment of ESKD as this outcome is more likely to be at risk of detection bias. Eight of 16 studies, reporting data on this outcome, were at unclear or high risk for detection bias; the other eight studies were at low risk of bias since the need to commence dialysis was determined by personnel independent of the trial investigators. Where outcome assessment for the need to commence dialysis is not blinded, the time of dialysis commencement may be influenced by the physicians' knowledge of the treatment groups (<a href="./references#CD001892-bbs2-0067" title="KasiskeBL , LakatuaJD , MaJZ , LouisTA . A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. American Journal of Kidney Diseases1998;31(6):954-61. [MEDLINE: 9631839]">Kasiske 1998</a>). Five studies were assessed at high risk of attrition bias with eleven studies at low risk. Eleven studies were at high risk for reporting bias as they did not include data which could be included in a meta‐analysis. </p> <p>The overall certainty of the evidence using GRADE (<a href="./references#CD001892-bbs2-0058" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ, et al. GRADE Guidelines:1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383-94. [MEDLINE: 2119558]">GRADE 2011a</a>; <a href="./references#CD001892-bbs2-0059" title="BalshemH , HelfandM , SchunemannHJ , OxmanAD , KunzR , BrozekJ , et al. GRADE Guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology2011;64(4):401-6. [MEDLINE: 21208779]">GRADE 2011b</a>) was assessed as moderate, low or very low for different outcomes (<a href="./full#CD001892-tbl-0001">summary of findings Table 1</a>; <a href="./full#CD001892-tbl-0002">summary of findings Table 2</a>). The certainty of the evidence for death was assessed as moderate for studies comparing low with normal protein diets and for studies comparing very low with low or normal protein diets. The certainty of the evidence for ESKD was low for studies comparing low with normal protein diets and moderate for studies comparing very low with low or normal protein intake. The certainty of the evidence for end or change in GFR and body weight was assessed as very low. </p> </section> <section id="CD001892-sec-0067"> <h3 class="title" id="CD001892-sec-0067">Potential biases in the review process</h3> <p>A comprehensive search of the Cochrane Kidney and Transplant’s Specialised Register was performed for this review thus reducing the possibility that potential eligible studies were omitted from the review. Eligible studies published after the last search date or published in conference proceedings not routinely searched could have been missed. The review was completed independently by at least two authors who participated in all steps of the review, which limited the risk of errors in determining study eligibility, in data extraction, in risk of bias assessment and in data synthesis. </p> </section> <section id="CD001892-sec-0068"> <h3 class="title" id="CD001892-sec-0068">Agreements and disagreements with other studies or reviews</h3> <p>The 2009 update of this review found that reduced protein intake in CKD participants reduced the number of participants, who died or reached ESKD (<a href="./references#CD001892-bbs2-0081" title="FouqueD , LavilleM . Low protein diets for chronic kidney disease in non diabetic adults. Cochrane Database of Systematic Reviews2009, Issue 2. Art. No: CD001892. [DOI: 10.1002/14651858.CD001892.pub3]">Fouque 2009</a>). The benefit was primarily seen in the subgroup of studies comparing very low protein diets with low or normal protein diets. In this update with additional studies, we were able to report separately on death and ESKD. We confirmed that the reduction in the number of participants reaching ESKD was limited to studies comparing very low protein diet with low or normal protein diets (moderate certainty evidence). </p> <p>Two other systematic reviews have evaluated the efficacy of low protein diets in participants with CKD. Five RCTs, including 1413 participants with non‐diabetic CKD, were reviewed by <a href="./references#CD001892-bbs2-0073" title="PedriniMT , LeveyAS , LauJ , ChalmersTC , WangPH . The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis. Annals of Internal Medicine1996;124(7):627-32. [MEDLINE: 96201235]">Pedrini 1996</a>. Dietary protein restriction compared with a normal protein intake reduced the risk of the combined outcome of death and ESKD (RR 0.67, 95% CI 0.50 to 0.89). All five RCTs are included in our updated review and include two large studies (<a href="./references#CD001892-bbs2-0009" title="D'AmicoG , GentileMG , FellinG , MannaG , CofanoF . Effect of dietary protein restriction on the progression of renal failure: a prospective randomized trial. Nephrology Dialysis Transplantation1994;9(11):1590-4. [MEDLINE: 7870348]LocatelliF , AlbertiD , GentileMG , GrazianiG , BucciantiG , CosciP , et al. Effects of two different protein prescriptions on chronic renal failure progression. Cooperative study. [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:20. LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA , et al. Blood pressure and chronic renal failure progression: results from a multicentre trial [abstract]. Nephrology Dialysis Transplantation1992;7(7):712. LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA , et al. Factors affecting chronic renal failure progression: results from a multicentre trial. The Northern Italian Cooperative Study Group. Mineral &amp; Electrolyte Metabolism1992;18(2-5):295-302. [MEDLINE: 1465079]LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA . Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group. Lancet1991;337(8753):1299-304. [MEDLINE: 1674294]LocatelliF , Del VecchioL , AndrulliS , MaraiP , TentoriF . The role of underlying nephropathy in the progression of renal disease. Kidney International - Supplement2000;75:S49-55. [MEDLINE: 10828762]LocatelliF , MarcelliD , et al. Factors affecting the progression of chronic renal failure: a multivariate analysis [abstract]. Nephrology Dialysis Transplantation1989;4(5):457. LocatelliF , MarcelliD , TentoriF , MaraiP . Hypertension and progression of chronic renal failure (CRF): a prospective study [abstract]. In: 11th International Congress of Nephrology; 1990 Jul 15-20; Tokyo, Japan. 1990:37A. LocatelliF . Controlled study of protein-restricted diet in chronic renal failure. Contributions to Nephrology1989;75:141-6. [MEDLINE: 2697498]LocatelliF . Dietary compliance in patients with chronic renal failure: experience in a northern Italy trial. Contributions to Nephrology1990;81:102-6. [MEDLINE: 2093485]TentoriF , MaraiP , MarcelliD , PontiR , LocatelliF . Monocentric prospective randomized controlled study on the progression rate of chronic renal failure (CRF) with two different protein intakes [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:20. TentoriF , MaraiP . Monocentric prospective randomised controlled study on the progression rate of chronic renal failure with two different protein intakes [abstract]. Nephrology Dialysis Transplantation1987;2(5):400-1. ">Locatelli 1989</a>; <a href="./references#CD001892-bbs2-0011" title="BeckGJ , BergRL , CogginsCH , GassmanJJ , HunsickerLG , SchluchterMD , et al. Design and statistical issues of the Modification of Diet in Renal Disease Trial. The Modification of Diet in Renal Disease Study Group. Controlled Clinical Trials1991;12(5):566-86. [MEDLINE: 1664792]Buckalew VM Jr, BergRL , WangSR , PorushJG , RauchS , SchulmanG . Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. American Journal of Kidney Diseases1996;28(6):811-21. [MEDLINE: 8957032]ChawlaV , WangX , GreeneJ , KusekJW , CollinsAJ , LeveyAS , et al. Dyslipidemia and mortality in chronic kidney disease [abstract no: TH-PO895]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A-2A. ChenJL , LernerD , RuthazerR , Castaneda-SceppaC , LeveyAS . Association of physical activity with mortality in chronic kidney disease. Journal of Nephrology2008;21(2):243-52. [MEDLINE: 18446720]ChenJL , SceppaC , RuthazerR , LeveyAS . Leisure time physical activity status and mortality in chronic kidney disease: preliminary findings from the MDRD study [abstract no: 21]. American Journal of Kidney Diseases2006;47(4):A24. CogginsCH , Breyer LewisJ , CaggiulaAW , CastaldoLS , KlahrS , WangSR . Differences between women and men with chronic renal disease. Nephrology Dialysis Transplantation1998;13(6):1430-7. [MEDLINE: 9641172]CoyneT , OlsonM , BradhamK , GarconM , GregoryP , ScherchL . Dietary satisfaction correlated with adherence in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1301-6. [MEDLINE: 7594127]DennisVW . Decoding the Modification of Diet in Renal Disease Study. Cleveland Clinic Journal of Medicine1994;61(4):254-7. [MEDLINE: 7923742]DolecekTA , OlsonMB , CaggiulaAW , DwyerJT , MilasNC , GillisBP , et al. Registered dietitian time requirements in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1307-12. [MEDLINE: 7594128]Effects of diet and antihypertensive therapy on creatinine clearance and serum creatinine concentration in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Aug;8(8):1354]. Journal of the American Society of Nephrology1996;7(4):556-66. [MEDLINE: 8724889]Effects of dietary protein restriction on the progression of moderate renal disease in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Mar;8(3):493]. Journal of the American Society of Nephrology1996;7(12):2616-26. [MEDLINE: 8989740]GassmanJJ , DrabikMJ , LeathermanJR , FaticaKJ , McPhersonJA , Modification of Diet in Renal Disease Study Group. Development and use of distributed data entry and electronic communication in a multi-center study of progressive renal disease [abstract]. Kidney International1989;35(1):226. GennariFJ , HoodVL , GreeneT , WangX , LeveyAS . Effect of Dietary Protein Intake on Serum Total CO2 Concentration in Chronic Kidney Disease: Modification of Diet in Renal Disease Study Findings. Clinical Journal of the American Society of Nephrology: CJASN2006;1(1):52-7. [MEDLINE: 17699190]GillisBP , AverbachFM , CaggiulaAW , JonesFL , NaujelisJ , MaurerE , et al. Features of the nutrient database and analysis system for the Modification of Diet in Renal Disease Study.[Erratum appears in Control Clin Trials 1994 Aug;15(4):326]. Controlled Clinical Trials1994;15(1):44-58. [MEDLINE: 8149770]GillisBP , CaggiulaAW , ChiavacciAT , CoyneT , DoroshenkoL , MilasNC , et al. Nutrition intervention program of the Modification of Diet in Renal Disease Study: a self-management approach. Journal of the American Dietetic Association1995;95(11):1288-94. [MEDLINE: 7594125]GramsME , CoreshJ , SegevDL , KucirkaLM , TighiouartH , SarnakMJ . Vascular disease, ESRD, and death: interpreting competing risk analyses. Clinical Journal of the American Society of Nephrology: CJASN2012;7(10):1606-14. [MEDLINE: 22859747]GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. GramsME , TinA , RebholzCM , ShafiT , KottgenA , PerroneRD , et al. Metabolomic alterations associated with cause of CKD. Clinical Journal of The American Society of Nephrology: CJASN2017;12(11):1787-94. [MEDLINE: 28971980]GreeneT , BeckG , WangS , KusekJ , LeveyA , Modification of Diet in Renal Disease Study Group. The effect of the low protein diet in the MDRD study A is dependent on the underlying rate of disease progression [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A. GreeneT , BourgoignieJJ , HabweV , KusekJW , SnetselaarLG , SoucieJM , et al. Baseline characteristics in the Modification of Diet in Renal Disease Study.[Republished from J Am Soc Nephrol 1993 May;3(11):1819-34]. Journal of the American Society of Nephrology1993;4(5):1221-36. [MEDLINE: 8305650]HebertLA , GreeneT , HunsickerLG , LeveyAS , WangS , MDRD Study Group. Relationship of urine volume (uv) and urine osmolality (Uosm) to the progression of renal disease in the Modification of Diet in Renal Disease (MDRD) study [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A-6A. HebertLA , KusekJW , GreeneT , AgodoaLY , JonesCA , LeveyAS , et al. Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group. Hypertension1997;30(3 (Pt 1)):428-35. [MEDLINE: 9314428]HunsickerLG , AdlerS , CaggiulaA , EnglandBK , GreeneT , KusekJW , et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney International1997;51(6):1908-19. [MEDLINE: 9186882]HunsickerLG , MDRD Study Group. Secondary analysis of the Modification of Diet in Renal Disease (MDRD) study [abstract]. In: 13th International Congress of Nephrology; 1995 Jul 2-6; Madrid, Spain. 1995:64. IxJH , ShlipakMG , SarnakMJ , BeckGJ , GreeneT , WangX , et al. Fetuin-A is not associated with all-cause or cardiovascular mortality in chronic kidney disease: data from the Modification of Diet in Renal Disease (MDRD) study [abstract no: SU-PO711]. Journal of the American Society of Nephrology2007;18(Abstracts Issue):741A. KlahrS , BreyerJA , BeckGJ , DennisVW , HartmanJA , RothD , et al. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group.[Erratum appears in J Am Soc Nephrol 1995 Oct;6(4):1318]. Journal of the American Society of Nephrology1995;5(12):2037-47. [MEDLINE: 7579052]KlahrS , LeveyAS , BeckGJ , CaggiulaAW , HunsickerL , KusekJW , et al. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. New England Journal of Medicine1994;330(13):877-84. [MEDLINE: 8114857]KlahrS , Modification of Diet in Renal Disease Study. The Modification of Diet in Renal Disease Study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]KlahrS . Primary and secondary results of the modification of diet in renal disease study. Mineral &amp; Electrolyte Metabolism1996;22(1-3):138-42. [MEDLINE: 8676806]KoppleJD , GreeneT , ChumleaWC , HollingerD , MaroniBJ , MerrillD , et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney International2000;57(4):1688-703. [MEDLINE: 10760105]KoppleJD , LeveyAS , GreeneT , ChumleaWC , GassmanJJ , HollingerDL , et al. Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. Kidney International1997;52(3):778-91. [MEDLINE: 9291200]KuE , GliddenDV , JohansenKL , SarnakM , TighiouartH , GrimesB , et al. Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease. Kidney International2015;87(5):1055-60. [MEDLINE: 25493952]KusekJW , CoyneT , deVelascoA , DrabikMJ , FinlayRA , GassmanJJ , et al. Recruitment experience in the full-scale phase of the Modification of Diet in Renal Disease Study. Controlled Clinical Trials1993;14(6):538-57. [MEDLINE: 8119068]KusekJW , CoyneT , deVelascoA , GassmanJ , KieferS , PowersS , et al. Recruitment experience in the full scale phase of the Modification of Diet in Renal Disease (MDRD) Study [abstract]. Controlled Clinical Trials1991;12:678. KwongYT , StevensLA , SelvinE , ZhangYL , GreeneT , Van LenteF , et al. Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. American Journal of Kidney Diseases2010;56(1):39-49. [MEDLINE: 20537455]LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , LeveyAS , MilasNC , et al. Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. Hypertension1997;29(2):641-50. [MEDLINE: 9040451]Leonberg-YooAK , TighiouartH , LeveyAS , BeckGJ , SarnakMJ . Urine potassium excretion, kidney failure, and mortality in CKD. American Journal of Kidney Diseases2017;69(3):341-9. [MEDLINE: 27233381]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , BoschJP , LewisJB , GreeneT , RogersN , RothD , et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of Internal Medicine1999;130(6):461-70. [MEDLINE: 10075613]LeveyAS , CoreshJ , GreeneT , StevensLA , ZhangYL , HendriksenS , et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate.[Erratum appears in Ann Intern Med. 2008 Oct 7;149(7):519]. Annals of Internal Medicine2006;145(4):247-54. [MEDLINE: 16908915]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study Group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]LeveyAS , GreeneT , SarnakM , WangX , BeckGJ , KusekJW , et al. Effect of low protein diet on progression of kidney disease in the Modification of Diet in Renal Disease study A: long-term follow-up [abstract no: SU-PO247]. Journal of the American Society of Nephrology2004;15(Oct):586A-7A. LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2006;48(6):879-88. [MEDLINE: 17162142]LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. The effect of very low protein diet on progression of kidney disease and mortality in Modification of Diet in Renal Disease Study B [abstract no: SU-PO246]. Journal of the American Society of Nephrology2004;15(Oct):586A. LeveyAS , GreeneT , SchluchterMD , ClearyPA , TeschanPE , LorenzRA , et al. Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. Journal of the American Society of Nephrology1993;4(5):1159-71. [MEDLINE: 8305642]MaderoM , SarnakM , WangX , GreeneT , CollinsA , BeckG , et al. Uric acid and development of kidney failure in chronic kidney disease [abstract no: F-PO1932]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):547A. MaderoM , SarnakMJ , WangX , GreeneT , BeckGJ , KusekJW , et al. Uric acid and long-term outcomes in CKD. American Journal of Kidney Diseases2009;53(5):796-803. [MEDLINE: 19303683]MaderoM , SarnakMJ , WangX , SceppaCC , GreeneT , BeckGJ , et al. Body mass index and mortality in CKD. American Journal of Kidney Diseases2007;50(3):404-11. [MEDLINE: 17720519]MaderoM , WangX , GreenT , HunsickerLG , BeckGJ , KusekJW , et al. Effect of trial participation on outcomes in the randomized and non-randomized cohorts of the Modification of Diet in Renal Disease study [abstract no: F-PO037]. Journal of the American Society of Nephrology2006;17(Abstracts):344A. MDRD Study Group, ChumleaWC , GassmanJJ , HollingerDL , MerrillD , ScherchLK , et al. Nutritional response to diet prescription in the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, HunsickerLG , AdlerS , CaggiulaAW , EnglandB , GreeneT , et al. Relationship among baseline proteinuria (p), mean arterial blood pressure (map) during follow-up, and decline in glomerular filtration rate (aGFR) in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, KoppleJD , ChumleaWC , GassmanJJ , HollingerDL , MaroniBJ , et al. Relationship between FGR and nutritional status - results from the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, KusekJW , AgodoaL , GreeneT , JonesC . Comparison of decline of GFR in blacks versus non-blacks in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , BoschJP , CaggiulaAW , GreeneT , et al. Short-term effects of protein intake, blood pressure, and antihypertensive therapy on GFR in the MDRD study. Journal of the American Society of Nephrology1995;6(3):395. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , HunsickerLG , et al. A hypothesis for the results of the Modification of Diet in Renal Disease (MDRD) study. [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , KusekJW , et al. Trends toward a beneficial effect of a low protein diet during additional follow-up in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1994;5(3):336. MDRD Study Group, LeveyAS , BeckGJ . Trends toward a beneficial effect of a low protein diet during additional follow-up in the modification of diet in renal disease study. MDRD Study Group. [abstract]. Nephrology Dialysis Transplantation1995;10(6):985. MDRD Study Group, LeveyAS , BoschJP , CogginsCH , GreeneT , MitchWE , et al. Effects of diet and blood pressure on creatinine clearance (CCr) and serum creatinine (PCr) in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, PetersonJC , BurkartJ , GreeneT , HebertL , KingA , et al. The effect of blood pressure control on progression of renal disease depends on level of proteinuria (p) at baseline evaluation [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, PetersonJC , GreeneT , KlahrS , BurkartJM , HebertL , et al. Effect of reducing proteinuria (PR) on subsequent glomerular filtration rate (GFR) decline in patients with chronic renal failure (CRF) [abstract]. Journal of the American Society of Nephrology1994;5(3):339. MDRD Study Group, PorushJG , LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , et al. Efficacy of anti-hypertensive interventions in reducing blood pressure in the MDRD study [abstract]. Journal of the American Society of Nephrology1995;6(3):400. MDRD Study Group, PowersSN , KurtzmanDA , PetotGJ , RaizmanDJ , WetsteinL . Promoting dietary compliance through computer-assisted education, assessment, and counseling. [abstract]. Kidney International1988;36(Suppl 27):S306. MDRD Study Group, RoccoMV , CoyneT , EastinS , FaubertJ , GassmanJJ , et al. Patient symptoms and quality of life in the MDRD study at enrollment-correlation with GFR [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group. The modification of diet in renal disease study: results from the full-scale trial [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:593. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Hemoglobin A1c and mortality in chronic kidney disease [abstract no: F-FC149]. Journal of the American Society of Nephrology2005;16:71A. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Insulin resistance as a predictor of all-cause and cardiovascular mortality (CVD) in chronic kidney disease (CKD) [abstract no: F-P0284]. Journal of the American Society of Nephrology2004;15(Oct):128A. MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. Journal of the American Society of Nephrology2005;16(11):3411-7. [MEDLINE: 16207824]MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD. American Journal of Kidney Diseases2005;46(3):455-63. [MEDLINE: 16129207]MenonV , GreeneT , WangX , PereiraAA , MarcovinaSM , BeckGJ , et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney International2005;68(2):766-72. [MEDLINE: 16014054]MenonV , GreenT , PereiraA , XueleiW , BeckG , KusekJ , et al. C-reactive protein (CRP) as a predictor of all-cause and cardiovascular (CVD) mortality in patients with chronic kidney disease (CKD) [abstract no: F-P0275]. Journal of the American Society of Nephrology2004;15(Oct):125A-6A. MenonV , KoppleJD , WangX , BeckGJ , CollinsAJ , KusekJW , et al. Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2009;53(2):208-17. [MEDLINE: 18950911]MenonV , LiL , GreeneT , WangX , ChandraP , BalakrishnanV , et al. Adiponectin and outcomes in chronic kidney disease [abstract no: TH-PO430]. Journal of the American Society of Nephrology2006;17(Abstracts):199A. MenonV , LiL , WangX , GreeneT , BalakrishnanV , MaderoM , et al. Adiponectin and mortality in patients with chronic kidney disease. Journal of the American Society of Nephrology2006;17(9):2599-606. [MEDLINE: 16885405]MenonV , SarnakMJ , GreeneT , WangX , PereiraAA , BeckGJ , et al. Relationship between homocysteine and mortality in chronic kidney disease. Circulation2006;113(12):1572-7. [MEDLINE: 16549639]MenonV , ShlipakMG , WangX , CoreshJ , GreeneT , StevensL , et al. Cystatin C as a risk factor for outcomes in chronic kidney disease. Annals of Internal Medicine2007;147(1):19-27. [MEDLINE: 17606957]MenonV , TighiouartH , VaughnNS , BeckGJ , KusekJW , CollinsAJ , et al. Serum bicarbonate and long-term outcomes in CKD. American Journal of Kidney Diseases2010;56(5):907-14. [MEDLINE: 20605301]MenonV , WangX , GreeneT , BeckGJ , KusekJW , MarcovinaSM , et al. Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. American Journal of Kidney Diseases2003;42(1):44-52. [MEDLINE: 12830455]MenonV , WangX , GreeneT , BeckGJ , KusekJW , SelhubJ , et al. Homocysteine in chronic kidney disease: effect of low protein diet and repletion with B vitamins. Kidney International2005;67(4):1539-46. [MEDLINE: 15780109]MenonV , WangX , SarnakMJ , HunsickerLH , MaderoM , BeckGJ , et al. Long-term outcomes in nondiabetic chronic kidney disease. Kidney International2008;73(11):1310-5. [MEDLINE: 18337713]MilasNC , NowalkMP , AkpeleL , CastaldoL , CoyneT , DoroshenkoL , et al. Factors associated with adherence to the dietary protein intervention in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1295-300. [MEDLINE: 7594126]NewsomeB , IxJH , TighiouartH , SarnakMJ , LeveyAS , BeckGJ , et al. Effect of protein restriction on serum and urine phosphate in the modification of diet in renal disease (MDRD) study. American Journal of Kidney Diseases2013;61(6):1045-6. [MEDLINE: 23415016]OlsonM , CoyneT , CaggiulaA , GregoryP . Patient satisfaction with a dietary intervention: the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):107S. OlsonM , CoyneT , CaggiulaA . Social factors influence dietary satisfaction in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1996;17(2 Suppl):133S. OlsonM , DolecekT , CaggiulaA , DwyerJ . Time required for the protein intervention in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):129S-30S. PetersonJC , AdlerS , BurkartJM , GreeneT , HebertLA , HunsickerLG , et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Annals of Internal Medicine1995;123(10):754-62. [MEDLINE: 7574193]PiccoliM , CodognottoM . Missing stratification by polycistic kidney disease (PKD) flaws risk estimates of GFR decline. Lesson from the MDRD Study [abstract no: F-PO175]. Journal of the American Society of Nephrology2004;15(Oct):103A. RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]RoccoMV , GassmanJJ , WangSR , KaplanRM . Cross-sectional study of quality of life and symptoms in chronic renal disease patients: the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1997;29(6):888-96. [MEDLINE: 9186075]SarnakMJ , GreeneT , WangX , BeckG , KusekJW , CollinsAJ , et al. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease study. Annals of Internal Medicine2005;142(5):342-51. [MEDLINE: 15738453]SarnakMJ , WangSR , BeckGJ , KusekJW , SelhubJ , GreeneT , et al. Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression. American Journal of Kidney Diseases2002;40(5):932-9. [MEDLINE: 12407637]SarnakMJ , WangX , GreeneT , GeraldJ , BeckJ , KusekJW , et al. Effect of strict blood pressure control on long-term outcome in the Modification of Diet in Renal Disease (MDRD) study [abstract no: F-P0599]. Journal of the American Society of Nephrology2003;14(Nov):192A. SchluchterMD . Estimating correlation between alternative measures of disease progression in a longitudinal study. Modification of Diet in Renal Disease Study. Statistics in Medicine1990;9(10):1175-88. [MEDLINE: 2247718]Short-term effects of protein intake, blood pressure, and antihypertensive therapy on glomerular filtration rate in the Modification of Diet in Renal Disease Study. Journal of the American Society of Nephrology1996;7(10):2097-109. [MEDLINE: 8915969]StollarC , ScherchL , AdlerS , KusekJ , CaggiulaA . Patterns of patient dietary compliance in the Modification of Diet in Renal Disease (MDRD) study, phase III. [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:609. TangriN , StevensLA , SchmidCH , ZhangYL , BeckGJ , GreeneT , et al. Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney International2011;79(4):471-7. [MEDLINE: 20980977]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]YamamotoME , OlsonMB , StollarC , MDRD Study Group. Effects of weight and Na+ change on blood pressures of hypertensive MDRD study patients [abstract]. Journal of the American Society of Nephrology1995;6(3):408. YoungJA , TerrinN , GreeneT , WangX , BeckG , KusekJ , et al. Asymmetric dimethylarginine and prevalent cardiovascular disease in patients with chronic kidney disease [abstract no: F-PO935]. Journal of the American Society of Nephrology2007;18(Abstracts):308A-9A. YoungJA , TerrinN , WangX , GreenT , BeckG , KusekJ , et al. ADMA and mortality in stage 3-4 chronic kidney disease [abstract no: TH-PO894]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A. ">MDRD 1 1989</a>; <a href="./references#CD001892-bbs2-0012" title="GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. KlahrS . The modification of diet in renal disease study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]">MDRD 2 1989</a>). This study evaluated the number of participants reaching ESKD but did not evaluate change in GFR. </p> <p><a href="./references#CD001892-bbs2-0067" title="KasiskeBL , LakatuaJD , MaJZ , LouisTA . A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. American Journal of Kidney Diseases1998;31(6):954-61. [MEDLINE: 9631839]">Kasiske 1998</a> evaluated 13 RCTs (1919 participants) including four studies of patients with diabetic CKD. As in this systematic review, the Modification of Diet in Renal Disease study (<a href="./references#CD001892-bbs2-0011" title="BeckGJ , BergRL , CogginsCH , GassmanJJ , HunsickerLG , SchluchterMD , et al. Design and statistical issues of the Modification of Diet in Renal Disease Trial. The Modification of Diet in Renal Disease Study Group. Controlled Clinical Trials1991;12(5):566-86. [MEDLINE: 1664792]Buckalew VM Jr, BergRL , WangSR , PorushJG , RauchS , SchulmanG . Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. American Journal of Kidney Diseases1996;28(6):811-21. [MEDLINE: 8957032]ChawlaV , WangX , GreeneJ , KusekJW , CollinsAJ , LeveyAS , et al. Dyslipidemia and mortality in chronic kidney disease [abstract no: TH-PO895]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A-2A. ChenJL , LernerD , RuthazerR , Castaneda-SceppaC , LeveyAS . Association of physical activity with mortality in chronic kidney disease. Journal of Nephrology2008;21(2):243-52. [MEDLINE: 18446720]ChenJL , SceppaC , RuthazerR , LeveyAS . Leisure time physical activity status and mortality in chronic kidney disease: preliminary findings from the MDRD study [abstract no: 21]. American Journal of Kidney Diseases2006;47(4):A24. CogginsCH , Breyer LewisJ , CaggiulaAW , CastaldoLS , KlahrS , WangSR . Differences between women and men with chronic renal disease. Nephrology Dialysis Transplantation1998;13(6):1430-7. [MEDLINE: 9641172]CoyneT , OlsonM , BradhamK , GarconM , GregoryP , ScherchL . Dietary satisfaction correlated with adherence in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1301-6. [MEDLINE: 7594127]DennisVW . Decoding the Modification of Diet in Renal Disease Study. Cleveland Clinic Journal of Medicine1994;61(4):254-7. [MEDLINE: 7923742]DolecekTA , OlsonMB , CaggiulaAW , DwyerJT , MilasNC , GillisBP , et al. Registered dietitian time requirements in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1307-12. [MEDLINE: 7594128]Effects of diet and antihypertensive therapy on creatinine clearance and serum creatinine concentration in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Aug;8(8):1354]. Journal of the American Society of Nephrology1996;7(4):556-66. [MEDLINE: 8724889]Effects of dietary protein restriction on the progression of moderate renal disease in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Mar;8(3):493]. Journal of the American Society of Nephrology1996;7(12):2616-26. [MEDLINE: 8989740]GassmanJJ , DrabikMJ , LeathermanJR , FaticaKJ , McPhersonJA , Modification of Diet in Renal Disease Study Group. Development and use of distributed data entry and electronic communication in a multi-center study of progressive renal disease [abstract]. Kidney International1989;35(1):226. GennariFJ , HoodVL , GreeneT , WangX , LeveyAS . Effect of Dietary Protein Intake on Serum Total CO2 Concentration in Chronic Kidney Disease: Modification of Diet in Renal Disease Study Findings. Clinical Journal of the American Society of Nephrology: CJASN2006;1(1):52-7. [MEDLINE: 17699190]GillisBP , AverbachFM , CaggiulaAW , JonesFL , NaujelisJ , MaurerE , et al. Features of the nutrient database and analysis system for the Modification of Diet in Renal Disease Study.[Erratum appears in Control Clin Trials 1994 Aug;15(4):326]. Controlled Clinical Trials1994;15(1):44-58. [MEDLINE: 8149770]GillisBP , CaggiulaAW , ChiavacciAT , CoyneT , DoroshenkoL , MilasNC , et al. Nutrition intervention program of the Modification of Diet in Renal Disease Study: a self-management approach. Journal of the American Dietetic Association1995;95(11):1288-94. [MEDLINE: 7594125]GramsME , CoreshJ , SegevDL , KucirkaLM , TighiouartH , SarnakMJ . Vascular disease, ESRD, and death: interpreting competing risk analyses. Clinical Journal of the American Society of Nephrology: CJASN2012;7(10):1606-14. [MEDLINE: 22859747]GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. GramsME , TinA , RebholzCM , ShafiT , KottgenA , PerroneRD , et al. Metabolomic alterations associated with cause of CKD. Clinical Journal of The American Society of Nephrology: CJASN2017;12(11):1787-94. [MEDLINE: 28971980]GreeneT , BeckG , WangS , KusekJ , LeveyA , Modification of Diet in Renal Disease Study Group. The effect of the low protein diet in the MDRD study A is dependent on the underlying rate of disease progression [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A. GreeneT , BourgoignieJJ , HabweV , KusekJW , SnetselaarLG , SoucieJM , et al. Baseline characteristics in the Modification of Diet in Renal Disease Study.[Republished from J Am Soc Nephrol 1993 May;3(11):1819-34]. Journal of the American Society of Nephrology1993;4(5):1221-36. [MEDLINE: 8305650]HebertLA , GreeneT , HunsickerLG , LeveyAS , WangS , MDRD Study Group. Relationship of urine volume (uv) and urine osmolality (Uosm) to the progression of renal disease in the Modification of Diet in Renal Disease (MDRD) study [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A-6A. HebertLA , KusekJW , GreeneT , AgodoaLY , JonesCA , LeveyAS , et al. Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group. Hypertension1997;30(3 (Pt 1)):428-35. [MEDLINE: 9314428]HunsickerLG , AdlerS , CaggiulaA , EnglandBK , GreeneT , KusekJW , et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney International1997;51(6):1908-19. [MEDLINE: 9186882]HunsickerLG , MDRD Study Group. Secondary analysis of the Modification of Diet in Renal Disease (MDRD) study [abstract]. In: 13th International Congress of Nephrology; 1995 Jul 2-6; Madrid, Spain. 1995:64. IxJH , ShlipakMG , SarnakMJ , BeckGJ , GreeneT , WangX , et al. Fetuin-A is not associated with all-cause or cardiovascular mortality in chronic kidney disease: data from the Modification of Diet in Renal Disease (MDRD) study [abstract no: SU-PO711]. Journal of the American Society of Nephrology2007;18(Abstracts Issue):741A. KlahrS , BreyerJA , BeckGJ , DennisVW , HartmanJA , RothD , et al. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group.[Erratum appears in J Am Soc Nephrol 1995 Oct;6(4):1318]. Journal of the American Society of Nephrology1995;5(12):2037-47. [MEDLINE: 7579052]KlahrS , LeveyAS , BeckGJ , CaggiulaAW , HunsickerL , KusekJW , et al. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. New England Journal of Medicine1994;330(13):877-84. [MEDLINE: 8114857]KlahrS , Modification of Diet in Renal Disease Study. The Modification of Diet in Renal Disease Study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]KlahrS . Primary and secondary results of the modification of diet in renal disease study. Mineral &amp; Electrolyte Metabolism1996;22(1-3):138-42. [MEDLINE: 8676806]KoppleJD , GreeneT , ChumleaWC , HollingerD , MaroniBJ , MerrillD , et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney International2000;57(4):1688-703. [MEDLINE: 10760105]KoppleJD , LeveyAS , GreeneT , ChumleaWC , GassmanJJ , HollingerDL , et al. Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. Kidney International1997;52(3):778-91. [MEDLINE: 9291200]KuE , GliddenDV , JohansenKL , SarnakM , TighiouartH , GrimesB , et al. Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease. Kidney International2015;87(5):1055-60. [MEDLINE: 25493952]KusekJW , CoyneT , deVelascoA , DrabikMJ , FinlayRA , GassmanJJ , et al. Recruitment experience in the full-scale phase of the Modification of Diet in Renal Disease Study. Controlled Clinical Trials1993;14(6):538-57. [MEDLINE: 8119068]KusekJW , CoyneT , deVelascoA , GassmanJ , KieferS , PowersS , et al. Recruitment experience in the full scale phase of the Modification of Diet in Renal Disease (MDRD) Study [abstract]. Controlled Clinical Trials1991;12:678. KwongYT , StevensLA , SelvinE , ZhangYL , GreeneT , Van LenteF , et al. Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. American Journal of Kidney Diseases2010;56(1):39-49. [MEDLINE: 20537455]LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , LeveyAS , MilasNC , et al. Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. Hypertension1997;29(2):641-50. [MEDLINE: 9040451]Leonberg-YooAK , TighiouartH , LeveyAS , BeckGJ , SarnakMJ . Urine potassium excretion, kidney failure, and mortality in CKD. American Journal of Kidney Diseases2017;69(3):341-9. [MEDLINE: 27233381]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , BoschJP , LewisJB , GreeneT , RogersN , RothD , et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of Internal Medicine1999;130(6):461-70. [MEDLINE: 10075613]LeveyAS , CoreshJ , GreeneT , StevensLA , ZhangYL , HendriksenS , et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate.[Erratum appears in Ann Intern Med. 2008 Oct 7;149(7):519]. Annals of Internal Medicine2006;145(4):247-54. [MEDLINE: 16908915]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study Group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]LeveyAS , GreeneT , SarnakM , WangX , BeckGJ , KusekJW , et al. Effect of low protein diet on progression of kidney disease in the Modification of Diet in Renal Disease study A: long-term follow-up [abstract no: SU-PO247]. Journal of the American Society of Nephrology2004;15(Oct):586A-7A. LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2006;48(6):879-88. [MEDLINE: 17162142]LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. The effect of very low protein diet on progression of kidney disease and mortality in Modification of Diet in Renal Disease Study B [abstract no: SU-PO246]. Journal of the American Society of Nephrology2004;15(Oct):586A. LeveyAS , GreeneT , SchluchterMD , ClearyPA , TeschanPE , LorenzRA , et al. Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. Journal of the American Society of Nephrology1993;4(5):1159-71. [MEDLINE: 8305642]MaderoM , SarnakM , WangX , GreeneT , CollinsA , BeckG , et al. Uric acid and development of kidney failure in chronic kidney disease [abstract no: F-PO1932]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):547A. MaderoM , SarnakMJ , WangX , GreeneT , BeckGJ , KusekJW , et al. Uric acid and long-term outcomes in CKD. American Journal of Kidney Diseases2009;53(5):796-803. [MEDLINE: 19303683]MaderoM , SarnakMJ , WangX , SceppaCC , GreeneT , BeckGJ , et al. Body mass index and mortality in CKD. American Journal of Kidney Diseases2007;50(3):404-11. [MEDLINE: 17720519]MaderoM , WangX , GreenT , HunsickerLG , BeckGJ , KusekJW , et al. Effect of trial participation on outcomes in the randomized and non-randomized cohorts of the Modification of Diet in Renal Disease study [abstract no: F-PO037]. Journal of the American Society of Nephrology2006;17(Abstracts):344A. MDRD Study Group, ChumleaWC , GassmanJJ , HollingerDL , MerrillD , ScherchLK , et al. Nutritional response to diet prescription in the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, HunsickerLG , AdlerS , CaggiulaAW , EnglandB , GreeneT , et al. Relationship among baseline proteinuria (p), mean arterial blood pressure (map) during follow-up, and decline in glomerular filtration rate (aGFR) in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, KoppleJD , ChumleaWC , GassmanJJ , HollingerDL , MaroniBJ , et al. Relationship between FGR and nutritional status - results from the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, KusekJW , AgodoaL , GreeneT , JonesC . Comparison of decline of GFR in blacks versus non-blacks in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , BoschJP , CaggiulaAW , GreeneT , et al. Short-term effects of protein intake, blood pressure, and antihypertensive therapy on GFR in the MDRD study. Journal of the American Society of Nephrology1995;6(3):395. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , HunsickerLG , et al. A hypothesis for the results of the Modification of Diet in Renal Disease (MDRD) study. [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , KusekJW , et al. Trends toward a beneficial effect of a low protein diet during additional follow-up in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1994;5(3):336. MDRD Study Group, LeveyAS , BeckGJ . Trends toward a beneficial effect of a low protein diet during additional follow-up in the modification of diet in renal disease study. MDRD Study Group. [abstract]. Nephrology Dialysis Transplantation1995;10(6):985. MDRD Study Group, LeveyAS , BoschJP , CogginsCH , GreeneT , MitchWE , et al. Effects of diet and blood pressure on creatinine clearance (CCr) and serum creatinine (PCr) in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, PetersonJC , BurkartJ , GreeneT , HebertL , KingA , et al. The effect of blood pressure control on progression of renal disease depends on level of proteinuria (p) at baseline evaluation [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, PetersonJC , GreeneT , KlahrS , BurkartJM , HebertL , et al. Effect of reducing proteinuria (PR) on subsequent glomerular filtration rate (GFR) decline in patients with chronic renal failure (CRF) [abstract]. Journal of the American Society of Nephrology1994;5(3):339. MDRD Study Group, PorushJG , LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , et al. Efficacy of anti-hypertensive interventions in reducing blood pressure in the MDRD study [abstract]. Journal of the American Society of Nephrology1995;6(3):400. MDRD Study Group, PowersSN , KurtzmanDA , PetotGJ , RaizmanDJ , WetsteinL . Promoting dietary compliance through computer-assisted education, assessment, and counseling. [abstract]. Kidney International1988;36(Suppl 27):S306. MDRD Study Group, RoccoMV , CoyneT , EastinS , FaubertJ , GassmanJJ , et al. Patient symptoms and quality of life in the MDRD study at enrollment-correlation with GFR [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group. The modification of diet in renal disease study: results from the full-scale trial [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:593. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Hemoglobin A1c and mortality in chronic kidney disease [abstract no: F-FC149]. Journal of the American Society of Nephrology2005;16:71A. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Insulin resistance as a predictor of all-cause and cardiovascular mortality (CVD) in chronic kidney disease (CKD) [abstract no: F-P0284]. Journal of the American Society of Nephrology2004;15(Oct):128A. MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. Journal of the American Society of Nephrology2005;16(11):3411-7. [MEDLINE: 16207824]MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD. American Journal of Kidney Diseases2005;46(3):455-63. [MEDLINE: 16129207]MenonV , GreeneT , WangX , PereiraAA , MarcovinaSM , BeckGJ , et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney International2005;68(2):766-72. [MEDLINE: 16014054]MenonV , GreenT , PereiraA , XueleiW , BeckG , KusekJ , et al. C-reactive protein (CRP) as a predictor of all-cause and cardiovascular (CVD) mortality in patients with chronic kidney disease (CKD) [abstract no: F-P0275]. Journal of the American Society of Nephrology2004;15(Oct):125A-6A. MenonV , KoppleJD , WangX , BeckGJ , CollinsAJ , KusekJW , et al. Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2009;53(2):208-17. [MEDLINE: 18950911]MenonV , LiL , GreeneT , WangX , ChandraP , BalakrishnanV , et al. Adiponectin and outcomes in chronic kidney disease [abstract no: TH-PO430]. Journal of the American Society of Nephrology2006;17(Abstracts):199A. MenonV , LiL , WangX , GreeneT , BalakrishnanV , MaderoM , et al. Adiponectin and mortality in patients with chronic kidney disease. Journal of the American Society of Nephrology2006;17(9):2599-606. [MEDLINE: 16885405]MenonV , SarnakMJ , GreeneT , WangX , PereiraAA , BeckGJ , et al. Relationship between homocysteine and mortality in chronic kidney disease. Circulation2006;113(12):1572-7. [MEDLINE: 16549639]MenonV , ShlipakMG , WangX , CoreshJ , GreeneT , StevensL , et al. Cystatin C as a risk factor for outcomes in chronic kidney disease. Annals of Internal Medicine2007;147(1):19-27. [MEDLINE: 17606957]MenonV , TighiouartH , VaughnNS , BeckGJ , KusekJW , CollinsAJ , et al. Serum bicarbonate and long-term outcomes in CKD. American Journal of Kidney Diseases2010;56(5):907-14. [MEDLINE: 20605301]MenonV , WangX , GreeneT , BeckGJ , KusekJW , MarcovinaSM , et al. Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. American Journal of Kidney Diseases2003;42(1):44-52. [MEDLINE: 12830455]MenonV , WangX , GreeneT , BeckGJ , KusekJW , SelhubJ , et al. Homocysteine in chronic kidney disease: effect of low protein diet and repletion with B vitamins. Kidney International2005;67(4):1539-46. [MEDLINE: 15780109]MenonV , WangX , SarnakMJ , HunsickerLH , MaderoM , BeckGJ , et al. Long-term outcomes in nondiabetic chronic kidney disease. Kidney International2008;73(11):1310-5. [MEDLINE: 18337713]MilasNC , NowalkMP , AkpeleL , CastaldoL , CoyneT , DoroshenkoL , et al. Factors associated with adherence to the dietary protein intervention in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1295-300. [MEDLINE: 7594126]NewsomeB , IxJH , TighiouartH , SarnakMJ , LeveyAS , BeckGJ , et al. Effect of protein restriction on serum and urine phosphate in the modification of diet in renal disease (MDRD) study. American Journal of Kidney Diseases2013;61(6):1045-6. [MEDLINE: 23415016]OlsonM , CoyneT , CaggiulaA , GregoryP . Patient satisfaction with a dietary intervention: the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):107S. OlsonM , CoyneT , CaggiulaA . Social factors influence dietary satisfaction in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1996;17(2 Suppl):133S. OlsonM , DolecekT , CaggiulaA , DwyerJ . Time required for the protein intervention in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):129S-30S. PetersonJC , AdlerS , BurkartJM , GreeneT , HebertLA , HunsickerLG , et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Annals of Internal Medicine1995;123(10):754-62. [MEDLINE: 7574193]PiccoliM , CodognottoM . Missing stratification by polycistic kidney disease (PKD) flaws risk estimates of GFR decline. Lesson from the MDRD Study [abstract no: F-PO175]. Journal of the American Society of Nephrology2004;15(Oct):103A. RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]RoccoMV , GassmanJJ , WangSR , KaplanRM . Cross-sectional study of quality of life and symptoms in chronic renal disease patients: the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1997;29(6):888-96. [MEDLINE: 9186075]SarnakMJ , GreeneT , WangX , BeckG , KusekJW , CollinsAJ , et al. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease study. Annals of Internal Medicine2005;142(5):342-51. [MEDLINE: 15738453]SarnakMJ , WangSR , BeckGJ , KusekJW , SelhubJ , GreeneT , et al. Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression. American Journal of Kidney Diseases2002;40(5):932-9. [MEDLINE: 12407637]SarnakMJ , WangX , GreeneT , GeraldJ , BeckJ , KusekJW , et al. Effect of strict blood pressure control on long-term outcome in the Modification of Diet in Renal Disease (MDRD) study [abstract no: F-P0599]. Journal of the American Society of Nephrology2003;14(Nov):192A. SchluchterMD . Estimating correlation between alternative measures of disease progression in a longitudinal study. Modification of Diet in Renal Disease Study. Statistics in Medicine1990;9(10):1175-88. [MEDLINE: 2247718]Short-term effects of protein intake, blood pressure, and antihypertensive therapy on glomerular filtration rate in the Modification of Diet in Renal Disease Study. Journal of the American Society of Nephrology1996;7(10):2097-109. [MEDLINE: 8915969]StollarC , ScherchL , AdlerS , KusekJ , CaggiulaA . Patterns of patient dietary compliance in the Modification of Diet in Renal Disease (MDRD) study, phase III. [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:609. TangriN , StevensLA , SchmidCH , ZhangYL , BeckGJ , GreeneT , et al. Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney International2011;79(4):471-7. [MEDLINE: 20980977]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]YamamotoME , OlsonMB , StollarC , MDRD Study Group. Effects of weight and Na+ change on blood pressures of hypertensive MDRD study patients [abstract]. Journal of the American Society of Nephrology1995;6(3):408. YoungJA , TerrinN , GreeneT , WangX , BeckG , KusekJ , et al. Asymmetric dimethylarginine and prevalent cardiovascular disease in patients with chronic kidney disease [abstract no: F-PO935]. Journal of the American Society of Nephrology2007;18(Abstracts):308A-9A. YoungJA , TerrinN , WangX , GreenT , BeckG , KusekJ , et al. ADMA and mortality in stage 3-4 chronic kidney disease [abstract no: TH-PO894]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A. ">MDRD 1 1989</a>; <a href="./references#CD001892-bbs2-0012" title="GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. KlahrS . The modification of diet in renal disease study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]">MDRD 2 1989</a>) was treated as two studies. The difference in dietary protein intake between the intervention and control groups was 0.33 ± 0.26 g/kg/day. In the pooled results, the authors found that dietary protein restriction reduced the rate of decline in estimated GFR by only 0.53 mL/min/year (95% CI 0.08 to 0.98). They concluded that though there was a decline in GFR with protein restriction, the magnitude of this effect was relatively weak. This review evaluated changes in GFR but not the number of participants, who died or reached ESKD. The authors pointed out that their results were in keeping with the major findings of the MDRD study, which showed little benefit of protein restriction on the number of participants reaching ESKD or on GFR in participants with GFR below 30 mL/min/1.73 m<sup>2</sup> (<a href="./references#CD001892-bbs2-0012" title="GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. KlahrS . The modification of diet in renal disease study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]">MDRD 2 1989</a>). </p> <p>The use of low protein diets in participants with CKD varies between countries and within countries. Few nephrologists in the USA or Canada prescribe dietary therapy for participants with CKD (<a href="./references#CD001892-bbs2-0065" title="Kalantar-ZadehK , MooreLW , TortoriciAR , ChouJA , St- JulesDE , AounA , et al. North American Experience with low protein diet for non dialysis dependent chronic kidney disease. BMC Nephrology2016;17(1):90. [MEDLINE: 27435088]">Kalantar‐ Zadeh 2016</a>) following the negative results of the MDRD study (<a href="./references#CD001892-bbs2-0011" title="BeckGJ , BergRL , CogginsCH , GassmanJJ , HunsickerLG , SchluchterMD , et al. Design and statistical issues of the Modification of Diet in Renal Disease Trial. The Modification of Diet in Renal Disease Study Group. Controlled Clinical Trials1991;12(5):566-86. [MEDLINE: 1664792]Buckalew VM Jr, BergRL , WangSR , PorushJG , RauchS , SchulmanG . Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. American Journal of Kidney Diseases1996;28(6):811-21. [MEDLINE: 8957032]ChawlaV , WangX , GreeneJ , KusekJW , CollinsAJ , LeveyAS , et al. Dyslipidemia and mortality in chronic kidney disease [abstract no: TH-PO895]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A-2A. ChenJL , LernerD , RuthazerR , Castaneda-SceppaC , LeveyAS . Association of physical activity with mortality in chronic kidney disease. Journal of Nephrology2008;21(2):243-52. [MEDLINE: 18446720]ChenJL , SceppaC , RuthazerR , LeveyAS . Leisure time physical activity status and mortality in chronic kidney disease: preliminary findings from the MDRD study [abstract no: 21]. American Journal of Kidney Diseases2006;47(4):A24. CogginsCH , Breyer LewisJ , CaggiulaAW , CastaldoLS , KlahrS , WangSR . Differences between women and men with chronic renal disease. Nephrology Dialysis Transplantation1998;13(6):1430-7. [MEDLINE: 9641172]CoyneT , OlsonM , BradhamK , GarconM , GregoryP , ScherchL . Dietary satisfaction correlated with adherence in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1301-6. [MEDLINE: 7594127]DennisVW . Decoding the Modification of Diet in Renal Disease Study. Cleveland Clinic Journal of Medicine1994;61(4):254-7. [MEDLINE: 7923742]DolecekTA , OlsonMB , CaggiulaAW , DwyerJT , MilasNC , GillisBP , et al. Registered dietitian time requirements in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1307-12. [MEDLINE: 7594128]Effects of diet and antihypertensive therapy on creatinine clearance and serum creatinine concentration in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Aug;8(8):1354]. Journal of the American Society of Nephrology1996;7(4):556-66. [MEDLINE: 8724889]Effects of dietary protein restriction on the progression of moderate renal disease in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Mar;8(3):493]. Journal of the American Society of Nephrology1996;7(12):2616-26. [MEDLINE: 8989740]GassmanJJ , DrabikMJ , LeathermanJR , FaticaKJ , McPhersonJA , Modification of Diet in Renal Disease Study Group. Development and use of distributed data entry and electronic communication in a multi-center study of progressive renal disease [abstract]. Kidney International1989;35(1):226. GennariFJ , HoodVL , GreeneT , WangX , LeveyAS . Effect of Dietary Protein Intake on Serum Total CO2 Concentration in Chronic Kidney Disease: Modification of Diet in Renal Disease Study Findings. Clinical Journal of the American Society of Nephrology: CJASN2006;1(1):52-7. [MEDLINE: 17699190]GillisBP , AverbachFM , CaggiulaAW , JonesFL , NaujelisJ , MaurerE , et al. Features of the nutrient database and analysis system for the Modification of Diet in Renal Disease Study.[Erratum appears in Control Clin Trials 1994 Aug;15(4):326]. Controlled Clinical Trials1994;15(1):44-58. [MEDLINE: 8149770]GillisBP , CaggiulaAW , ChiavacciAT , CoyneT , DoroshenkoL , MilasNC , et al. Nutrition intervention program of the Modification of Diet in Renal Disease Study: a self-management approach. Journal of the American Dietetic Association1995;95(11):1288-94. [MEDLINE: 7594125]GramsME , CoreshJ , SegevDL , KucirkaLM , TighiouartH , SarnakMJ . Vascular disease, ESRD, and death: interpreting competing risk analyses. Clinical Journal of the American Society of Nephrology: CJASN2012;7(10):1606-14. [MEDLINE: 22859747]GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. GramsME , TinA , RebholzCM , ShafiT , KottgenA , PerroneRD , et al. Metabolomic alterations associated with cause of CKD. Clinical Journal of The American Society of Nephrology: CJASN2017;12(11):1787-94. [MEDLINE: 28971980]GreeneT , BeckG , WangS , KusekJ , LeveyA , Modification of Diet in Renal Disease Study Group. The effect of the low protein diet in the MDRD study A is dependent on the underlying rate of disease progression [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A. GreeneT , BourgoignieJJ , HabweV , KusekJW , SnetselaarLG , SoucieJM , et al. Baseline characteristics in the Modification of Diet in Renal Disease Study.[Republished from J Am Soc Nephrol 1993 May;3(11):1819-34]. Journal of the American Society of Nephrology1993;4(5):1221-36. [MEDLINE: 8305650]HebertLA , GreeneT , HunsickerLG , LeveyAS , WangS , MDRD Study Group. Relationship of urine volume (uv) and urine osmolality (Uosm) to the progression of renal disease in the Modification of Diet in Renal Disease (MDRD) study [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A-6A. HebertLA , KusekJW , GreeneT , AgodoaLY , JonesCA , LeveyAS , et al. Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group. Hypertension1997;30(3 (Pt 1)):428-35. [MEDLINE: 9314428]HunsickerLG , AdlerS , CaggiulaA , EnglandBK , GreeneT , KusekJW , et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney International1997;51(6):1908-19. [MEDLINE: 9186882]HunsickerLG , MDRD Study Group. Secondary analysis of the Modification of Diet in Renal Disease (MDRD) study [abstract]. In: 13th International Congress of Nephrology; 1995 Jul 2-6; Madrid, Spain. 1995:64. IxJH , ShlipakMG , SarnakMJ , BeckGJ , GreeneT , WangX , et al. Fetuin-A is not associated with all-cause or cardiovascular mortality in chronic kidney disease: data from the Modification of Diet in Renal Disease (MDRD) study [abstract no: SU-PO711]. Journal of the American Society of Nephrology2007;18(Abstracts Issue):741A. KlahrS , BreyerJA , BeckGJ , DennisVW , HartmanJA , RothD , et al. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group.[Erratum appears in J Am Soc Nephrol 1995 Oct;6(4):1318]. Journal of the American Society of Nephrology1995;5(12):2037-47. [MEDLINE: 7579052]KlahrS , LeveyAS , BeckGJ , CaggiulaAW , HunsickerL , KusekJW , et al. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. New England Journal of Medicine1994;330(13):877-84. [MEDLINE: 8114857]KlahrS , Modification of Diet in Renal Disease Study. The Modification of Diet in Renal Disease Study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]KlahrS . Primary and secondary results of the modification of diet in renal disease study. Mineral &amp; Electrolyte Metabolism1996;22(1-3):138-42. [MEDLINE: 8676806]KoppleJD , GreeneT , ChumleaWC , HollingerD , MaroniBJ , MerrillD , et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney International2000;57(4):1688-703. [MEDLINE: 10760105]KoppleJD , LeveyAS , GreeneT , ChumleaWC , GassmanJJ , HollingerDL , et al. Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. Kidney International1997;52(3):778-91. [MEDLINE: 9291200]KuE , GliddenDV , JohansenKL , SarnakM , TighiouartH , GrimesB , et al. Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease. Kidney International2015;87(5):1055-60. [MEDLINE: 25493952]KusekJW , CoyneT , deVelascoA , DrabikMJ , FinlayRA , GassmanJJ , et al. Recruitment experience in the full-scale phase of the Modification of Diet in Renal Disease Study. Controlled Clinical Trials1993;14(6):538-57. [MEDLINE: 8119068]KusekJW , CoyneT , deVelascoA , GassmanJ , KieferS , PowersS , et al. Recruitment experience in the full scale phase of the Modification of Diet in Renal Disease (MDRD) Study [abstract]. Controlled Clinical Trials1991;12:678. KwongYT , StevensLA , SelvinE , ZhangYL , GreeneT , Van LenteF , et al. Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. American Journal of Kidney Diseases2010;56(1):39-49. [MEDLINE: 20537455]LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , LeveyAS , MilasNC , et al. Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. Hypertension1997;29(2):641-50. [MEDLINE: 9040451]Leonberg-YooAK , TighiouartH , LeveyAS , BeckGJ , SarnakMJ . Urine potassium excretion, kidney failure, and mortality in CKD. American Journal of Kidney Diseases2017;69(3):341-9. [MEDLINE: 27233381]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , BoschJP , LewisJB , GreeneT , RogersN , RothD , et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of Internal Medicine1999;130(6):461-70. [MEDLINE: 10075613]LeveyAS , CoreshJ , GreeneT , StevensLA , ZhangYL , HendriksenS , et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate.[Erratum appears in Ann Intern Med. 2008 Oct 7;149(7):519]. Annals of Internal Medicine2006;145(4):247-54. [MEDLINE: 16908915]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study Group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]LeveyAS , GreeneT , SarnakM , WangX , BeckGJ , KusekJW , et al. Effect of low protein diet on progression of kidney disease in the Modification of Diet in Renal Disease study A: long-term follow-up [abstract no: SU-PO247]. Journal of the American Society of Nephrology2004;15(Oct):586A-7A. LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2006;48(6):879-88. [MEDLINE: 17162142]LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. The effect of very low protein diet on progression of kidney disease and mortality in Modification of Diet in Renal Disease Study B [abstract no: SU-PO246]. Journal of the American Society of Nephrology2004;15(Oct):586A. LeveyAS , GreeneT , SchluchterMD , ClearyPA , TeschanPE , LorenzRA , et al. Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. Journal of the American Society of Nephrology1993;4(5):1159-71. [MEDLINE: 8305642]MaderoM , SarnakM , WangX , GreeneT , CollinsA , BeckG , et al. Uric acid and development of kidney failure in chronic kidney disease [abstract no: F-PO1932]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):547A. MaderoM , SarnakMJ , WangX , GreeneT , BeckGJ , KusekJW , et al. Uric acid and long-term outcomes in CKD. American Journal of Kidney Diseases2009;53(5):796-803. [MEDLINE: 19303683]MaderoM , SarnakMJ , WangX , SceppaCC , GreeneT , BeckGJ , et al. Body mass index and mortality in CKD. American Journal of Kidney Diseases2007;50(3):404-11. [MEDLINE: 17720519]MaderoM , WangX , GreenT , HunsickerLG , BeckGJ , KusekJW , et al. Effect of trial participation on outcomes in the randomized and non-randomized cohorts of the Modification of Diet in Renal Disease study [abstract no: F-PO037]. Journal of the American Society of Nephrology2006;17(Abstracts):344A. MDRD Study Group, ChumleaWC , GassmanJJ , HollingerDL , MerrillD , ScherchLK , et al. Nutritional response to diet prescription in the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, HunsickerLG , AdlerS , CaggiulaAW , EnglandB , GreeneT , et al. Relationship among baseline proteinuria (p), mean arterial blood pressure (map) during follow-up, and decline in glomerular filtration rate (aGFR) in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, KoppleJD , ChumleaWC , GassmanJJ , HollingerDL , MaroniBJ , et al. Relationship between FGR and nutritional status - results from the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, KusekJW , AgodoaL , GreeneT , JonesC . Comparison of decline of GFR in blacks versus non-blacks in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , BoschJP , CaggiulaAW , GreeneT , et al. Short-term effects of protein intake, blood pressure, and antihypertensive therapy on GFR in the MDRD study. Journal of the American Society of Nephrology1995;6(3):395. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , HunsickerLG , et al. A hypothesis for the results of the Modification of Diet in Renal Disease (MDRD) study. [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , KusekJW , et al. Trends toward a beneficial effect of a low protein diet during additional follow-up in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1994;5(3):336. MDRD Study Group, LeveyAS , BeckGJ . Trends toward a beneficial effect of a low protein diet during additional follow-up in the modification of diet in renal disease study. MDRD Study Group. [abstract]. Nephrology Dialysis Transplantation1995;10(6):985. MDRD Study Group, LeveyAS , BoschJP , CogginsCH , GreeneT , MitchWE , et al. Effects of diet and blood pressure on creatinine clearance (CCr) and serum creatinine (PCr) in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, PetersonJC , BurkartJ , GreeneT , HebertL , KingA , et al. The effect of blood pressure control on progression of renal disease depends on level of proteinuria (p) at baseline evaluation [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, PetersonJC , GreeneT , KlahrS , BurkartJM , HebertL , et al. Effect of reducing proteinuria (PR) on subsequent glomerular filtration rate (GFR) decline in patients with chronic renal failure (CRF) [abstract]. Journal of the American Society of Nephrology1994;5(3):339. MDRD Study Group, PorushJG , LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , et al. Efficacy of anti-hypertensive interventions in reducing blood pressure in the MDRD study [abstract]. Journal of the American Society of Nephrology1995;6(3):400. MDRD Study Group, PowersSN , KurtzmanDA , PetotGJ , RaizmanDJ , WetsteinL . Promoting dietary compliance through computer-assisted education, assessment, and counseling. [abstract]. Kidney International1988;36(Suppl 27):S306. MDRD Study Group, RoccoMV , CoyneT , EastinS , FaubertJ , GassmanJJ , et al. Patient symptoms and quality of life in the MDRD study at enrollment-correlation with GFR [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group. The modification of diet in renal disease study: results from the full-scale trial [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:593. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Hemoglobin A1c and mortality in chronic kidney disease [abstract no: F-FC149]. Journal of the American Society of Nephrology2005;16:71A. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Insulin resistance as a predictor of all-cause and cardiovascular mortality (CVD) in chronic kidney disease (CKD) [abstract no: F-P0284]. Journal of the American Society of Nephrology2004;15(Oct):128A. MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. Journal of the American Society of Nephrology2005;16(11):3411-7. [MEDLINE: 16207824]MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD. American Journal of Kidney Diseases2005;46(3):455-63. [MEDLINE: 16129207]MenonV , GreeneT , WangX , PereiraAA , MarcovinaSM , BeckGJ , et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney International2005;68(2):766-72. [MEDLINE: 16014054]MenonV , GreenT , PereiraA , XueleiW , BeckG , KusekJ , et al. C-reactive protein (CRP) as a predictor of all-cause and cardiovascular (CVD) mortality in patients with chronic kidney disease (CKD) [abstract no: F-P0275]. Journal of the American Society of Nephrology2004;15(Oct):125A-6A. MenonV , KoppleJD , WangX , BeckGJ , CollinsAJ , KusekJW , et al. Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2009;53(2):208-17. [MEDLINE: 18950911]MenonV , LiL , GreeneT , WangX , ChandraP , BalakrishnanV , et al. Adiponectin and outcomes in chronic kidney disease [abstract no: TH-PO430]. Journal of the American Society of Nephrology2006;17(Abstracts):199A. MenonV , LiL , WangX , GreeneT , BalakrishnanV , MaderoM , et al. Adiponectin and mortality in patients with chronic kidney disease. Journal of the American Society of Nephrology2006;17(9):2599-606. [MEDLINE: 16885405]MenonV , SarnakMJ , GreeneT , WangX , PereiraAA , BeckGJ , et al. Relationship between homocysteine and mortality in chronic kidney disease. Circulation2006;113(12):1572-7. [MEDLINE: 16549639]MenonV , ShlipakMG , WangX , CoreshJ , GreeneT , StevensL , et al. Cystatin C as a risk factor for outcomes in chronic kidney disease. Annals of Internal Medicine2007;147(1):19-27. [MEDLINE: 17606957]MenonV , TighiouartH , VaughnNS , BeckGJ , KusekJW , CollinsAJ , et al. Serum bicarbonate and long-term outcomes in CKD. American Journal of Kidney Diseases2010;56(5):907-14. [MEDLINE: 20605301]MenonV , WangX , GreeneT , BeckGJ , KusekJW , MarcovinaSM , et al. Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. American Journal of Kidney Diseases2003;42(1):44-52. [MEDLINE: 12830455]MenonV , WangX , GreeneT , BeckGJ , KusekJW , SelhubJ , et al. Homocysteine in chronic kidney disease: effect of low protein diet and repletion with B vitamins. Kidney International2005;67(4):1539-46. [MEDLINE: 15780109]MenonV , WangX , SarnakMJ , HunsickerLH , MaderoM , BeckGJ , et al. Long-term outcomes in nondiabetic chronic kidney disease. Kidney International2008;73(11):1310-5. [MEDLINE: 18337713]MilasNC , NowalkMP , AkpeleL , CastaldoL , CoyneT , DoroshenkoL , et al. Factors associated with adherence to the dietary protein intervention in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1295-300. [MEDLINE: 7594126]NewsomeB , IxJH , TighiouartH , SarnakMJ , LeveyAS , BeckGJ , et al. Effect of protein restriction on serum and urine phosphate in the modification of diet in renal disease (MDRD) study. American Journal of Kidney Diseases2013;61(6):1045-6. [MEDLINE: 23415016]OlsonM , CoyneT , CaggiulaA , GregoryP . Patient satisfaction with a dietary intervention: the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):107S. OlsonM , CoyneT , CaggiulaA . Social factors influence dietary satisfaction in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1996;17(2 Suppl):133S. OlsonM , DolecekT , CaggiulaA , DwyerJ . Time required for the protein intervention in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):129S-30S. PetersonJC , AdlerS , BurkartJM , GreeneT , HebertLA , HunsickerLG , et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Annals of Internal Medicine1995;123(10):754-62. [MEDLINE: 7574193]PiccoliM , CodognottoM . Missing stratification by polycistic kidney disease (PKD) flaws risk estimates of GFR decline. Lesson from the MDRD Study [abstract no: F-PO175]. Journal of the American Society of Nephrology2004;15(Oct):103A. RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]RoccoMV , GassmanJJ , WangSR , KaplanRM . Cross-sectional study of quality of life and symptoms in chronic renal disease patients: the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1997;29(6):888-96. [MEDLINE: 9186075]SarnakMJ , GreeneT , WangX , BeckG , KusekJW , CollinsAJ , et al. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease study. Annals of Internal Medicine2005;142(5):342-51. [MEDLINE: 15738453]SarnakMJ , WangSR , BeckGJ , KusekJW , SelhubJ , GreeneT , et al. Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression. American Journal of Kidney Diseases2002;40(5):932-9. [MEDLINE: 12407637]SarnakMJ , WangX , GreeneT , GeraldJ , BeckJ , KusekJW , et al. Effect of strict blood pressure control on long-term outcome in the Modification of Diet in Renal Disease (MDRD) study [abstract no: F-P0599]. Journal of the American Society of Nephrology2003;14(Nov):192A. SchluchterMD . Estimating correlation between alternative measures of disease progression in a longitudinal study. Modification of Diet in Renal Disease Study. Statistics in Medicine1990;9(10):1175-88. [MEDLINE: 2247718]Short-term effects of protein intake, blood pressure, and antihypertensive therapy on glomerular filtration rate in the Modification of Diet in Renal Disease Study. Journal of the American Society of Nephrology1996;7(10):2097-109. [MEDLINE: 8915969]StollarC , ScherchL , AdlerS , KusekJ , CaggiulaA . Patterns of patient dietary compliance in the Modification of Diet in Renal Disease (MDRD) study, phase III. [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:609. TangriN , StevensLA , SchmidCH , ZhangYL , BeckGJ , GreeneT , et al. Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney International2011;79(4):471-7. [MEDLINE: 20980977]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]YamamotoME , OlsonMB , StollarC , MDRD Study Group. Effects of weight and Na+ change on blood pressures of hypertensive MDRD study patients [abstract]. Journal of the American Society of Nephrology1995;6(3):408. YoungJA , TerrinN , GreeneT , WangX , BeckG , KusekJ , et al. Asymmetric dimethylarginine and prevalent cardiovascular disease in patients with chronic kidney disease [abstract no: F-PO935]. Journal of the American Society of Nephrology2007;18(Abstracts):308A-9A. YoungJA , TerrinN , WangX , GreenT , BeckG , KusekJ , et al. ADMA and mortality in stage 3-4 chronic kidney disease [abstract no: TH-PO894]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A. ">MDRD 1 1989</a>; <a href="./references#CD001892-bbs2-0012" title="GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. KlahrS . The modification of diet in renal disease study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]">MDRD 2 1989</a>) while low protein diets are more commonly prescribed in Europe (<a href="./references#CD001892-bbs2-0056" title="BellizziV , CupistiA , LocatelliF , BolascoP , BrunoriG , CancariniG , et al. Low-protein diets for chronic kidney disease patients: the Italian experience. BMC Nephrology2016;17(1):77. [MEDLINE: 27401096]">Bellizzi 2016</a>). International (<a href="./references#CD001892-bbs2-0068" title="LevinA , StevensPE , BilousRW , CoreshJ , De FranciscoAL , De JongPE , et al. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney international - Supplement2013;3(1):1-150. [EMBASE: 369856107]">KDIGO 2012</a>) and national guidelines (<a href="./references#CD001892-bbs2-0077" title="WrightM , JonesC . Renal Association clinical practice guideline on nutrition in CKD. Nephron2011;118 Suppl 1:153-64. [MEDLINE: 21555894]">Wright 2011</a>) now recommend protein intakes of 0.75 to 0.8 g/kg/day for adults with GFR ≤ 30 mL/min/ 1.73 m<sup>2</sup>. These recommendations are in line with the recommended daily intake (RDI) for the general population. The average protein intake in adults in developed countries is approximately twice the RDI so guidelines suggest that participants with excess protein intakes reduce their intake to RDI levels since a high protein intake may accelerate the decline of kidney function in CKD (<a href="./references#CD001892-bbs2-0068" title="LevinA , StevensPE , BilousRW , CoreshJ , De FranciscoAL , De JongPE , et al. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney international - Supplement2013;3(1):1-150. [EMBASE: 369856107]">KDIGO 2012</a>; <a href="./references#CD001892-bbs2-0064" title="JohnsonDW , AtaiE , ChanM , PoonRK , ScottC , ToussaintND , et al. KHA-CARI Guideline: Early chronic kidney disease: Detection, prevention and management. Nephrology2013;18(5):340-50. [MEDLINE: 23506545]">Johnson 2013</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD001892-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/urn:x-wiley:14651858:media:CD001892:CD001892-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD001892-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_n/nCD001892-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_t/tCD001892-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/full#CD001892-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_n/nCD001892-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001892-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/urn:x-wiley:14651858:media:CD001892:CD001892-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD001892-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_n/nCD001892-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_t/tCD001892-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/full#CD001892-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_n/nCD001892-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001892-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/urn:x-wiley:14651858:media:CD001892:CD001892-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD001892-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_n/nCD001892-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_t/tCD001892-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/full#CD001892-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_n/nCD001892-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001892-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/urn:x-wiley:14651858:media:CD001892:CD001892-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Low protein diet versus normal protein diet, Outcome 1: Death (all causes)" data-id="CD001892-fig-0004" src="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_n/nCD001892-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_t/tCD001892-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Low protein diet versus normal protein diet, Outcome 1: Death (all causes)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/references#CD001892-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_n/nCD001892-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001892-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/urn:x-wiley:14651858:media:CD001892:CD001892-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Low protein diet versus normal protein diet, Outcome 2: ESKD" data-id="CD001892-fig-0005" src="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_n/nCD001892-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_t/tCD001892-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Low protein diet versus normal protein diet, Outcome 2: ESKD</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/references#CD001892-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_n/nCD001892-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001892-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/urn:x-wiley:14651858:media:CD001892:CD001892-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Low protein diet versus normal protein diet, Outcome 3: End or change in GFR" data-id="CD001892-fig-0006" src="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_n/nCD001892-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_t/tCD001892-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Low protein diet versus normal protein diet, Outcome 3: End or change in GFR </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/references#CD001892-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_n/nCD001892-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001892-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/urn:x-wiley:14651858:media:CD001892:CD001892-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Very low protein diet versus low or normal protein diet, Outcome 1: Death (all causes)" data-id="CD001892-fig-0007" src="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_n/nCD001892-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_t/tCD001892-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Very low protein diet versus low or normal protein diet, Outcome 1: Death (all causes) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/references#CD001892-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_n/nCD001892-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001892-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/urn:x-wiley:14651858:media:CD001892:CD001892-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Very low protein diet versus low or normal protein diet, Outcome 2: ESKD" data-id="CD001892-fig-0008" src="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_n/nCD001892-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_t/tCD001892-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Very low protein diet versus low or normal protein diet, Outcome 2: ESKD </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/references#CD001892-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_n/nCD001892-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001892-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/urn:x-wiley:14651858:media:CD001892:CD001892-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Very low protein diet versus low or normal protein diet, Outcome 3: End or change in GFR" data-id="CD001892-fig-0009" src="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_n/nCD001892-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_t/tCD001892-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Very low protein diet versus low or normal protein diet, Outcome 3: End or change in GFR </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/references#CD001892-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_n/nCD001892-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001892-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/urn:x-wiley:14651858:media:CD001892:CD001892-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Nutritional measures, Outcome 1: Final body weight" data-id="CD001892-fig-0010" src="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_n/nCD001892-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_t/tCD001892-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Nutritional measures, Outcome 1: Final body weight</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/references#CD001892-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_n/nCD001892-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001892-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/urn:x-wiley:14651858:media:CD001892:CD001892-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Nutritional measures, Outcome 2: Protein energy wasting" data-id="CD001892-fig-0011" src="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_n/nCD001892-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_t/tCD001892-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Nutritional measures, Outcome 2: Protein energy wasting</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/references#CD001892-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/media/CDSR/CD001892/image_n/nCD001892-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD001892-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Low protein diet versus normal protein diet for non‐diabetic adults with chronic kidney disease (CKD)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Low protein diet versus normal protein diet for non‐diabetic adults with CKD</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> non‐diabetic adults with CKD<br/><b>Setting:</b> all settings<br/><b>Intervention:</b> low protein diet<br/><b>Comparison:</b> normal protein diet </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with normal protein diet</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with low protein diet</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Death (all causes)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>55 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>42 per 1,000<br/>(28 to 65) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.77<br/>(0.51 to 1.18) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1680 (5)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ESKD</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>144 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>151 per 1,000<br/>(105 to 220) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.05<br/>(0.73 to 1.53) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1814 (6)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>End or change in GFR</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>The SMD for end or change in GFR was 0.18 lower (0.75 lower to 0.38 higher) with low protein diet compared to normal protein diet </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1680 (8)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>ESKD:</b> end‐stage kidney disease; <b>GFR:</b> glomerular filtration rate; <b>SMD</b> ‐ standardised mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> The confidence intervals include potential for important benefits and harms </p> <p><sup>2</sup> Important and unexplained heterogeneity present </p> <p><sup>3</sup> The outcome reported is a surrogate outcome </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Low protein diet versus normal protein diet for non‐diabetic adults with chronic kidney disease (CKD)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/full#CD001892-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001892-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Very low protein diet versus low or normal protein diet for non‐diabetic adults with chronic kidney disease (CKD)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Very low protein diet versus low or normal protein diet for non‐diabetic adults with CKD</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> non‐diabetic adults with CKD<br/><b>Setting:</b> all settings<br/><b>Intervention:</b> Very low protein diet<br/><b>Comparison:</b> low or normal protein diet </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with low or normal protein diet</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with very low protein diet</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Death (all causes)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>39 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>49 per 1,000<br/>(24 to 99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.26<br/>(0.62 to 2.54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>681 (6)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ESKD</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>458 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>293 per 1,000<br/>(225 to 389) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.64<br/>(0.49 to 0.85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1010 (10)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>End or change in GFR</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>The SMD for end or change in GFR was 0.12 (0.27 lower to 0.52 higher) with very low protein diet compared to low or normal protein diet </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>456 (6)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2 3 4</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>ESKD:</b> end‐stage kidney disease; <b>GFR:</b> glomerular filtration rate; <b>SMD</b> ‐ standardised mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> The confidence intervals are wide and include potential for important benefits and harms </p> <p><sup>2</sup> Serious unexplained heterogeneity </p> <p><sup>3</sup> Outcome is a surrogate outcome </p> <p><sup>4</sup> Unclear allocation concealment in 4 studies contributing information to analysis </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Very low protein diet versus low or normal protein diet for non‐diabetic adults with chronic kidney disease (CKD)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/full#CD001892-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001892-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Nutritional measures for non‐diabetic adults with chronic kidney disease (CKD)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Nutritional measures for non‐diabetic adults with CKD</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> non‐diabetic adults with CKD<br/><b>Setting:</b> all settings<br/><b>Intervention:</b> very low of low protein diet<br/><b>Comparison:</b> normal or low protein diet </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with normal or low protein diet</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with very low or low protein diet</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Final body weight: low protein versus normal protein diet</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>The mean final body weight 3.09 kg lower (5.02 to 1.16 lower) with low protein diet compared to normal protein diet </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>223 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Final body weight: very low protein diet versus low protein diet</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>The mean final body weight 1.4 kg higher (3.40 lower to 6.21 higher) with very low protein diet compared to low protein diet </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>291 (4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>3 4</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Protein energy wasting (malnutrition)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>6 per 1,000<br/>(2 to 17) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.31<br/>(0.42 to 4.13) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2373 (15)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Increased risk of bias related to incomplete outcome data and selective reporting </p> <p><sup>2</sup> Small studies and wide confidence intervals and include potential for important benefits and harms </p> <p><sup>3</sup> 3/4 studies are unclear for allocation concealment and random sequence generation </p> <p><sup>4</sup> Serious unexplained heterogeneity </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Nutritional measures for non‐diabetic adults with chronic kidney disease (CKD)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/full#CD001892-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001892-tbl-0004"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Prescribed versus calculated differences in protein intake in studies comparing low with normal or free protein diets</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Difference in prescribed protein intake</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Difference in actual protein intake</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Difference between prescribed and actual protein intake</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0005" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 1 1990</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.4 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.12 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.28 g/kg/day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0001" title="AlvestrandA , BuchtH , GutierrezA , BergströmJ . Progression of chronic renal failure in man as influenced by frequency and quality of clinical follow-ups [abstract]. Kidney International1985;27(1):240. BergstromJ , AlvestrandA , BuchtH , GutierrezA . Progression of chronic renal failure in man is retarded with more frequent clinical follow-ups and better blood pressure control. Clinical Nephrology1986;25(1):1-6. [MEDLINE: 3955903]BergstromJ , AlvestrandA , BuchtH , GutierrezA . Stockholm clinical study on progression of chronic renal failure--an interim report. Kidney International - Supplement1989;36(Suppl 27):S110-4. [MEDLINE: 2636644]BergstromJ , AlvestrandA , BuchtH , GutierrezA . What is the role of controls in an outpatient department on progression of renal disease?Blood Purification1988;6(6):336-42. [MEDLINE: 3061400]">Bergstrom 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.45 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.21 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.24 g/kg/day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0003" title="CianciarusoB , PotaA , BellizziV , Di GiuseppeD , Di MiccoL , MinutoloR , et al. Effect of a low- versus moderate-protein diet on progression of CKD: follow-up of a randomized controlled trial. American Journal of Kidney Diseases2009;54(6):1052-61. [MEDLINE: 19800722]CianciarusoB , PotaA , PisaniA , TorracaS , AnnecchiniR , LombardiP , et al. Metabolic effects of two low protein diets in chronic kidney disease stage 4-5--a randomized controlled trial. Nephrology Dialysis Transplantation2008;23(2):636-44. [MEDLINE: 17981885]CianciarusoB , PotaA , TorracaS , SommaG , NazzaroP , AnnecchiniR , et al. Comparison of two different protein intakes (0.3-0.6 vs 0.7-0.9 g/kg/day) on the metabolic control of advanced renal failure [abstract no: MP197]. In: 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal. 2004:295. PotaA , PisaniA , AnnecchiniR , Di GiuseppeD , CuccurulloP , CaputoDL , et al. Treatment of chronic renal failure (CRF) with two different low protein diets. Effects on the metabolic control and on the cardiovascular risk factors [abstract no: MP306]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv401. PotaA , PisaniA , RavaniP , Di MiccoL , Di GiuseppeD , SabbatiniM , et al. Impact of two different low protein diets on survival of CKD patients (stage4-5) [abstract no: TH-PO880]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):308A. ">Cianciaruso 2008a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.25 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.17 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.08 g/kg/day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0002" title="ChauveauP , LebkiriB , PloyardF , CiancioniC , ManNK , JungersP . Effect of keto analogs of essential amino acids on the progress of advanced renal insufficiency: controlled prospective study [Effet des cetoanalogues des acides amines essentiels sur la progression de l'insuffisance renale chronique avancee: etude prospective controlee]. Nephrologie1986;7(5):137-42. [MEDLINE: 3796783]JungersP , ChauveauP , PloyardF , LebkiriB , CiancioniC , ManNK . Comparison of ketoacids and low protein diet on advanced chronic renal failure progression. Kidney International - Supplement1987;22:S67-71. [MEDLINE: 3323621]">Chauveau 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.2 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.2 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 g/kg/day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0009" title="D'AmicoG , GentileMG , FellinG , MannaG , CofanoF . Effect of dietary protein restriction on the progression of renal failure: a prospective randomized trial. Nephrology Dialysis Transplantation1994;9(11):1590-4. [MEDLINE: 7870348]LocatelliF , AlbertiD , GentileMG , GrazianiG , BucciantiG , CosciP , et al. Effects of two different protein prescriptions on chronic renal failure progression. Cooperative study. [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:20. LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA , et al. Blood pressure and chronic renal failure progression: results from a multicentre trial [abstract]. Nephrology Dialysis Transplantation1992;7(7):712. LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA , et al. Factors affecting chronic renal failure progression: results from a multicentre trial. The Northern Italian Cooperative Study Group. Mineral &amp; Electrolyte Metabolism1992;18(2-5):295-302. [MEDLINE: 1465079]LocatelliF , AlbertiD , GrazianiG , BucciantiG , RedaelliB , GiangrandeA . Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group. Lancet1991;337(8753):1299-304. [MEDLINE: 1674294]LocatelliF , Del VecchioL , AndrulliS , MaraiP , TentoriF . The role of underlying nephropathy in the progression of renal disease. Kidney International - Supplement2000;75:S49-55. [MEDLINE: 10828762]LocatelliF , MarcelliD , et al. Factors affecting the progression of chronic renal failure: a multivariate analysis [abstract]. Nephrology Dialysis Transplantation1989;4(5):457. LocatelliF , MarcelliD , TentoriF , MaraiP . Hypertension and progression of chronic renal failure (CRF): a prospective study [abstract]. In: 11th International Congress of Nephrology; 1990 Jul 15-20; Tokyo, Japan. 1990:37A. LocatelliF . Controlled study of protein-restricted diet in chronic renal failure. Contributions to Nephrology1989;75:141-6. [MEDLINE: 2697498]LocatelliF . Dietary compliance in patients with chronic renal failure: experience in a northern Italy trial. Contributions to Nephrology1990;81:102-6. [MEDLINE: 2093485]TentoriF , MaraiP , MarcelliD , PontiR , LocatelliF . Monocentric prospective randomized controlled study on the progression rate of chronic renal failure (CRF) with two different protein intakes [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:20. TentoriF , MaraiP . Monocentric prospective randomised controlled study on the progression rate of chronic renal failure with two different protein intakes [abstract]. Nephrology Dialysis Transplantation1987;2(5):400-1. ">Locatelli 1989</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.4 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.18 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.22 g/kg/day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0013" title="CogginsCH , DwyerJT , GreeneT , PetotG , SnetselaarLG , Van LenteF , et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):514-23. [MEDLINE: 8154486]KlahrS , LeveyAS , SandbergAM , WilliamsGW , MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International1989;35(1):195. KoppleJD , BergR , HouserH , SteinmanTI , TeschanP . Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S184-94. [MEDLINE: 2636655]LaidlawSA , BergRL , KoppleJD , NaitoH , WalkerWG , WalserM . Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):504-13. [MEDLINE: 8154485]LeveyAS , BergRL , GassmanJJ , HallPM , WalkerWG . Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S73-80. [MEDLINE: 2636677]LeveyAS , GassmanJJ , HallPM , WalkerWG , MDRD Study Group. Poor correlation of rates of change of creatinine clearance, reciprocal serum creatinine and GFR [abstract]. Kidney International1989;35(1):197. LeveyAS , GassmanJJ , HallPM , WalkerWG . Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. Journal of the American Society of Nephrology1991;1(9):1087-94. [MEDLINE: 1912407]MDRD Study Group, MitchME , SteinmanTI . Objectives and design of the cooperative study, Modification of Diet in Renal Disease [abstract]. Kidney International1987;31(1):210. PerroneR , SteinmanT , RoyalH , LawlorM , HunsickerL , Modification of Diet in Renal Disease Study Group. Markers of GFR: comparison of 99TC-DTPA (TC), 169YB-DTPA (YB) and 125I-Iothalamate (IO) to inulin (IN) [abstract]. Kidney International1987;31(1):213. PerroneRD , SteinmanTI , BeckGJ , SkibinskiCI , RoyalHD , LawlorM , et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1990;16(3):224-35. [MEDLINE: 2205098]TeschanPE , BeckGJ , DwyerJT , GreeneT , KlahrS , LevyAS , et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clinical Nephrology1998;50(5):273-83. [MEDLINE: 9840314]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]">MDRD Feasibility A 1989</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.625 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.19 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.435 g/kg/day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0011" title="BeckGJ , BergRL , CogginsCH , GassmanJJ , HunsickerLG , SchluchterMD , et al. Design and statistical issues of the Modification of Diet in Renal Disease Trial. The Modification of Diet in Renal Disease Study Group. Controlled Clinical Trials1991;12(5):566-86. [MEDLINE: 1664792]Buckalew VM Jr, BergRL , WangSR , PorushJG , RauchS , SchulmanG . Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. American Journal of Kidney Diseases1996;28(6):811-21. [MEDLINE: 8957032]ChawlaV , WangX , GreeneJ , KusekJW , CollinsAJ , LeveyAS , et al. Dyslipidemia and mortality in chronic kidney disease [abstract no: TH-PO895]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A-2A. ChenJL , LernerD , RuthazerR , Castaneda-SceppaC , LeveyAS . Association of physical activity with mortality in chronic kidney disease. Journal of Nephrology2008;21(2):243-52. [MEDLINE: 18446720]ChenJL , SceppaC , RuthazerR , LeveyAS . Leisure time physical activity status and mortality in chronic kidney disease: preliminary findings from the MDRD study [abstract no: 21]. American Journal of Kidney Diseases2006;47(4):A24. CogginsCH , Breyer LewisJ , CaggiulaAW , CastaldoLS , KlahrS , WangSR . Differences between women and men with chronic renal disease. Nephrology Dialysis Transplantation1998;13(6):1430-7. [MEDLINE: 9641172]CoyneT , OlsonM , BradhamK , GarconM , GregoryP , ScherchL . Dietary satisfaction correlated with adherence in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1301-6. [MEDLINE: 7594127]DennisVW . Decoding the Modification of Diet in Renal Disease Study. Cleveland Clinic Journal of Medicine1994;61(4):254-7. [MEDLINE: 7923742]DolecekTA , OlsonMB , CaggiulaAW , DwyerJT , MilasNC , GillisBP , et al. Registered dietitian time requirements in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1307-12. [MEDLINE: 7594128]Effects of diet and antihypertensive therapy on creatinine clearance and serum creatinine concentration in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Aug;8(8):1354]. Journal of the American Society of Nephrology1996;7(4):556-66. [MEDLINE: 8724889]Effects of dietary protein restriction on the progression of moderate renal disease in the Modification of Diet in Renal Disease Study.[Erratum appears in J Am Soc Nephrol 1997 Mar;8(3):493]. Journal of the American Society of Nephrology1996;7(12):2616-26. [MEDLINE: 8989740]GassmanJJ , DrabikMJ , LeathermanJR , FaticaKJ , McPhersonJA , Modification of Diet in Renal Disease Study Group. Development and use of distributed data entry and electronic communication in a multi-center study of progressive renal disease [abstract]. Kidney International1989;35(1):226. GennariFJ , HoodVL , GreeneT , WangX , LeveyAS . Effect of Dietary Protein Intake on Serum Total CO2 Concentration in Chronic Kidney Disease: Modification of Diet in Renal Disease Study Findings. Clinical Journal of the American Society of Nephrology: CJASN2006;1(1):52-7. [MEDLINE: 17699190]GillisBP , AverbachFM , CaggiulaAW , JonesFL , NaujelisJ , MaurerE , et al. Features of the nutrient database and analysis system for the Modification of Diet in Renal Disease Study.[Erratum appears in Control Clin Trials 1994 Aug;15(4):326]. Controlled Clinical Trials1994;15(1):44-58. [MEDLINE: 8149770]GillisBP , CaggiulaAW , ChiavacciAT , CoyneT , DoroshenkoL , MilasNC , et al. Nutrition intervention program of the Modification of Diet in Renal Disease Study: a self-management approach. Journal of the American Dietetic Association1995;95(11):1288-94. [MEDLINE: 7594125]GramsME , CoreshJ , SegevDL , KucirkaLM , TighiouartH , SarnakMJ . Vascular disease, ESRD, and death: interpreting competing risk analyses. Clinical Journal of the American Society of Nephrology: CJASN2012;7(10):1606-14. [MEDLINE: 22859747]GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. GramsME , TinA , RebholzCM , ShafiT , KottgenA , PerroneRD , et al. Metabolomic alterations associated with cause of CKD. Clinical Journal of The American Society of Nephrology: CJASN2017;12(11):1787-94. [MEDLINE: 28971980]GreeneT , BeckG , WangS , KusekJ , LeveyA , Modification of Diet in Renal Disease Study Group. The effect of the low protein diet in the MDRD study A is dependent on the underlying rate of disease progression [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A. GreeneT , BourgoignieJJ , HabweV , KusekJW , SnetselaarLG , SoucieJM , et al. Baseline characteristics in the Modification of Diet in Renal Disease Study.[Republished from J Am Soc Nephrol 1993 May;3(11):1819-34]. Journal of the American Society of Nephrology1993;4(5):1221-36. [MEDLINE: 8305650]HebertLA , GreeneT , HunsickerLG , LeveyAS , WangS , MDRD Study Group. Relationship of urine volume (uv) and urine osmolality (Uosm) to the progression of renal disease in the Modification of Diet in Renal Disease (MDRD) study [abstract]. Journal of the American Society of Nephrology1999;10(Program &amp; Abstracts):165A-6A. HebertLA , KusekJW , GreeneT , AgodoaLY , JonesCA , LeveyAS , et al. Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group. Hypertension1997;30(3 (Pt 1)):428-35. [MEDLINE: 9314428]HunsickerLG , AdlerS , CaggiulaA , EnglandBK , GreeneT , KusekJW , et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney International1997;51(6):1908-19. [MEDLINE: 9186882]HunsickerLG , MDRD Study Group. Secondary analysis of the Modification of Diet in Renal Disease (MDRD) study [abstract]. In: 13th International Congress of Nephrology; 1995 Jul 2-6; Madrid, Spain. 1995:64. IxJH , ShlipakMG , SarnakMJ , BeckGJ , GreeneT , WangX , et al. Fetuin-A is not associated with all-cause or cardiovascular mortality in chronic kidney disease: data from the Modification of Diet in Renal Disease (MDRD) study [abstract no: SU-PO711]. Journal of the American Society of Nephrology2007;18(Abstracts Issue):741A. KlahrS , BreyerJA , BeckGJ , DennisVW , HartmanJA , RothD , et al. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group.[Erratum appears in J Am Soc Nephrol 1995 Oct;6(4):1318]. Journal of the American Society of Nephrology1995;5(12):2037-47. [MEDLINE: 7579052]KlahrS , LeveyAS , BeckGJ , CaggiulaAW , HunsickerL , KusekJW , et al. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. New England Journal of Medicine1994;330(13):877-84. [MEDLINE: 8114857]KlahrS , Modification of Diet in Renal Disease Study. The Modification of Diet in Renal Disease Study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]KlahrS . Primary and secondary results of the modification of diet in renal disease study. Mineral &amp; Electrolyte Metabolism1996;22(1-3):138-42. [MEDLINE: 8676806]KoppleJD , GreeneT , ChumleaWC , HollingerD , MaroniBJ , MerrillD , et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney International2000;57(4):1688-703. [MEDLINE: 10760105]KoppleJD , LeveyAS , GreeneT , ChumleaWC , GassmanJJ , HollingerDL , et al. Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. Kidney International1997;52(3):778-91. [MEDLINE: 9291200]KuE , GliddenDV , JohansenKL , SarnakM , TighiouartH , GrimesB , et al. Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease. Kidney International2015;87(5):1055-60. [MEDLINE: 25493952]KusekJW , CoyneT , deVelascoA , DrabikMJ , FinlayRA , GassmanJJ , et al. Recruitment experience in the full-scale phase of the Modification of Diet in Renal Disease Study. Controlled Clinical Trials1993;14(6):538-57. [MEDLINE: 8119068]KusekJW , CoyneT , deVelascoA , GassmanJ , KieferS , PowersS , et al. Recruitment experience in the full scale phase of the Modification of Diet in Renal Disease (MDRD) Study [abstract]. Controlled Clinical Trials1991;12:678. KwongYT , StevensLA , SelvinE , ZhangYL , GreeneT , Van LenteF , et al. Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. American Journal of Kidney Diseases2010;56(1):39-49. [MEDLINE: 20537455]LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , LeveyAS , MilasNC , et al. Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. Hypertension1997;29(2):641-50. [MEDLINE: 9040451]Leonberg-YooAK , TighiouartH , LeveyAS , BeckGJ , SarnakMJ . Urine potassium excretion, kidney failure, and mortality in CKD. American Journal of Kidney Diseases2017;69(3):341-9. [MEDLINE: 27233381]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , BoschJP , LewisJB , GreeneT , RogersN , RothD , et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of Internal Medicine1999;130(6):461-70. [MEDLINE: 10075613]LeveyAS , CoreshJ , GreeneT , StevensLA , ZhangYL , HendriksenS , et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate.[Erratum appears in Ann Intern Med. 2008 Oct 7;149(7):519]. Annals of Internal Medicine2006;145(4):247-54. [MEDLINE: 16908915]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study Group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]LeveyAS , GreeneT , SarnakM , WangX , BeckGJ , KusekJW , et al. Effect of low protein diet on progression of kidney disease in the Modification of Diet in Renal Disease study A: long-term follow-up [abstract no: SU-PO247]. Journal of the American Society of Nephrology2004;15(Oct):586A-7A. LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2006;48(6):879-88. [MEDLINE: 17162142]LeveyAS , GreeneT , SarnakMJ , WangX , BeckGJ , KusekJW , et al. The effect of very low protein diet on progression of kidney disease and mortality in Modification of Diet in Renal Disease Study B [abstract no: SU-PO246]. Journal of the American Society of Nephrology2004;15(Oct):586A. LeveyAS , GreeneT , SchluchterMD , ClearyPA , TeschanPE , LorenzRA , et al. Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. Journal of the American Society of Nephrology1993;4(5):1159-71. [MEDLINE: 8305642]MaderoM , SarnakM , WangX , GreeneT , CollinsA , BeckG , et al. Uric acid and development of kidney failure in chronic kidney disease [abstract no: F-PO1932]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):547A. MaderoM , SarnakMJ , WangX , GreeneT , BeckGJ , KusekJW , et al. Uric acid and long-term outcomes in CKD. American Journal of Kidney Diseases2009;53(5):796-803. [MEDLINE: 19303683]MaderoM , SarnakMJ , WangX , SceppaCC , GreeneT , BeckGJ , et al. Body mass index and mortality in CKD. American Journal of Kidney Diseases2007;50(3):404-11. [MEDLINE: 17720519]MaderoM , WangX , GreenT , HunsickerLG , BeckGJ , KusekJW , et al. Effect of trial participation on outcomes in the randomized and non-randomized cohorts of the Modification of Diet in Renal Disease study [abstract no: F-PO037]. Journal of the American Society of Nephrology2006;17(Abstracts):344A. MDRD Study Group, ChumleaWC , GassmanJJ , HollingerDL , MerrillD , ScherchLK , et al. Nutritional response to diet prescription in the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, HunsickerLG , AdlerS , CaggiulaAW , EnglandB , GreeneT , et al. Relationship among baseline proteinuria (p), mean arterial blood pressure (map) during follow-up, and decline in glomerular filtration rate (aGFR) in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, KoppleJD , ChumleaWC , GassmanJJ , HollingerDL , MaroniBJ , et al. Relationship between FGR and nutritional status - results from the MDRD study [abstract]. Journal of the American Society of Nephrology1994;5(3):335. MDRD Study Group, KusekJW , AgodoaL , GreeneT , JonesC . Comparison of decline of GFR in blacks versus non-blacks in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , BoschJP , CaggiulaAW , GreeneT , et al. Short-term effects of protein intake, blood pressure, and antihypertensive therapy on GFR in the MDRD study. Journal of the American Society of Nephrology1995;6(3):395. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , HunsickerLG , et al. A hypothesis for the results of the Modification of Diet in Renal Disease (MDRD) study. [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, LeveyAS , BeckGJ , CaggiulaAW , GreeneT , KusekJW , et al. Trends toward a beneficial effect of a low protein diet during additional follow-up in the Modification of Diet in Renal Disease study [abstract]. Journal of the American Society of Nephrology1994;5(3):336. MDRD Study Group, LeveyAS , BeckGJ . Trends toward a beneficial effect of a low protein diet during additional follow-up in the modification of diet in renal disease study. MDRD Study Group. [abstract]. Nephrology Dialysis Transplantation1995;10(6):985. MDRD Study Group, LeveyAS , BoschJP , CogginsCH , GreeneT , MitchWE , et al. Effects of diet and blood pressure on creatinine clearance (CCr) and serum creatinine (PCr) in the MDRD study [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):253. MDRD Study Group, PetersonJC , BurkartJ , GreeneT , HebertL , KingA , et al. The effect of blood pressure control on progression of renal disease depends on level of proteinuria (p) at baseline evaluation [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group, PetersonJC , GreeneT , KlahrS , BurkartJM , HebertL , et al. Effect of reducing proteinuria (PR) on subsequent glomerular filtration rate (GFR) decline in patients with chronic renal failure (CRF) [abstract]. Journal of the American Society of Nephrology1994;5(3):339. MDRD Study Group, PorushJG , LazarusJM , BourgoignieJJ , BuckalewVM , GreeneT , et al. Efficacy of anti-hypertensive interventions in reducing blood pressure in the MDRD study [abstract]. Journal of the American Society of Nephrology1995;6(3):400. MDRD Study Group, PowersSN , KurtzmanDA , PetotGJ , RaizmanDJ , WetsteinL . Promoting dietary compliance through computer-assisted education, assessment, and counseling. [abstract]. Kidney International1988;36(Suppl 27):S306. MDRD Study Group, RoccoMV , CoyneT , EastinS , FaubertJ , GassmanJJ , et al. Patient symptoms and quality of life in the MDRD study at enrollment-correlation with GFR [abstract]. Journal of the American Society of Nephrology1993;4(Program &amp; Abstracts):254. MDRD Study Group. The modification of diet in renal disease study: results from the full-scale trial [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:593. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Hemoglobin A1c and mortality in chronic kidney disease [abstract no: F-FC149]. Journal of the American Society of Nephrology2005;16:71A. MenonV , GreeneT , PereiraA , WangX , BeckG , KusekJ , et al. Insulin resistance as a predictor of all-cause and cardiovascular mortality (CVD) in chronic kidney disease (CKD) [abstract no: F-P0284]. Journal of the American Society of Nephrology2004;15(Oct):128A. MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. Journal of the American Society of Nephrology2005;16(11):3411-7. [MEDLINE: 16207824]MenonV , GreeneT , PereiraAA , WangX , BeckGJ , KusekJW , et al. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD. American Journal of Kidney Diseases2005;46(3):455-63. [MEDLINE: 16129207]MenonV , GreeneT , WangX , PereiraAA , MarcovinaSM , BeckGJ , et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney International2005;68(2):766-72. [MEDLINE: 16014054]MenonV , GreenT , PereiraA , XueleiW , BeckG , KusekJ , et al. C-reactive protein (CRP) as a predictor of all-cause and cardiovascular (CVD) mortality in patients with chronic kidney disease (CKD) [abstract no: F-P0275]. Journal of the American Society of Nephrology2004;15(Oct):125A-6A. MenonV , KoppleJD , WangX , BeckGJ , CollinsAJ , KusekJW , et al. Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. American Journal of Kidney Diseases2009;53(2):208-17. [MEDLINE: 18950911]MenonV , LiL , GreeneT , WangX , ChandraP , BalakrishnanV , et al. Adiponectin and outcomes in chronic kidney disease [abstract no: TH-PO430]. Journal of the American Society of Nephrology2006;17(Abstracts):199A. MenonV , LiL , WangX , GreeneT , BalakrishnanV , MaderoM , et al. Adiponectin and mortality in patients with chronic kidney disease. Journal of the American Society of Nephrology2006;17(9):2599-606. [MEDLINE: 16885405]MenonV , SarnakMJ , GreeneT , WangX , PereiraAA , BeckGJ , et al. Relationship between homocysteine and mortality in chronic kidney disease. Circulation2006;113(12):1572-7. [MEDLINE: 16549639]MenonV , ShlipakMG , WangX , CoreshJ , GreeneT , StevensL , et al. Cystatin C as a risk factor for outcomes in chronic kidney disease. Annals of Internal Medicine2007;147(1):19-27. [MEDLINE: 17606957]MenonV , TighiouartH , VaughnNS , BeckGJ , KusekJW , CollinsAJ , et al. Serum bicarbonate and long-term outcomes in CKD. American Journal of Kidney Diseases2010;56(5):907-14. [MEDLINE: 20605301]MenonV , WangX , GreeneT , BeckGJ , KusekJW , MarcovinaSM , et al. Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. American Journal of Kidney Diseases2003;42(1):44-52. [MEDLINE: 12830455]MenonV , WangX , GreeneT , BeckGJ , KusekJW , SelhubJ , et al. Homocysteine in chronic kidney disease: effect of low protein diet and repletion with B vitamins. Kidney International2005;67(4):1539-46. [MEDLINE: 15780109]MenonV , WangX , SarnakMJ , HunsickerLH , MaderoM , BeckGJ , et al. Long-term outcomes in nondiabetic chronic kidney disease. Kidney International2008;73(11):1310-5. [MEDLINE: 18337713]MilasNC , NowalkMP , AkpeleL , CastaldoL , CoyneT , DoroshenkoL , et al. Factors associated with adherence to the dietary protein intervention in the Modification of Diet in Renal Disease Study. Journal of the American Dietetic Association1995;95(11):1295-300. [MEDLINE: 7594126]NewsomeB , IxJH , TighiouartH , SarnakMJ , LeveyAS , BeckGJ , et al. Effect of protein restriction on serum and urine phosphate in the modification of diet in renal disease (MDRD) study. American Journal of Kidney Diseases2013;61(6):1045-6. [MEDLINE: 23415016]OlsonM , CoyneT , CaggiulaA , GregoryP . Patient satisfaction with a dietary intervention: the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):107S. OlsonM , CoyneT , CaggiulaA . Social factors influence dietary satisfaction in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1996;17(2 Suppl):133S. OlsonM , DolecekT , CaggiulaA , DwyerJ . Time required for the protein intervention in the Modification of Diet in Renal Disease Study [abstract]. Controlled Clinical Trials1995;16(3 Suppl):129S-30S. PetersonJC , AdlerS , BurkartJM , GreeneT , HebertLA , HunsickerLG , et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Annals of Internal Medicine1995;123(10):754-62. [MEDLINE: 7574193]PiccoliM , CodognottoM . Missing stratification by polycistic kidney disease (PKD) flaws risk estimates of GFR decline. Lesson from the MDRD Study [abstract no: F-PO175]. Journal of the American Society of Nephrology2004;15(Oct):103A. RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]RoccoMV , GassmanJJ , WangSR , KaplanRM . Cross-sectional study of quality of life and symptoms in chronic renal disease patients: the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1997;29(6):888-96. [MEDLINE: 9186075]SarnakMJ , GreeneT , WangX , BeckG , KusekJW , CollinsAJ , et al. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease study. Annals of Internal Medicine2005;142(5):342-51. [MEDLINE: 15738453]SarnakMJ , WangSR , BeckGJ , KusekJW , SelhubJ , GreeneT , et al. Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression. American Journal of Kidney Diseases2002;40(5):932-9. [MEDLINE: 12407637]SarnakMJ , WangX , GreeneT , GeraldJ , BeckJ , KusekJW , et al. Effect of strict blood pressure control on long-term outcome in the Modification of Diet in Renal Disease (MDRD) study [abstract no: F-P0599]. Journal of the American Society of Nephrology2003;14(Nov):192A. SchluchterMD . Estimating correlation between alternative measures of disease progression in a longitudinal study. Modification of Diet in Renal Disease Study. Statistics in Medicine1990;9(10):1175-88. [MEDLINE: 2247718]Short-term effects of protein intake, blood pressure, and antihypertensive therapy on glomerular filtration rate in the Modification of Diet in Renal Disease Study. Journal of the American Society of Nephrology1996;7(10):2097-109. [MEDLINE: 8915969]StollarC , ScherchL , AdlerS , KusekJ , CaggiulaA . Patterns of patient dietary compliance in the Modification of Diet in Renal Disease (MDRD) study, phase III. [abstract]. In: 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:609. TangriN , StevensLA , SchmidCH , ZhangYL , BeckGJ , GreeneT , et al. Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney International2011;79(4):471-7. [MEDLINE: 20980977]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]YamamotoME , OlsonMB , StollarC , MDRD Study Group. Effects of weight and Na+ change on blood pressures of hypertensive MDRD study patients [abstract]. Journal of the American Society of Nephrology1995;6(3):408. YoungJA , TerrinN , GreeneT , WangX , BeckG , KusekJ , et al. Asymmetric dimethylarginine and prevalent cardiovascular disease in patients with chronic kidney disease [abstract no: F-PO935]. Journal of the American Society of Nephrology2007;18(Abstracts):308A-9A. YoungJA , TerrinN , WangX , GreenT , BeckG , KusekJ , et al. ADMA and mortality in stage 3-4 chronic kidney disease [abstract no: TH-PO894]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):311A. ">MDRD 1 1989</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.72 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.4 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.32 g/kg/day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0015" title="MeloniC , TatangeloP , CiprianiS , RossiV , SuraciC , TozzoC , et al. Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure. Journal of Renal Nutrition2004;14(4):208-13. [MEDLINE: 15483780]">Meloni 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.4 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.87 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.47 g/kg/day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0021" title="WilliamsP , StevensME , FassG , BoneJM . A randomised trial of the effect of protein and phosphate restriction on the progression of chronic renal failure [abstract]. In: 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK. 1987:38. WilliamsPS , StevensM , FassG , BoneJM . A randomised trial of the effect of protein and phosphate restriction on the progression of chronic renal failure [abstract]. Nephrology Dialysis Transplantation1987;2(4):285. WilliamsPS , StevensM , IronsL , FassG , BoneJM . Failure of  dietary protein/phosphate restriction to slow the progression of chronic renal failure; a prospective randomised controlled trial [abstract]. Nephrology Dialysis Transplantation1990;5(8):674. WilliamsPS , StevensME , FassG , IronsL , BoneJM . Failure of dietary protein and phosphate restriction to retard the rate of progression of chronic renal failure: a prospective, randomized, controlled trial. Quarterly Journal of Medicine1991;81(294):837-55. [MEDLINE: 1801057]WilliamsPS , StevensME . A randomised trial of the effect of protein and phosphate restriction on the progression of chronic renal failure [abstract]. Nephrology Dialysis Transplantation1987;2(5):401. ">Williams 1991</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.4 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.45 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.05 g/kg/day</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Prescribed versus calculated differences in protein intake in studies comparing low with normal or free protein diets</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/full#CD001892-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001892-tbl-0005"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Prescribed versus calculated differences in protein intake in studies comparing very low with low protein diets</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Difference in prescribed protein intake</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Difference in actual protein intake</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0006" title="European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. An interim analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1992;98:133-41. [MEDLINE: 1493725]European Study Group for the Conservative Management of Chronic Renal Failure. Dietary compliance in the trial of the European Study Group. A preliminary analysis. European Study Group for the Conservative Management of Chronic Renal Failure. Contributions to Nephrology1990;81:61-70. [MEDLINE: 2093513]">ESGCMCRF 2 1990</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.21 g/kg/day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0004" title="Di IorioBR , BellizziV , MinutoloR , De NicolaL , IodiceC , ConteG . Supplemented very low-protein diet in advanced CRF: is it money saving?Kidney International2004;65(2):742. [MEDLINE: 14717953]Di IorioBR , MinutoloR , De NicolaL , BellizziV , CatapanoF , IodiceC , et al. Supplemented very low protein diet ameliorates responsiveness to erythropoietin in chronic renal failure. Kidney International2003;64(5):1822-8. [MEDLINE: 14717953]">Di Iorio 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.29 g/kg/day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0007" title="GarneataL , MircescuG . Effect of low-protein diet supplemented with keto acids on progression of chronic kidney disease. Journal of Renal Nutrition2013;23(3):210-3. [MEDLINE: 23611549]GarneataL , MocanuE , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues-effects on mineral bone metabolism disorders in advanced chronic kidney disease [abstract no: FP396]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i167-8. [EMBASE: 622605156]GarneataL , StancuA , DragomirD , MircescuG . Effect of very low protein diet supplemented with ketoanalogues of the essential amino acids on the progression of chronic kidney disease [abstract]. Nephrology Dialysis Transplantation2014;29(Suppl 3):iii39. [EMBASE: 71491557]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression. Journal of the American Society of Nephrology2016;27(7):2164-76. [MEDLINE: 26823552]GarneataL , StancuA , DragomirD , StefanG , MircescuG . Vegetarian very low protein diet supplemented with ketoanalogues in stage 5 CKD patients [abstract no: SP373]. Nephrology Dialysis Transplantation2018;33(Suppl 1):i472. [EMBASE: 622606118]">Garneata 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.29 g/kg/day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0010" title="MalvyD , MaingourdC , PengloanJ , BagrosP , NivetH . Effects of severe protein restriction with ketoanalogues in advanced renal failure. Journal of the American College of Nutrition1999;18(5):481-6. [MEDLINE: 10511331]NivetH , MaingourdC , MalvyD , PengloanJ , BagrosPH . Effects of severe protein-restriction with ketoanalogues in advanced renal failure [abstract]. Journal of the American Society of Nephrology1992;3(3):286. ">Malvy 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.21 g/kg/day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0014" title="CogginsCH , DwyerJT , GreeneT , PetotG , SnetselaarLG , Van LenteF , et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):514-23. [MEDLINE: 8154486]KlahrS , LeveyAS , SandbergAM , WilliamsGW , MDRD Study Group. Major results of the feasibility study of the Modification of Diet in Renal Disease (MDRD) study [abstract]. Kidney International1989;35(1):195. KoppleJD , BergR , HouserH , SteinmanTI , TeschanP . Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S184-94. [MEDLINE: 2636655]LaidlawSA , BergRL , KoppleJD , NaitoH , WalkerWG , WalserM . Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1994;23(4):504-13. [MEDLINE: 8154485]LeveyAS , BergRL , GassmanJJ , HallPM , WalkerWG . Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney International - Supplement1989;27:S73-80. [MEDLINE: 2636677]LeveyAS , GassmanJJ , HallPM , WalkerWG , Modification of Diet in Renal Disease Study. Poor correlation of rates of change of creatinine clearance, reciprocal serum creatinine and GFR [abstract]. Kidney International1989;35(1):197. LeveyAS , GassmanJJ , HallPM , WalkerWG . Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. Journal of the American Society of Nephrology1991;1(9):1087-94. [MEDLINE: 1912407]MDRD Study Group, MitchME , SteinmanTI . Objectives and design of the cooperative study, Modification of Diet in Renal Disease [abstract]. Kidney International1987;31(1):210. PerroneR , SteinmanT , RoyalH , LawlorM , HunsickerL , Modification of Diet in Renal Disease Study Group. Markers of GFR: comparison of 99TC-DTPA (TC), 169YB-DTPA (YB) and 125I-Iothalamate (IO) to inulin (IN) [abstract]. Kidney International1987;31(1):213. PerroneRD , SteinmanTI , BeckGJ , SkibinskiCI , RoyalHD , LawlorM , et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1990;16(3):224-35. [MEDLINE: 2205098]TeschanPE , BeckGJ , DwyerJT , GreeneT , KlahrS , LevyAS , et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clinical Nephrology1998;50(5):273-83. [MEDLINE: 9840314]The Modification of Diet in Renal Disease Study: design, methods, and results from the feasibility study. American Journal of Kidney Diseases1992;20(1):18-33. [MEDLINE: 1621675]">MDRD Feasibility B 1989</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.295 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.22 g/kg/day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0012" title="GramsME , TighiouartH , CoreshJ , SarnakMJ . Vascular disease-associated mortality during CKD progression: the MDRD study [abstract no: TH-PO332]. Journal of the American Society of Nephrology2011;22(Abstract Suppl):189A. KlahrS . The modification of diet in renal disease study. New England Journal of Medicine1989;320(13):864-6. [MEDLINE: 2494456]LeveyAS , AdlerS , CaggiulaAW , EnglandBK , GreeneT , HunsickerLG , et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. American Journal of Kidney Diseases1996;27(5):652-63. [MEDLINE: 8629624]LeveyAS , GreeneT , BeckGJ , CaggiulaAW , KusekJW , HunsickerLG , et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. Journal of the American Society of Nephrology1999;10(11):2426-39. [MEDLINE: 10541304]RebholzCM , ZhengZ , GramsME , AppelLJ , SarnakMJ , InkerLA , et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. American Journal of Clinical Nutrition2019;109(3):517-25. [MEDLINE: 30753252]">MDRD 2 1989</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3 g/kg/day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001892-bbs2-0017" title="MircescuG , GarneataL , StancuSH , CapusaC . Effects of a supplemented hypoproteic diet in chronic kidney disease. Journal of Renal Nutrition2007;17(3):179-88. [MEDLINE: 17462550]">Mircescu 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3 g/kg/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.27 g/kg/day</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Prescribed versus calculated differences in protein intake in studies comparing very low with low protein diets</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/full#CD001892-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001892-tbl-0006"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Final body weight in participants in MDRD studies 1 and 2</span></div> <tbody> <tr> <td align="" class="headercell" colspan="1" rowspan="3" valign=""></td> <th align="center" class="headercell" colspan="4" rowspan="1" scope="col" valign=""> <p><b>MDRD Study 1</b> </p> </th> <th align="center" class="headercell" colspan="4" rowspan="1" scope="col" valign=""> <p><b>MDRD Study 2</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign=""> <p><b>Usual protein diet</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign=""> <p><b>Low protein diet</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign=""> <p><b>Low protein diet</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign=""> <p><b>Very low protein diet</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Final body weight (kg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Final body weight (kg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Final body weight (kg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Final body weight (kg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Men</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>88.5 ± 14.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>179 to 183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83.2 ± 12.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>165 to 170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79.6 ± 11.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74 to 77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79.3 ± 10.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69 to 71</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Women</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72.2 ± 14.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98 to 105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69.3 ± 13.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>107 to 115</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65.9 ± 11.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49 to 51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65.0 ± 14.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49 to 52</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Final body weight in participants in MDRD studies 1 and 2</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/full#CD001892-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001892-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Low protein diet versus normal protein diet</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Death (all causes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1680</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.51, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 ESKD <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1814</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.73, 1.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 End or change in GFR <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1680</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.18 [‐0.75, 0.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Low protein diet versus normal protein diet</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/references#CD001892-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001892-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Very low protein diet versus low or normal protein diet</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Death (all causes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>681</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.62, 2.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 ESKD <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.49, 0.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 End or change in GFR <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>456</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [‐0.27, 0.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Very low protein diet versus low or normal protein diet</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/references#CD001892-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001892-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Nutritional measures</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Final body weight <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>514</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.46 [‐3.93, 3.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.1 Low protein versus normal protein diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>223</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.09 [‐5.02, ‐1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.2 Very low protein diet versus low protein diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>291</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.40 [‐3.40, 6.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Protein energy wasting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2373</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [0.42, 4.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Nutritional measures</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001892.pub5/references#CD001892-tbl-0009">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD001892.pub5&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD001892-note-0006">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD001892-note-0016">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD001892-note-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD001892-note-0014">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD001892-note-0012">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD001892-note-0011">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD001892-note-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD001892-note-0015">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD001892-note-0009">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD001892-note-0007">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD001892-note-0008">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001892\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001892\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001892\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001892\x2epub5"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001892\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001892\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001892\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001892\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001892\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001892\x2epub5"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001892\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001892\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001892\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001892\x2epub5"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001892\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001892\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001892\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001892\x2epub5"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=mvgXlmVk&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001892.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001892.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD001892.pub5/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD001892.pub5/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001892.pub5%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740719743528"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001892.pub5/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740719743532"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001892.pub5/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918df0308a9a9371',t:'MTc0MDcxOTc0My4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 